Sentence,class,file
http://dx.doi.org/10.1212/WNL.0b013e31826170b622815555 .,Non-OADS,/arxiv_data1/oa_pdf/8b/4e/main.PMC4536304.pdf
"Neurology 78 (1), 03.115. http://dx.doi.org/10.1212/WNL.78.1_ MeetingAbstracts.P03.115 .",Non-OADS,/arxiv_data1/oa_pdf/8b/4e/main.PMC4536304.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/8b/4e/main.PMC4536304.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/8b/4e/main.PMC4536304.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/8b/4e/main.PMC4536304.pdf
http://dx.doi.org/10.1177/10738584010070041011488399 .,Non-OADS,/arxiv_data1/oa_pdf/8b/4e/main.PMC4536304.pdf
http://dx.doi.org/10.1007/ s10143-014-0527-924497269 .,Non-OADS,/arxiv_data1/oa_pdf/8b/4e/main.PMC4536304.pdf
http://dx.doi.org/10.1159/ 00036557525358872 .,Non-OADS,/arxiv_data1/oa_pdf/8b/4e/main.PMC4536304.pdf
"Biometrika 80 (1), 27–38.http://dx.doi.org/10.1093/biomet/80.1.27 .",Non-OADS,/arxiv_data1/oa_pdf/8b/4e/main.PMC4536304.pdf
http://dx.doi.org/10.1016/j.neuroimage.2011.07.06821835245 .,OADS,/arxiv_data1/oa_pdf/8b/4e/main.PMC4536304.pdf
http://dx.doi.org/10.1016/j.neuron.2014.10.04725569345 .,OADS,/arxiv_data1/oa_pdf/8b/4e/main.PMC4536304.pdf
"Test 12 (1), 1 –77.http://dx.doi.org/10.1007/BF02595811 .",Non-OADS,/arxiv_data1/oa_pdf/8b/4e/main.PMC4536304.pdf
http://dx.doi.org/10.1007/ s00234-012-1121-x23223825 .,Non-OADS,/arxiv_data1/oa_pdf/8b/4e/main.PMC4536304.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/8b/4e/main.PMC4536304.pdf
http://dx.doi.org/ 10.1111/j.1528-1167.2007.01485.x18177358 .,Non-OADS,/arxiv_data1/oa_pdf/8b/4e/main.PMC4536304.pdf
http://dx.doi.org/10.1111/j.1528-1167.2011.03278.,Non-OADS,/arxiv_data1/oa_pdf/8b/4e/main.PMC4536304.pdf
"4, 31. http://dx.doi.org/10.3389/fneur.2013.0003123565107 .",Non-OADS,/arxiv_data1/oa_pdf/8b/4e/main.PMC4536304.pdf
http://dx.doi.org/10.1016/j.neuroimage.,OADS,/arxiv_data1/oa_pdf/8b/4e/main.PMC4536304.pdf
http://dx.doi.org/10.1016/j.yebeh.2011.08.01921962756 .,OADS,/arxiv_data1/oa_pdf/8b/4e/main.PMC4536304.pdf
http://dx.doi.org/10.1001/archneur.58.6.93311405808 .,Non-OADS,/arxiv_data1/oa_pdf/8b/4e/main.PMC4536304.pdf
http://dx.doi.org/ 10.1111/j.1528-1157.1991.tb04671.x2044503 .,Non-OADS,/arxiv_data1/oa_pdf/8b/4e/main.PMC4536304.pdf
http://dx.doi.org/10.1111/j.1528-1157.2000.,Non-OADS,/arxiv_data1/oa_pdf/8b/4e/main.PMC4536304.pdf
http://dx.doi.org/10.1093/cercor/bhl10917088374 .,Non-OADS,/arxiv_data1/oa_pdf/8b/4e/main.PMC4536304.pdf
http://dx.doi.org/10.1111/j.1528-1167.2011.,Non-OADS,/arxiv_data1/oa_pdf/8b/4e/main.PMC4536304.pdf
http://dx.doi.org/10.1001/archneur.57.5.,Non-OADS,/arxiv_data1/oa_pdf/8b/4e/main.PMC4536304.pdf
"3 (2), 74 –82.http://dx.doi.org/10.1002/(SICI)1097-0150(1998)3:2 b74:: AID-IGS4 N3.0.CO;2-H9784955 .",Non-OADS,/arxiv_data1/oa_pdf/8b/4e/main.PMC4536304.pdf
http://dx.doi.org/10.1109/TBME.2005.85423316189970 .,Non-OADS,/arxiv_data1/oa_pdf/8b/4e/main.PMC4536304.pdf
http://dx.doi.org/10.1158/ 0008-5472.CAN-11-394322710433 .,Non-OADS,/arxiv_data1/oa_pdf/8b/4e/main.PMC4536304.pdf
http://dx.doi.org/10.1016/j.jns.2014.09.02925300772 .,OADS,/arxiv_data1/oa_pdf/8b/4e/main.PMC4536304.pdf
http://dx.doi.org/10.1111/j.1528-1167.2009.02481.,Non-OADS,/arxiv_data1/oa_pdf/8b/4e/main.PMC4536304.pdf
"Epilepsia 38 (1), 74 –80.http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/8b/4e/main.PMC4536304.pdf
Health 249 –271http://dx.doi.org/ 10.1007/0-387-29362-0_15 .,Non-OADS,/arxiv_data1/oa_pdf/8b/4e/main.PMC4536304.pdf
http://dx.doi.org/10.1371/journal.pone.010421125089698 .,Non-OADS,/arxiv_data1/oa_pdf/8b/4e/main.PMC4536304.pdf
http://dx.doi.org/10.1111/epi.1272125041176 .,Non-OADS,/arxiv_data1/oa_pdf/8b/4e/main.PMC4536304.pdf
"36 (1), 85 –98.http://dx.doi.org/10.1002/hbm.2261425137314 .",Non-OADS,/arxiv_data1/oa_pdf/8b/4e/main.PMC4536304.pdf
http://dx.doi.org/10.1007/s12149-012-0573-822311414 .,Non-OADS,/arxiv_data1/oa_pdf/8b/4e/main.PMC4536304.pdf
http://dx.doi.org/10.1212/WNL.42.2.4161736176 .,Non-OADS,/arxiv_data1/oa_pdf/8b/4e/main.PMC4536304.pdf
http://dx.doi.org/10.1016/j.yebeh.2011.06.02221798813 .,OADS,/arxiv_data1/oa_pdf/8b/4e/main.PMC4536304.pdf
http://dx.doi.org/10.1093/ bioinformatics/btl11716595560 .,Non-OADS,/arxiv_data1/oa_pdf/8b/4e/main.PMC4536304.pdf
"2012, 630853. http://dx.doi.org/10.1155/ 2012/63085322957234 .",Non-OADS,/arxiv_data1/oa_pdf/8b/4e/main.PMC4536304.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8b/4e/main.PMC4536304.pdf
"http://dx.doi.org/10.1046/j.1528-1157.2001.080874.x11207796 .Thivard, L., Bouilleret, V., Chassoux, F., Adam, C., Dormont, D., Baulac, M., Semah, F., Dupont, S., 2011.",Non-OADS,/arxiv_data1/oa_pdf/8b/4e/main.PMC4536304.pdf
"97 (1 –2), 170– 182. http://dx.doi.org/10.1016/j.eplepsyres.",OADS,/arxiv_data1/oa_pdf/8b/4e/main.PMC4536304.pdf
http://dx.doi.org/10.1016/j.eplepsyres.2004.08.,OADS,/arxiv_data1/oa_pdf/8b/4e/main.PMC4536304.pdf
http://dx.doi.org/10.1111/j.1528-1167.2007.01254.,Non-OADS,/arxiv_data1/oa_pdf/8b/4e/main.PMC4536304.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/8b/4e/main.PMC4536304.pdf
http://dx.doi.org/ 10.1006/nimg.2000.060610913319 .,OADS,/arxiv_data1/oa_pdf/8b/4e/main.PMC4536304.pdf
"106 (1 –2), 155– 163. http://dx.doi.org/10.1016/j.eplepsyres.2013.05.",Non-OADS,/arxiv_data1/oa_pdf/8b/4e/main.PMC4536304.pdf
http://dx.doi.org/10.3978/j.issn.2223-4292.2015.02.0325853085 .,Non-OADS,/arxiv_data1/oa_pdf/8b/4e/main.PMC4536304.pdf
"41, 91 –97.http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/8b/4e/main.PMC4536304.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
http://dx.doi.org/10.1016/j.nicl.2015.07.003 2213-1582/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
Theequations to calculate each of these measures can be found in Rubinov and Sporns [48] ( https://sites.google.com/site/bctnet/ measures/list ).,OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
http://dx.doi.org/10.1016/0092-8674(93)90585- E8458085 .,OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
http://dx.doi.org/10.1016/S1474-4422(09)70170-X19646924 .,OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
http://dx.doi.org/10.1212/WNL.0b013e31826e9a5d23035064 .,Non-OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
"36 (1), 50 –66.http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
http://dx.doi.org/10.1016/S0006-3495(94)80775- 18130344 .,OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
http://dx.doi.org/10.1148/ radiology.201.3.89392098939209 .,Non-OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
http://dx.doi.org/10.1007/978-1-61737-992-5_621279600 .,Non-OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
http://dx.doi.org/10.1002/mrm.2292421469191 .,Non-OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
http://dx.doi.org/10.3174/ajnr.A212820488902 .,Non-OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
http://dx.doi.org/10.1007/s11682-011-9121- 821437574 .,Non-OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
http://dx.doi.org/10.1016/j.nicl.2012.12.00124179770 .,OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
http://dx.doi.org/10.1371/journal.pone.010967625340651 .,Non-OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
http://dx.doi.org/10.1007/s00415-009-0086-019267169 .,Non-OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
http://dx.doi.org/10.1016/j.expneurol.2008.12.02619320010 .,OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
http://dx.doi.org/10.1136/jnnp.,OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
http://dx.doi.org/10.1016/j.neuroimage.2014.06.,OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
http://dx.doi.org/10.1523/JNEUROSCI.0141-08.200818448652 .,Non-OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
http://dx.doi.org/10.1371/journal.pcbi.100010018584043 .41 O.F.F.,Non-OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
http://dx.doi.org/ 10.1523/JNEUROSCI.4136-10.201021159959 .,Non-OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
http://dx.doi.org/10.1212/WNL.0b013e31828c2ee523486876 .,Non-OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
http://dx.doi.org/10.3233/JAD-13054223948936 .,Non-OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
http://dx.doi.org/10.1093/ brain/awp08919439423 .,Non-OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
"219 (1), 193– 209. http://dx.doi.org/10.1007/s00429- 012-0494-223232826 .",Non-OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
http://dx.doi.org/10.1523/ JNEUROSCI.1929-08.200818784304 .,Non-OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
"LancetN e u r o l .1 0( 1 ) ,3 1 –42.http://dx.doi.org/10.1016/S1474-4422(10)70276- 321130037.",Non-OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
http://dx.doi.org/10.1111/j.1399-0004.2004.00241.,Non-OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
http://dx.doi.org/10.1002/ana.,Non-OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
http://dx.doi.org/10.1080/ 13803395.2010.54122821302170 .,Non-OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
http://dx.doi.org/10.1002/hbm.,Non-OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
http://dx.doi.org/10.1016/j.neuroimage.,OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
http://dx.doi.org/10.1002/mrm.2516524687400 .,Non-OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
http://dx.doi.org/10.1002/hbm.2103221319270 .,Non-OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
"Neuroimage 86, 67 –80.http://dx.doi.org/10.1016/ j.neuroimage.2013.07.06723927905 .",OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
http://dx.doi.org/10.1006/nimg.2001.097811771995 .,Non-OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
http://dx.doi.org/10.1109/TMI.2009.203561619923044 .,Non-OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
http://dx.doi.org/ 10.1016/j.neuroimage.2013.03.01523523807 .,OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
http://dx.doi.org/10.1371/journal.pcbi.,Non-OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
http://dx.doi.org/10.1371/journal.pone.,Non-OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
"12, 28. http://dx.doi.org/10.1186/ 1471-2377-12-2822632066 .",Non-OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
"87 (19), 198701. http://dx.doi.org/10.1103/PhysRevLett.87.19870111690461 .",Non-OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
http://dx.doi.org/10.1385/NI:2:2:14515319512 .,Non-OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
"71 (6 Pt 2), 065103. http://dx.doi.org/10.1103/PhysRevE.71.06510316089800 .",Non-OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
http://dx.doi.org/10.1016/j.socnet.2009.02.002 .,OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
http://dx.doi.org/10.1126/science.106510311988575 .,Non-OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
http://dx.doi.org/10.1038/309189623998 .,Non-OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
http://dx.doi.org/ 10.1371/journal.pone.000205118446219 .,Non-OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
http://dx.doi.org/10.1177/107385840629318217079517 .,Non-OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
http://dx.doi.org/10.1016/0378-8733(78)90021-7 .,OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
http://dx.doi.org/10.1016/j.pneurobio.2004.03.,OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
"Neuropsychologia 46 (8), 2152– 2160. http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
"Cortex 7 (1), 18 –30.http://dx.doi.org/ 10.1093/cercor/7.1.189023429 .",Non-OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
"16 (1), 17 –42.http://dx.doi.org/10.1007/s11065-006-9002- x16794878 .",Non-OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
http://dx.doi.org/10.1016/j.expneurol.2012.06.,OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
http://dx.doi.org/10.1016/j.cortex.2013.05.,OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
"Psychiatry 2, 77. http://dx.doi.org/10.3389/fpsyt.2011.0007722291664 .",Non-OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
http://dx.doi.org/10.1016/j.neuroimage.,OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
http://dx.doi.org/10.1093/brain/awp08119369489 .,Non-OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
http://dx.doi.org/10.1016/ j.neuroimage.2013.02.05823501047 .,OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
http://dx.doi.org/10.1016/j.brainresbull.2010.04.00320385209 .,OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
http://dx.doi.org/10.1089/brain.2014.031325490902 .,Non-OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
http://dx.doi.org/10.1523/JNEUROSCI.,OADS,/arxiv_data1/oa_pdf/e2/ab/main.PMC4536305.pdf
Article and publication date are online at http://www.genesdev.org/cgi/doi/10.1101/gad.262998.115.© 2015 Kwon et al.,Non-OADS,/arxiv_data1/oa_pdf/3e/56/1587.PMC4536306.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-is-sue publication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/3e/56/1587.PMC4536306.pdf
"After six months, it is available under a Creative Commons Li- cense (Attribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/3e/56/1587.PMC4536306.pdf
"Results and Discussion Siz2 sumoylates recombination proteins in response to zeocin To investigate the mechanism of DNA break-induced sumoylation, we chose the SUMO ligase Siz2 as a model enzyme and examined cells after treatment with zeocin [Keywords : homologous recombination; DNA damage response; protein sumoylation; DNA break resection]Corresponding author: zhaox1@mskcc.org Article is online at http://www.genesdev.org/cgi/doi/10.1101/gad.265058.",OADS,/arxiv_data1/oa_pdf/41/b7/1593.PMC4536307.pdf
"115.© 2015 Chung and Zhao This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).After six months, it is available under a Creative Commons License (Attri- bution-NonCommercial 4.0 International), as described at http:// creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/41/b7/1593.PMC4536307.pdf
"Corresponding authors: yoonjehyun@gmail.com, shohng@snu.ac.kr Article is online at http://www.genesdev.org/cgi/doi/10.1101/gad.263749.",Non-OADS,/arxiv_data1/oa_pdf/fb/a8/1599.PMC4536308.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publi-cation date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/fb/a8/1599.PMC4536308.pdf
Article and publication date areonline at http://www.genesdev.org/cgi/doi/10.1101/gad.263574.115.© 2015 Lee et al.,OADS,/arxiv_data1/oa_pdf/bd/27/1605.PMC4536309.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue pub-lication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/bd/27/1605.PMC4536309.pdf
"Af-ter six months, it is available under a Creative Commons License(Attribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/bd/27/1605.PMC4536309.pdf
(http://www.targetscan.org) and miRanda (http://www.,Non-OADS,/arxiv_data1/oa_pdf/bd/27/1605.PMC4536309.pdf
"Before mapping the raw small RNA sequencing reads on the reference genome, the quality of the reads was eval- uated by FastQC (http://www.bioinformatics.babraham.ac.uk/ projects/fastqc), and attached adaptor sequences at the 3 ′ends were removed by in-house PERL script.",OADS,/arxiv_data1/oa_pdf/bd/27/1605.PMC4536309.pdf
Adapter-trimmed smallRNA reads were then mapped on the reference genome mm10 downloaded from the University of California at Santa Cruz ge- nome browser (http://genome.ucsc.edu) by Burrows-Wheeler Aligner (http://bio-bwa.sourceforge.net) software with default options.,OADS,/arxiv_data1/oa_pdf/bd/27/1605.PMC4536309.pdf
The measurement of cross-section areas (CSAs) was performed using NIH ImageJ software (http://rsb.info.nih.gov/ij).,OADS,/arxiv_data1/oa_pdf/bd/27/1605.PMC4536309.pdf
"Finally, several co-receptors and modulators of VEGFC/VEGFR3 signalingplay crucial roles in lymphangiogenesis (for review, see Corresponding author: b.hogan@imb.uq.edu.au Article is online at http://www.genesdev.org/cgi/doi/10.1101/gad.263210.115.© 2015 Koltowska et al.",Non-OADS,/arxiv_data1/oa_pdf/ab/77/1618.PMC4536310.pdf
"This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).After six months, it is available under a Creative Commons License (At-tribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/ab/77/1618.PMC4536310.pdf
Article and publication date areonline at http://www.genesdev.org/cgi/doi/10.1101/gad.262642.115.© 2015 Rodriguez-Barrueco et al.,Non-OADS,/arxiv_data1/oa_pdf/57/c5/1631.PMC4536311.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after thefull-issue publication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/57/c5/1631.PMC4536311.pdf
"After six months, it is available under a Creative CommonsLicense (Attribution-NonCommercial 4.0 International), as described athttp://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/57/c5/1631.PMC4536311.pdf
"To further completeour preclinical studies, seven different orthotopically in-jected cell lines in NOD scid mice representing the four subtypes, a patient-derived HR −/HER2+xenograft, and a transgenic HER2+breast cancer mouse model, FVB-Tg (MMTV-Erbb2)NK1Mul/J (http://jaxmice.jax.org/strain/005038.html), were treated with ruxolitinib .",Non-OADS,/arxiv_data1/oa_pdf/57/c5/1631.PMC4536311.pdf
Article and publication date areonline at http://www.genesdev.org/cgi/doi/10.1101/gad.267104.115.© 2015 Yoshida et al.,OADS,/arxiv_data1/oa_pdf/18/0f/1649.PMC4536312.pdf
"This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).After six months, it is available under a Creative Commons License (At-tribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/18/0f/1649.PMC4536312.pdf
All SAXS data were analyzed with the software appli- cations embedded in the ATSAS package (http://www.embl- hamburg.de/biosaxs/software.html).,OADS,/arxiv_data1/oa_pdf/18/0f/1649.PMC4536312.pdf
Inactivation of SMC during growth in rich medium leads to the ac-cumulation of unresolved origins and a lethal defect in Corresponding author: rudner@hms.harvard.edu Article is online at http://www.genesdev.org/cgi/doi/10.1101/gad.265876.115.© 2015 Wang et al.,Non-OADS,/arxiv_data1/oa_pdf/37/30/1661.PMC4536313.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publi-cation date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/37/30/1661.PMC4536313.pdf
"Aftersix months, it is available under a Creative Commons License (At-tribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/37/30/1661.PMC4536313.pdf
Accession numbers All sequence data reported in this study have been deposited at Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo)with accession number GSE68418.,Non-OADS,/arxiv_data1/oa_pdf/37/30/1661.PMC4536313.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.051524.115.,OADS,/arxiv_data1/oa_pdf/62/f7/1532.PMC4536315.pdf
"This article, published in RNA , is available under a Creative Commons License (Attribution-NonCommercial 4.0 Internation-al), as described at http://creativecommons.org/licenses/by-nc/4.0/.REPORT 1532 RNA 21:1532 –1543; Published by Cold Spring Harbor Laboratory Press for the RNA Society",Non-OADS,/arxiv_data1/oa_pdf/62/f7/1532.PMC4536315.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.052324.115.© 2015 Cornes et al.,OADS,/arxiv_data1/oa_pdf/eb/f7/1544.PMC4536316.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/eb/f7/1544.PMC4536316.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.REPORT 1544 RNA 21:1544 –1553; Published by Cold Spring Harbor Laboratory Press for the RNA Society",Non-OADS,/arxiv_data1/oa_pdf/eb/f7/1544.PMC4536316.pdf
http://www.wormbook.org.,Non-OADS,/arxiv_data1/oa_pdf/eb/f7/1544.PMC4536316.pdf
http://www.wormbook.org.,Non-OADS,/arxiv_data1/oa_pdf/eb/f7/1544.PMC4536316.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.052944.115.© 2015 Lu et al.,OADS,/arxiv_data1/oa_pdf/12/c7/1554.PMC4536317.pdf
"After 12 months, it is availableunder a Creative Commons License (Attribution-NonCommercial 4.0 Inter-national), as described at http://creativecommons.org/licenses/by-nc/4.0/.REPORT 1554 RNA 21:1554 –1565; Published by Cold Spring Harbor Laboratory Press for the RNA Society",Non-OADS,/arxiv_data1/oa_pdf/12/c7/1554.PMC4536317.pdf
"The modified program used for findingjunction-spanning reads, Vicinal v3.0, is available at https://sites.google.com/site/zhipeng0426/programming.",Non-OADS,/arxiv_data1/oa_pdf/12/c7/1554.PMC4536317.pdf
"2011), http://intermine.modencode.org/query/experiment.do?experiment= Small+RNABiology and biotechnology of circular tRNA introns www.rnajournal.org 1561",OADS,/arxiv_data1/oa_pdf/12/c7/1554.PMC4536317.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.049007.114.© 2015 Fagerlund et al.,OADS,/arxiv_data1/oa_pdf/da/f3/1591.PMC4536320.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/da/f3/1591.PMC4536320.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/da/f3/1591.PMC4536320.pdf
coefficient of Pop1 (1.11 × 105M−1cm−1) was calculated using ExPASy ProtParam tool (http://www.expasy.org); measurement er-rors were estimated to be <5%.,OADS,/arxiv_data1/oa_pdf/da/f3/1591.PMC4536320.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.048876.114.© 2015 Manzano et al.,OADS,/arxiv_data1/oa_pdf/da/9d/1606.PMC4536321.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/da/9d/1606.PMC4536321.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/da/9d/1606.PMC4536321.pdf
"The predicted mature miR-142-3p/ −1 se- quences are invariant across vertebrates (http://genome.ucsc .edu/), but less conserved portions of the pri-miRNA couldlead to differences in isomiR expression.",Non-OADS,/arxiv_data1/oa_pdf/da/9d/1606.PMC4536321.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.052076.115.© 2015 Bonneau et al.,OADS,/arxiv_data1/oa_pdf/a1/16/1621.PMC4536322.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/a1/16/1621.PMC4536322.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/a1/16/1621.PMC4536322.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.052449.115.© 2015 He and Jacobson This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http:// rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/a7/64/1633.PMC4536323.pdf
"After 12 months, it is availableunder a Creative Commons License (Attribution-NonCommercial 4.0 Inter-national), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/a7/64/1633.PMC4536323.pdf
"Sequence similarity between different Upf1 orPat1-interacting segments and sequence conservation of the Dcp1,Edc3, Pat1, and Upf1-binding domains or motifs and the Dcp2cis-inhibitory element among the Dcp2 orthologs were carried out with the multiple sequence alignment software Clustal Omega host-ed on a web server (http://www.ebi.ac.uk/Tools/msa/).",OADS,/arxiv_data1/oa_pdf/a7/64/1633.PMC4536323.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.052464.115.© 2015 Hudson and Zaher This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/5d/a2/1648.PMC4536324.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommer-cial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/5d/a2/1648.PMC4536324.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.051805.115.© 2015 Koubek et al.,OADS,/arxiv_data1/oa_pdf/9a/4c/1672.PMC4536326.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/9a/4c/1672.PMC4536326.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.METHOD 1672 RNA 21:1672 –1682; Published by Cold Spring Harbor Laboratory Press for the RNA Society",Non-OADS,/arxiv_data1/oa_pdf/9a/4c/1672.PMC4536326.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.051631.115.© 2015 Mefferd et al.,OADS,/arxiv_data1/oa_pdf/9f/cf/1683.PMC4536327.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/9f/cf/1683.PMC4536327.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.METHOD RNA 21:1683 –1689; Published by Cold Spring Harbor Laboratory Press for the RNA Society 1683",Non-OADS,/arxiv_data1/oa_pdf/9f/cf/1683.PMC4536327.pdf
"MATERIALS AND METHODS CRISPR/Cas9 constructs, tRNA, and sgRNA design Human tRNA sequences were obtained from the Genomic tRNA database (http://gtrnadb.ucsc.edu) and the MHV68 tRNA M1-7 se-quence was obtained from Bogerd et al.",OADS,/arxiv_data1/oa_pdf/9f/cf/1683.PMC4536327.pdf
"Briefly, reads >15 nt were collapsed intoFASTA format with the FASTX-Toolkit (http://hannonlab.cshl.edu/ fastx_toolkit/index.html) using the following pipeline: fastq_quali- ty_filter –Q 33 | fastq_to_fasta –Q 33 | fastx_clipper -a TruSeq- Index# -l 15 | fastx_collapser.",OADS,/arxiv_data1/oa_pdf/9f/cf/1683.PMC4536327.pdf
DATA DEPOSITION The raw sequencing data obtained from small RNA deep sequencinghave been submitted to the NCBI Gene Expression Omnibus(GEO) (http://www.ncbi.nlm.nih.gov/geo/) under accession num-ber GSE69720.,OADS,/arxiv_data1/oa_pdf/9f/cf/1683.PMC4536327.pdf
Available at: http://www.whocc.no/atc_ddd_index .,OADS,/arxiv_data1/oa_pdf/75/b4/ofv108.PMC4536331.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fb/be/ofv105.PMC4536332.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ec/01/rjv106.PMC4536334.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cb/c2/main.PMC4536469.pdf
http://dx.doi.org/10.1016/j.nicl.2014.12.0032213-1582/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/cb/c2/main.PMC4536469.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cb/c2/main.PMC4536469.pdf
"The stimuli of both localizer and ER scans were presented on black background using E-Prime software (http://www.pstnet.com/products/e-prime/ ), back-projected on a translucent screen located at the rear of the scanner, and viewed by par-ticipants through a mirror mounted on the head coil.",OADS,/arxiv_data1/oa_pdf/cb/c2/main.PMC4536469.pdf
"We extracted the hemodynamic response for each subject in the right FFA, using a standard canonical hemodynam- ic response function plus temporal derivative, with the MarsBar toolbox (http://marsbar.sourceforge.net ) and in-house software written in Matlab ( http://www.mathworks.com/products/matlab/).",OADS,/arxiv_data1/oa_pdf/cb/c2/main.PMC4536469.pdf
http://dx.doi.org/10.1097/QAI.0b013e318249db1722269799 .,Non-OADS,/arxiv_data1/oa_pdf/cb/c2/main.PMC4536469.pdf
http://dx.doi.org/10.1080/1355028080229811219040188 .,Non-OADS,/arxiv_data1/oa_pdf/cb/c2/main.PMC4536469.pdf
http://dx.doi.org/10.1371/journal.pone.0061399 .,Non-OADS,/arxiv_data1/oa_pdf/cb/c2/main.PMC4536469.pdf
http://dx.doi.org/10.1128/CDLI.12.9.1013-1019.200516148165 .,Non-OADS,/arxiv_data1/oa_pdf/cb/c2/main.PMC4536469.pdf
"Epidemiology 9 (2), 117– 125. http://dx.doi.org/ 10.1097/00001648-199803000-000049504278 .",Non-OADS,/arxiv_data1/oa_pdf/cb/c2/main.PMC4536469.pdf
187 –194http://dx.doi.org/10.1145/311535.311556 .673 C. Liu et al.,OADS,/arxiv_data1/oa_pdf/cb/c2/main.PMC4536469.pdf
http://dx.doi.org/10.1006/nimg.,OADS,/arxiv_data1/oa_pdf/cb/c2/main.PMC4536469.pdf
http://dx.doi.org/10.1212/01.wnl.0000218305.,Non-OADS,/arxiv_data1/oa_pdf/cb/c2/main.PMC4536469.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/cb/c2/main.PMC4536469.pdf
http://dx.doi.org/10.1212/WNL.57.6.100111571324 .,Non-OADS,/arxiv_data1/oa_pdf/cb/c2/main.PMC4536469.pdf
http://dx.doi.org/ 10.2217/bmm.09.6320477714 .,Non-OADS,/arxiv_data1/oa_pdf/cb/c2/main.PMC4536469.pdf
http://dx.doi.org/10.1016/S1473-3099(13)70269-X24156898.,OADS,/arxiv_data1/oa_pdf/cb/c2/main.PMC4536469.pdf
http://dx.doi.org/10.1146/annurev-med-042909-09375621090961 .,Non-OADS,/arxiv_data1/oa_pdf/cb/c2/main.PMC4536469.pdf
http://dx.doi.org/10.1016/j.pneurobio.2009.10.,OADS,/arxiv_data1/oa_pdf/cb/c2/main.PMC4536469.pdf
"8 (1), 33 –44.http://dx.doi.org/10.1038/ nrn204017180161 .",Non-OADS,/arxiv_data1/oa_pdf/cb/c2/main.PMC4536469.pdf
http://dx.doi.org/10.1001/ archneur.1997.005501600540169109743 .,Non-OADS,/arxiv_data1/oa_pdf/cb/c2/main.PMC4536469.pdf
http://dx.doi.org/10.1097/00002030- 2004 01001-0000915075499 .,Non-OADS,/arxiv_data1/oa_pdf/cb/c2/main.PMC4536469.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cb/c2/main.PMC4536469.pdf
http://dx.doi.org/10.1093/cercor/bhj10016400159 .,Non-OADS,/arxiv_data1/oa_pdf/cb/c2/main.PMC4536469.pdf
http://dx.doi.org/10.1006/nimg.1995.,Non-OADS,/arxiv_data1/oa_pdf/cb/c2/main.PMC4536469.pdf
"62 (5), 487– 495. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/cb/c2/main.PMC4536469.pdf
"Cortex 17 (2), 325– 338. http://dx.doi.org/10.1093/cercor/bhj15016525131 .",Non-OADS,/arxiv_data1/oa_pdf/cb/c2/main.PMC4536469.pdf
http://dx.doi.org/ 10.1016/j.neuroimage.2010.01.10720139012 .,OADS,/arxiv_data1/oa_pdf/cb/c2/main.PMC4536469.pdf
http://dx.doi.org/10.1080/0954026070187789418240061 .,Non-OADS,/arxiv_data1/oa_pdf/cb/c2/main.PMC4536469.pdf
http://dx.doi.org/10.1212/WNL.,Non-OADS,/arxiv_data1/oa_pdf/cb/c2/main.PMC4536469.pdf
"10 (1), 14 –23.http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/cb/c2/main.PMC4536469.pdf
http://dx.doi.org/10.1371/journal.pone.0061826 .,Non-OADS,/arxiv_data1/oa_pdf/cb/c2/main.PMC4536469.pdf
http://dx.doi.org/10.1097/QAD.0b013e3283427da721297425 .,Non-OADS,/arxiv_data1/oa_pdf/cb/c2/main.PMC4536469.pdf
"Neuron 22 (1), 189– 199.http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/cb/c2/main.PMC4536469.pdf
"17 (1), 3 –16.http://dx.doi.org/10.1007/s13365-010- 0006-121174240 .",Non-OADS,/arxiv_data1/oa_pdf/cb/c2/main.PMC4536469.pdf
http://dx.doi.org/10.1212/WNL.0b013e318200d72721135382 .,Non-OADS,/arxiv_data1/oa_pdf/cb/c2/main.PMC4536469.pdf
http://dx.doi.org/10.1097/QAI.0b013e31825a366822688010 .,Non-OADS,/arxiv_data1/oa_pdf/cb/c2/main.PMC4536469.pdf
http://dx.doi.org/10.1007/s13365- 012-0114-122653528 .,Non-OADS,/arxiv_data1/oa_pdf/cb/c2/main.PMC4536469.pdf
http://dx.doi.org/10.1152/jn.91207.200819211656 .,Non-OADS,/arxiv_data1/oa_pdf/cb/c2/main.PMC4536469.pdf
http://dx.doi.org/10.1016/j.nicl.2013.02.00224179786 .,OADS,/arxiv_data1/oa_pdf/cb/c2/main.PMC4536469.pdf
http://dx.doi.org/10.1016/j.neuron.2007.02.01517359923 .,OADS,/arxiv_data1/oa_pdf/cb/c2/main.PMC4536469.pdf
http://dx.doi.org/10.1016/j.neuron.2006.03.,OADS,/arxiv_data1/oa_pdf/cb/c2/main.PMC4536469.pdf
http://dx.doi.org/10.1093/cercor/bhr28522016479 .,Non-OADS,/arxiv_data1/oa_pdf/cb/c2/main.PMC4536469.pdf
http://dx.doi.org/10.1098/rstb.2006.193417118927 .,Non-OADS,/arxiv_data1/oa_pdf/cb/c2/main.PMC4536469.pdf
http://dx.doi.org/10.1126/ science.106113311520991 .,Non-OADS,/arxiv_data1/oa_pdf/cb/c2/main.PMC4536469.pdf
http://dx.doi.org/10.1080/ 1355028090297395219499455 .,Non-OADS,/arxiv_data1/oa_pdf/cb/c2/main.PMC4536469.pdf
http://dx.doi.org/10.1007/s00415-010-5883-y21207051 .,Non-OADS,/arxiv_data1/oa_pdf/cb/c2/main.PMC4536469.pdf
http://dx.doi.org/10.1162/jocn_a_0002621452937 .,Non-OADS,/arxiv_data1/oa_pdf/cb/c2/main.PMC4536469.pdf
http://dx.doi.org/10.1016/S1364- 6613(00)01769-111684480 .674 C. Liu et al.,OADS,/arxiv_data1/oa_pdf/cb/c2/main.PMC4536469.pdf
http://dx.doi.org/10.1152/jn.00485.201324848472 .,Non-OADS,/arxiv_data1/oa_pdf/cb/c2/main.PMC4536469.pdf
http://dx.doi.org/10.1007/s11481- 010-9205-z20396973 .,Non-OADS,/arxiv_data1/oa_pdf/cb/c2/main.PMC4536469.pdf
http://dx.doi.org/10.1212/WNL.0b013e3181a55f6519433739 .,Non-OADS,/arxiv_data1/oa_pdf/cb/c2/main.PMC4536469.pdf
http://dx.doi.org/10.1007/s11481-013-9504-2 .,Non-OADS,/arxiv_data1/oa_pdf/cb/c2/main.PMC4536469.pdf
http://dx.doi.org/10.1059/0003-4819-153-7- 201010050-0001320921548 .,Non-OADS,/arxiv_data1/oa_pdf/cb/c2/main.PMC4536469.pdf
http://dx.doi.org/10.1002/ana.4103203041416802 .,Non-OADS,/arxiv_data1/oa_pdf/cb/c2/main.PMC4536469.pdf
"157 (1 –2), 3–10.http://dx.doi.org/10.1016/j.jneuroim.2004.08.04215579274 .",OADS,/arxiv_data1/oa_pdf/cb/c2/main.PMC4536469.pdf
http://dx.doi.org/10.1055/s-2008- 104083110718534 .,Non-OADS,/arxiv_data1/oa_pdf/cb/c2/main.PMC4536469.pdf
http://dx.doi.org/10.5041/RMMJ.1008923908849 .,Non-OADS,/arxiv_data1/oa_pdf/cb/c2/main.PMC4536469.pdf
http://dx.doi.org/10.1016/j.bbr.2007.11.,OADS,/arxiv_data1/oa_pdf/cb/c2/main.PMC4536469.pdf
http://dx.doi.org/10.1371/ journal.pone.004731023144815 .,Non-OADS,/arxiv_data1/oa_pdf/cb/c2/main.PMC4536469.pdf
http://dx.doi.org/10.1038/ nrn320022395804 .,Non-OADS,/arxiv_data1/oa_pdf/cb/c2/main.PMC4536469.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/cb/c2/main.PMC4536469.pdf
http://dx.doi.org/10.1016/j.expneurol.,OADS,/arxiv_data1/oa_pdf/cb/c2/main.PMC4536469.pdf
http://dx.doi.org/10.2174/187460981110401003321204781 .,Non-OADS,/arxiv_data1/oa_pdf/cb/c2/main.PMC4536469.pdf
http://dx.doi.org/10.1007/s12035-011-8195-z21717292 .,Non-OADS,/arxiv_data1/oa_pdf/cb/c2/main.PMC4536469.pdf
"62 (1), 36– 42.http://dx.doi.org/ 10.1097/QAI.0b013e318278ffa423111573 .Sarma, M.K., Nagarajan, R., Keller, M.A., Kumar, R., Nielsen-Saines, K., Michalik, D.E., Deville, J., Church, J.A., Thomas, M.A., 2014.",Non-OADS,/arxiv_data1/oa_pdf/cb/c2/main.PMC4536469.pdf
http://dx.doi.org/ 10.1097/QAD.0b013e3283437f9a21160410 .,Non-OADS,/arxiv_data1/oa_pdf/cb/c2/main.PMC4536469.pdf
http://dx.doi.org/10.1097/QAD.0b013e3283354a7b19996937 .,Non-OADS,/arxiv_data1/oa_pdf/cb/c2/main.PMC4536469.pdf
http://dx.doi.org/10.1111/j.1468-1293.2008.,Non-OADS,/arxiv_data1/oa_pdf/cb/c2/main.PMC4536469.pdf
"3, 328. http://dx.doi.org/10.3389/fgene.",Non-OADS,/arxiv_data1/oa_pdf/cb/c2/main.PMC4536469.pdf
http://dx.doi.org/10.1017/S135561771100098121892988 .,Non-OADS,/arxiv_data1/oa_pdf/cb/c2/main.PMC4536469.pdf
http://dx.doi.org/10.1212/WNL.,Non-OADS,/arxiv_data1/oa_pdf/cb/c2/main.PMC4536469.pdf
http://dx.doi.org/10.1093/brain/awh26915319273 .,Non-OADS,/arxiv_data1/oa_pdf/cb/c2/main.PMC4536469.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1c/ce/main.PMC4536470.pdf
A complete listing ofADNI investigators can be found at: http://adni.loni.usc.edu/wp-content/uploads/how_ to_apply/ADNI_Acknowledgement_List.pdf .,OADS,/arxiv_data1/oa_pdf/1c/ce/main.PMC4536470.pdf
http://dx.doi.org/10.1016/j.nicl.2015.06.007 2213-1582/© 2015 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/1c/ce/main.PMC4536470.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1c/ce/main.PMC4536470.pdf
"Materials and methods The data for the present study were obtained from the database of the Alzheimer 3s Disease Neuroimaging Initiative (ADNI), available at http://adni.loni.usc.edu .",OADS,/arxiv_data1/oa_pdf/1c/ce/main.PMC4536470.pdf
For a more detailed and up to date description of the ADNI please refer to http://www.adni-info.org .,Non-OADS,/arxiv_data1/oa_pdf/1c/ce/main.PMC4536470.pdf
Detailed information about neuropsycho- logical testing and diagnostic criteria are available at the ADNI website (http://adni.loni.usc.edu/methods ).,Non-OADS,/arxiv_data1/oa_pdf/1c/ce/main.PMC4536470.pdf
All imaging protocols and preprocessing procedures are available at the ADNI website ( http://adni.loni.usc.edu/methods/ ).,OADS,/arxiv_data1/oa_pdf/1c/ce/main.PMC4536470.pdf
AV45 and FDG-PET data processing Subject AV45 and FDG standardized uptake value ratios (SUVRs) were calculated at ADNI core laboratories following a standardized pipeline that is available at the ADNI website ( http://adni.loni.usc.edu/ methods/pet-analysis/ ).,OADS,/arxiv_data1/oa_pdf/1c/ce/main.PMC4536470.pdf
"Brie ﬂy, diffusion tensors were ﬁtted to the data using CAMINO ( http://cmic.cs.ucl.ac.uk/camino/ )a n d FA and MD maps were calculated and coregistered to IR-SPGR data in order to extract total WM mean FA and MD.",OADS,/arxiv_data1/oa_pdf/1c/ce/main.PMC4536470.pdf
Pri- vate sector contributions are facilitated by the Foundation for the Na- tional Institutes of Health ( http://www.fnih.org ).,Non-OADS,/arxiv_data1/oa_pdf/1c/ce/main.PMC4536470.pdf
http://dx.doi.org/10.1016/j.jalz.2011.03.00821514249 .,OADS,/arxiv_data1/oa_pdf/1c/ce/main.PMC4536470.pdf
http://dx.doi.org/10.1523/JNEUROSCI.5062-08.,Non-OADS,/arxiv_data1/oa_pdf/1c/ce/main.PMC4536470.pdf
http://dx.doi.org/10.1371/journal.pone.006517523762308 .,Non-OADS,/arxiv_data1/oa_pdf/1c/ce/main.PMC4536470.pdf
http://dx.doi.org/10.1002/ana.2195520373343 .,Non-OADS,/arxiv_data1/oa_pdf/1c/ce/main.PMC4536470.pdf
"21 (1), 83–92.http://dx.doi.org/10.1097/WCO.0b013e3282f4594b18180656 .",Non-OADS,/arxiv_data1/oa_pdf/1c/ce/main.PMC4536470.pdf
http://dx.doi.org/10.1093/brain/ awu13225057133 .,Non-OADS,/arxiv_data1/oa_pdf/1c/ce/main.PMC4536470.pdf
http://dx.doi.org/10.1089/brain.2012.,Non-OADS,/arxiv_data1/oa_pdf/1c/ce/main.PMC4536470.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/1c/ce/main.PMC4536470.pdf
"13 (2), 79 –92.http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/1c/ce/main.PMC4536470.pdf
http://dx.doi.org/10.2214/ajr.149.2.3513496763 .,Non-OADS,/arxiv_data1/oa_pdf/1c/ce/main.PMC4536470.pdf
http://dx.doi.org/10.1371/journal.pone.008625824465994 .,Non-OADS,/arxiv_data1/oa_pdf/1c/ce/main.PMC4536470.pdf
http://dx.doi.org/10.1523/JNEUROSCI.2308-09.200920016083 .,Non-OADS,/arxiv_data1/oa_pdf/1c/ce/main.PMC4536470.pdf
"21 (1), 27 –58.http://dx.doi.org/10.1214/aoms/1177729885 .",Non-OADS,/arxiv_data1/oa_pdf/1c/ce/main.PMC4536470.pdf
http://dx.doi.org/10.1371/journal.pbio.006015918597554 .,Non-OADS,/arxiv_data1/oa_pdf/1c/ce/main.PMC4536470.pdf
http://dx.doi.org/10.1523/JNEUROSCI.0141-08.200818448652 .665 F.U.,OADS,/arxiv_data1/oa_pdf/1c/ce/main.PMC4536470.pdf
http://dx.doi.org/10.1016/j.neuroimage.2007.02.,OADS,/arxiv_data1/oa_pdf/1c/ce/main.PMC4536470.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/1c/ce/main.PMC4536470.pdf
http://dx.doi.org/10.1016/S1474-4422(12)70291-023332364 .,OADS,/arxiv_data1/oa_pdf/1c/ce/main.PMC4536470.pdf
http://dx.doi.org/ 10.1016/S1474-4422(09)70299-620083042 .,OADS,/arxiv_data1/oa_pdf/1c/ce/main.PMC4536470.pdf
http://dx.doi.org/10.2967/jnumed.111.09034022331215 .,Non-OADS,/arxiv_data1/oa_pdf/1c/ce/main.PMC4536470.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/1c/ce/main.PMC4536470.pdf
http://dx.doi.org/10.1371/journal.pcbi.,Non-OADS,/arxiv_data1/oa_pdf/1c/ce/main.PMC4536470.pdf
http://dx.doi.org/ 10.1523/JNEUROSCI.4136-10.201021159959 .,Non-OADS,/arxiv_data1/oa_pdf/1c/ce/main.PMC4536470.pdf
http://dx.doi.org/10.1016/ j.jalz.2011.03.00521514250 .,OADS,/arxiv_data1/oa_pdf/1c/ce/main.PMC4536470.pdf
http://dx.doi.org/10.1196/annals.1427.00719076441 .,Non-OADS,/arxiv_data1/oa_pdf/1c/ce/main.PMC4536470.pdf
http://dx.doi.org/10.1371/journal.pone.,Non-OADS,/arxiv_data1/oa_pdf/1c/ce/main.PMC4536470.pdf
http://dx.doi.org/10.1007/s00234-013-1195-023644540 .,Non-OADS,/arxiv_data1/oa_pdf/1c/ce/main.PMC4536470.pdf
http://dx.doi.org/10.1016/j.nicl.2014.02.00124936411 .,OADS,/arxiv_data1/oa_pdf/1c/ce/main.PMC4536470.pdf
http://dx.doi.org/10.1016/j.neuron.2011.12.,OADS,/arxiv_data1/oa_pdf/1c/ce/main.PMC4536470.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1c/ce/main.PMC4536470.pdf
http://dx.doi.org/10.1093/brain/ awt06523539189 .,Non-OADS,/arxiv_data1/oa_pdf/1c/ce/main.PMC4536470.pdf
http://dx.doi.org/10.1371/journal.pone.001378821072180 .,Non-OADS,/arxiv_data1/oa_pdf/1c/ce/main.PMC4536470.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1c/ce/main.PMC4536470.pdf
http://dx.doi.org/10.1007/s12035-013-8418- 623877934 .,Non-OADS,/arxiv_data1/oa_pdf/1c/ce/main.PMC4536470.pdf
http://dx.doi.org/10.1016/j.nbd.,OADS,/arxiv_data1/oa_pdf/1c/ce/main.PMC4536470.pdf
http://dx.doi.org/10.1016/j.jalz.2011.03.00321514248 .,OADS,/arxiv_data1/oa_pdf/1c/ce/main.PMC4536470.pdf
http://dx.doi.org/10.1001/archneurol.2009.27220008651 .,Non-OADS,/arxiv_data1/oa_pdf/1c/ce/main.PMC4536470.pdf
"191 (1), 77 –85.http://dx.doi.org/10.1016/j.expneurol.2004.09.",OADS,/arxiv_data1/oa_pdf/1c/ce/main.PMC4536470.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/1c/ce/main.PMC4536470.pdf
http://dx.doi.org/10.1016/j.euroneuro.2010.03.00820471808 .,OADS,/arxiv_data1/oa_pdf/1c/ce/main.PMC4536470.pdf
http://dx.doi.org/10.1371/journal.pone.001370121060892 .,Non-OADS,/arxiv_data1/oa_pdf/1c/ce/main.PMC4536470.pdf
http://dx.doi.org/ 10.1002/ana.2224821280088 .,Non-OADS,/arxiv_data1/oa_pdf/1c/ce/main.PMC4536470.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/1c/ce/main.PMC4536470.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1c/ce/main.PMC4536470.pdf
"Aging 34 (5), 1440 – 1450. http://dx.doi.org/10.1016/j.neurobiolaging.2012.11.01723273575 .666 F.U.",OADS,/arxiv_data1/oa_pdf/1c/ce/main.PMC4536470.pdf
http://clinicaltrials.gov/show/NCT01687998.,Non-OADS,/arxiv_data1/oa_pdf/0f/e9/10.1177_1074248415575153.PMC4536537.pdf
http://clinicaltrials.gov/show/NCT01810432.,Non-OADS,/arxiv_data1/oa_pdf/0f/e9/10.1177_1074248415575153.PMC4536537.pdf
"Retrieved from http://journal.frontiersin.org/  article/10.3389/neuro.09.004.2009/full Engle, R. W. (2002).",Non-OADS,/arxiv_data1/oa_pdf/24/2f/10.1177_0963721415577356.PMC4536538.pdf
Available from http://www.fda.gov/ Safety/MedWatch/SafetyInformation/ SafetyAlertsforHumanMedicalProducts/ucm188703.htm.,Non-OADS,/arxiv_data1/oa_pdf/71/f8/214.PMC4536638.pdf
Available from http://www.fda.gov/Drugs/DrugSafety/ucm446845.htm?source=govdelivery&utm_ medium=email&utm_source=govdelivery.,Non-OADS,/arxiv_data1/oa_pdf/71/f8/214.PMC4536638.pdf
"Features •	memory capacity: none •	display: black and white, nontouch  •	power supply: battery •	calibration: none  •	Separate test cartridge and sampling device  •	data export: none •	accessories: one•	memory capacity: 500 patient results  and 500 control results •	display: color touch  •	power supply: ac /dc adapter  •	calibration: none  •	integrated test cartridge and sampling  device •	data export:   ❍uSb flash drive  ❍ethernet port  ❍rS232 •	accessories: barcode scanner,   purchased separately•	memory capacity: 4,000 patient and  control records •	color touch display •	power supply: ac /dc adapter •	calibration: lot specific calibration card •	Separate test cartridge and sampling device  •	data export  ❍uSb flash drive  ❍ethernet port  ❍accessories: barcode scanner,   onboard printer approximate cost per  unit (prices vary by distributor)$40 for unit with 2 cartridges (for the home-use version) $170 for unit with 20 cartridges$3,500 for base station$120 for 15 single-use testing kits$60 for 2 control sets$2,100–3,600 for base station$75 for 10 single-use testing kits$60 for 2 control sets company i nternet  addresshttp://www.ptsdiagnostics.com http://www.axis-shield.com http://www.siemens.comTABLe 2.",Non-OADS,/arxiv_data1/oa_pdf/00/21/201.PMC4536639.pdf
Available  from http://report.nih.gov/nihfactsheets/Pdfs/PointofCareDiagnosticTesting(NIBIB).,OADS,/arxiv_data1/oa_pdf/00/21/201.PMC4536639.pdf
Available from http://www.cms.gov/ Medicare/Coverage/DeterminationProcess/ downloads/id35TA.pdf.,OADS,/arxiv_data1/oa_pdf/00/21/201.PMC4536639.pdf
Available from http://www.ngsp.org.,Non-OADS,/arxiv_data1/oa_pdf/00/21/201.PMC4536639.pdf
Available from http://www.forbes.com/ sites/greatspeculations/2013/09/23/anoth - er-diabetes-device-bites-the-dust.,Non-OADS,/arxiv_data1/oa_pdf/00/21/201.PMC4536639.pdf
Available from  http://www.a1cnow.com/Our-Products/ Overview.aspx.,Non-OADS,/arxiv_data1/oa_pdf/00/21/201.PMC4536639.pdf
Available from http://www.cardiochek.com/component/docman/doc_download/440- pts-inc-acquires-a1cnow-and-expands- product-portfolio?Itemid=152.,OADS,/arxiv_data1/oa_pdf/00/21/201.PMC4536639.pdf
Available  from http://www.ngsp.org/CAP/CAP13b.,Non-OADS,/arxiv_data1/oa_pdf/00/21/201.PMC4536639.pdf
Available from http://www.ngsp.org/interf.asp.,Non-OADS,/arxiv_data1/oa_pdf/00/21/201.PMC4536639.pdf
Available from http://www.cdc.gov/diabetes/oubs/pdf/ndfs_2011.pdf.,Non-OADS,/arxiv_data1/oa_pdf/00/21/201.PMC4536639.pdf
Available from http://nkdep.nih.gov/resources/quick-reference-uacr-gfr.shtml.,OADS,/arxiv_data1/oa_pdf/af/cd/162.PMC4536646.pdf
Available from  http://nkdep.nih.gov/lab-evaluation/gfr/ reporting.shtml.,OADS,/arxiv_data1/oa_pdf/af/cd/162.PMC4536646.pdf
Available from http://nkdep.nih.gov/ lab-evaluation/urine-albumin/urine-   albumin-standardization.shtml.,OADS,/arxiv_data1/oa_pdf/af/cd/162.PMC4536646.pdf
Available from http://www.idf.org/diabetesatlas.,Non-OADS,/arxiv_data1/oa_pdf/a8/dc/158.PMC4536647.pdf
Available from http://www.who.int/diabetes/facts.,Non-OADS,/arxiv_data1/oa_pdf/a8/dc/158.PMC4536647.pdf
Available from http://www.cdc.gov/hchs/ nhis.htm.,OADS,/arxiv_data1/oa_pdf/7d/01/193.PMC4536648.pdf
Available from  http://www.cdc.gov/brfss/about/about_brfss.htm.,OADS,/arxiv_data1/oa_pdf/7d/01/193.PMC4536648.pdf
Available from http://www.cdc.,Non-OADS,/arxiv_data1/oa_pdf/7d/01/193.PMC4536648.pdf
Available from http://www.cdc.gov/brfss/annual_data/pdf-ques/2008brfss.pdf.,OADS,/arxiv_data1/oa_pdf/7d/01/193.PMC4536648.pdf
Available  from http://www.floridahealth.gov/reports-and-data/survey-data/behav - ioral-risk-factor-surveillance-system/survey-instruments/_documents/2008_BRFSS_questionnaire.pdf.,OADS,/arxiv_data1/oa_pdf/7d/01/193.PMC4536648.pdf
Available from  http://www.bls.gov/emp/ep_chart_001.htm.,OADS,/arxiv_data1/oa_pdf/7d/01/193.PMC4536648.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d1/50/ccid-8-443.PMC4536759.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical, Cosmetic and Investigational Dermatology 2015:8 443–448Clinical, Cosmetic and Investigational Dermatology Video abstract Point your Smar tPhone at the code abo ve.",Non-OADS,/arxiv_data1/oa_pdf/d1/50/ccid-8-443.PMC4536759.pdf
"Or use: http://youtu.be/nIsTTkRJYG sDove press submit your manuscript | www.dovepress.co m Dove press  443OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CCID.S8686 3In vitro inhibition of hyaluronidase by sodium  copper chlorophyllin complex and chlorophyllin  analogs John P McCook1 Peter l Dorogi2 David B Vasily3 Dustin r Cefalo4 1Discovery Partners, llC, Frisco,   TX, 2Chl Industries, llC, easton,   Pa, 3aesthetica Cosmetic and laser  surgery Center, Bethlehem, P a,   4Frontier scientific, Inc., logan, UT,   Usa Correspondence: John P McCook   Discovery Partners, llC, 4913 southern  hills Drive, Frisco, TX 75034, Usa   Tel +1 214 448 6513   Fax +1 610 861 8228   email johnmccook@att.ne tBackground:  Inhibitors of hyaluronidase are potent agents that maintain hyaluronic acid  homeostasis and may serve as anti-aging, anti-inflammatory, and anti-microbial agents.",Non-OADS,/arxiv_data1/oa_pdf/d1/50/ccid-8-443.PMC4536759.pdf
"Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journa lClinical, Cosmetic and Investigational Dermatology is an interna - tional, peer-reviewed, open access, online journal that focuses on  the latest clinical and experimental research in all aspects of skin  disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/d1/50/ccid-8-443.PMC4536759.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d1/50/ccid-8-443.PMC4536759.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b0/1e/ccid-8-437.PMC4536760.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical, Cosmetic and Investigational Dermatology 2015:8 437–442Clinical, Cosmetic and Investigational Dermatology Dove press submit your manuscript | www.dovepress.co m Dove press  437OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CCID.S8641 8associations between cardiovascular risk factors  and psoriasis in Iran Mahmoud Farshchian akram ansar Mohammadreza sobhan Psoriasis research Center,   Department of Dermatology,   Farshchian hospital, hamadan  University of Medical sciences,   hamadan, Iran Correspondence: Mohammadreza sobhan   Psoriasis research Center, Department  of Dermatology, Farshchian hospital,  hamadan University of Medical sciences,  Mirzade eshghy street, hamadan  65168408741, Iran   Tel +98 912 108 9455   Fax +98 813 826 9808   email mreza_sobhan@yahoo.co mBackground:  Psoriasis is a common chronic inflammatory skin disease.",Non-OADS,/arxiv_data1/oa_pdf/b0/1e/ccid-8-437.PMC4536760.pdf
"Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journa lClinical, Cosmetic and Investigational Dermatology is an interna - tional, peer-reviewed, open access, online journal that focuses on  the latest clinical and experimental research in all aspects of skin  disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/b0/1e/ccid-8-437.PMC4536760.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b0/1e/ccid-8-437.PMC4536760.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/04/7c/copd-10-1591.PMC4536761.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of COPD 2015:10 1591–1597International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1591OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S8264 3Thiazolidinediones are associated with a reduced  risk of COPD exacerbations seppo T rinne1,2 Chuan-Fen liu3,4 laura C Feemster3,5 Bridget F Collins3,5 Christopher l Bryson3,6 Thomas g O’riordan7 David h au3,4 1Department of Veterans affairs, V a  Connecticut healthcare system, West  haven, 2Division of Pulmonary and  Critical Care, Yale University, new  haven, CT, Usa; 3Va Puget sound  health Care system, Department  of Veterans affairs, 4Department  of health services, University of  Washington, 5Division of Pulmonary  and Critical Care, University of  Washington, 6Division of general  Internal Medicine, University of  Washington, 7gilead sciences, Inc.,   seattle, W a, UsaBackground:  Thiazolidinediones (TZDs) are oral antihyperglycemic medications that are  selective agonists to peroxisome proliferator-activated receptor gamma and have been shown  to have potent anti-inflammatory effects in the lung.",Non-OADS,/arxiv_data1/oa_pdf/04/7c/copd-10-1591.PMC4536761.pdf
"This approach typically relies on treatment with  long-acting bronchodilators and inhaled corticosteroids; however, these interventions  are not always effective.7 One clinical trial found that despite therapy with inhaled  bronchodilators (tiotropium and salmeterol) and inhaled corticosteroids (fluticasone  propionate), 60% of patients with COPD had an exacerbation during the study year.8 Correspondence: seppo T rinne Department of Veterans affairs, Va  Connecticut healthcare system, 950  Campbell avenue, Building 35a, room  2-234, West haven, CT 06516, Usa Tel +1 203 932 5711x3541 email seppo.rinne@va.go vJournal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Rinne et al Running head recto: Thiazolidinediones and COPD exacerbations DOI: http://dx.doi.org/10.2147/COPD.S82643",Non-OADS,/arxiv_data1/oa_pdf/04/7c/copd-10-1591.PMC4536761.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/04/7c/copd-10-1591.PMC4536761.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/04/7c/copd-10-1591.PMC4536761.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/fb/8e/cia-10-1305.PMC4536762.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2015:10 1305–1310Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1305OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S8427 1sex differences in use of inhalants by elderly  patients with asthma Masahiro hirose rieko Kondo naoaki Ban Kazunobu Kuwabara Mamoru shiga Takahiko horiguchi Department of respiratory Medicine  II, Fujita health University school of  Medicine, nagoya, Aichi, JapanBackground:  The number of elderly patients with asthma has been increasing in Japan.",Non-OADS,/arxiv_data1/oa_pdf/fb/8e/cia-10-1305.PMC4536762.pdf
"Methods The subjects were 155 adults patients with bronchial asthma who made regular visits  to Banbuntane Hotokukai Hospital at Fujita Health University and to related medical Correspondence: Masahiro hirose Depatment of respiraory Medicine II, Fujita health University school  of Medicine, 3-6-10, Otobashi,  nakagawa-ku, nagoya, 454-85-09, Japan Fax +81 52 323 5675 email hiromasa87@yahoo.co.j p Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Hirose et al Running head recto: Inhalation therapy in elderly patients DOI: http://dx.doi.org/10.2147/CIA.S84271",Non-OADS,/arxiv_data1/oa_pdf/fb/8e/cia-10-1305.PMC4536762.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/fb/8e/cia-10-1305.PMC4536762.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/fb/8e/cia-10-1305.PMC4536762.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d0/1f/bctt-7-223.PMC4536763.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pBreast Cancer: Targets and Therapy 2015:7 223–230Breast Cancer: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  223Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/BCTT .S7450 9establishment and characterization of a receptor- negative, hormone-nonresponsive breast cancer  cell line from an iraqi patient ahmed Majeed  al-shammari1 Mortadha a alshami2 Mahfoodha abbas Umran2 asmaa amer almukhtar3 nahi Y Yaseen1 Khansaa raad1 ayman a hussien1 1experimental Therapy Department,   iraqi Center for Cancer and Medical  genetic research, Mustansiriya  University,  2Biotechnology  Department, Collage of science,   Baghdad University,  3Medical genetics  Department, iraqi Center for Cancer  and Medical genetic research,   Mustansiriya University, Baghdad, iraq Correspondence: ahmed Majeed  al-shammari   experimental Therapy Department, iraqi  Center for Cancer and Medical genetic  research, Mustansiriya University,  Box 15007, al-Yarmook Post   Office, Baghdad, Iraq   Tel +96 478 0914 3825  email ahmed.alshammari@iccmgr.or gAbstract:  A new breast cancer cell line (AMJ13) has been established from an Iraqi breast  cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/d0/1f/bctt-7-223.PMC4536763.pdf
"Breast Cancer: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/breast-cancer---targets-and-therapy-journa lBreast Cancer: Targets and Therapy is an international, peer-   reviewed open access journal focusing on breast cancer research,  identification of therapeutic targets and the optimal use of preven - tative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/d0/1f/bctt-7-223.PMC4536763.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d9/48/vhrm-11-437.PMC4536764.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.ph pVascular Health and Risk Management 2015:11 437–450Vascular Health and Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  437ReViewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/VHRM.S6379 1Secondary stroke prevention: challenges and  solutions Charles esenwa Jose Gutierrez Department of Neurology, College  of Physicians and Surgeons, Columbia  University Medical Center, New Y ork,   NY, USA Correspondence: Jose Gutierrez   Department of Neurology, College  of Physicians and Surgeons,  Columbia University Medical Center,  710 W 168th Street, 6th floor,   Suite 639, New York, NY, 10032, USA   Tel +1 212 305 1710   Fax +1 212 305 3741   email jg3233@cumc.columbia.ed uAbstract:  Stroke is the leading cause of disability in the USA and a major cause of mortality  worldwide.",Non-OADS,/arxiv_data1/oa_pdf/d9/48/vhrm-11-437.PMC4536764.pdf
"Vascular Health and Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/vascular-health-and-risk-management-journa lVascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on  concise rapid reporting of clinical studies on the processes involved  in the maintenance of vascular health; the monitoring, prevention and  treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/d9/48/vhrm-11-437.PMC4536764.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d9/48/vhrm-11-437.PMC4536764.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/17/1a/cia-10-1283.PMC4536765.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2015:10 1283–1287Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1283CAse reportopen access to scientific and medical research open Access Full text Article http: //dx.doi.org/10.2147/CIA.S8471 1Is oxycodone/naloxone effective and safe in  managing chronic pain of a fragile elderly patient  with multiple skin ulcers of the lower limbs?,Non-OADS,/arxiv_data1/oa_pdf/17/1a/cia-10-1283.PMC4536765.pdf
"Wound  pain can be explained by a variety of mechanisms: inflammatory processes increasing  the sensitivity of pain receptors, tissue damage causing stimulation of pain receptors,  damage to terminal end of the axon and/or presynaptic terminal, and possibly local Correspondence: Fabio Guerriero Department of Internal Medicine and  Medical therapy, section of Geriatrics,  University of pavia, via emilia 12,  27100 pavia, Italy tel +39 0382 38 1772 Fax +39 0382 38 1217 email fabio_guerriero@yahoo.i t Journal name: Clinical Interventions in Aging Article Designation: Case report Y ear: 2015 Volume: 10 Running head verso: Guerriero et al Running head recto: Oxycodone/naloxone as an effective and safe drug combination DOI: http://dx.doi.org/10.2147/CIA.S84711",Non-OADS,/arxiv_data1/oa_pdf/17/1a/cia-10-1283.PMC4536765.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/17/1a/cia-10-1283.PMC4536765.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/17/1a/cia-10-1283.PMC4536765.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/.,Non-OADS,/arxiv_data1/oa_pdf/1d/2f/jpr-8-499.PMC4536834.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Pain Research 2015:8 499–505Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  499ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JPR.S8661 1Self-reported nonrestorative sleep in fibromyalgia –   relationship to impairments of body functions,  personal function factors, and quality of life Gunilla M Liedberg1 Mathilda Björk2 Björn Börsbo3 1Department of social and Welfare  Studies, Linköping University,   Norrköping, 2Rehabilitation Centre  and Department of Medical and  Health Sciences, 3Rehabilitation  Medicine, Department of Medicine  and Health Sciences (IMH), Linköping  University, Linköping, Sweden Correspondence: Björn Börsbo   Rehabilitation Medicine, Department of  Medicine and Health Sciences, Linköping  University, SE-581 85 Linköping, Sweden   Tel +46 70 792 2161   email bjorn.borsbo@ liu.s ePurpose:  The purpose of this study was: 1) to determine variables that might characterize good  or bad sleep; and 2) to describe the relationship between sleep, impairment of body func - tions, personal function factors, and quality of life based on quality of sleep in women with   fibromyalgia (FM).",Non-OADS,/arxiv_data1/oa_pdf/1d/2f/jpr-8-499.PMC4536834.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/1d/2f/jpr-8-499.PMC4536834.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/1d/2f/jpr-8-499.PMC4536834.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/82/04/opth-9-1417.PMC4536835.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 1417–1420Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1417Case seriesopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S8333 5Preretinal hemorrhage as a presenting sign  of idiopathic macular telangiectasia type 2 James M Osher1,2 robert a sisk1,2 Michael r Petersen2 1Department of Ophthalmology,   University of Cincinnati, 2Cincinnati  eye institute, Cincinnati, OH, UsaAbstract:  We report three cases of idiopathic macular telangiectasia type 2 with temporally  decentered preretinal hemorrhage as the presenting sign.",Non-OADS,/arxiv_data1/oa_pdf/82/04/opth-9-1417.PMC4536835.pdf
"She  was treated with intravitreal bevacizumab monthly with clearing of the hemorrhage Correspondence: robert a sisk Cincinnati eye institute, 1945 Cei Drive,  Cincinnati, OH 45242, Usa Tel +1 513 984 5133 Fax +1 513 281 2313 email rsisk@cincinnatieye.co m Journal name: Clinical Ophthalmology Article Designation: Case Series Y ear: 2015 Volume: 9 Running head verso: Osher et al Running head recto: Preretinal hemorrhage and macular telangiectasia DOI: http://dx.doi.org/10.2147/OPTH.S83335",Non-OADS,/arxiv_data1/oa_pdf/82/04/opth-9-1417.PMC4536835.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/82/04/opth-9-1417.PMC4536835.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/82/04/opth-9-1417.PMC4536835.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e6/aa/tacg-8-181.PMC4536836.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pThe Application of Clinical Genetics 2015:8 181–188The Application of Clinical Genetics Dove press submit your manuscript | www.dovepress.co m Dove press  181Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TACG.S6863 5Pulmonary capillary hemangiomatosis: a focus on  the EIF2AK4  mutation in onset and pathogenesis Lijiang Ma1,* Ruijun Bao2,* 1Department of Pediatrics and  Medicine, Division of Molecular  Genetics, Columbia University  Medical Center, New Y ork, NY, 2The  Children’s iBD Center, Mount Sinai  Hospital, New Y ork, NY, USA *These authors contributed equally to  this work Correspondence: Lijiang Ma   Department of Pediatrics and Medicine,  Division of Molecular Genetics, Columbia  University Medical Center, 1150 St.  Nicholas Ave, New York, NY 10032,  USA  Tel +1 212 851 5318  Fax +1 212 851 5306  email lm2689@columbia.ed uAbstract:  Pulmonary capillary hemangiomatosis (PCH) is a pulmonary vascular disease that  mainly affects small capillaries in the lung, and is often misdiagnosed as pulmonary arterial  hypertension or pulmonary veno-occlusive disease due to similarities in their clinical presenta - tions, prognosis, and management.",Non-OADS,/arxiv_data1/oa_pdf/e6/aa/tacg-8-181.PMC4536836.pdf
"The Application of Clinical Genetics Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/the-application-of-clinical-genetics-journa lThe Application of Clinical Genetics is an international, peer-reviewed  open access journal that welcomes laboratory and clinical findings in  the field of human genetics.",Non-OADS,/arxiv_data1/oa_pdf/e6/aa/tacg-8-181.PMC4536836.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e6/aa/tacg-8-181.PMC4536836.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e9/be/ndt-11-2063.PMC4536837.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 2063–2070Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  2063OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S8991 6Mental health status, aggression, and poor driving  distinguish traffic offenders from non-offenders  but health status predicts driving behavior in both  groups Nasrin abdoli1,2 Vahid Farnia3 ali Delavar4 Fariborz Dortaj4 alireza esmaeili5 Noorali Farrokhi4 Majid Karami6 Jalal shakeri3 Edith Holsboer-Trachsler7 serge Brand7,8 1international University of imam  reza, Mashhad, iran; 2Kermanshah  University of Medical sciences,   Kermanshah, iran; 3substance  abuse Prevention research center,   Psychiatry Department, Kermanshah  University of Medical sciences,   Kermanshah, iran; 4allameh Tabataba’i  University, T ehran, iran; 5Police  University, T ehran, iran; 6Baharestan  research center, Kermanshah  Transportation T erminal, Kermanshah,   iran; 7center for affective, stress and  sleep Disorders, Psychiatric clinics  of the University of Basel, Basel,   switzerland; 8Department of sport  and health science, sport science  section, University of Basel, Basel,   switzerlandBackground:  In Iran, traffic accidents and deaths from traffic accidents are among the highest  in the world, and generally, driver behavior rather than technical failures or environmental con - ditions are responsible for traffic accidents.",Non-OADS,/arxiv_data1/oa_pdf/e9/be/ndt-11-2063.PMC4536837.pdf
"One focus of research has been on associations between personality traits and driving  behavior.8–11 The main pattern to emerge from this is an association between poor driving  behavior and trait anxiety,11 excitement seeking,8 narcissism,10 and antagonism, negative  affectivity, and disinhibition.9 This approach thus points to a particular constellation correspondence: serge Brand center for affective, stress and sleep  Disorders, Psychiatric clinics of the  University of Basel, Wilhelm Klein-Strasse  27, 4012 Basel, switzerland Tel +41 61 325 5114 Fax +41 61 325 5513 email s erge.brand@upkbs.c h Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Abdoli et al Running head recto: Health, aggression, and driving behavior: traffic offenders vs non-offenders DOI: http://dx.doi.org/10.2147/NDT.S89916",Non-OADS,/arxiv_data1/oa_pdf/e9/be/ndt-11-2063.PMC4536837.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/e9/be/ndt-11-2063.PMC4536837.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e9/be/ndt-11-2063.PMC4536837.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e2/34/idr-8-287.PMC4536838.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInfection and Drug Resistance 2015:8 287–296Infection and Drug Resistance Dove press submit your manuscript | www.dovepress.co m Dove press  287RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IDR.S4881 0Bloodstream infections in intensive care unit  patients: distribution and antibiotic resistance   of bacteria vincenzo Russotto1 Andrea Cortegiani1 Giorgio Graziano2 Laura Saporito2 Santi Maurizio Raineri1 Caterina Mammina2 Antonino Giarratano1 1Department of Biopathology and  Medical Biotechnologies (DIBIM eD),   Section of Anaesthesia, Analgesia,   Intensive Care and emergency,   Paolo Giaccone University Hospital,   University of Palermo, Palermo, Italy;   2Department of Sciences for Health  Promotion and Mother-Child Care,   University of Palermo, Palermo, Italy Correspondence: Andrea Cortegiani   Department of Biopathology and Medical  Biotechnologies (DIBIMeD), Section  of Anaesthesia, Analgesia, Intensive  Care and emergency, Paolo Giaccone  University Hospital, University   of Palermo,  129 via del vespro,   Palermo  90127, Italy   Tel +39 091 655 2727  email andreacortegiani85@gmail.co mAbstract:  Bloodstream infections (BSIs) are among the leading infections in critically ill  patients.",Non-OADS,/arxiv_data1/oa_pdf/e2/34/idr-8-287.PMC4536838.pdf
"Infection and Drug Resistance Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/infection-and-drug-resistance-journa lInfection and Drug Resistance is an international, peer-reviewed open- access journal that focuses on the optimal treatment of infection (bacte - rial, fungal and viral) and the development and institution of preventive  strategies to minimize the development and spread of resistance.",Non-OADS,/arxiv_data1/oa_pdf/e2/34/idr-8-287.PMC4536838.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e2/34/idr-8-287.PMC4536838.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/47/17/opth-9-1437.PMC4536839.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 1437–1442Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1437Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S7753 8Folate status in type 2 diabetic patients with and  without retinopathy giulia Malaguarnera1 Caterina gagliano2,3 salvatore salomone1 Maria giordano4 Claudio Bucolo1 antonino Pappalardo5 Filippo Drago1 Filippo Caraci6,7 T eresio avitabile2 Massimo Motta5 1Department of Biomedical and  Biotechnological sciences, University  of Catania, Catania, italy; 2Department  of Ophthalmology, University of  Catania, Catania, italy; 3neurovisual  science T echnology (nesT), Catania,   Catania, italy; 4gerontology and  Bone Metabolic Disease section,   Department of Medical sciences,   University of T urin, T urin; 5Department  of Medical and Paediatric sciences,   University of Catania, italy;   6Department of Drug sciences,   University of Catania, Catania, italy;   7irCCs association Oasi Maria s.s.- institute for research on Mental  retardation and Brain aging, Troina,   enna, italyBackground:  Folate deficiency is associated with cardiovascular disease, megaloblastic anemia,  and with hyperhomocysteinemia.",Non-OADS,/arxiv_data1/oa_pdf/47/17/opth-9-1437.PMC4536839.pdf
"During passage of small amounts of folic acid through the gut cells and liver, reduc - tion and l-carbon substitution is complete, and 5-methyltetrahydrofolate is by far the  most predominant form entering the systemic circulation.Correspondence: giulia Malaguarnera Department of Clinical and Molecular  Biomedicine, international PhD  programme in neuropharmacology,  University of Catania, Viale  andrea Doria 6, 95125 Catania, italy Tel +39 95 726 2008 Fax +39 95 726 2011 email giulia.malaguarnera@live.itJournal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Malaguarnera et al Running head recto: Folate status in type 2 diabetic patients DOI: http://dx.doi.org/10.2147/OPTH.S77538",Non-OADS,/arxiv_data1/oa_pdf/47/17/opth-9-1437.PMC4536839.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/47/17/opth-9-1437.PMC4536839.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/47/17/opth-9-1437.PMC4536839.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4d/e6/ijn-10-4919.PMC4536840.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 4919–4936International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4919RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJN.S8231 0Peptides and proteins used to enhance gold  nanoparticle delivery to the brain: preclinical  approaches Carolina velasco-Aguirre1,2,* Francisco Morales1,2,* eduardo Gallardo-T oledo1,2 Simon Guerrero1,2 ernest Giralt3,4 eyleen Araya5 Marcelo J Kogan1,2 1Departamento de Química  Farmacológica y T oxicológica,   Facultad de Ciencias Químicas y  Farmacéuticas, Universidad de Chile,   2Advanced Center for Chronic  Diseases (ACCDiS), Santiago, Chile;   3Institute for Research in Biomedicine  (IRB Barcelona), Barcelona, Spain,   4Department of Organic Chemistry,   University of Barcelona, Barcelona,   Spain; 5Departamento de Ciencias  Químicas, Facultad de Ciencias  exactas, Universidad Andrés Bello,   Andrés Bello, Santiago, Chile *These authors contributed equally  to this workAbstract:  An exciting and emerging field in nanomedicine involves the use of gold nanopar - ticles (AuNPs) in the preclinical development of new strategies for the treatment and diagnosis  of brain-related diseases such as neurodegeneration and cerebral tumors.",Non-OADS,/arxiv_data1/oa_pdf/4d/e6/ijn-10-4919.PMC4536840.pdf
"An exciting and emerging field involves the use of AuNPs for the development of  new tools for the treatment of brain-related diseases such as neurodegeneration and  brain tumors, and includes the use of GNSs to destroy in vitro the β-amyloid aggregates  involved in Alzheimer’s disease.2,5,6 However, as discussed by Krol,7 the delivery of Correspondence: Marcelo J Kogan Departamento de Química Farmacológica  y Toxicológica, Facultad de Ciencias  Químicas y Farmacéuticas, Universidad  de Chile, Santos Dumont 964,  Independencia, Santiago, Chile Tel +56 229782897 email mkogan@ciq.uchile.c l Journal name: International Journal of Nanomedicine Article Designation: Review Y ear: 2015 Volume: 10 Running head verso: Velasco-Aguirre et al Running head recto: Peptides and proteins to enhance AuNPs’ delivery to the brain DOI: http://dx.doi.org/10.2147/IJN.S82310",Non-OADS,/arxiv_data1/oa_pdf/4d/e6/ijn-10-4919.PMC4536840.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/4d/e6/ijn-10-4919.PMC4536840.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/4d/e6/ijn-10-4919.PMC4536840.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4b/80/ijn-10-5081.PMC4536841.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 5081–5092International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  5081OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7968 4Nanostructured lipid system as a strategy  to improve the anti- Candida  albicans  activity  of Astronium  sp.,Non-OADS,/arxiv_data1/oa_pdf/4b/80/ijn-10-5081.PMC4536841.pdf
"C. albicans  is a dimorphic fungus and a commensal of the skin, gastrointestinal tract,  and genitalia and is classified as an opportunistic pathogen (ie, a pathogen that only correspondence: Taís Maria Bauab Department of Biological sciences,  school of Pharmaceutical sciences,  UNesP – Univ estadual Paulista, rodovia  araraquara-Jaú, km 01, araraquara,  sP ceP 14801-902, Brazil Tel +55 16 3301 6955 Fax +55 16 3301 6940 email bauabtm@fcfar.unesp.b r Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Bonifácio et al Running head recto: Use of nanostructured lipid system DOI: http://dx.doi.org/10.2147/IJN.S79684",Non-OADS,/arxiv_data1/oa_pdf/4b/80/ijn-10-5081.PMC4536841.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/4b/80/ijn-10-5081.PMC4536841.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/4b/80/ijn-10-5081.PMC4536841.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6c/c2/idr-8-279.PMC4536842.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInfection and Drug Resistance 2015:8 279–285Infection and Drug Resistance Dove press submit your manuscript | www.dovepress.co m Dove press  279ORIg Inal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IDR.S8634 1Outpatient parenteral antimicrobial therapy with  ceftriaxone for acute tonsillopharyngitis: efficacy,  patient satisfaction, cost effectiveness, and safety samah al alawi1 somaya abdulkarim1 hazem elhennawy1 anwar al-Mansoor2 ahmed al ansari3,4,5 1Department of Family Medicine,   2Department of Dietetics and  Nutrition, 3Training and education  Department, Bahrain Defence  Force Hospital, Riffa, 4arabian gulf  University, Manama, 5Royal college  of Surgeons of Ireland, Busaiteen,   Kingdom of Bahrain correspondence: ahmed al ansari   Training and Education Department,  Bahrain Defense Force Hospital, Off  Waly Alahed Avenue, PO Box  28743,  West Riffa, Kingdom of Bahrain   Tel +973 1776 6666  email ahmed.alansari@bdfmedical.or gBackground:  Outpatient parenteral antimicrobial therapy (OPAT) is the administration of  intravenous antimicrobial therapy to patients in an outpatient setting.",Non-OADS,/arxiv_data1/oa_pdf/6c/c2/idr-8-279.PMC4536842.pdf
"Infection and Drug Resistance Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/infection-and-drug-resistance-journa lInfection and Drug Resistance is an international, peer-reviewed open- access journal that focuses on the optimal treatment of infection (bacte - rial, fungal and viral) and the development and institution of preventive  strategies to minimize the development and spread of resistance.",Non-OADS,/arxiv_data1/oa_pdf/6c/c2/idr-8-279.PMC4536842.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/6c/c2/idr-8-279.PMC4536842.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b9/82/ndt-11-2055.PMC4536843.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 2055–2061Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  2055OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S8658 1combined application of eicosapentaenoic  acid and docosahexaenoic acid on depression  in women: a meta-analysis of double-blind  randomized controlled trials Jia-run Yang Dong han Zheng-xue Qiao Xue Tian Dong Qi Xiao-hui Qiu Department of Medical Psychology,   Public health institute of harbin  Medical University, harbin,   heilongjiang Province, People’s  republic of chinaObjectives:  Previous randomized controlled trials (RCTs) suggest that depression can be  effectively treated by omega-3 polyunsaturated fatty acids (PUFAs).",Non-OADS,/arxiv_data1/oa_pdf/b9/82/ndt-11-2055.PMC4536843.pdf
"Keywords:  depression, omega-3 polyunsaturated fatty acids, PUFAs, docosahexaenoic acid,  DHA, eicosapentaenoic acid, EPA Introduction Depression is one of the most debilitating mental disorders in psychiatry field, which  affects more than 10% of the population and results in more than 10% of the global  disease burden.1–3 There are about 10%–20% free-living elderly subjects and 20%–30%  elderly hospitalized patients experiencing the depressive symptoms.4 Currently, despite  a large number of established medication options for depression, about 19%–34%  of patients fail to respond to the first-line treatments.5 On the other hand, the female  preponderance of depression and its emergence in adolescence was reported by most  of the studies.6 Studies reported that the prevalence of depression was doubled in girls  than boys between 15 years and 19 years,7 and this trend persisted until 54 years.8  Some studies reported a higher prevalence of depression in women than men, even  after menopause.9 This sex disparity indicated that gonadal hormones might play a correspondence: Xiao-hui Qiu Department of Medical Psychology,  Public health institute of harbin Medical  University, 157 Baojian road, Nangang  District, harbin 150081, heilongjiang  Province, People’s republic of china Tel +86 451 8666 9485 Fax +86 451 8666 9485 email wangguowei40@163.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Y ang et al Running head recto: Combined application of eicosapentaenoic acid and docosahexaenoic acid DOI: http://dx.doi.org/10.2147/NDT.S86581",Non-OADS,/arxiv_data1/oa_pdf/b9/82/ndt-11-2055.PMC4536843.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/b9/82/ndt-11-2055.PMC4536843.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b9/82/ndt-11-2055.PMC4536843.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a8/4e/ijn-10-5093.PMC4536844.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 5093–5106International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  5093OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S8490 9Caenorhabditis elegans  as an alternative in vivo  model to determine oral uptake, nanotoxicity,  and efficacy of melatonin-loaded lipid-core  nanocapsules on paraquat damage Mariele Feiffer charão1,2 caroline souto2 Natália Brucker1,2 anelise Barth1,2 Denise s Jornada1,3 Daiandra Fagundez4 Daiana silva Ávila4 Vera L Eifler-Lima1,5 silvia s guterres1,3 adriana r Pohlmann1,6 solange cristina garcia1,2 1Post-Graduate Programme  in Pharmaceutical sciences,     2laboratory of T oxicology (la TOX),   Department of analysis, Pharmacy  Faculty, 3Department of Production  and control of Drugs, Pharmacy  Faculty, Federal University of  rio grande do sul, Porto alegre,   4research group in Biochemistry and  Toxicology in caenorhabditis elegans  (gBTox ce), Federal University of  Pampa – UNIP aMPa, Uruguaiana,   5laboratory of Medical synthesis  Organic (la sOM), Pharmacy Faculty,   6Department of Organic chemistry,   chemistry Institute, Federal  University of rio grande do sul,   Porto alegre, rs, BrazilAbstract:  Caenorhabditis elegans is an alternative in vivo model that is being successfully  used to assess the pharmacological and toxic effects of drugs.",Non-OADS,/arxiv_data1/oa_pdf/a8/4e/ijn-10-5093.PMC4536844.pdf
"Keywords:  C. elegans , nanotoxicology, rhodamine B-labeled polymer Introduction Nanotechnology has increased exponentially in order to fulfill biomedical applica - tions.1 Polymeric nanoparticles (NPs) obtained from biodegradable polymers are  being studied as carriers for drug delivery.2–5 Lipid-core nanocapsules (LNC) are a  special type of particle due to the hybrid characteristics between polymeric and lipid  NP.6 These particles have an organogel core formed by a mixture of sorbitan monos - tearate and medium chain triglycerides, which increases drug encapsulation capacity  by up to 40 times.7 Recently, it has been described that the polymeric nanocapsules,  prepared with poly( ε-caprolactone) (PCL) and polysorbate 80 (PS80), may improve  the biological action4,8 of drugs, increase the drug bioavailability,9 and in case of anti - oxidant substances, their encapsulation has been shown to be able to improve their correspondence: solange cristina garcia Toxicology laboratory, Pharmacy Faculty,  Federal University of rio grande do sul,  avenida Ipiranga 2752, Porto alegre, rs  90610-000, Brazil Tel +55 51 3308 5297 Fax +55 51 3308 5437 email solange.garcia@ufrgs.b rJournal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Charão et al Running head recto: Caenorhabditis elegans as an alternative in vivo model DOI: http://dx.doi.org/10.2147/IJN.S84909",Non-OADS,/arxiv_data1/oa_pdf/a8/4e/ijn-10-5093.PMC4536844.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/a8/4e/ijn-10-5093.PMC4536844.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a8/4e/ijn-10-5093.PMC4536844.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/16/2e/jpr-8-459.PMC4536845.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Pain Research 2015:8 459–475Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  459ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JPR.S8807 6Development of opioid-induced constipation: post  hoc analysis of data from a 12-week prospective,  open-label, blinded-endpoint streamlined study   in low-back pain patients treated with prolonged- release WhO step iii opioids Michael a Ueberall1 gerhard hh Mueller- schwefe2 1institute for neurological  sciences, n uremberg, germany;   2interdisciplinary center for Pain and  Palliative care Medicine, göppingen,   germany correspondence: Michael a Ueberall   institute for neurological sciences,  nordostpark 51, 90411,   nuremberg, germany   Tel +49 911 2177 3760   Fax +49 911 2177 3761   email michael.ueberall@ifnap.d eBackground:  Opioid-induced constipation is the most prevalent patient complaint associated  with longer-term opioid use and interferes with analgesic efficacy, functionality, quality of life,  and patient compliance.",Non-OADS,/arxiv_data1/oa_pdf/16/2e/jpr-8-459.PMC4536845.pdf
"Available from: http://www.dgss.org/deutscher-schmerzfrageboge n.  Accessed April 10, 2015.",Non-OADS,/arxiv_data1/oa_pdf/16/2e/jpr-8-459.PMC4536845.pdf
"Available from: http://www.dgss.org/fileadmin/ pdf/12_DSF_Manual_2012.2.pd f. Accessed April 10, 2015.",Non-OADS,/arxiv_data1/oa_pdf/16/2e/jpr-8-459.PMC4536845.pdf
"Available at: https://www.mun - dipharma.de/fileadmin/mundipharma-relaunch/documents/public/ gebrauchsinformationen/GI_MST_10-30-60-100-200mg.pd f. Accessed  July 06, 2015.",Non-OADS,/arxiv_data1/oa_pdf/16/2e/jpr-8-459.PMC4536845.pdf
"Available at: https://www.mundipharma.de/fileadmin/ mundipharma-relaunch/documents/public/gebrauchsinformationen/ GI_Oxygesic_5-10-20-40-80mg.pd f. Accessed July 06, 2015.",Non-OADS,/arxiv_data1/oa_pdf/16/2e/jpr-8-459.PMC4536845.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/16/2e/jpr-8-459.PMC4536845.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/16/2e/jpr-8-459.PMC4536845.pdf
Available from: http://www.dgss.org/deutscher- schmerzfragebogen.,Non-OADS,/arxiv_data1/oa_pdf/16/2e/jpr-8-459.PMC4536845.pdf
"804 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9d/82/jsv034.PMC4536848.pdf
Retrieved from http://www.ssb.no/a/publikasjoner/pdf/rapp_200812/rapp_200812.pdf.,Non-OADS,/arxiv_data1/oa_pdf/9d/82/jsv034.PMC4536848.pdf
Retrieved from http://ffdd.ru/activity/attach/information/182/parental_leave_childcare_and_gender_e-quality_in_the_nordic_countries.pdf.,OADS,/arxiv_data1/oa_pdf/9d/82/jsv034.PMC4536848.pdf
Retrieved from http://dx.doi.org/10.1787/ empl-outlook-2011-en.,Non-OADS,/arxiv_data1/oa_pdf/9d/82/jsv034.PMC4536848.pdf
Retrievedfrom: https://www.nav.no/Forsiden/_attachment/1073745905?,Non-OADS,/arxiv_data1/oa_pdf/9d/82/jsv034.PMC4536848.pdf
Retrieved from http://www.ssb.no/a/en/histstat/aar- bok/2011_en.pdf.,OADS,/arxiv_data1/oa_pdf/9d/82/jsv034.PMC4536848.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/56/14/kev008.PMC4536856.pdf
"Patient- reported outcome measures: use in medical product de-velopment to support labeling claims, 2009. http://www.fda.gov/downloads/Drugs/Guidances/UCM193282.pdf(15 February 2014, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/56/14/kev008.PMC4536856.pdf
"Lincoln, RI:QualityMetric Incorporated 2010. https://www.optum.com/optum-outcomes/what-we-do/health-surveys/sf-36v2-health-survey.html (26 February 2015, date lastaccessed).",OADS,/arxiv_data1/oa_pdf/56/14/kev008.PMC4536856.pdf
"Manchester, UK University of Salford, 2014.http://usir.salford.ac.uk/30755/ (11 January 2014, datelast accessed).",Non-OADS,/arxiv_data1/oa_pdf/56/14/kev008.PMC4536856.pdf
"Manchester, UK: University of Salford, 2014.http://usir.salford.ac.uk/30752/ (11 January 2014, datelast accessed).",Non-OADS,/arxiv_data1/oa_pdf/56/14/kev008.PMC4536856.pdf
http://www.literacytrust.org.,Non-OADS,/arxiv_data1/oa_pdf/56/14/kev008.PMC4536856.pdf
"Published by Oxford University Press on behalf of the British Society for Rheumatology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0d/4a/kev023.PMC4536857.pdf
"For this analysis, we also ﬁtted the model to rates of opportunistic infection (0.7–9.3/100 person-years) and mortality (3.29/100 person-years) from ART -treated children in the P1060 trial, as well as published probabilities of switching from ﬁrst-line to second-line ART (9–22% at 36 months; Appendix, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/9d/49/aids-29-1247.PMC4536981.pdf
"Input data We used International Epidemiologic Database to Evaluate AIDS (IeDEA) East African data to derive rates of CD4þ% or CD4þdecline, opportunistic infections, and death through age 13 years, and data from the Cape T own AIDS Cohort to derive event risks at ages greater than 13 (Appendix, http://links.lww.com/QAD/A686)[21,22].",OADS,/arxiv_data1/oa_pdf/9d/49/aids-29-1247.PMC4536981.pdf
"Base-case ART data were from the P1060 trial, including 24 and 48-week rates of RNA suppression, CD4þ% gains on suppressive ART, and risk of late failure on each regimen (Table 1; Appendix, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/9d/49/aids-29-1247.PMC4536981.pdf
"outpatient visits, inpatient days, laboratory testing, and medications) by country-speciﬁc unit costs for South Africa and Co ˆte d’Ivoire, using pediatric-speciﬁc data when possible (Table 1; Appendix, http://links.lww.com/QAD/A686) [23–27].",Non-OADS,/arxiv_data1/oa_pdf/9d/49/aids-29-1247.PMC4536981.pdf
"ART costs were from Clinton Health Access Initiative (CHAI) price lists, calculated for each age from WHO weight-based dosing recommendations (Appendix, http://links.lww.com/QAD/A686) [6,11,15].",Non-OADS,/arxiv_data1/oa_pdf/9d/49/aids-29-1247.PMC4536981.pdf
"We also varied opportunistic infection and mortality rates (reﬂecting populations with different disease progression rates, such as children with postpartum infection [16]), healthcare costs, ART costs, and the discount rate (Appendix, http://links.lww.com/QAD/A686).",Non-OADS,/arxiv_data1/oa_pdf/9d/49/aids-29-1247.PMC4536981.pdf
"Modeled monitoring and switchingstrategiesincludedvariousCD4þandHIV-RNA testing frequencies; delays to conﬁrming ﬁrst-line ART failureandinitiatingsecond-lineART;andclinical,CD4þ% or CD4þcell count, and RNA thresholds for switching to second-line ART (Appendix, http://links.lww.com/ QAD/A686).",OADS,/arxiv_data1/oa_pdf/9d/49/aids-29-1247.PMC4536981.pdf
"Modeled ART sequencing strategies included: one available line of ART, availability of third- line darunavir/ritonavir based ART, and additional strat- egies requested by the WHO HIV Guidelines Committee (Appendix, http://links.lww.com/QAD/A686).",Non-OADS,/arxiv_data1/oa_pdf/9d/49/aids-29-1247.PMC4536981.pdf
Complete inputs are shown in Appendix Table A (http://links.lww.com/QAD/A686) for children aged below and at least 60 months.,Non-OADS,/arxiv_data1/oa_pdf/9d/49/aids-29-1247.PMC4536981.pdf
"(Appendix, http://links.lww.com/QAD/A686) [33,34].",Non-OADS,/arxiv_data1/oa_pdf/9d/49/aids-29-1247.PMC4536981.pdf
"Univariate sensitivity analyses First-line lopinavir/ritonavir remained cost-saving com- pared to ﬁrst-line nevirapine for all ages at presentation (6–35 months) and using Co ˆte d’Ivoire costs (Table 3), although the time required for ﬁrst-line lopinavir/ ritonavir to become cost-saving compared to ﬁrst-line nevirapine was much longer with Co ˆte d’Ivoire costs than with South Africa costs (26.4 vs. 8.7 years; Appendix, http://links.lww.com/QAD/A686).",Non-OADS,/arxiv_data1/oa_pdf/9d/49/aids-29-1247.PMC4536981.pdf
"Results were also robust to variation in most clinical and economic parameters (Appendix, http://links.lww.com/QAD/ A686).",OADS,/arxiv_data1/oa_pdf/9d/49/aids-29-1247.PMC4536981.pdf
Discounting is at 3% per year (results using alternative discount rates are shown in the Appendix (http://links.lww.com/ QAD/A686).,Non-OADS,/arxiv_data1/oa_pdf/9d/49/aids-29-1247.PMC4536981.pdf
"We therefore calibrated our model to ﬁt short-term opportunistic infection and mortality observations for ART -treated children (Appendix, http://links.lww.com/QAD/A686) [8,9].",Non-OADS,/arxiv_data1/oa_pdf/9d/49/aids-29-1247.PMC4536981.pdf
"A, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/9d/49/aids-29-1247.PMC4536981.pdf
"Pro- gress report on the global plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive, 2013. http://www.unaids.org/en/media/unaids/ contentassets/documents/unaidspublication/2013/20130625_ progress_global_plan_en.pdf.",Non-OADS,/arxiv_data1/oa_pdf/9d/49/aids-29-1247.PMC4536981.pdf
2013. http://www.childre- nandaids.org/.,Non-OADS,/arxiv_data1/oa_pdf/9d/49/aids-29-1247.PMC4536981.pdf
2012. http://d2pd3b5abq75bb.cloudfront.net/2012/ 07/12/15/03/07/163/CHAI_ARV_Ceiling_Price_List_- May_2012.pdf.,OADS,/arxiv_data1/oa_pdf/9d/49/aids-29-1247.PMC4536981.pdf
2013. http://www.who.int/hiv/pub/guidelines/arv2013/ download/en/index.html.,Non-OADS,/arxiv_data1/oa_pdf/9d/49/aids-29-1247.PMC4536981.pdf
2010. http://www.who.int/choice/costs/CER_ thresholds/en/index.html.,Non-OADS,/arxiv_data1/oa_pdf/9d/49/aids-29-1247.PMC4536981.pdf
2010. http://www.who.int/hiv/pub/ paediatric/infants2010/en/index.html.,Non-OADS,/arxiv_data1/oa_pdf/9d/49/aids-29-1247.PMC4536981.pdf
2013. http://www.who.int/hiv/pub/prev_care/edm/en/index.html.,Non-OADS,/arxiv_data1/oa_pdf/9d/49/aids-29-1247.PMC4536981.pdf
2006. http://wiredspace.wits.ac.,OADS,/arxiv_data1/oa_pdf/9d/49/aids-29-1247.PMC4536981.pdf
2014. http://www.who.int/choice/en/.,Non-OADS,/arxiv_data1/oa_pdf/9d/49/aids-29-1247.PMC4536981.pdf
2012. http://www.clinicaltrials.gov/ct2/ show/NCT01127204?term=MONOD&rank=1.,Non-OADS,/arxiv_data1/oa_pdf/9d/49/aids-29-1247.PMC4536981.pdf
11 http://repository.academyhealth.org/egems/vol3/iss1/11 DOI: 10.13063/2327-9214.1171,Non-OADS,/arxiv_data1/oa_pdf/dc/e0/egems1171.PMC4537082.pdf
11 http://repository.academyhealth.org/egems/vol3/iss1/11 DOI: 10.13063/2327-9214.1171,Non-OADS,/arxiv_data1/oa_pdf/dc/e0/egems1171.PMC4537082.pdf
11 http://repository.academyhealth.org/egems/vol3/iss1/11 DOI: 10.13063/2327-9214.1171,Non-OADS,/arxiv_data1/oa_pdf/dc/e0/egems1171.PMC4537082.pdf
11 http://repository.academyhealth.org/egems/vol3/iss1/11 DOI: 10.13063/2327-9214.1171,Non-OADS,/arxiv_data1/oa_pdf/dc/e0/egems1171.PMC4537082.pdf
11 http://repository.academyhealth.org/egems/vol3/iss1/11 DOI: 10.13063/2327-9214.1171,Non-OADS,/arxiv_data1/oa_pdf/dc/e0/egems1171.PMC4537082.pdf
11 http://repository.academyhealth.org/egems/vol3/iss1/11 DOI: 10.13063/2327-9214.1171,Non-OADS,/arxiv_data1/oa_pdf/dc/e0/egems1171.PMC4537082.pdf
11 http://repository.academyhealth.org/egems/vol3/iss1/11 DOI: 10.13063/2327-9214.1171,Non-OADS,/arxiv_data1/oa_pdf/dc/e0/egems1171.PMC4537082.pdf
11 http://repository.academyhealth.org/egems/vol3/iss1/11 DOI: 10.13063/2327-9214.1171,Non-OADS,/arxiv_data1/oa_pdf/dc/e0/egems1171.PMC4537082.pdf
14 http://repository.academyhealth.org/egems/vol3/iss1/14 DOI: 10.13063/2327-9214.1181,Non-OADS,/arxiv_data1/oa_pdf/3f/39/egems1181.PMC4537083.pdf
14 http://repository.academyhealth.org/egems/vol3/iss1/14 DOI: 10.13063/2327-9214.1181,Non-OADS,/arxiv_data1/oa_pdf/3f/39/egems1181.PMC4537083.pdf
14 http://repository.academyhealth.org/egems/vol3/iss1/14 DOI: 10.13063/2327-9214.1181,Non-OADS,/arxiv_data1/oa_pdf/3f/39/egems1181.PMC4537083.pdf
14 http://repository.academyhealth.org/egems/vol3/iss1/14 DOI: 10.13063/2327-9214.1181,Non-OADS,/arxiv_data1/oa_pdf/3f/39/egems1181.PMC4537083.pdf
14 http://repository.academyhealth.org/egems/vol3/iss1/14 DOI: 10.13063/2327-9214.1181,Non-OADS,/arxiv_data1/oa_pdf/3f/39/egems1181.PMC4537083.pdf
14 http://repository.academyhealth.org/egems/vol3/iss1/14 DOI: 10.13063/2327-9214.1181,Non-OADS,/arxiv_data1/oa_pdf/3f/39/egems1181.PMC4537083.pdf
14 http://repository.academyhealth.org/egems/vol3/iss1/14 DOI: 10.13063/2327-9214.1181,Non-OADS,/arxiv_data1/oa_pdf/3f/39/egems1181.PMC4537083.pdf
14 http://repository.academyhealth.org/egems/vol3/iss1/14 DOI: 10.13063/2327-9214.1181,Non-OADS,/arxiv_data1/oa_pdf/3f/39/egems1181.PMC4537083.pdf
14 http://repository.academyhealth.org/egems/vol3/iss1/14 DOI: 10.13063/2327-9214.1181,Non-OADS,/arxiv_data1/oa_pdf/3f/39/egems1181.PMC4537083.pdf
14 http://repository.academyhealth.org/egems/vol3/iss1/14 DOI: 10.13063/2327-9214.1181,Non-OADS,/arxiv_data1/oa_pdf/3f/39/egems1181.PMC4537083.pdf
12 http://repository.academyhealth.org/egems/vol3/iss1/12 DOI: 10.13063/2327-9214.1125,Non-OADS,/arxiv_data1/oa_pdf/b7/c6/egems1125.PMC4537084.pdf
12 http://repository.academyhealth.org/egems/vol3/iss1/12 DOI: 10.13063/2327-9214.1125,Non-OADS,/arxiv_data1/oa_pdf/b7/c6/egems1125.PMC4537084.pdf
12 http://repository.academyhealth.org/egems/vol3/iss1/12 DOI: 10.13063/2327-9214.1125,Non-OADS,/arxiv_data1/oa_pdf/b7/c6/egems1125.PMC4537084.pdf
12 http://repository.academyhealth.org/egems/vol3/iss1/12 DOI: 10.13063/2327-9214.1125,Non-OADS,/arxiv_data1/oa_pdf/b7/c6/egems1125.PMC4537084.pdf
12 http://repository.academyhealth.org/egems/vol3/iss1/12 DOI: 10.13063/2327-9214.1125,Non-OADS,/arxiv_data1/oa_pdf/b7/c6/egems1125.PMC4537084.pdf
12 http://repository.academyhealth.org/egems/vol3/iss1/12 DOI: 10.13063/2327-9214.1125,Non-OADS,/arxiv_data1/oa_pdf/b7/c6/egems1125.PMC4537084.pdf
12 http://repository.academyhealth.org/egems/vol3/iss1/12 DOI: 10.13063/2327-9214.1125,Non-OADS,/arxiv_data1/oa_pdf/b7/c6/egems1125.PMC4537084.pdf
13 http://repository.academyhealth.org/egems/vol3/iss1/13 DOI: 10.13063/2327-9214.1118,Non-OADS,/arxiv_data1/oa_pdf/60/e0/egems1118.PMC4537085.pdf
13 http://repository.academyhealth.org/egems/vol3/iss1/13 DOI: 10.13063/2327-9214.1118,Non-OADS,/arxiv_data1/oa_pdf/60/e0/egems1118.PMC4537085.pdf
13 http://repository.academyhealth.org/egems/vol3/iss1/13 DOI: 10.13063/2327-9214.1118,Non-OADS,/arxiv_data1/oa_pdf/60/e0/egems1118.PMC4537085.pdf
13 http://repository.academyhealth.org/egems/vol3/iss1/13 DOI: 10.13063/2327-9214.1118,Non-OADS,/arxiv_data1/oa_pdf/60/e0/egems1118.PMC4537085.pdf
13 http://repository.academyhealth.org/egems/vol3/iss1/13 DOI: 10.13063/2327-9214.1118,Non-OADS,/arxiv_data1/oa_pdf/60/e0/egems1118.PMC4537085.pdf
13 http://repository.academyhealth.org/egems/vol3/iss1/13 DOI: 10.13063/2327-9214.1118,Non-OADS,/arxiv_data1/oa_pdf/60/e0/egems1118.PMC4537085.pdf
4 http://repository.academyhealth.org/egems/vol3/iss2/4 DOI: 10.13063/2327-9214.1166,Non-OADS,/arxiv_data1/oa_pdf/b7/51/egems1166.PMC4537144.pdf
4 http://repository.academyhealth.org/egems/vol3/iss2/4 DOI: 10.13063/2327-9214.1166,Non-OADS,/arxiv_data1/oa_pdf/b7/51/egems1166.PMC4537144.pdf
4 http://repository.academyhealth.org/egems/vol3/iss2/4 DOI: 10.13063/2327-9214.1166,Non-OADS,/arxiv_data1/oa_pdf/b7/51/egems1166.PMC4537144.pdf
4 http://repository.academyhealth.org/egems/vol3/iss2/4 DOI: 10.13063/2327-9214.1166,Non-OADS,/arxiv_data1/oa_pdf/b7/51/egems1166.PMC4537144.pdf
4 http://repository.academyhealth.org/egems/vol3/iss2/4 DOI: 10.13063/2327-9214.1166,Non-OADS,/arxiv_data1/oa_pdf/b7/51/egems1166.PMC4537144.pdf
4 http://repository.academyhealth.org/egems/vol3/iss2/4 DOI: 10.13063/2327-9214.1166,Non-OADS,/arxiv_data1/oa_pdf/b7/51/egems1166.PMC4537144.pdf
4 http://repository.academyhealth.org/egems/vol3/iss2/4 DOI: 10.13063/2327-9214.1166,Non-OADS,/arxiv_data1/oa_pdf/b7/51/egems1166.PMC4537144.pdf
1 http://repository.academyhealth.org/egems/vol3/iss2/1 DOI: 10.13063/2327-9214.1184,Non-OADS,/arxiv_data1/oa_pdf/4c/db/egems1184.PMC4537145.pdf
1 http://repository.academyhealth.org/egems/vol3/iss2/1 DOI: 10.13063/2327-9214.1184,Non-OADS,/arxiv_data1/oa_pdf/4c/db/egems1184.PMC4537145.pdf
10 http://repository.academyhealth.org/egems/vol3/iss2/10 DOI: 10.13063/2327-9214.1150,Non-OADS,/arxiv_data1/oa_pdf/43/1d/egems1150.PMC4537146.pdf
10 http://repository.academyhealth.org/egems/vol3/iss2/10 DOI: 10.13063/2327-9214.1150,Non-OADS,/arxiv_data1/oa_pdf/43/1d/egems1150.PMC4537146.pdf
10 http://repository.academyhealth.org/egems/vol3/iss2/10 DOI: 10.13063/2327-9214.1150,Non-OADS,/arxiv_data1/oa_pdf/43/1d/egems1150.PMC4537146.pdf
10 http://repository.academyhealth.org/egems/vol3/iss2/10 DOI: 10.13063/2327-9214.1150,Non-OADS,/arxiv_data1/oa_pdf/43/1d/egems1150.PMC4537146.pdf
10 http://repository.academyhealth.org/egems/vol3/iss2/10 DOI: 10.13063/2327-9214.1150,Non-OADS,/arxiv_data1/oa_pdf/43/1d/egems1150.PMC4537146.pdf
10 http://repository.academyhealth.org/egems/vol3/iss2/10 DOI: 10.13063/2327-9214.1150,Non-OADS,/arxiv_data1/oa_pdf/43/1d/egems1150.PMC4537146.pdf
10 http://repository.academyhealth.org/egems/vol3/iss2/10 DOI: 10.13063/2327-9214.1150,Non-OADS,/arxiv_data1/oa_pdf/43/1d/egems1150.PMC4537146.pdf
5 http://repository.academyhealth.org/egems/vol3/iss2/5 DOI: 10.13063/2327-9214.1159,Non-OADS,/arxiv_data1/oa_pdf/e3/e5/egems1159.PMC4537147.pdf
5 http://repository.academyhealth.org/egems/vol3/iss2/5 DOI: 10.13063/2327-9214.1159,Non-OADS,/arxiv_data1/oa_pdf/e3/e5/egems1159.PMC4537147.pdf
5 http://repository.academyhealth.org/egems/vol3/iss2/5 DOI: 10.13063/2327-9214.1159,Non-OADS,/arxiv_data1/oa_pdf/e3/e5/egems1159.PMC4537147.pdf
5 http://repository.academyhealth.org/egems/vol3/iss2/5 DOI: 10.13063/2327-9214.1159,Non-OADS,/arxiv_data1/oa_pdf/e3/e5/egems1159.PMC4537147.pdf
5 http://repository.academyhealth.org/egems/vol3/iss2/5 DOI: 10.13063/2327-9214.1159,Non-OADS,/arxiv_data1/oa_pdf/e3/e5/egems1159.PMC4537147.pdf
5 http://repository.academyhealth.org/egems/vol3/iss2/5 DOI: 10.13063/2327-9214.1159,Non-OADS,/arxiv_data1/oa_pdf/e3/e5/egems1159.PMC4537147.pdf
5 http://repository.academyhealth.org/egems/vol3/iss2/5 DOI: 10.13063/2327-9214.1159,Non-OADS,/arxiv_data1/oa_pdf/e3/e5/egems1159.PMC4537147.pdf
8 http://repository.academyhealth.org/egems/vol3/iss2/8 DOI: 10.13063/2327-9214.1153,Non-OADS,/arxiv_data1/oa_pdf/95/c1/egems1153.PMC4537149.pdf
8 http://repository.academyhealth.org/egems/vol3/iss2/8 DOI: 10.13063/2327-9214.1153,Non-OADS,/arxiv_data1/oa_pdf/95/c1/egems1153.PMC4537149.pdf
8 http://repository.academyhealth.org/egems/vol3/iss2/8 DOI: 10.13063/2327-9214.1153,Non-OADS,/arxiv_data1/oa_pdf/95/c1/egems1153.PMC4537149.pdf
8 http://repository.academyhealth.org/egems/vol3/iss2/8 DOI: 10.13063/2327-9214.1153,Non-OADS,/arxiv_data1/oa_pdf/95/c1/egems1153.PMC4537149.pdf
8 http://repository.academyhealth.org/egems/vol3/iss2/8 DOI: 10.13063/2327-9214.1153,Non-OADS,/arxiv_data1/oa_pdf/95/c1/egems1153.PMC4537149.pdf
8 http://repository.academyhealth.org/egems/vol3/iss2/8 DOI: 10.13063/2327-9214.1153,Non-OADS,/arxiv_data1/oa_pdf/95/c1/egems1153.PMC4537149.pdf
8 http://repository.academyhealth.org/egems/vol3/iss2/8 DOI: 10.13063/2327-9214.1153,Non-OADS,/arxiv_data1/oa_pdf/95/c1/egems1153.PMC4537149.pdf
8 http://repository.academyhealth.org/egems/vol3/iss2/8 DOI: 10.13063/2327-9214.1153,Non-OADS,/arxiv_data1/oa_pdf/95/c1/egems1153.PMC4537149.pdf
3 http://repository.academyhealth.org/egems/vol3/iss2/3 DOI: 10.13063/2327-9214.1152,Non-OADS,/arxiv_data1/oa_pdf/e4/7a/egems1152.PMC4537150.pdf
3 http://repository.academyhealth.org/egems/vol3/iss2/3 DOI: 10.13063/2327-9214.1152,Non-OADS,/arxiv_data1/oa_pdf/e4/7a/egems1152.PMC4537150.pdf
3 http://repository.academyhealth.org/egems/vol3/iss2/3 DOI: 10.13063/2327-9214.1152,Non-OADS,/arxiv_data1/oa_pdf/e4/7a/egems1152.PMC4537150.pdf
3 http://repository.academyhealth.org/egems/vol3/iss2/3 DOI: 10.13063/2327-9214.1152,Non-OADS,/arxiv_data1/oa_pdf/e4/7a/egems1152.PMC4537150.pdf
3 http://repository.academyhealth.org/egems/vol3/iss2/3 DOI: 10.13063/2327-9214.1152,Non-OADS,/arxiv_data1/oa_pdf/e4/7a/egems1152.PMC4537150.pdf
3 http://repository.academyhealth.org/egems/vol3/iss2/3 DOI: 10.13063/2327-9214.1152,Non-OADS,/arxiv_data1/oa_pdf/e4/7a/egems1152.PMC4537150.pdf
3 http://repository.academyhealth.org/egems/vol3/iss2/3 DOI: 10.13063/2327-9214.1152,Non-OADS,/arxiv_data1/oa_pdf/e4/7a/egems1152.PMC4537150.pdf
3 http://repository.academyhealth.org/egems/vol3/iss2/3 DOI: 10.13063/2327-9214.1152,Non-OADS,/arxiv_data1/oa_pdf/e4/7a/egems1152.PMC4537150.pdf
3 http://repository.academyhealth.org/egems/vol3/iss2/3 DOI: 10.13063/2327-9214.1152,Non-OADS,/arxiv_data1/oa_pdf/e4/7a/egems1152.PMC4537150.pdf
3 http://repository.academyhealth.org/egems/vol3/iss2/3 DOI: 10.13063/2327-9214.1152,Non-OADS,/arxiv_data1/oa_pdf/e4/7a/egems1152.PMC4537150.pdf
7 http://repository.academyhealth.org/egems/vol3/iss2/7 DOI: 10.13063/2327-9214.1165,Non-OADS,/arxiv_data1/oa_pdf/04/9b/egems1165.PMC4537151.pdf
7 http://repository.academyhealth.org/egems/vol3/iss2/7 DOI: 10.13063/2327-9214.1165,Non-OADS,/arxiv_data1/oa_pdf/04/9b/egems1165.PMC4537151.pdf
7 http://repository.academyhealth.org/egems/vol3/iss2/7 DOI: 10.13063/2327-9214.1165,Non-OADS,/arxiv_data1/oa_pdf/04/9b/egems1165.PMC4537151.pdf
7 http://repository.academyhealth.org/egems/vol3/iss2/7 DOI: 10.13063/2327-9214.1165,Non-OADS,/arxiv_data1/oa_pdf/04/9b/egems1165.PMC4537151.pdf
7 http://repository.academyhealth.org/egems/vol3/iss2/7 DOI: 10.13063/2327-9214.1165,Non-OADS,/arxiv_data1/oa_pdf/04/9b/egems1165.PMC4537151.pdf
7 http://repository.academyhealth.org/egems/vol3/iss2/7 DOI: 10.13063/2327-9214.1165,Non-OADS,/arxiv_data1/oa_pdf/04/9b/egems1165.PMC4537151.pdf
11 http://repository.academyhealth.org/egems/vol3/iss2/11 DOI: 10.13063/2327-9214.1149,Non-OADS,/arxiv_data1/oa_pdf/2a/ed/egems1149.PMC4537152.pdf
11 http://repository.academyhealth.org/egems/vol3/iss2/11 DOI: 10.13063/2327-9214.1149,Non-OADS,/arxiv_data1/oa_pdf/2a/ed/egems1149.PMC4537152.pdf
11 http://repository.academyhealth.org/egems/vol3/iss2/11 DOI: 10.13063/2327-9214.1149,Non-OADS,/arxiv_data1/oa_pdf/2a/ed/egems1149.PMC4537152.pdf
11 http://repository.academyhealth.org/egems/vol3/iss2/11 DOI: 10.13063/2327-9214.1149,Non-OADS,/arxiv_data1/oa_pdf/2a/ed/egems1149.PMC4537152.pdf
11 http://repository.academyhealth.org/egems/vol3/iss2/11 DOI: 10.13063/2327-9214.1149,Non-OADS,/arxiv_data1/oa_pdf/2a/ed/egems1149.PMC4537152.pdf
11 http://repository.academyhealth.org/egems/vol3/iss2/11 DOI: 10.13063/2327-9214.1149,Non-OADS,/arxiv_data1/oa_pdf/2a/ed/egems1149.PMC4537152.pdf
11 http://repository.academyhealth.org/egems/vol3/iss2/11 DOI: 10.13063/2327-9214.1149,Non-OADS,/arxiv_data1/oa_pdf/2a/ed/egems1149.PMC4537152.pdf
11 http://repository.academyhealth.org/egems/vol3/iss2/11 DOI: 10.13063/2327-9214.1149,Non-OADS,/arxiv_data1/oa_pdf/2a/ed/egems1149.PMC4537152.pdf
11 http://repository.academyhealth.org/egems/vol3/iss2/11 DOI: 10.13063/2327-9214.1149,Non-OADS,/arxiv_data1/oa_pdf/2a/ed/egems1149.PMC4537152.pdf
9 http://repository.academyhealth.org/egems/vol3/iss2/9 DOI: 10.13063/2327-9214.1142,Non-OADS,/arxiv_data1/oa_pdf/fd/80/egems1142.PMC4537153.pdf
9 http://repository.academyhealth.org/egems/vol3/iss2/9 DOI: 10.13063/2327-9214.1142,Non-OADS,/arxiv_data1/oa_pdf/fd/80/egems1142.PMC4537153.pdf
9 http://repository.academyhealth.org/egems/vol3/iss2/9 DOI: 10.13063/2327-9214.1142,Non-OADS,/arxiv_data1/oa_pdf/fd/80/egems1142.PMC4537153.pdf
9 http://repository.academyhealth.org/egems/vol3/iss2/9 DOI: 10.13063/2327-9214.1142,Non-OADS,/arxiv_data1/oa_pdf/fd/80/egems1142.PMC4537153.pdf
9 http://repository.academyhealth.org/egems/vol3/iss2/9 DOI: 10.13063/2327-9214.1142,Non-OADS,/arxiv_data1/oa_pdf/fd/80/egems1142.PMC4537153.pdf
9 http://repository.academyhealth.org/egems/vol3/iss2/9 DOI: 10.13063/2327-9214.1142,Non-OADS,/arxiv_data1/oa_pdf/fd/80/egems1142.PMC4537153.pdf
6 http://repository.academyhealth.org/egems/vol3/iss2/6 DOI: 10.13063/2327-9214.1136,Non-OADS,/arxiv_data1/oa_pdf/f8/df/egems1136.PMC4537154.pdf
6 http://repository.academyhealth.org/egems/vol3/iss2/6 DOI: 10.13063/2327-9214.1136,Non-OADS,/arxiv_data1/oa_pdf/f8/df/egems1136.PMC4537154.pdf
6 http://repository.academyhealth.org/egems/vol3/iss2/6 DOI: 10.13063/2327-9214.1136,Non-OADS,/arxiv_data1/oa_pdf/f8/df/egems1136.PMC4537154.pdf
6 http://repository.academyhealth.org/egems/vol3/iss2/6 DOI: 10.13063/2327-9214.1136,Non-OADS,/arxiv_data1/oa_pdf/f8/df/egems1136.PMC4537154.pdf
6 http://repository.academyhealth.org/egems/vol3/iss2/6 DOI: 10.13063/2327-9214.1136,Non-OADS,/arxiv_data1/oa_pdf/f8/df/egems1136.PMC4537154.pdf
6 http://repository.academyhealth.org/egems/vol3/iss2/6 DOI: 10.13063/2327-9214.1136,Non-OADS,/arxiv_data1/oa_pdf/f8/df/egems1136.PMC4537154.pdf
6 http://repository.academyhealth.org/egems/vol3/iss2/6 DOI: 10.13063/2327-9214.1136,Non-OADS,/arxiv_data1/oa_pdf/f8/df/egems1136.PMC4537154.pdf
"The remaining unmappedreads were subsequently analyzed by Nucleotide BLAST against the database (GenBank Release 191) from the National Center for Biotechnology Information (http://www.ncbi.nlm.nih.gov/genbank /), with a cutoff E-value of ,1e ;20 and hit length of .80 bases.",OADS,/arxiv_data1/oa_pdf/d5/73/NEURIMMINFL2014003863.PMC4537311.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2b/3d/bhu052.PMC4537421.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/64/8d/bhu077.PMC4537432.pdf
"Published by Oxford University Press.This is an Open Access article distributed under the terms of the Creative Commons Attributio n Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provi ded the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b0/4c/bhu082.PMC4537433.pdf
Supplementary Material Supplementary material can be found at: http://www.cercor.oxford journals.org/.,Non-OADS,/arxiv_data1/oa_pdf/b0/4c/bhu082.PMC4537433.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f1/e4/bhu095.PMC4537441.pdf
Supplementary Material Supplementary material can be found at: http://www.cercor.oxford journals.org/ Funding MPvdH is supported by a Fellowship of the Brain Center Rudolf Magnus and a VENI grant of the Dutch Council for Re-search (VENI: 451-12-001 NWO).,Non-OADS,/arxiv_data1/oa_pdf/f1/e4/bhu095.PMC4537441.pdf
"Chomnawang) 10  October 2014 http://dx.doi.org/10.1016/j.ijantimicag.2015.01.005 Trimethoprim/sulfamethoxazole  resistance  in clinical  isolates  of  Burkholderia  pseudomallei from  Thailand Sir, Burkholderia pseudomallei  is  the  cause  of  melioidosis,  a  seri- ous  infection associated with a  mortality  rate  of  14–43%  [1].",Non-OADS,/arxiv_data1/oa_pdf/0a/4e/main.PMC4537509.pdf
"Supplementary  data Supplementary  data  associated  with  this  article  can  be found,  in  the  online  version,  at  http://dx.doi.org/10.1016/ j.ijantimicag.2015.01.006 .",OADS,/arxiv_data1/oa_pdf/0a/4e/main.PMC4537509.pdf
"E-mail address: narisara@tropmedres.ac  (N.  Chantratita) 22  January  2015 27 January  2015 http://dx.doi.org/10.1016/j.ijantimicag.2015.01.006 Changing  antimicrobial  resistance  patterns  and trends  of  Shigella  isolates  in  Ningbo,  mid-east China,  2005–2013 Sir Presently, the  increase  in  antimicrobial-resistant  Shigella  iso- lates  has  been  greatly  crippling  the  treatment  of  shigellosis.",Non-OADS,/arxiv_data1/oa_pdf/0a/4e/main.PMC4537509.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribu - tion-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncom - mercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/33/c0/jjm-08-05-19279.PMC4537521.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribu - tion-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncom - mercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/ab/1d/jjm-08-05-17430.PMC4537522.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/35/7c/num-07-03-27233.PMC4537598.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/39/72/num-07-03-26760.PMC4537599.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/04/4b/num-07-03-27253.PMC4537616.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/25/16/num-07-03-27107.PMC4537641.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Carapetis JR, McDonald M, Wilson NJ.",Non-OADS,/arxiv_data1/oa_pdf/ac/ef/heartasia-2015-010641.PMC4537650.pdf
2005. http://www.undp.or.id/papua/docs/PNA_en.pdf (accessed11 Jun 2015).,Non-OADS,/arxiv_data1/oa_pdf/ac/ef/heartasia-2015-010641.PMC4537650.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/fc/be/ircmj-17-06-28238.PMC4537783.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/d1/a2/ircmj-17-06-23638.PMC4537784.pdf
Available from: http://aids.ir/userfiles/files/Report%20HIV- AIDS%20END91.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d1/a2/ircmj-17-06-23638.PMC4537784.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/6c/3a/ircmj-17-06-23324.PMC4537785.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/c8/d4/ircmj-17-06-27504.PMC4537786.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/93/29/ircmj-17-06-20705.PMC4537787.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/ae/2b/ircmj-17-06-25831.PMC4537788.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/69/ab/ircmj-17-06-18780.PMC4537789.pdf
"For a complete list of the antibodies in this array, please see the following link: http://www.rndsystems.com/product_detail_objectname_kinaseantibodyarray.aspx.",OADS,/arxiv_data1/oa_pdf/04/eb/onc2014473a.PMC4537852.pdf
", SuperCurve: SuperCurve Package, R package version 1.4.1.2011) as described.60The protein expression data (RPPA) for breast, lung, kidney and bladder cancers samples were downloaded from the TCPAwebsite (http://bioinformatics.mdanderson.org/main/TCPA).",OADS,/arxiv_data1/oa_pdf/04/eb/onc2014473a.PMC4537852.pdf
The statistical differences between curves were calculated using ‘compareGrowthCurves ’ function of the StatMod software (http://bioinf.wehi.edu.au/software/compareCurves) for IVIS metastatic tumor growth curves.,OADS,/arxiv_data1/oa_pdf/04/eb/onc2014473a.PMC4537852.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)p27 promotes tumor metastasis via Twist1 upregulation D Zhao et al 5459 © 2015 Macmillan Publishers Limited Oncogene (2015) 5447 –5459",Non-OADS,/arxiv_data1/oa_pdf/04/eb/onc2014473a.PMC4537852.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0a/1d/main.PMC4537859.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2015) 22, 585–590 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2015.06.029 1319-562X ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/0a/1d/main.PMC4537859.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0a/1d/main.PMC4537859.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2015) 22, 645–650 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2015.04.011 1319-562X ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/1d/ab/main.PMC4537860.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1d/ab/main.PMC4537860.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1d/ab/main.PMC4537860.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2015) 22, 513 –520 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2014.08.003 1319-562X ª2014 Production and hosting by Elsevier B.V. on behalf of King Saud University.",Non-OADS,/arxiv_data1/oa_pdf/aa/8a/main.PMC4537861.pdf
2011 http://www.ats-sea.agr.gc.ca/afr/pdf/5699-eng.pdf .,Non-OADS,/arxiv_data1/oa_pdf/aa/8a/main.PMC4537861.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2015) 22, 543–550 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2015.01.002 1319-562X ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/84/3d/main.PMC4537862.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/84/3d/main.PMC4537862.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/84/3d/main.PMC4537862.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/54/c8/main.PMC4537863.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2015) 22, 580–584 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2015.01.015 1319-562X ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/54/c8/main.PMC4537863.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/54/c8/main.PMC4537863.pdf
Available at: http://www.serd.ait.ac.th/ (20.12.12).,Non-OADS,/arxiv_data1/oa_pdf/54/c8/main.PMC4537863.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ee/93/main.PMC4537864.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2015) 22, 570–574 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2015.04.008 1319-562X ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/ee/93/main.PMC4537864.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ee/93/main.PMC4537864.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2015) 22, 551–555 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2014.11.023 1319-562X ª2014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/c9/d6/main.PMC4537865.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c9/d6/main.PMC4537865.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c9/d6/main.PMC4537865.pdf
"Nature Publishing Group, London, < http://www.els.net/ >.",Non-OADS,/arxiv_data1/oa_pdf/c9/d6/main.PMC4537865.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1f/ab/main.PMC4537866.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2015) 22, 600–603 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2015.06.013 1319-562X ª2015 Production and hosting by Elsevier B.V. on behalf of King Saud University.",Non-OADS,/arxiv_data1/oa_pdf/1f/ab/main.PMC4537866.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1f/ab/main.PMC4537866.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2015) 22, 556–563 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2015.02.012 1319-562X ª2015 Production and hosting by Elsevier B.V. on behalf of King Saud University.",Non-OADS,/arxiv_data1/oa_pdf/9b/98/main.PMC4537867.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9b/98/main.PMC4537867.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9b/98/main.PMC4537867.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2015) 22, 604–609 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2014.12.006 1319-562X ª2014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/4c/64/main.PMC4537868.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4c/64/main.PMC4537868.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4c/64/main.PMC4537868.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2015) 22, 610–622 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2015.01.012 1319-562X ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/4c/5c/main.PMC4537869.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4c/5c/main.PMC4537869.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4c/5c/main.PMC4537869.pdf
"Gene Ontology (GO) WebGestalt server for functional enrichment We used WebGestalt, WEB-based GEne SeT AnaLysis Toolkit (available at http://bioinfo.vanderbilt.edu/webgestalt/ ) (Zhang et al., 2005 ) for GO enrichment analysis of the common prioritized genes and the interactors in the protein network.",OADS,/arxiv_data1/oa_pdf/4c/5c/main.PMC4537869.pdf
"Further, we have used KOBAS (KEGG Orthology Based Annotation System, avail- able at http://kobas.cbi.pku.edu.cn/home.do )(Xie et al., 2011) to perform KEGG database based enrichment analysis of the prioritized genes obtained using housekeeping and ALL speciﬁc training genes.",OADS,/arxiv_data1/oa_pdf/4c/5c/main.PMC4537869.pdf
http://dx.doi.org/10.1080/ 07391102.07392014.07998710 .,Non-OADS,/arxiv_data1/oa_pdf/4c/5c/main.PMC4537869.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ab/c7/main.PMC4537870.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2015) 22, 575–579 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2015.05.011 1319-562X ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/ab/c7/main.PMC4537870.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ab/c7/main.PMC4537870.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/10/99/main.PMC4537871.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2015) 22, 526–531 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2015.01.006 1319-562X ª2015 The Author.",Non-OADS,/arxiv_data1/oa_pdf/10/99/main.PMC4537871.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/10/99/main.PMC4537871.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/01/d1/main.PMC4537872.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2015) 22, 631–636 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2015.02.003 1319-562X ª2015 The Author.",Non-OADS,/arxiv_data1/oa_pdf/01/d1/main.PMC4537872.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/01/d1/main.PMC4537872.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f0/61/main.PMC4537873.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2015) 22, 637–644 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2015.01.007 1319-562X ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/f0/61/main.PMC4537873.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f0/61/main.PMC4537873.pdf
"12, 2. http://dx.doi.org/ 10.1186/1477-3155-12-2 .",Non-OADS,/arxiv_data1/oa_pdf/f0/61/main.PMC4537873.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b7/d7/main.PMC4537874.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2015) 22, 532–538 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2015.01.011 1319-562X ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/b7/d7/main.PMC4537874.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b7/d7/main.PMC4537874.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/76/bb/main.PMC4537875.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2015) 22, 539–542 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2015.01.003 1319-562X ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/76/bb/main.PMC4537875.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/76/bb/main.PMC4537875.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b0/01/main.PMC4537876.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2015) 22, 656–663 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2015.06.002 1319-562X ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/b0/01/main.PMC4537876.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b0/01/main.PMC4537876.pdf
"FAO Cuts Wheat Production Forecast but Considers Supplies Adequate, < http://www.fao.org/news/story/tr/item/ 44570/icode/en/ >.",Non-OADS,/arxiv_data1/oa_pdf/b0/01/main.PMC4537876.pdf
"Plant 37, 1737. http://dx.doi.org/10.1007/s11738-014-1737-z .",Non-OADS,/arxiv_data1/oa_pdf/b0/01/main.PMC4537876.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3c/05/main.PMC4537877.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2015) 22, 564–569 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2015.03.003 1319-562X ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/3c/05/main.PMC4537877.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3c/05/main.PMC4537877.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.sjbs.2015.",OADS,/arxiv_data1/oa_pdf/3c/05/main.PMC4537877.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1e/4d/main.PMC4537878.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2015) 22, 623–630 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2015.01.010 1319-562X ª2015 Production and hosting by Elsevier B.V. on behalf of King Saud University.",Non-OADS,/arxiv_data1/oa_pdf/1e/4d/main.PMC4537878.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1e/4d/main.PMC4537878.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/44/02/main.PMC4537879.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2015) 22, 651–655 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2015.04.018 1319-562X ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/44/02/main.PMC4537879.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/44/02/main.PMC4537879.pdf
"The sequencing results were examined by Blast online compar-ison ( http://www.ncbi.nlm.nih.gov ) for identiﬁcation of the strains ( Stach et al., 2001 ).",OADS,/arxiv_data1/oa_pdf/44/02/main.PMC4537879.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e3/39/main.PMC4537880.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2015) 22, 521–525 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2015.04.006 1319-562X ª2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/e3/39/main.PMC4537880.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e3/39/main.PMC4537880.pdf
"10 (10), 47.http://dx.doi.org/10.1186/1472-6882-10-47 .",Non-OADS,/arxiv_data1/oa_pdf/e3/39/main.PMC4537880.pdf
http://dx.doi.org/10.1016/j .,OADS,/arxiv_data1/oa_pdf/e3/39/main.PMC4537880.pdf
"10, 132. http://dx.doi.org/ 10.4172/2327-5146.1000132 .",Non-OADS,/arxiv_data1/oa_pdf/e3/39/main.PMC4537880.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b7/0d/main.PMC4537881.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2015) 22, 591–599 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2015.06.027 1319-562X ª2015 Production and hosting by Elsevier B.V. on behalf of King Saud University.",Non-OADS,/arxiv_data1/oa_pdf/b7/0d/main.PMC4537881.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b7/0d/main.PMC4537881.pdf
http://dx.doi.org/10.1371/journal.pone.,Non-OADS,/arxiv_data1/oa_pdf/b7/0d/main.PMC4537881.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/15/3a/main.PMC4537883.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2015.07.020 2049-0801/ ©2015 Published by Elsevier Ltd on behalf of IJS Publishing Group Limited.,Non-OADS,/arxiv_data1/oa_pdf/15/3a/main.PMC4537883.pdf
MATERIALS AND METHODS The web-based survey launched by AMD has been avail-able from the homepage of the web-version of the journal Diabetes Care (http://care.diabetesjournals.org) throughout the month of December 2013.,Non-OADS,/arxiv_data1/oa_pdf/dd/0c/bmjdrc-2015-000109.PMC4537916.pdf
"Furthermore,the survey has been available on the AMD website (http://www.aemmedi.it) between December 2013 and September 2014.",OADS,/arxiv_data1/oa_pdf/dd/0c/bmjdrc-2015-000109.PMC4537916.pdf
"Online visibility of the algorithms In the online survey period and in the months after its conclusion, we registered a signi ﬁcant increase in the number of unique users who visited the websites of the AMD algorithms (http://www.aemmedi.it/algoritmi_it_ 2013 and http://www.aemmedi.it/algoritmi_en_2013/), as well as in the number of page views of the algorithms, and in the average time spent by visitors on algorithmspages, compared to the period preceding the survey (table 3 ).",OADS,/arxiv_data1/oa_pdf/dd/0c/bmjdrc-2015-000109.PMC4537916.pdf
"The study design implies that the results of the survey reﬂect the opinions of its participants; they could be sys- tematically different from the opinions of non-Table 3 Single accesses to the AMD algorithms websites and average time on site before and after the onlineadvertising initiative (http://www.aemmedi.it/algoritmi_it_2013/ and http://www.aemmedi.it/algoritmi_en_2013/) MonthUnique visitorsPage views Average time onsite Italian English Oct 2013 836 1971 298 4 05200 Nov 2013 1235 4056 789 805600 Dec 2013 (advertising)4726 6046 11 736 1202400 Jan 2014 8978 9897 14 054 1204400 Feb 2014 9912 17 613 16 827 1305600 Mar 2014 11 927 20 582 14 418 1402100 Apr 2014 9596 16 576 9026 1102700 May 2014 4467 11 347 1263 805600 Jun 2014 3189 10 921 854 602900 Jul 2014 2027 7625 1278 503100 Aug 2014 926 2398 981 400800 Sep 2014 1857 6538 258 404100 Oct 2014 2154 11 528 136 701700 Nov 2014 3127 10 327 318 800200 Dec 2014 2654 6428 278 501100 Jan 2015 1938 5238 326 402900 69 549 149 091 7284 801300 AMD, Italian Association of Diabetologists.",Non-OADS,/arxiv_data1/oa_pdf/dd/0c/bmjdrc-2015-000109.PMC4537916.pdf
"Global Guideline for Type 2 Diabetes, 2012. http://www.idf.org/global-guideline-type-2-diabetes-2012 (accessed 24 Feb 2015).",Non-OADS,/arxiv_data1/oa_pdf/dd/0c/bmjdrc-2015-000109.PMC4537916.pdf
2009. http://www.idf.org/guidelines/self-monitoring (accessed 24 Feb 2015).,Non-OADS,/arxiv_data1/oa_pdf/dd/0c/bmjdrc-2015-000109.PMC4537916.pdf
http://www.aemmedi.it/algoritmi_en_2014/ (accessed 24 Feb 2015).,Non-OADS,/arxiv_data1/oa_pdf/dd/0c/bmjdrc-2015-000109.PMC4537916.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjdrc-2015- 000114).,Non-OADS,/arxiv_data1/oa_pdf/4d/e7/bmjdrc-2015-000114.PMC4537917.pdf
"Data were submitted to the Leiden Open Variant Database (LOVD), under the following accession links: http://databases.lovd.nl/shared/individuals/ Patient 1: 00016140Patient 2: 00016141Patient 3: 00016142 Patient 4: 00016143 Patient 5: 00016144Patient 6: 00016145Patient 7: 00016146 Patient 8: 00016147 Patient 9: 00016148 Informed consent forms All laboratories provided additional information on their local informed consent procedures.",OADS,/arxiv_data1/oa_pdf/0d/84/ejhg2014279a.PMC4538197.pdf
"To view a copy of this license, visit http://creativeco mmons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on European Journal of Human Genetics website (http://www.nature.com/ejhg)NGS-based genome diagnostics implementation TV r i j e n h o e k et al 1150 European Journal of Human Genetics",Non-OADS,/arxiv_data1/oa_pdf/0d/84/ejhg2014279a.PMC4538197.pdf
"2 National Institute for Healt and Care Excellence (NICE): Familial breast cancer: Classi ﬁcation and care of people at risk of familial breast cancer and management of breast cancer and related risks in people with a family history of breast cancer 2013, http://publications.nice.org.uk/familial-breast-cancer-cg164.",Non-OADS,/arxiv_data1/oa_pdf/40/12/ejhg2014269a.PMC4538217.pdf
"10 Henneman L, Van Hoyweghen I Moving beyond public fear of genetic discrimination 2013, https://www.genevaassociation.org/media/77290/ga2013-health28-henneman- van_hoyweghen.pdf.",Non-OADS,/arxiv_data1/oa_pdf/40/12/ejhg2014269a.PMC4538217.pdf
"20 ABIM Foundation: Choosing wisely 2014, http://www.choosingwisely.org/.",Non-OADS,/arxiv_data1/oa_pdf/40/12/ejhg2014269a.PMC4538217.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Predictive genetic testing and right not to know AG Schuurman et al 1128 European Journal of Human Genetics",Non-OADS,/arxiv_data1/oa_pdf/40/12/ejhg2014269a.PMC4538217.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/d8/2b/bmjopen-2015-007921.PMC4538243.pdf
EPI-NYT 2013;20. http://www.ssi.dk/Aktuelt/Nyhedsbreve/EPI-NYT/2013/Uge%2020%20-%202013.aspx 16. http://www.statistikbanken.dk/statbank5a/default.asp?w=1280.,OADS,/arxiv_data1/oa_pdf/d8/2b/bmjopen-2015-007921.PMC4538243.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015-008048).,Non-OADS,/arxiv_data1/oa_pdf/94/4a/bmjopen-2015-008048.PMC4538244.pdf
"Trial register and Directory of Open-Access repository websites including http://www.ClinicalTrials.gov, http://www.who.int/trialsearch/ and http://www.",OADS,/arxiv_data1/oa_pdf/4d/96/bmjopen-2015-008036.PMC4538245.pdf
http://www.who.int/chp 4.,Non-OADS,/arxiv_data1/oa_pdf/4d/96/bmjopen-2015-008036.PMC4538245.pdf
2011. http://www.cdc.gov/chronicdisease/resources/publications/AAG/obesity.htm 6.,Non-OADS,/arxiv_data1/oa_pdf/4d/96/bmjopen-2015-008036.PMC4538245.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015-007885).,Non-OADS,/arxiv_data1/oa_pdf/4d/e2/bmjopen-2015-007885.PMC4538246.pdf
2010. http://www.who.int/bulletin/volumes/88/4/10-040410/en/index.html 2.,Non-OADS,/arxiv_data1/oa_pdf/4d/e2/bmjopen-2015-007885.PMC4538246.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2015-007794).,Non-OADS,/arxiv_data1/oa_pdf/b1/ea/bmjopen-2015-007794.PMC4538248.pdf
Data sharing statement There ICCP-2010 data set is available from the Irish Social Science Data Archive: http://www.ucd.ie/issda/ The survey questionnaire is available at: http://www.ucd.ie/t4cms/ICCP_2010_-_main_questionnaire.pdf.,OADS,/arxiv_data1/oa_pdf/b1/ea/bmjopen-2015-007794.PMC4538248.pdf
2013. http://www.un.,Non-OADS,/arxiv_data1/oa_pdf/b1/ea/bmjopen-2015-007794.PMC4538248.pdf
2014. http://www.ons.gov.uk/ons/rel/vsob1/marriages-in-england-and-wales--provisional-/2012/index.html(accessed 16 Dec 2014).,Non-OADS,/arxiv_data1/oa_pdf/b1/ea/bmjopen-2015-007794.PMC4538248.pdf
1980. http://www.irishstatutebook.ie/1980/en/si/0248.html (accessed 16Dec 2014).,Non-OADS,/arxiv_data1/oa_pdf/b1/ea/bmjopen-2015-007794.PMC4538248.pdf
2011. http://www.rte.ie/news/2011/0216/297748-pill/ (accessed 16 Dec 2014).,Non-OADS,/arxiv_data1/oa_pdf/b1/ea/bmjopen-2015-007794.PMC4538248.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-008152).,Non-OADS,/arxiv_data1/oa_pdf/28/d9/bmjopen-2015-008152.PMC4538249.pdf
2015[http://www.albertanetcare.,Non-OADS,/arxiv_data1/oa_pdf/28/d9/bmjopen-2015-008152.PMC4538249.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015-007945).,Non-OADS,/arxiv_data1/oa_pdf/7a/bd/bmjopen-2015-007945.PMC4538250.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2015-008058).,Non-OADS,/arxiv_data1/oa_pdf/12/bf/bmjopen-2015-008058.PMC4538251.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/12/bf/bmjopen-2015-008058.PMC4538251.pdf
http://www.who.int/mental_health/suicide-prevention/world_report_2014 (accessed 1 June 2015).,Non-OADS,/arxiv_data1/oa_pdf/46/4c/bmjopen-2015-008261.PMC4538253.pdf
National Census 2010. http://www.e-stat.go.jp/SG1/estat/GL08020103.do?_toGL08020103_&tclassID=000001038689&cycleCode=0&requestSender=estat (accessed 1 Jun 2015).,OADS,/arxiv_data1/oa_pdf/46/4c/bmjopen-2015-008261.PMC4538253.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 008672).,Non-OADS,/arxiv_data1/oa_pdf/c5/d7/bmjopen-2015-008672.PMC4538254.pdf
2015. http://data.worldbank.org/country/austria 14.,Non-OADS,/arxiv_data1/oa_pdf/c5/d7/bmjopen-2015-008672.PMC4538254.pdf
2015. http://data.worldbank.org/country/slovak-republic 15.,Non-OADS,/arxiv_data1/oa_pdf/c5/d7/bmjopen-2015-008672.PMC4538254.pdf
2015. http://data.worldbank.org/indicator/NY.GNP.PCAP.PP.CD 16.,Non-OADS,/arxiv_data1/oa_pdf/c5/d7/bmjopen-2015-008672.PMC4538254.pdf
2015. http://ec.europa.eu/eurostat/tgm/table.do?tab=table&init=1&language=en&pcode=tec00114&plugin=1 17.,Non-OADS,/arxiv_data1/oa_pdf/c5/d7/bmjopen-2015-008672.PMC4538254.pdf
2013. http://www.R-project.org/ 18.,Non-OADS,/arxiv_data1/oa_pdf/c5/d7/bmjopen-2015-008672.PMC4538254.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/c9/ae/bmjopen-2015-008697.PMC4538256.pdf
http://onlinelibrary.wiley.com/doi/10.1002/14651858.,Non-OADS,/arxiv_data1/oa_pdf/c9/ae/bmjopen-2015-008697.PMC4538256.pdf
http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD011165/abstract 62.,Non-OADS,/arxiv_data1/oa_pdf/c9/ae/bmjopen-2015-008697.PMC4538256.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 008546).,Non-OADS,/arxiv_data1/oa_pdf/98/93/bmjopen-2015-008546.PMC4538258.pdf
"Academy of Medical Royal Colleges, 2013. http://www.aomrc.org.uk/projects/obesity-steering-group.html (accessed 15 Jan 2014).",Non-OADS,/arxiv_data1/oa_pdf/98/93/bmjopen-2015-008546.PMC4538258.pdf
"Report of a working party.Royal College of Physicians, 2013. https://www.rcplondon.ac.uk/resources/action-obesity-comprehensive-care-all (accessed Apr2014).",Non-OADS,/arxiv_data1/oa_pdf/98/93/bmjopen-2015-008546.PMC4538258.pdf
"NICE, 2014. http://www.nice.org.uk/ (accessed 1 Sep 2014).",Non-OADS,/arxiv_data1/oa_pdf/98/93/bmjopen-2015-008546.PMC4538258.pdf
"NICE, 2014. http://www.nice.org.uk/guidance/ph53 (accessed 18 Aug 2014).",Non-OADS,/arxiv_data1/oa_pdf/98/93/bmjopen-2015-008546.PMC4538258.pdf
http://www.nice.org.uk/guidance/ph1 (accessed 30 Jun 2015).,Non-OADS,/arxiv_data1/oa_pdf/98/93/bmjopen-2015-008546.PMC4538258.pdf
http://www.nice.org.uk/guidance/ph24 (accessed 30 Jun 2015).,Non-OADS,/arxiv_data1/oa_pdf/98/93/bmjopen-2015-008546.PMC4538258.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015-008657).,Non-OADS,/arxiv_data1/oa_pdf/95/cc/bmjopen-2015-008657.PMC4538259.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/4a/07/bmjopen-2015-008306.PMC4538262.pdf
2011. http://www.abs.gov.au (cited 20 January 2014).,Non-OADS,/arxiv_data1/oa_pdf/4a/07/bmjopen-2015-008306.PMC4538262.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015-008265).,Non-OADS,/arxiv_data1/oa_pdf/f9/40/bmjopen-2015-008265.PMC4538263.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-007336).,Non-OADS,/arxiv_data1/oa_pdf/13/51/bmjopen-2014-007336.PMC4538264.pdf
"Washington, DC: Georgetown University, 2010. https://georgetown.box.com/s/wntf7bah8ls1vbbg6ar3 24.",Non-OADS,/arxiv_data1/oa_pdf/13/51/bmjopen-2014-007336.PMC4538264.pdf
To view these filesplease visit the journal (http://dx.doi.org/10.1136/ bmjopen-2015-007628).,Non-OADS,/arxiv_data1/oa_pdf/54/73/bmjopen-2015-007628.PMC4538265.pdf
"Competing interests Both authors have completed the ICMJE uniform disclosure form at http://www.icmje.org/coi_disclosure.pdf and declare: DG received a research grant from Cancer Care Ontario to support the submitted work; LN was paid from the Cancer Care Ontario grant to participate as aco-investigator and co-develop methods, conduct interviews with participants, assist in data analysis and recommendation development, and assist with dissemination activities; both authors have no financial relationships with anyorganisations that might have an interest in the submitted work in the previous 3 years; no other relationships or activities that could appear to have influenced the submitted work.",Non-OADS,/arxiv_data1/oa_pdf/54/73/bmjopen-2015-007628.PMC4538265.pdf
doi:10.1136/bmjopen-2015- 008573 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-008573).,Non-OADS,/arxiv_data1/oa_pdf/b1/0e/bmjopen-2015-008573.PMC4538267.pdf
http://www.cdc.gov/ physicalactivity/data/facts.html (accessed 13 Apr 2015).,OADS,/arxiv_data1/oa_pdf/b1/0e/bmjopen-2015-008573.PMC4538267.pdf
"IASP, 2010. http://www.iasp-pain.org/DeclarationofMontreal (accessed 17 June 2015).",Non-OADS,/arxiv_data1/oa_pdf/75/f3/bmjopen-2014-006984.PMC4538268.pdf
Dec 2010. http://healthsocialaccountability.org (accessed 17 Jun 2015).,Non-OADS,/arxiv_data1/oa_pdf/75/f3/bmjopen-2014-006984.PMC4538268.pdf
June 2013. http://www.efic.org/index.asp?sub=40275570 Ac7l08 (accessed 17 Jun 2015).,Non-OADS,/arxiv_data1/oa_pdf/75/f3/bmjopen-2014-006984.PMC4538268.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2015-008375).,Non-OADS,/arxiv_data1/oa_pdf/a8/5c/bmjopen-2015-008375.PMC4538270.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/a8/5c/bmjopen-2015-008375.PMC4538270.pdf
19. http://www.tillotts.com/tillots-services/case-studies/colpermin (accessed 12 Dec 2014).,Non-OADS,/arxiv_data1/oa_pdf/a8/5c/bmjopen-2015-008375.PMC4538270.pdf
doi:10.1136/bmjopen-2015- 007581 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-007581).,Non-OADS,/arxiv_data1/oa_pdf/d8/6b/bmjopen-2015-007581.PMC4538271.pdf
Data sharing statement Additional data can be accessed via the Dryad data repository at http://datadryad.org/ with the doi:10.5061/dryad.4bv57.,OADS,/arxiv_data1/oa_pdf/d8/6b/bmjopen-2015-007581.PMC4538271.pdf
Unesco inscribed the Mediterranean diet in 2010 and again in 2013 on the list of the Intangible Cultural Heritage ofHumanity (http://www.unesco.org/culture/ich/index.,Non-OADS,/arxiv_data1/oa_pdf/87/13/bmjopen-2015-008222.PMC4538272.pdf
2013. http://www.idf.org/diabetesatlas (accessed 10 Feb 2015).,Non-OADS,/arxiv_data1/oa_pdf/87/13/bmjopen-2015-008222.PMC4538272.pdf
http://www.health.gov/dietaryguidelines/ 2015-scientific-report/07-chapter-2/ 31.,Non-OADS,/arxiv_data1/oa_pdf/87/13/bmjopen-2015-008222.PMC4538272.pdf
"CensusBureau Reports, 2013. http://www.census.gov/newsroom/releases/archives/population/cb13 –112.html (accessed 18 Aug 2014).",OADS,/arxiv_data1/oa_pdf/a0/6a/bmjopen-2014-007232.PMC4538273.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 008958).,Non-OADS,/arxiv_data1/oa_pdf/c8/d8/bmjopen-2015-008958.PMC4538275.pdf
"If our study ﬁndings are positive, we will enlist assistance from the Law Enforcement and HIV Network (http://www.leahn.org) to widely disseminate our PEP materials as a potential model for othercountries.",Non-OADS,/arxiv_data1/oa_pdf/c8/d8/bmjopen-2015-008958.PMC4538275.pdf
Global Comission Drug Policy 2012. http://globalcommissionondrugs.org/ wp-content/themes/gcdp_v1/pdf/GCDP_HIV-AIDS_2012_REFERENCE.pdf (last accessed 13 May 2015).,Non-OADS,/arxiv_data1/oa_pdf/c8/d8/bmjopen-2015-008958.PMC4538275.pdf
"Auditoría al SNSP, 2007. http://www.asf.gob.mx/Trans/Informes/ir2007i/indice.",Non-OADS,/arxiv_data1/oa_pdf/c8/d8/bmjopen-2015-008958.PMC4538275.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2014-007429).,Non-OADS,/arxiv_data1/oa_pdf/62/70/bmjopen-2014-007429.PMC4538277.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/62/70/bmjopen-2014-007429.PMC4538277.pdf
2014. http://www.ipaq.ki.se/scoring.pdf (accessed 10 Dec 2014).,Non-OADS,/arxiv_data1/oa_pdf/62/70/bmjopen-2014-007429.PMC4538277.pdf
1997. http://www.who.int/nutrition/publications/obesity_executive_summary.pdf (accessed 10 Dec 2014).,Non-OADS,/arxiv_data1/oa_pdf/62/70/bmjopen-2014-007429.PMC4538277.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 008566).,Non-OADS,/arxiv_data1/oa_pdf/b5/f6/bmjopen-2015-008566.PMC4538278.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/b5/f6/bmjopen-2015-008566.PMC4538278.pdf
http://www.utmb.edu/olivercenter/projects/current/pvr_1.asp (accessed 14 Mar 2015).,Non-OADS,/arxiv_data1/oa_pdf/b5/f6/bmjopen-2015-008566.PMC4538278.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2015-008938).,Non-OADS,/arxiv_data1/oa_pdf/e3/e1/bmjopen-2015-008938.PMC4538285.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2015-009097).,Non-OADS,/arxiv_data1/oa_pdf/b6/42/bmjopen-2015-009097.PMC4538286.pdf
http://www.connectingforhealth.nhs.uk/systemsandservices/data/uktc/readcodes 17.,Non-OADS,/arxiv_data1/oa_pdf/15/5c/bmjopen-2015-008365.PMC4538287.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-007034).,Non-OADS,/arxiv_data1/oa_pdf/be/b9/bmjopen-2014-007034.PMC4538290.pdf
http://www.smhi.se/airviro/ modules/ 30.,Non-OADS,/arxiv_data1/oa_pdf/be/b9/bmjopen-2014-007034.PMC4538290.pdf
"Available at: http://usir.salford.a- c.uk/29319/ Hammond A, Woodbridge S, O’Brein R, et al.",Non-OADS,/arxiv_data1/oa_pdf/06/1f/10.1177_0308022615581312.PMC4538318.pdf
"For more detailed information onSAGE’s policy for self-archiving, see https://us.sagepub.com/en-us/nam/author-information.",Non-OADS,/arxiv_data1/oa_pdf/a3/b0/10.1177_0308022615599175.PMC4538319.pdf
Available at: http://www.researchinfonet.org/publish/finch/ (accessed 27 July 2015).,Non-OADS,/arxiv_data1/oa_pdf/a3/b0/10.1177_0308022615599175.PMC4538319.pdf
Available at: http://www.hefce.ac.uk/pubs/year/ 2014/201407/ (accessed 25 July 2015).,Non-OADS,/arxiv_data1/oa_pdf/a3/b0/10.1177_0308022615599175.PMC4538319.pdf
Available at: http://journals.plos.org/plosone/article?id ¼10.1371/journal.pone.,Non-OADS,/arxiv_data1/oa_pdf/a3/b0/10.1177_0308022615599175.PMC4538319.pdf
Available at: http://www.rcuk.ac.uk/research/openaccess/policy/ (accessed 27 July 2015).,Non-OADS,/arxiv_data1/oa_pdf/a3/b0/10.1177_0308022615599175.PMC4538319.pdf
Available at: http://www.theguardian.com/higher-education-network/blog/2013/oct/21/open-access-myths-peter-suber-harvard (accessed 27 July 2015).,Non-OADS,/arxiv_data1/oa_pdf/a3/b0/10.1177_0308022615599175.PMC4538319.pdf
Sage Choice (2015) Available at: http://www.sagepub.com/oa/ choice.cp (accessed 27 July 2015).,Non-OADS,/arxiv_data1/oa_pdf/a3/b0/10.1177_0308022615599175.PMC4538319.pdf
Available at: http://www.sparc.arl.org/sites/default/files/Open%20Access%20Fact%20Sheet.pdf(accessed 27 July 2015).466 British Journal of Occupational Therapy 78(8),Non-OADS,/arxiv_data1/oa_pdf/a3/b0/10.1177_0308022615599175.PMC4538319.pdf
"Nonetheless, this study offers support that omega-3 supplementation may be an effective augmentation for pharmacological treatments of ADHD (NCT01554462: The Effects of EPA/DHA Supplementation on Cognitive Control in Children with ADHD; http://clinicaltrials.gov/show/NCT01554462).Neuropsychopharmacology (2015) 40,2298–2306; doi:10.1038/npp.2015.73; published online 22 April 2015/C12/C12/C12/C12/C12/C12/C12/C12/C12/C12/C12/C12/C12/C12/C12/C12/C12/C12/C12/C12/C12/C12/C12/C12/C12/C12/C12/C12/C12/C12/C12/C12/C12/C12/C12/C12/C12/C12/C12/C12/C12/C12/C12/C12/C12/C12/C12/C12/C12/C12/C12/C12/C12/C12/C12/C12/C12/C12 INTRODUCTION Attention deficit/hyperactivity disorder (ADHD) is one of the most common child psychiatric disorders and is characterizedby symptoms of inattention, hyperactivity, and impulsivity(American Psychiatric Association, 1994).",Non-OADS,/arxiv_data1/oa_pdf/84/44/npp201573a.PMC4538345.pdf
"To view a copy of this license,visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies the paper on the Neuropsychopharmacology website (http://www.nature.com/npp)Omega-3 fatty acids in children with ADHD DJ Bos et al 2306 Neuropsychopharmacology",Non-OADS,/arxiv_data1/oa_pdf/84/44/npp201573a.PMC4538345.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies the paper on the Neuropsychopharmacology website (http://www.nature.com/npp)SERM increases hippocampal activity during learning J Kindler et al 2397 Neuropsychopharmacology",Non-OADS,/arxiv_data1/oa_pdf/25/61/npp201588a.PMC4538353.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/lupus-2015- 000104).,Non-OADS,/arxiv_data1/oa_pdf/8b/f5/lupus-2015-000104.PMC4538379.pdf
22. http://www.whocc.no/ddd/definition_and_general_considera/ (5 December 2014).,Non-OADS,/arxiv_data1/oa_pdf/eb/17/openhrt-2015-000288.PMC4538388.pdf
"Address correspondence to Preethi Krishnan, preethi.krishnan@abbvie.com.Supplemental material for this article may be found at http://dx.doi.org/10.1128 /AAC.00998-15 .",Non-OADS,/arxiv_data1/oa_pdf/81/ff/zac5445.PMC4538512.pdf
http://dx.doi.org/10.1111/j.1469-0691.2010 .03432.x .,Non-OADS,/arxiv_data1/oa_pdf/81/ff/zac5445.PMC4538512.pdf
http://dx.doi.org/10.1002/hep.26744 .,Non-OADS,/arxiv_data1/oa_pdf/81/ff/zac5445.PMC4538512.pdf
http://dx.doi.org/10.1099/vir .0.80401-0 .,Non-OADS,/arxiv_data1/oa_pdf/81/ff/zac5445.PMC4538512.pdf
Lancet 384: 414 – 426. http://dx.doi.org/10.1016/S0140-6736(14)60538-9 .,OADS,/arxiv_data1/oa_pdf/81/ff/zac5445.PMC4538512.pdf
http://dx.doi.org/10.1056/NEJMoa1306227 .,OADS,/arxiv_data1/oa_pdf/81/ff/zac5445.PMC4538512.pdf
http://dx.doi.org/10.1128/AAC.04227-14 .,Non-OADS,/arxiv_data1/oa_pdf/81/ff/zac5445.PMC4538512.pdf
http://dx.doi.org/10.1128/AAC.04226-14 .,Non-OADS,/arxiv_data1/oa_pdf/81/ff/zac5445.PMC4538512.pdf
http://dx.doi.org/10.1016/S0168-8278(10) 60764-7 .,OADS,/arxiv_data1/oa_pdf/81/ff/zac5445.PMC4538512.pdf
http://dx.doi .org/10.1128/AAC.04619-14 .,Non-OADS,/arxiv_data1/oa_pdf/81/ff/zac5445.PMC4538512.pdf
http://dx.doi.org/10.1093 /nar/gkl970 .,Non-OADS,/arxiv_data1/oa_pdf/81/ff/zac5445.PMC4538512.pdf
Antiviral Res 73:40 – 49. http://dx.doi.org/10 .1016/j.antiviral.2006.07.005 .,OADS,/arxiv_data1/oa_pdf/81/ff/zac5445.PMC4538512.pdf
Antimi-crob Agents Chemother 49:4305– 4314. http://dx.doi.org/10.1128/AAC .49.10.4305-4314.2005 .,Non-OADS,/arxiv_data1/oa_pdf/81/ff/zac5445.PMC4538512.pdf
http://dx.doi.org/10.1021/jm401398x .,Non-OADS,/arxiv_data1/oa_pdf/81/ff/zac5445.PMC4538512.pdf
Methods Mol Biol 537:39 – 64. http://dx.doi.org/10 .1007/978-1-59745-251-9_3 .,OADS,/arxiv_data1/oa_pdf/81/ff/zac5445.PMC4538512.pdf
http://dx.doi.org/10.1007/BF02101694 .,Non-OADS,/arxiv_data1/oa_pdf/81/ff/zac5445.PMC4538512.pdf
http://dx.doi.org/10.1093 /bioinformatics/bts199 .,Non-OADS,/arxiv_data1/oa_pdf/81/ff/zac5445.PMC4538512.pdf
http://dx.doi.org/10.1093/molbev/msr121 .,Non-OADS,/arxiv_data1/oa_pdf/81/ff/zac5445.PMC4538512.pdf
J Infect Dis 211:1288 – 1295. http://dx.doi.org/10.1093/infdis/jiu613 .,OADS,/arxiv_data1/oa_pdf/81/ff/zac5445.PMC4538512.pdf
http://dx.doi.org /10.1053/j.gastro.2014.04.045 .,OADS,/arxiv_data1/oa_pdf/81/ff/zac5445.PMC4538512.pdf
http://dx.doi.org/10.1056/NEJMoa1315722 .,OADS,/arxiv_data1/oa_pdf/81/ff/zac5445.PMC4538512.pdf
N Engl J Med 370:1983– 1992. http://dx.doi.org/10.1056/NEJMoa1402338 .,OADS,/arxiv_data1/oa_pdf/81/ff/zac5445.PMC4538512.pdf
http://dx.doi.org /10.1056/NEJMoa1402869 .,OADS,/arxiv_data1/oa_pdf/81/ff/zac5445.PMC4538512.pdf
http://dx.doi.org/10.1056/NEJMoa1401561 .Krishnan et al.,OADS,/arxiv_data1/oa_pdf/81/ff/zac5445.PMC4538512.pdf
"Address correspondence to Anna Gillman, anna.gillman@medsci.uu.se.Supplemental material for this article may be found at http://dx.doi.org/10.1128 /AAC.00886-15 .",Non-OADS,/arxiv_data1/oa_pdf/24/c4/zac5196.PMC4538561.pdf
All avian N9 sequences available from the NCBI Inﬂuenza Virus Resource da-tabase ( 44)(http://www.ncbi.nlm.nih.gov/genomes/FLU/FLU.html ) were downloaded on 15 February 2015 and aligned with BioEdit v7.2.5software.,OADS,/arxiv_data1/oa_pdf/24/c4/zac5196.PMC4538561.pdf
http://dx.doi.org/10.1371/journal.pone.0008935 .,Non-OADS,/arxiv_data1/oa_pdf/24/c4/zac5196.PMC4538561.pdf
http://dx.doi.org /10.1098/rspb.2008.1501 .,Non-OADS,/arxiv_data1/oa_pdf/24/c4/zac5196.PMC4538561.pdf
http://dx.doi.org/10.1371/journal.ppat.1000076 .,Non-OADS,/arxiv_data1/oa_pdf/24/c4/zac5196.PMC4538561.pdf
http://dx.doi.org/10.1126/science.1122438 .,Non-OADS,/arxiv_data1/oa_pdf/24/c4/zac5196.PMC4538561.pdf
http://dx.doi.org/10.1016/S0140-6736(13)60938-1 .,OADS,/arxiv_data1/oa_pdf/24/c4/zac5196.PMC4538561.pdf
http://dx.doi.org/10 .1017/S1466252310000071 .,Non-OADS,/arxiv_data1/oa_pdf/24/c4/zac5196.PMC4538561.pdf
http://dx.doi.org/10.1146/annurev -med-010714-112311 .,Non-OADS,/arxiv_data1/oa_pdf/24/c4/zac5196.PMC4538561.pdf
http://dx.doi .org/10.1038/nature12515 .,Non-OADS,/arxiv_data1/oa_pdf/24/c4/zac5196.PMC4538561.pdf
http://dx.doi.org/10.1038/nature12392 .,Non-OADS,/arxiv_data1/oa_pdf/24/c4/zac5196.PMC4538561.pdf
http://dx.doi.org/10.1038/nature14348 .,Non-OADS,/arxiv_data1/oa_pdf/24/c4/zac5196.PMC4538561.pdf
http://dx.doi.org/10.1016/S0140-6736(14)60726-1 .,OADS,/arxiv_data1/oa_pdf/24/c4/zac5196.PMC4538561.pdf
http://dx.doi.org/10.1111/nyas.12462 .,Non-OADS,/arxiv_data1/oa_pdf/24/c4/zac5196.PMC4538561.pdf
http://dx.doi.org/10 .1038/clpt.2009.142 .,Non-OADS,/arxiv_data1/oa_pdf/24/c4/zac5196.PMC4538561.pdf
http://dx.doi.org/10.1093/infdis/jit554 .,OADS,/arxiv_data1/oa_pdf/24/c4/zac5196.PMC4538561.pdf
http://dx.doi.org/10.1016/S0140-6736(13)61125-3 .,OADS,/arxiv_data1/oa_pdf/24/c4/zac5196.PMC4538561.pdf
InfectEcol Epidemiol 2. http://dx.doi.org/10.3402/iee.v2i0.18385 .,OADS,/arxiv_data1/oa_pdf/24/c4/zac5196.PMC4538561.pdf
http://dx.doi.org/10 .1371/journal.pone.0000986 .,Non-OADS,/arxiv_data1/oa_pdf/24/c4/zac5196.PMC4538561.pdf
http://dx.doi.org/10.1016/j.chemosphere.2010.07.023 .,OADS,/arxiv_data1/oa_pdf/24/c4/zac5196.PMC4538561.pdf
http://dx.doi.org/10.1016/j.scitotenv.2008.06.032 .,OADS,/arxiv_data1/oa_pdf/24/c4/zac5196.PMC4538561.pdf
http://dx.doi.org/10.1371/journal.pone.0006064 .,Non-OADS,/arxiv_data1/oa_pdf/24/c4/zac5196.PMC4538561.pdf
http://dx.doi.org/10.1021/es303203c .,Non-OADS,/arxiv_data1/oa_pdf/24/c4/zac5196.PMC4538561.pdf
http://dx.doi.org/10.1289/ehp.0900930 .,Non-OADS,/arxiv_data1/oa_pdf/24/c4/zac5196.PMC4538561.pdf
http://dx.doi.org /10.1021/es903216p .,Non-OADS,/arxiv_data1/oa_pdf/24/c4/zac5196.PMC4538561.pdf
Environ SciTechnol 45:4307– 4314. http://dx.doi.org/10.1021/es1032629 .,OADS,/arxiv_data1/oa_pdf/24/c4/zac5196.PMC4538561.pdf
http://dx.doi.org/10.1371/journal.pone.0071230 .,Non-OADS,/arxiv_data1/oa_pdf/24/c4/zac5196.PMC4538561.pdf
http://dx.doi.org/10.1371/journal.pone.0024742 .,Non-OADS,/arxiv_data1/oa_pdf/24/c4/zac5196.PMC4538561.pdf
http://dx.doi.org /10.1128/AEM.04034-14 .,Non-OADS,/arxiv_data1/oa_pdf/24/c4/zac5196.PMC4538561.pdf
EmergInfect Dis 13:404 – 411. http://dx.doi.org/10.3201/eid1303.061130 .,Non-OADS,/arxiv_data1/oa_pdf/24/c4/zac5196.PMC4538561.pdf
http://dx.doi.org /10.1128/JVI.79.5.2814-2822.2005 .,OADS,/arxiv_data1/oa_pdf/24/c4/zac5196.PMC4538561.pdf
http://dx.doi.org/10.1007/s007050170002 .,Non-OADS,/arxiv_data1/oa_pdf/24/c4/zac5196.PMC4538561.pdf
http://dx.doi.org/10.7589/2011-11-335 .,Non-OADS,/arxiv_data1/oa_pdf/24/c4/zac5196.PMC4538561.pdf
http://dx.doi.org/10.1016/0003-2697(79)90362-2 .,OADS,/arxiv_data1/oa_pdf/24/c4/zac5196.PMC4538561.pdf
http://www.nisn.org/documents /Zambon_-_VIRGIL_IC50_SOP.pdf .,Non-OADS,/arxiv_data1/oa_pdf/24/c4/zac5196.PMC4538561.pdf
http://dx.doi.org/10.1016/j.jpba.2012.02.011 .,OADS,/arxiv_data1/oa_pdf/24/c4/zac5196.PMC4538561.pdf
J Virol 82:596 – 601. http://dx.doi .org/10.1128/JVI.02005-07 .,Non-OADS,/arxiv_data1/oa_pdf/24/c4/zac5196.PMC4538561.pdf
Emerg Infect Dis 19:1635– 1638. http://dx.doi.org/10.3201/eid1910.130609 .,Non-OADS,/arxiv_data1/oa_pdf/24/c4/zac5196.PMC4538561.pdf
http://dx.doi.org/10 .1093/infdis/jiu447 .,Non-OADS,/arxiv_data1/oa_pdf/24/c4/zac5196.PMC4538561.pdf
Antimicrob Agents Chemother 58:6398 – 6405. http://dx.doi.org/10.1128/AAC.02956-14 .,Non-OADS,/arxiv_data1/oa_pdf/24/c4/zac5196.PMC4538561.pdf
http://dx.doi.org/10.1128/AAC.00555-08 .,Non-OADS,/arxiv_data1/oa_pdf/24/c4/zac5196.PMC4538561.pdf
http://dx.doi.org/10.1371/journal .pone.0117822 .,Non-OADS,/arxiv_data1/oa_pdf/24/c4/zac5196.PMC4538561.pdf
http://dx.doi.org/10.1111/irv.12047 .,Non-OADS,/arxiv_data1/oa_pdf/24/c4/zac5196.PMC4538561.pdf
http://dx.doi.org/10.1371/journal.pone.0066105 .,Non-OADS,/arxiv_data1/oa_pdf/24/c4/zac5196.PMC4538561.pdf
http://dx.doi.org/10.1371/journal .ppat.1002914 .,Non-OADS,/arxiv_data1/oa_pdf/24/c4/zac5196.PMC4538561.pdf
http://dx.doi.org/10.1128/AAC.01848-13 .,Non-OADS,/arxiv_data1/oa_pdf/24/c4/zac5196.PMC4538561.pdf
http://dx.doi.org/10.1128/AAC.05994-11 .,Non-OADS,/arxiv_data1/oa_pdf/24/c4/zac5196.PMC4538561.pdf
http://dx.doi .org/10.1086/508777 .,Non-OADS,/arxiv_data1/oa_pdf/24/c4/zac5196.PMC4538561.pdf
http://dx.doi.org/10.1128/JCM.01732-10 .,Non-OADS,/arxiv_data1/oa_pdf/24/c4/zac5196.PMC4538561.pdf
Nat Commun 5:5029. http://dx.doi.org /10.1038/ncomms6029 .,OADS,/arxiv_data1/oa_pdf/24/c4/zac5196.PMC4538561.pdf
http://dx.doi.org/10.1128/JVI.02473-14 .,Non-OADS,/arxiv_data1/oa_pdf/24/c4/zac5196.PMC4538561.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comAbstract Background:  Although the superficial middle cerebral vein (SMCV) usually  connects with the cavernous sinus, there are several anatomical variations.",Non-OADS,/arxiv_data1/oa_pdf/5e/6a/SNI-6-130.PMC4538574.pdf
"Surgical Neurology International 2015, 6:130  http://www.surgicalneurologyint.com/content/6/1/130INTRODUCTION The superficial middle cerebral vein (SMCV) typically  either connects with the proximal sphenoparietal sinus  and then flows into the cavernous sinus or directly drains  into the cavernous sinus.",Non-OADS,/arxiv_data1/oa_pdf/5e/6a/SNI-6-130.PMC4538574.pdf
"Surgical Neurology International 2015, 6:130  http://www.surgicalneurologyint.com/content/6/1/130RESULTS Surgical results Total tumor removal was achieved in only 1  of 17 patients [Patient 3 in Table 1].",Non-OADS,/arxiv_data1/oa_pdf/5e/6a/SNI-6-130.PMC4538574.pdf
"Surgical Neurology International 2015, 6:130  http://www.surgicalneurologyint.com/content/6/1/130connecting with the transverse sinus [Figure 2b].",Non-OADS,/arxiv_data1/oa_pdf/5e/6a/SNI-6-130.PMC4538574.pdf
"Surgical Neurology International 2015, 6:130  http://www.surgicalneurologyint.com/content/6/1/130the temporal lobe of Patient 3 likely led to a cerebral  contusion caused by spatula compression.",Non-OADS,/arxiv_data1/oa_pdf/5e/6a/SNI-6-130.PMC4538574.pdf
"Surgical Neurology International 2015, 6:130  http://www.surgicalneurologyint.com/content/6/1/130be better in order to minimize the risk of injuring the  venous drainages of the SMCV and superior petrosal vein.",Non-OADS,/arxiv_data1/oa_pdf/5e/6a/SNI-6-130.PMC4538574.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSir, We read with great interest, the recent review about  capillary hemangiomas of cauda equina published by  Liu et al.",Non-OADS,/arxiv_data1/oa_pdf/fb/49/SNI-6-133.PMC4538575.pdf
Surg Neurol Int 2015;6:133. http://surgicalneurologyint.com/Capillary‑hemangioma‑of‑the‑cauda‑equina/ Access this article online Quick Response Code: Website:    www.surgicalneurologyint.com DOI:    10.4103/2152-7806.162551  Figure 1: Sagittal (a) and axial (b) postcontrast T1-weighted spinal  magnetic resonance imaging showing a well-circumscribed lesion at  L2 level with intense enhancement after gadolinium administrationb a Figure 2: Intraoperative view of lesion.,Non-OADS,/arxiv_data1/oa_pdf/fb/49/SNI-6-133.PMC4538575.pdf
"Surgical Neurology International 2015, 6:133  http://www.surgicalneurologyint.com/content/6/1/133To our knowledge, we report the first intraoperative  picture of a capillary hemangioma of cauda equina.",Non-OADS,/arxiv_data1/oa_pdf/fb/49/SNI-6-133.PMC4538575.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comsni_232_15R2 Abstract Background:  A successfully applied clip for a ruptured aneurysm keeps the  aneurysm’s neck closed, preventing rerupture throughout the patient’s life.",Non-OADS,/arxiv_data1/oa_pdf/02/a7/SNI-6-134.PMC4538576.pdf
Surg Neurol Int 2015;6:134. http://surgicalneurologyint.com/Rebleeding-from-clipped-aneurysm-after-35-years:-Report-of-2-cases/ Copyright: © 2015 Ishida A.,Non-OADS,/arxiv_data1/oa_pdf/02/a7/SNI-6-134.PMC4538576.pdf
"Surgical Neurology International 2015, 6:134  http://www.surgicalneurologyint.com/content/6/1/134to cause SAH as time passes.",Non-OADS,/arxiv_data1/oa_pdf/02/a7/SNI-6-134.PMC4538576.pdf
"Surgical Neurology International 2015, 6:134  http://www.surgicalneurologyint.com/content/6/1/134patient presented with a severe headache.",Non-OADS,/arxiv_data1/oa_pdf/02/a7/SNI-6-134.PMC4538576.pdf
"Surgical Neurology International 2015, 6:134  http://www.surgicalneurologyint.com/content/6/1/134neck remnant, but it would have been really small and  grown at an extremely slow pace.” Kashimura et al.",Non-OADS,/arxiv_data1/oa_pdf/02/a7/SNI-6-134.PMC4538576.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comOriginal Article A value‑based, no‑cost‑to‑patient health model in the developing  world: Critical appraisal of a unique patient‑centric neurosurgery  unit Sumit Thakar1, Ravi Dadlani1, Laxminadh Sivaraju1, Saritha Aryan1, Dilip Mohan1,   Narayanam Anantha Sai Kiran1, Ravikiran Rajarathnam1, Maya Shyam2, Venkatraman Sadanand1,3,  Alangar S. Hegde1 Departments of 1Neurosurgery and 2Finance and Accounts, Sri Sathya Sai Institute of Higher Medical Sciences, Whitefield, Bengaluru, Karnataka, India,   3Department of Neurosurgery, Loma Linda University, Loma Linda, California, USA E‑mail: *Sumit Thakar ‑ sumit.thakar@gmail.com; Ravi Dadlani ‑ ravi.dadlani@gmail.com; Laxminadh Sivaraju ‑ laxminadh.sivaraju@gmail.com;   Saritha Aryan ‑ saaryan@gmail.com; Dilip Mohan ‑ dilip.m@sssihms.org.in; Narayanam Anantha Sai Kiran ‑ saikiransssihms@gmail.com;   Ravikiran Rajarathnam ‑ ravikiran.r@sssihms.org.in; Maya Shyam ‑ shyamaya9@yahoo.com;  Venkatraman Sadanand ‑ venk99@gmail.com;   Alangar S. Hegde ‑ hegde.as@gmail.com   *Corresponding author Received: 24 March 15  Accepted: 24 June 15  Published: 07 August 15 Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.162484  Quick Response Code: Abstract Background:  It is well‑accepted that the current healthcare scenario worldwide is  due for a radical change, given that it is fraught with mounting costs and varying  quality.",Non-OADS,/arxiv_data1/oa_pdf/f9/43/SNI-6-131.PMC4538577.pdf
"Surg Neurol Int 2015;6:131. http://surgicalneurologyint.com/surgicalint_articles/A-value-based,-no-cost-to-patient-health-model-in-the-developing-world:-Critical-appraisal-of-a-unique-patient-centric- neurosurgery-unit/ Copyright: © 2015 Thakar S.  This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,   distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/f9/43/SNI-6-131.PMC4538577.pdf
"Surgical Neurology International 2015, 6:131  http://www.surgicalneurologyint.com/content/6/1/131INTRODUCTION Health models worldwide have been long riddled with  escalating costs, varying the quality of care and ethical  concerns related to commercialization of healthcare.",Non-OADS,/arxiv_data1/oa_pdf/f9/43/SNI-6-131.PMC4538577.pdf
"Surgical Neurology International 2015, 6:131  http://www.surgicalneurologyint.com/content/6/1/131leading to a Diplomate of National Board (DNB) in  Neurosurgery.",Non-OADS,/arxiv_data1/oa_pdf/f9/43/SNI-6-131.PMC4538577.pdf
"Surgical Neurology International 2015, 6:131  http://www.surgicalneurologyint.com/content/6/1/131used in any process that could affect the quality of the  end‑product.",Non-OADS,/arxiv_data1/oa_pdf/f9/43/SNI-6-131.PMC4538577.pdf
"Surgical Neurology International 2015, 6:131  http://www.surgicalneurologyint.com/content/6/1/131health model merits substantially from the dissemination  of human values in its structure, as detailed in the  section below.",Non-OADS,/arxiv_data1/oa_pdf/f9/43/SNI-6-131.PMC4538577.pdf
"Surgical Neurology International 2015, 6:131  http://www.surgicalneurologyint.com/content/6/1/1312011.",Non-OADS,/arxiv_data1/oa_pdf/f9/43/SNI-6-131.PMC4538577.pdf
Available from: http://www.oecd.org/els/health-systems/48723982.,Non-OADS,/arxiv_data1/oa_pdf/f9/43/SNI-6-131.PMC4538577.pdf
(Online article) http://www.nashp.org/wp‑content/uploads/sites/default/files/ cost_containment_approaches.pdf [Last accessed on 2015 Jun 20].,Non-OADS,/arxiv_data1/oa_pdf/f9/43/SNI-6-131.PMC4538577.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comWe must be careful not to rush to label glyphosate  as excessively toxic to humans because when used  properly and in proper quantities it is probably no more  dangerous and toxic than other effective herbicides on  the market.",Non-OADS,/arxiv_data1/oa_pdf/c7/b2/SNI-6-132.PMC4538578.pdf
"Surgical Neurology International 2015, 6:132  http://www.surgicalneurologyint.com/content/6/1/132The assertion, “(glyphosate) usage has increased  steadily.",Non-OADS,/arxiv_data1/oa_pdf/c7/b2/SNI-6-132.PMC4538578.pdf
"Surgical Neurology International 2015, 6:132  http://www.surgicalneurologyint.com/content/6/1/132of conditions, but no convincing clinical evidence of  causation relationship.",Non-OADS,/arxiv_data1/oa_pdf/c7/b2/SNI-6-132.PMC4538578.pdf
"Surgical Neurology International 2015, 6:132  http://www.surgicalneurologyint.com/content/6/1/132agrees with this and adds that this is “the weakest aspect  of their paper,” but he qualifies the statement suspecting  “stronger links with cancer and neurodegeneration.”  Glyphosate usage has increased, and so has autism as  well as the other conditions.",Non-OADS,/arxiv_data1/oa_pdf/c7/b2/SNI-6-132.PMC4538578.pdf
"Surgical Neurology International 2015, 6:132  http://www.surgicalneurologyint.com/content/6/1/132authors — that is, as “star wasting syndrome,” “collapse  of coral reefs” via “ecological pervasiveness,” “liver  damage,” “celiac disease,” “PD,” “anxiety syndromes,”  “Salmonella poisoning,” “mitochondrial damage,” “poor  sperm motility,” “poor bone development,” “phobias,”  “osteoporosis,” “autism,” “ AD,” “inflammatory bowel  disease,” “renal lithiasis,” “osteomalacia,” “cholestasis,”  “thyroid dysfunction,” “Lyme’s disease,” “panic  disorders,” “infertility,” etc., — is unwarranted given  the evidence, the variety of proposed mechanisms, and  logic provided by the authors.",Non-OADS,/arxiv_data1/oa_pdf/c7/b2/SNI-6-132.PMC4538578.pdf
"Surgical Neurology International 2015, 6:132  http://www.surgicalneurologyint.com/content/6/1/132glyphosate greatly enhances N‑methyl‑D‑aspartate receptor  sensitivity.",Non-OADS,/arxiv_data1/oa_pdf/c7/b2/SNI-6-132.PMC4538578.pdf
"Surgical Neurology International 2015, 6:132  http://www.surgicalneurologyint.com/content/6/1/132problem that India, for example, has tackled but not  solved satisfactorily.",Non-OADS,/arxiv_data1/oa_pdf/c7/b2/SNI-6-132.PMC4538578.pdf
"Surgical Neurology International 2015, 6:132  http://www.surgicalneurologyint.com/content/6/1/132will end up paying for in higher food bills; farmers  ending up with insufficient crops; and the poor and most  vulnerable in societies worldwide, starving.",Non-OADS,/arxiv_data1/oa_pdf/c7/b2/SNI-6-132.PMC4538578.pdf
Available from: http://haciendapublishing.com/articles/ public-health-social-science-and-scientific-method-part-ii.,Non-OADS,/arxiv_data1/oa_pdf/c7/b2/SNI-6-132.PMC4538578.pdf
Available from: http://www.haciendapub.com/articles/ public-health-social-science-and-scientific-method-part-i.,Non-OADS,/arxiv_data1/oa_pdf/c7/b2/SNI-6-132.PMC4538578.pdf
"Surgical Neurology International 2015, 6:132  http://www.surgicalneurologyint.com/content/6/1/1327.",Non-OADS,/arxiv_data1/oa_pdf/c7/b2/SNI-6-132.PMC4538578.pdf
Available from: http://www.epa.gov /pesticides/regulating/laws/fqpa/ backgrnd.htm.,Non-OADS,/arxiv_data1/oa_pdf/c7/b2/SNI-6-132.PMC4538578.pdf
Available from: http://www.fda.gov/food/ guidanceregulation /fsma/ucm239907.htm.,Non-OADS,/arxiv_data1/oa_pdf/c7/b2/SNI-6-132.PMC4538578.pdf
Available from: http://www.thegrocer.,Non-OADS,/arxiv_data1/oa_pdf/c7/b2/SNI-6-132.PMC4538578.pdf
"Surgical Neurology International 2015, 6:132  http://www.surgicalneurologyint.com/content/6/1/132and in teeth.",Non-OADS,/arxiv_data1/oa_pdf/c7/b2/SNI-6-132.PMC4538578.pdf
"Surgical Neurology International 2015, 6:132  http://www.surgicalneurologyint.com/content/6/1/132There is one biosphere to which everything is connected,  what affects one, affects all.",Non-OADS,/arxiv_data1/oa_pdf/c7/b2/SNI-6-132.PMC4538578.pdf
"Surgical Neurology International 2015, 6:132  http://www.surgicalneurologyint.com/content/6/1/132These findings baffled investigators who repeatedly wanted  to dismiss results as “a mystery or not compound related,”  because they did not see an increasing dose‑response  linear relationship as in, the dose makes the poison.",Non-OADS,/arxiv_data1/oa_pdf/c7/b2/SNI-6-132.PMC4538578.pdf
"Surgical Neurology International 2015, 6:132  http://www.surgicalneurologyint.com/content/6/1/132a US Senator to finally gain access and obtain these  studies for our continuing research.",Non-OADS,/arxiv_data1/oa_pdf/c7/b2/SNI-6-132.PMC4538578.pdf
"Surgical Neurology International 2015, 6:132  http://www.surgicalneurologyint.com/content/6/1/132purposes were actually corrupted studies, whether by  technician error, contaminated water and or feed or other  mistakes.",Non-OADS,/arxiv_data1/oa_pdf/c7/b2/SNI-6-132.PMC4538578.pdf
"Surgical Neurology International 2015, 6:132  http://www.surgicalneurologyint.com/content/6/1/132REPLY TO COMMENTARIES I take and accept Dr. Stephanie Seneff’s critical  comments on my letter in good faith in the same vein  as (I think) she accepted and rejected some of my  criticisms.",Non-OADS,/arxiv_data1/oa_pdf/c7/b2/SNI-6-132.PMC4538578.pdf
Available from: http://ec.europa.eu/enterprise/sectors/ chemicals/files/glp/guidance_xcont_final_18_01_2006_en.pdf  [Last accessed  on 2015 Jun 12].,Non-OADS,/arxiv_data1/oa_pdf/c7/b2/SNI-6-132.PMC4538578.pdf
"Surgical Neurology International 2015, 6:132  http://www.surgicalneurologyint.com/content/6/1/132throughout the letter, the author demonstrates  allegiance to the chemical industry, even stating that  getting rid of DDT was a bad idea, and he tries to  justify the thought with distorted reasoning.” I have and owe no allegiance to any chemical industry or  pharmaceutical company.",Non-OADS,/arxiv_data1/oa_pdf/c7/b2/SNI-6-132.PMC4538578.pdf
"Surgical Neurology International 2015, 6:132  http://www.surgicalneurologyint.com/content/6/1/132subsistence farming.",Non-OADS,/arxiv_data1/oa_pdf/c7/b2/SNI-6-132.PMC4538578.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7a/f1/pgpm-8-115.PMC4538689.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pPharmacogenomics and Personalized Medicine 2015:8 115–126Pharmacogenomics and Personalized Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  115Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PGPM.S3506 3economic evaluations of personalized medicine:  existing challenges and current developments Fatiha H Shabaruddin1 Nigel D Fleeman2 Katherine Payne3 1Department of Pharmacy,   University of Malaya, Kuala Lumpur,   Malaysia;  2Liverpool Reviews and  implementation Group (LRiG),   University of Liverpool, Liverpool,    UK; 3institute of Population Health,   The University of Manchester,   Manchester, UK Correspondence: Fatiha H Shabaruddin   Department of Pharmacy, Faculty of  Medicine, University of Malaya,   50603 Kuala Lumpur, Malaysia   Tel +60 3 7967 4700  Fax +60 3 7967 4964  email fatiha.shabaruddin@um.edu.m yAbstract:  Personalized medicine, with the aim of safely, effectively, and cost-effectively  targeting treatment to a prespecified patient population, has always been a long-time goal within  health care.",Non-OADS,/arxiv_data1/oa_pdf/7a/f1/pgpm-8-115.PMC4538689.pdf
Available  from: http://www.ispor.org/peguidelines/index.asp.,Non-OADS,/arxiv_data1/oa_pdf/7a/f1/pgpm-8-115.PMC4538689.pdf
Available from: http://www.fda.gov/drugs/ scienceresearch/researchareas/pharmacogenetics/ucm083378.htm.,Non-OADS,/arxiv_data1/oa_pdf/7a/f1/pgpm-8-115.PMC4538689.pdf
"Available from: http://www.york.ac.uk/ inst/crd/pdf/nhseed-handbook2007.pd f. Accessed May  1, 2014.",Non-OADS,/arxiv_data1/oa_pdf/7a/f1/pgpm-8-115.PMC4538689.pdf
Available  from: http://ctep.cancer.gov/protocolDevelopment/electronic_  applications/ctc.htm.,Non-OADS,/arxiv_data1/oa_pdf/7a/f1/pgpm-8-115.PMC4538689.pdf
Available from: http://www.fda.gov/downloads/ DrugsGuidance   ComplianceRegulatoryInformation /Guidances/UCM201790.pdf.,Non-OADS,/arxiv_data1/oa_pdf/7a/f1/pgpm-8-115.PMC4538689.pdf
Available from: https://www.gov.uk/apply-for-a-licence-to-market-a- medicine-in-the-uk.,Non-OADS,/arxiv_data1/oa_pdf/7a/f1/pgpm-8-115.PMC4538689.pdf
Available from: http://www.ema.europa.eu/ema/ index.jsp?curl =pages/regulation/landing/human_medicines_regulatory.,Non-OADS,/arxiv_data1/oa_pdf/7a/f1/pgpm-8-115.PMC4538689.pdf
"Pharmacogenomics and Personalized Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/pharmacogenomics-and-personalized-medicine-journa lPharmacogenomics and Personalized Medicine is an international, peer- reviewed, open access journal characterizing the influence of genotype  on pharmacology leading to the development of personalized treatment  programs and individualized drug selection for improved safety, efficacy  and sustainability.",Non-OADS,/arxiv_data1/oa_pdf/7a/f1/pgpm-8-115.PMC4538689.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/7a/f1/pgpm-8-115.PMC4538689.pdf
Available  from: https://www.nice.org.uk/proxy/?sourceurl =http://www.nice.org.,Non-OADS,/arxiv_data1/oa_pdf/7a/f1/pgpm-8-115.PMC4538689.pdf
Available  from: http://www.mrc.ac.uk/research/initiatives/stratified-medicine /.,Non-OADS,/arxiv_data1/oa_pdf/7a/f1/pgpm-8-115.PMC4538689.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8b/e8/pgpm-8-127.PMC4538690.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pPharmacogenomics and Personalized Medicine 2015:8 127–135Pharmacogenomics and Personalized Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  127Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PGPM.S6280 9Olaparib in the management of ovarian cancer Kristin Bixel1 John L Hays2 1Division of Gynecologic Oncology,   Department of Obstetrics and  Gynecology, 2Department of  Hematology Oncology, Ohio State  University, Columbus, OH, USA Correspondence: Kristin Bixel   Division of Gynecologic Oncology,  Department of Obstetrics and  Gynecology, Ohio State University,  M-210 Starling Loving Hall, 310 west   10th Avenue, Columbus, OH  43210, USA   Tel +1 614 293 7642  email k ristin.bixel@osumc.ed uAbstract:  Alterations in the homologous repair pathway are thought to occur in  30%–50%  of epithelial ovarian cancers.",Non-OADS,/arxiv_data1/oa_pdf/8b/e8/pgpm-8-127.PMC4538690.pdf
"Available from: http://www.nccn.org/professionals/ physician_gls/pdf/ovarian.pd f. Accessed April  28, 2015.",Non-OADS,/arxiv_data1/oa_pdf/8b/e8/pgpm-8-127.PMC4538690.pdf
"Pharmacogenomics and Personalized Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/pharmacogenomics-and-personalized-medicine-journa lPharmacogenomics and Personalized Medicine is an international, peer- reviewed, open access journal characterizing the influence of genotype  on pharmacology leading to the development of personalized treatment  programs and individualized drug selection for improved safety, efficacy  and sustainability.",Non-OADS,/arxiv_data1/oa_pdf/8b/e8/pgpm-8-127.PMC4538690.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/8b/e8/pgpm-8-127.PMC4538690.pdf
This  is  an  open  access  article  under  the  CC BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/19/38/main.PMC4538693.pdf
"It  is  prevalent  in  women  of  child  bearing  age,  especially http://dx.doi.org/10.1016/j.toxrep.2015.07.015 2214-7500/© 2015  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/19/38/main.PMC4538693.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by- nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/19/38/main.PMC4538693.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/71/86/main.PMC4538703.pdf
http://dx.doi.org/10.1016/j.gdata.2015.07.001 2213-5960/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/71/86/main.PMC4538703.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/71/86/main.PMC4538703.pdf
Contents lists available at ScienceDirect Genomics Data journal homepage: http://www.journa ls.elsevier.com/genomics-data/,Non-OADS,/arxiv_data1/oa_pdf/71/86/main.PMC4538703.pdf
"Subject area Epigenetics, DNA methylation Cell type Leukocyte Population description 17 Mother –Infant Pairs Total number of samples 34Technologies utilizedDNA extraction Qiagen PAXgene Blood DNA kitMethylated DNA collection kit Active Motif MethylCollector Ultra kitDNA ampli ﬁcation kit Sigma WGA3 kit Microarray type Affymetrix Human Promoter 1.0R Arrays Pathway analysis Ingenuity pathway analysis software and Database for Annotation, Visualization, and IntegratedDiscovery (DAVID) Measurement Variable DNA methylation levels at promoter-based CpG Islands Link to Public Data http://www.ncbi.nlm.nih.gov/geo/query/ acc.cgi?acc=GSE67976379 S. Gona et al.",OADS,/arxiv_data1/oa_pdf/71/86/main.PMC4538703.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 Inter - national License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the  original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/e1/13/traumamon-20-13530.PMC4538724.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 Inter - national License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the  original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/24/23/traumamon-20-17184.PMC4538725.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 Inter - national License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the  original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/8d/bb/traumamon-20-17709.PMC4538726.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 Inter - national License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the  original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/b3/f3/traumamon-20-17874.PMC4538727.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 Inter - national License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the  original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/b0/39/traumamon-20-17879.PMC4538728.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 Inter - national License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the  original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/e4/7e/traumamon-20-18198.PMC4538729.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 Inter - national License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the  original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/b4/79/traumamon-20-18686.PMC4538730.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 Inter - national License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the  original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/39/28/traumamon-20-23816.PMC4538731.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 Inter - national License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the  original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/1b/1a/traumamon-20-26075.PMC4538732.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 Inter - national License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the  original work is properly cited.The Dizin Ski Resort is unrivaled in the Middle East and  is the third of a series of national getaways chosen by the  Editor for recuperation, rest and re-invigoration of the  “stressed-out” trauma surgeon.",Non-OADS,/arxiv_data1/oa_pdf/7e/12/traumamon-20-28123.PMC4538733.pdf
Available from: http://en.wikipedia.org/ wiki/Dizin.,Non-OADS,/arxiv_data1/oa_pdf/7e/12/traumamon-20-28123.PMC4538733.pdf
Available from: http://en.wikivoyage.org/ wiki/Dizin.,Non-OADS,/arxiv_data1/oa_pdf/7e/12/traumamon-20-28123.PMC4538733.pdf
Resulting‘fastq’ files were processed using the Bioconductor pack- age for R programming ( http://www.bioconductor.org )t o assess read quality and produce a read-coverage file afteralignment of reads with Bowtie on the GRCh37 /hg19 as- semblyofthehumangenome(reportinguniquehitsandal- lowing no mismatches).,OADS,/arxiv_data1/oa_pdf/a5/9e/gkv390.PMC4538806.pdf
"The Integrative Genomics Viewer(http://www.broadinstitute.org/igv )wasthenusedtovisual- ize coverage, while rRNAs (representing <10% of mapped reads) were excluded from downstream analysis.",OADS,/arxiv_data1/oa_pdf/a5/9e/gkv390.PMC4538806.pdf
Tran-scriptswereassembledusingcufflinks( http://cufflinks.cbcb.,Non-OADS,/arxiv_data1/oa_pdf/a5/9e/gkv390.PMC4538806.pdf
All the other shRNA for was cloned into PLKO vector as described in Public TRC Portal (http://www.broadinstitute.org/rnai/public/ ).,OADS,/arxiv_data1/oa_pdf/67/bf/gkv392.PMC4538807.pdf
Novel transcript structures were assembledusing Cufflinks (version 2.1.1; 31) after removal of PCR- duplicateswithPicardtools( http://picard.sourceforge.net ).,OADS,/arxiv_data1/oa_pdf/bd/0d/gkv591.PMC4538811.pdf
The PacBio long reads are available at ftp://ftp-trace.ncbi.nih.gov/1000genomes/ftp/ technical/working/20131209 na12878 pacbio/Schadt/ .,OADS,/arxiv_data1/oa_pdf/99/92/gkv605.PMC4538813.pdf
BreakSeek running time BreakSeek was implemented in Python 2.7 as a stan- dalone program ( https://sourceforge.net/p/breakseek/ ).,OADS,/arxiv_data1/oa_pdf/99/92/gkv605.PMC4538813.pdf
"Figures were prepared us- ingprogramPyMOL(MolecularGraphicsSystem,Version 1.5.0.4 Schr ¨odinger, LLC; http://www.pymol.org ).",OADS,/arxiv_data1/oa_pdf/f1/fd/gkv640.PMC4538828.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org /licenses /by-nc-nd /4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided theoriginalworkisnotalteredortransformedinanyway,andthattheworkisproperlycited.Forcommercialre-use,pleasecontactjournals.permis sions@oup.com",Non-OADS,/arxiv_data1/oa_pdf/83/2f/gkv641.PMC4538829.pdf
"Published by Oxford University Press, on behalf of the Society of Systematic Biologists.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/14/85/syv026.PMC4538880.pdf
"For each ofthe ﬁve taxa, we selected the 10 journals included inWoS that published the largest numbers of articles onthe selected taxon in this period, totalling 47 journals(overlap of three journals among taxa; Table 1; see Online Appendix 1 available as Supplementary Materialon Dryad at http://dx.doi.org/10.5061/dryad.3t761, for the protocols of database queries and manualcontent curation and Online Appendix 2 for the dataavailable as Supplementary Material on Dryad athttp://dx.doi.org/10.5061/dryad.3t761).",Non-OADS,/arxiv_data1/oa_pdf/14/85/syv026.PMC4538880.pdf
"T oxins 0.55 0 65 0 16 0 17 0 15 0 17PLoS One 3.73 0 41 02050 1 6 0 1 8 T oxicon 2.92 0 213 0 52 0 67 0 47 0 47 • Zootaxa 0.97 36 25 10 7 4 4 10 6 12 8 All Journals 54 559 16 129 9 147 15 135 14 148 All Taxa All Journals 306 2291 72 553 65 528 91 594 78 616 Notes: For each of the ﬁve taxa, the 10 journals included in WoS were selected that published the largest numbers of articles on that taxon; see Online Appendix 1 for the protocols used and Online Appendix 2 for the data available as Supplementary Material on Dryad athttp://dx.doi.org/10.5061/dryad.3t761.IF=impact factor; tax/non-tax =number of taxonomic/non-taxonomic publications; ( •)/•= journals publishing both taxonomic and non-taxonomic publications in principle/on the focal taxa on a yearly basis 2009–2012.",Non-OADS,/arxiv_data1/oa_pdf/14/85/syv026.PMC4538880.pdf
See Online Appendix 1 for the protocols used and Online Appendix 2 for the data available as Supplementary Material on Dryad at http://dx.doi.org/10.5061/dryad.3t761.,Non-OADS,/arxiv_data1/oa_pdf/14/85/syv026.PMC4538880.pdf
"We estimated the 2009–2012 research community sizes for the ﬁve taxaanalyzed here (see Online Appendix 3 for the protocolused available as Supplementary Material on Dryadathttp://dx.doi.org/10.5061/dryad.3t761) and found differences by up to a factor of three (mosses: 2352authors, orchids: 1993, ciliates: 1281, ants: 3923, andsnakes: 2540).",OADS,/arxiv_data1/oa_pdf/14/85/syv026.PMC4538880.pdf
"2a; see Online Appendices 4 and 5 for the protocols of database queries and statisticalanalysis, available as Supplementary Material on Dryadathttp://dx.doi.org/10.5061/dryad.3t761, respectively) as well as for plants, microorganisms, and animals(Fig.",Non-OADS,/arxiv_data1/oa_pdf/14/85/syv026.PMC4538880.pdf
See Online Appendix 4a–hfor the database query protocols used and Appendix 5 for the regression analysis results available as Supplementary Material on Dryad athttp://dx.doi.org/10.5061/dryad.3t761.,OADS,/arxiv_data1/oa_pdf/14/85/syv026.PMC4538880.pdf
S UPPLEMENTARY MATERIAL Data available from the Dryad Data Repository: http://dx.doi.org/10.5061/dryad.3t761.,OADS,/arxiv_data1/oa_pdf/14/85/syv026.PMC4538880.pdf
"Published by Oxford University Press, on behalf of the Society of Systematic Biologists.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a0/fb/syv035.PMC4538882.pdf
Included individuals (Supplementary Table S1 available on Dryadathttp://dx.doi.org/10.5061/dryad.fn2nt were chosen to reﬂect the intraspeciﬁc diversity observed in TOPO6 (Brassac et al.,OADS,/arxiv_data1/oa_pdf/a0/fb/syv035.PMC4538882.pdf
"The PLUG database (http://plug.dna.affrc.go.jp/, last accessed June 19, 2015) was screened for rice landmark loci with uniquemapped orthologs in wheat and barley.",OADS,/arxiv_data1/oa_pdf/a0/fb/syv035.PMC4538882.pdf
"The single-copy status and the location ofall nuclear loci were checked by blasting the sequencesobtained for H. vulgare against its genome database (http://webblast.ipk-gatersleben.de/barley/viroblast .php, last accessed 19/06/2015; The International BarleyGenome Sequencing Consortium 2012).",OADS,/arxiv_data1/oa_pdf/a0/fb/syv035.PMC4538882.pdf
"1990 ) of our loci on the B. distachyon genome database ( http://www.brachypodium.org/, last accessed June 19, 2015).",OADS,/arxiv_data1/oa_pdf/a0/fb/syv035.PMC4538882.pdf
S UPPLEMENTARY MATERIAL Data available from the Dryad Digital Repository: http://dx.doi.org/10.5061/dryad.fn2nt.,OADS,/arxiv_data1/oa_pdf/a0/fb/syv035.PMC4538882.pdf
"Available from: http://tree.bio.ed.ac.uk/software/tracer/, last accessed June 19,2015.",OADS,/arxiv_data1/oa_pdf/a0/fb/syv035.PMC4538882.pdf
Available at: http://www.cdc.gov/pcd/ issues/2011/sep/10_0261.htm .,Non-OADS,/arxiv_data1/oa_pdf/49/3a/nihms714228.PMC4538996.pdf
Available at:  http://healthypeople.gov/2020/about/advisory/PhaseI.pdf 32.,Non-OADS,/arxiv_data1/oa_pdf/49/3a/nihms714228.PMC4538996.pdf
"(Epub 2011 Oct 26),  http://dx.doi.org/10.1016/j.jadohealth.2011.08.007 .",OADS,/arxiv_data1/oa_pdf/49/3a/nihms714228.PMC4538996.pdf
Available at: http://www.scld-nci.net/ linkdocs/products/factsheets93.pdf 59.,Non-OADS,/arxiv_data1/oa_pdf/49/3a/nihms714228.PMC4538996.pdf
"To improve our adRP molecular testing approach for routine  use, we devised a new simple and robust multiplex PCR assay  capable of amplifying the genetic loci of RHO  (GeneID: 6010;  OMIM 180380 ), PRPH2  (GeneID: 5961; OMIM 179605 ), Molecular Vision  2015; 21:857-870 <http://www.molvis.org/molvis/v 21/857> Received 13 February 2015 | Accepted 15 August 2015 | Published 18 August 2015© 2015 Molecular Vision 857New COL6A6  variant detected by whole-exome sequencing is  linked to break points in intron 4 and 3′-UTR, deleting exon 5 of  RHO , and causing adRP Miguel de Sousa Dias,1 Imma Hernan,1 Barbara Delás,2 Beatriz Pascual,1 Emma Borràs,1 Maria José  Gamundi,1 Begoña Mañé,1 Patricia Fernández-San José,3,4 Carmen Ayuso,3,4 Miguel Carballo1 1Molecular Genetics Unit, Hospital of Terrassa, Barcelona, Spain; 2Ophthalmology Service, Hospital of Terrassa Barcelona,  Spain; 3Department of Genetics, IIS-Jimenez Diaz Foundation (IIS-FJD), Madrid, Spain; 4Centre for Biomedical Network  Research on Rare Diseases (CIBERER), ISCIII, Madrid, Spain Purpose:  This study aimed to test a newly devised cost-effective multiplex PCR assay for the molecular diagnosis  of autosomal dominant retinitis pigmentosa (adRP), as well as the use of whole-exome sequencing (WES) to detect  disease-causing mutations in adRP.",Non-OADS,/arxiv_data1/oa_pdf/e4/94/mv-v21-857.PMC4539015.pdf
"Molecular Vision  2015; 21:857-870 <http://www.molvis.org/molvis/v 21/857> © 2015 Molecular Vision  858RP1 (GeneID: 6101; OMIM 603937 ), PRPF3  (GeneID: 9129;  OMIM 607301 ), PRPF8  (GeneID: 10594; OMIM 607300 ),  PRPF31  (GeneID: 26121; OMIM 606419 ), IMPDH1  (GeneID:  3614; OMIM 146690 ), NRL (GeneID: 4901; OMIM 162080 ),  CRX ( GeneID: 1406; OMIM 602225 ), KLHL7  (GeneID:  55975; OMIM 611119 ) and NR2E3  (GeneID: 10002; OMIM  604485 )—where most adRP-causing mutations have been  reported.",Non-OADS,/arxiv_data1/oa_pdf/e4/94/mv-v21-857.PMC4539015.pdf
"Molecular Vision  2015; 21:857-870 <http://www.molvis.org/molvis/v 21/857> © 2015 Molecular Vision  859simultaneously test several samples in a single sequencing  run, each sample library was constructed using a specific  adaptor.",OADS,/arxiv_data1/oa_pdf/e4/94/mv-v21-857.PMC4539015.pdf
"Molecular Vision  2015; 21:857-870 <http://www.molvis.org/molvis/v 21/857> © 2015 Molecular Vision  860Genetic variants that affected the splicing process were  analyzed using NetGene2 , NNSPLICE v0.9 , Human Splicing  Finder ( HSF), and RESCUE-ESE .",OADS,/arxiv_data1/oa_pdf/e4/94/mv-v21-857.PMC4539015.pdf
"Molecular Vision  2015; 21:857-870 <http://www.molvis.org/molvis/v 21/857> © 2015 Molecular Vision  861RP1 gene, for which the number of reads ranged from 3 to 27.",Non-OADS,/arxiv_data1/oa_pdf/e4/94/mv-v21-857.PMC4539015.pdf
Molecular Vision  2015; 21:857-870 <http://www.molvis.org/molvis/v 21/857> © 2015 Molecular Vision  862Table  3. v arian Ts causing  adrP ThaT were  found  in 18 PaTienTs sTudied  using  The mul TiPlex-Pcr aPProach .,Non-OADS,/arxiv_data1/oa_pdf/e4/94/mv-v21-857.PMC4539015.pdf
"Molecular Vision  2015; 21:857-870 <http://www.molvis.org/molvis/v 21/857> © 2015 Molecular Vision  863variants were identified in the remaining three families, and  further analysis of these families is ongoing.",Non-OADS,/arxiv_data1/oa_pdf/e4/94/mv-v21-857.PMC4539015.pdf
"Molecular Vision  2015; 21:857-870 <http://www.molvis.org/molvis/v 21/857> © 2015 Molecular Vision  864RPT65 family, who had been ophthalmologically examined  and followed for years in our hospital (Table 5).",Non-OADS,/arxiv_data1/oa_pdf/e4/94/mv-v21-857.PMC4539015.pdf
Molecular Vision  2015; 21:857-870 <http://www.molvis.org/molvis/v 21/857> © 2015 Molecular Vision  865examination prompted by experiencing certain vision diffi - culties in semidarkness.,Non-OADS,/arxiv_data1/oa_pdf/e4/94/mv-v21-857.PMC4539015.pdf
"Molecular Vision  2015; 21:857-870 <http://www.molvis.org/molvis/v 21/857> © 2015 Molecular Vision  866method that uses multiplex PCR and an NGS benchtop plat - form, and that can be performed in any routine molecular  genetics laboratory.",Non-OADS,/arxiv_data1/oa_pdf/e4/94/mv-v21-857.PMC4539015.pdf
Molecular Vision  2015; 21:857-870 <http://www.molvis.org/molvis/v 21/857> © 2015 Molecular Vision  867genetic variants that were present in patients and absent in the  unaffected family member revealed a list of 21 candidate vari - ants—of which only c.307G>A (p.Gly103Arg) in the COL6A6   gene cosegregated with the clinically diagnosed patients with  RP.,Non-OADS,/arxiv_data1/oa_pdf/e4/94/mv-v21-857.PMC4539015.pdf
Molecular Vision  2015; 21:857-870 <http://www.molvis.org/molvis/v 21/857> © 2015 Molecular Vision  868APPENDIX 3.,Non-OADS,/arxiv_data1/oa_pdf/e4/94/mv-v21-857.PMC4539015.pdf
Molecular Vision  2015; 21:857-870 <http://www.molvis.org/molvis/v 21/857> © 2015 Molecular Vision  86916.,Non-OADS,/arxiv_data1/oa_pdf/e4/94/mv-v21-857.PMC4539015.pdf
Molecular Vision  2015; 21:857-870 <http://www.molvis.org/molvis/v 21/857> © 2015 Molecular Vision  87038.,Non-OADS,/arxiv_data1/oa_pdf/e4/94/mv-v21-857.PMC4539015.pdf
"Among  the several causes of variable phenotypes are alternative Molecular Vision  2015; 21:871-882 <http://www.molvis.org/molvis/v 21/871> Received 1 July 2014 | Accepted 15 August 2015 | Published 18 August 2015© 2015 Molecular Vision 871Splice-site mutations identified in PDE6A  responsible for retinitis  pigmentosa in consanguineous Pakistani families Shahid Y. Khan,1 Shahbaz Ali,2 Muhammad Asif Naeem,2 Shaheen N. Khan,2 Tayyab Husnain,2 Nadeem H.  Butt,3 Zaheeruddin A. Qazi,4 Javed Akram,3,5 Sheikh Riazuddin,2,3,5 Radha Ayyagari,6 J.",Non-OADS,/arxiv_data1/oa_pdf/40/ef/mv-v21-871.PMC4539017.pdf
"Molecular Vision  2015; 21:871-882 <http://www.molvis.org/molvis/v 21/871> © 2015 Molecular Vision  872alleles, environmental factors, modifier genes, or a combina - tion of these factors [ 6,7].",Non-OADS,/arxiv_data1/oa_pdf/40/ef/mv-v21-871.PMC4539017.pdf
Molecular Vision  2015; 21:871-882 <http://www.molvis.org/molvis/v 21/871> © 2015 Molecular Vision  873fully penetrant disorder that has an affected allele frequency  of 0.001.,Non-OADS,/arxiv_data1/oa_pdf/40/ef/mv-v21-871.PMC4539017.pdf
Molecular Vision  2015; 21:871-882 <http://www.molvis.org/molvis/v 21/871> © 2015 Molecular Vision  874confirmed that this individual is clinically unaffected and  does not exhibit any symptoms of RP.,Non-OADS,/arxiv_data1/oa_pdf/40/ef/mv-v21-871.PMC4539017.pdf
"Molecular Vision  2015; 21:871-882 <http://www.molvis.org/molvis/v 21/871> © 2015 Molecular Vision  875incorrectly by the local ophthalmologist, and/or perhaps he  manifested another form of retinal degeneration that had been  misdiagnosed as RP.",Non-OADS,/arxiv_data1/oa_pdf/40/ef/mv-v21-871.PMC4539017.pdf
Molecular Vision  2015; 21:871-882 <http://www.molvis.org/molvis/v 21/871> © 2015 Molecular Vision  876 Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/40/ef/mv-v21-871.PMC4539017.pdf
"Molecular Vision  2015; 21:871-882 <http://www.molvis.org/molvis/v 21/871> © 2015 Molecular Vision  877generated consensus values of 81.30 and 52.35 for the wild- type (c.1408–2A) and mutant (of c.1408–2G) nucleotides,  respectively.",Non-OADS,/arxiv_data1/oa_pdf/40/ef/mv-v21-871.PMC4539017.pdf
Molecular Vision  2015; 21:871-882 <http://www.molvis.org/molvis/v 21/871> © 2015 Molecular Vision  878DISCUSSION We report in this study two splicing acceptor site mutations in  PDE6A  associated with autosomal recessive RP in two large  consanguineous Pakistani families.,Non-OADS,/arxiv_data1/oa_pdf/40/ef/mv-v21-871.PMC4539017.pdf
Molecular Vision  2015; 21:871-882 <http://www.molvis.org/molvis/v 21/871> © 2015 Molecular Vision  879 Figure 4.,Non-OADS,/arxiv_data1/oa_pdf/40/ef/mv-v21-871.PMC4539017.pdf
Molecular Vision  2015; 21:871-882 <http://www.molvis.org/molvis/v 21/871> © 2015 Molecular Vision  880 Figure 5.,Non-OADS,/arxiv_data1/oa_pdf/40/ef/mv-v21-871.PMC4539017.pdf
"Molecular Vision  2015; 21:871-882 <http://www.molvis.org/molvis/v 21/871> © 2015 Molecular Vision  881In conclusion, we identified two splice acceptor site  mutations segregated in two large consanguineous pedigrees  responsible for arRP.",Non-OADS,/arxiv_data1/oa_pdf/40/ef/mv-v21-871.PMC4539017.pdf
Molecular Vision  2015; 21:871-882 <http://www.molvis.org/molvis/v 21/871> © 2015 Molecular Vision  88212.,Non-OADS,/arxiv_data1/oa_pdf/40/ef/mv-v21-871.PMC4539017.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fd/59/main.PMC4539073.pdf
http://dx.doi.org/10.1016/j.mgene.2015.07.007 2214-5400/© 2015 The Author.,Non-OADS,/arxiv_data1/oa_pdf/fd/59/main.PMC4539073.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fd/59/main.PMC4539073.pdf
"Sequence homology-based prediction of deleterious nsSNPs by using SIFT The Sorting Intolerant from Tolerant (SIFT) server available at (http://sift.jcvi.org ) was used to predict the deleterious non- synonymous SNPs ( Ng and Henikoff, 2003 ).",OADS,/arxiv_data1/oa_pdf/fd/59/main.PMC4539073.pdf
Predicting the functional effect of nsSNPs by PROVEAN PROVEAN (Protein Variation Effect Analyzer) ( http://provean.jcvi.,OADS,/arxiv_data1/oa_pdf/fd/59/main.PMC4539073.pdf
"Structural homology-based prediction of functional consequences of coding nsSNPs by using PolyPhen The PolyPhen server ( http://genetics.bwh.harvard.edu/pph/ )w a s used to study the functional consequences of nsSNPs ( Ramensky et al., 2002; Adzhubei et al., 2010 ).",OADS,/arxiv_data1/oa_pdf/fd/59/main.PMC4539073.pdf
"Prediction of disease related amino acid substitution by MutPred MutPred ( http://mutpred.mutdb.org /) is a web based tool to predict the molecular cause of disease related amino acid substitution ( Li, 2009 ).",OADS,/arxiv_data1/oa_pdf/fd/59/main.PMC4539073.pdf
"Molecular phenotypic characterization of nsSNPs by SNPeffect The SNPeffect 4.0 ( http://snpeffect.switchlab.org /) server provides sequence and structure-based bioinformatics tools to predict the effect of protein-coding SNVs on the structural phenotype of proteins ( De Baets et al., 2012 ).",OADS,/arxiv_data1/oa_pdf/fd/59/main.PMC4539073.pdf
"Disease associated SNP prediction by nsSNP analyzer and PhD SNP nsSNP Analyzer ( http://snpanalyzer.uthsc.edu ) is a tool to predict the phenotypic effect (disease-associated vs. neutral) of a nsSNP by using a machine learning method called RandomForest, and extracting structural and evolutionary information from a query nsSNP ( Bao et al., 2005 ).",OADS,/arxiv_data1/oa_pdf/fd/59/main.PMC4539073.pdf
"PhD-SNP ( http://snps.biofold.org/phd-snp/phd-snp.html )i sa l s oa n SVM based classi ﬁer, trained over the million amino acid polymorphism163 A.M. Goswami / Meta Gene 5 (2015) 162 –172",Non-OADS,/arxiv_data1/oa_pdf/fd/59/main.PMC4539073.pdf
"Predicting the effect of nsSNP on protein structure –function by stSNP Structure SNP (StSNP) ( http://ilyinlab.org/StSNP/ )i sas e r v e rw h i c h provides the ability to analyze and compare human non-synonymous SNPs in protein structures, protein complexes, protein –protein inter- faces and metabolic networks ( Uzun et al., 2007 ).",OADS,/arxiv_data1/oa_pdf/fd/59/main.PMC4539073.pdf
"Structural conformation and conservation analysis of HSD3B2 ConSurf ( http://consurf.tau.ac.il /) was used for high-throughput characterization of the functional regions in the protein ( Ashkenazy et al., 2010 ).",OADS,/arxiv_data1/oa_pdf/fd/59/main.PMC4539073.pdf
"Secondary structure prediction of HSD3B2 by PSIPRED The PSIPERD program ( http://bioinf.cs.ucl.ac.uk/psipred/ ) incorpo- rates PSIPRED, GenTHREADER, and MEMSAT2 methods for protein structure prediction.",Non-OADS,/arxiv_data1/oa_pdf/fd/59/main.PMC4539073.pdf
Homology modeling using HHPred server HHpred ( http://toolkit.tuebingen.mpg.de/hhpred ) is a free protein function and protein structure prediction server based on the HHsearch method.,OADS,/arxiv_data1/oa_pdf/fd/59/main.PMC4539073.pdf
"Homology modeling using phyre 2 Phyre2 ( http://www.sbg.bio.ic.ac.uk/phyre2 ) uses the Hidden Mar- kov Method to generate alignments of a submitted protein sequence against proteins with published structures ( Kelley and Sternberg, 2009 ).",OADS,/arxiv_data1/oa_pdf/fd/59/main.PMC4539073.pdf
Homology modeling using RaptorX RaptorX ( http://raptorx.uchicago.edu/StructurePrediction/predict/ ) uses a non-linear scoring function to combine homologous information with structural information for a given template-sequence alignment.,OADS,/arxiv_data1/oa_pdf/fd/59/main.PMC4539073.pdf
"The predicted HSD3B2 models were evaluated using the ProSA web servers ( https://prosa.services.came.sbg.ac.at/prosa.php )(Wiederstein and Sippl, 2007 ).",OADS,/arxiv_data1/oa_pdf/fd/59/main.PMC4539073.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/86/93/jaa-8-087.PMC4539078.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Asthma and Allergy 2015:8 87–92Journal of Asthma and Allergy Dove press submit your manuscript | www.dovepress.co m Dove press  87Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JAA.S6993 2Profile of lebrikizumab and its potential in the  treatment of asthma Diego Jose Maselli1  Holly Keyt1  Linda Rogers2 1Department of Medicine, Division of  Pulmonary Diseases and Critical Care,   University of Texas Health Science  Center at San Antonio, San Antonio,   TX, 2Pulmonary, Critical Care, and  Sleep Medicine Division, Mount Sinai- National Jewish Health Respiratory  institute, icahn School of Medicine at  Mount Sinai, New Y ork, NY, USA Correspondence: Diego J Maselli   Department of Medicine, Division of  Pulmonary Diseases and Critical Care,  University of Texas Health Science  Center at San Antonio, 7400 Merton  Minter MC 111e, San Antonio,   TX 78249, USA   Tel +1 210 617 5256   Fax +1 210 949 3006   email masellicacer@uthscsa.ed uAbstract:  Interleukin (IL)-13 has been associated with multiple inflammatory features of  asthma.",Non-OADS,/arxiv_data1/oa_pdf/86/93/jaa-8-087.PMC4539078.pdf
"Journal of Asthma and Allergy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-asthma-and-allergy-journa lThe Journal of Asthma and Allergy is an international, peer-reviewed  open-access journal publishing original research, reports, editorials  and commentaries on the following topics: Asthma; Pulmonary physi - ology; Asthma related clinical health; Clinical immunology and the  immunological basis of disease; Pharmacological interventions and new therapies.",Non-OADS,/arxiv_data1/oa_pdf/86/93/jaa-8-087.PMC4539078.pdf
Visit http://www.dovepress.com/testimonials.ph p to read  real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/86/93/jaa-8-087.PMC4539078.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ca/b5/ott-8-2081.PMC4539079.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 2081–2088OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2081Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8622 2heme oxygenase-1 is a predictive biomarker for  therapeutic targeting of advanced clear cell renal  cell carcinoma treated with sorafenib or sunitinib Wan-Xiang Zheng* Fei Yan* Qin Xue guo-Jun Wu Wei-Jun Qin Fu-li Wang Jun Qin chun-Juan Tian Jian-lin Yuan Department of Urology, Xijing  hospital, Fourth Military Medical  University, Xi’an, shaanxi, People’s  republic of china *These authors contributed equally  to this workBackground:  We analyzed the expression of heme oxygenase-1 (HO-1) in patients undergoing  radical nephrectomy for advanced clear cell renal cell carcinoma (CC-RCC) and evaluated the  effects of the targeted therapies treated with sorafenib and sunitinib.",Non-OADS,/arxiv_data1/oa_pdf/ca/b5/ott-8-2081.PMC4539079.pdf
"After thorough research of the RCC signaling pathways, several biologic agents that  target the vascular endothelial growth factor (VEGF) pathway began to attract the attention  of researchers.1,2–5 Sorafenib and sunitinib are multitargeted tyrosine kinase inhibitors that  target several tyrosine kinases, including vascular endothelial growth factor (VEGFR),  platelet-derived growth factor receptor- β (PDGFR), RAF-1, wild-type and mutant BRAF, correspondence: Jian-lin Yuan Department of Urology, Xijing hospital,  Fourth Military Medical University,   no 127, changle West road, Xi’an,  shaanxi, 710032, People’s republic of  china Tel +86 136 0912 3155 Fax +86 29 8477 5317 email jianliny1010@126.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Zheng et al Running head recto: Heme oxygenase-1 as a predictive biomarker for targeting CC-RCC DOI: http://dx.doi.org/10.2147/OTT.S86222",Non-OADS,/arxiv_data1/oa_pdf/ca/b5/ott-8-2081.PMC4539079.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/ca/b5/ott-8-2081.PMC4539079.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ca/b5/ott-8-2081.PMC4539079.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5b/cb/dddt-9-4413.PMC4539080.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 4413–4416Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4413Case repor Topen access to scientific and medical research open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8557 1T ongguan capsule ameliorates coronary artery  stenosis in a 40-year-old woman Huan Ma1 Lei Wang1 Daozheng Huang2 Guoqing Liu3 Minzhou Zhang1 1Department of Critical Care  Medicine, Guangdong provincial  Hospital of Chinese Medicine,   2Department of Critical Care  Medicine, Guangdong General  Hospital, 3Medical Imaging Central,   Guangdong provincial Hospital  of Chinese Medicine, Guangzhou,   Guangdong, people’s republic of  ChinaAbstract:  Cardiovascular disease is the leading cause of death worldwide, with coronary  heart disease as the major contributor to this related mortality.",Non-OADS,/arxiv_data1/oa_pdf/5b/cb/dddt-9-4413.PMC4539080.pdf
"To the best of our knowledge, no Correspondence: Minzhou Zhang Department of Critical Care Medicine,  Guangdong provincial Hospital of  Chinese Medicine, 111 Dade road,  Yuexiu, Guangzhou, Guangdong 510120,  people’s republic of China Tel +86 20 8188 7233 Fax +86 20 8188 7233 email mahuannovel@163.co m Journal name: Drug Design, Development and Therapy Article Designation: Case report Y ear: 2015 Volume: 9 Running head verso: Ma et al Running head recto: Therapeutic effect of TGC in a patient with CHD DOI: http://dx.doi.org/10.2147/DDDT.S85571",Non-OADS,/arxiv_data1/oa_pdf/5b/cb/dddt-9-4413.PMC4539080.pdf
Detailed tables released ahead of full report: Available  from: http://www.cdc.gov/nchs/data/nvsr/nvsr64/nvsr64_02.pd f  3.,OADS,/arxiv_data1/oa_pdf/5b/cb/dddt-9-4413.PMC4539080.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/5b/cb/dddt-9-4413.PMC4539080.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/5b/cb/dddt-9-4413.PMC4539080.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a1/a4/dddt-9-4551.PMC4539081.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 4551–4557Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4551Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8358 8evaluation of trends of drug-prescribing patterns  based on WhO prescribing indicators at  outpatient departments of four hospitals in  southern ethiopia Temesgen sidamo  summoro1 Kassa Daka gidebo2 Zewde Zemma Kanche1 eskinder Wolka Woticha2 1school of Medicine, college of  health  sciences and Medicine, Wolaita sodo  University, Wolaita sodo, ethiopia;   2school of Public health, college of  health sciences and Medicine, Wolaita  sodo University, Wolaita sodo,   ethiopiaBackground:  Rational prescribing is a primary step to ensure rational drug use.",Non-OADS,/arxiv_data1/oa_pdf/a1/a4/dddt-9-4551.PMC4539081.pdf
"It also affects the treatment of  less severe conditions as people tend to remember the advice given and use it in later  episodes of self-medication.1correspondence: Temesgen sidamo  summoro school of Medicine, college of health  sciences and Medicine, Wolaita sodo  University, PO Box 138, Wolaita sodo,  ethiopia Tel +251 91 109 3567 email teme.yene2003@gmail.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Summoro et al Running head recto: WHO-based drug-prescribing patterns in 4 southern Ethiopian hospitals DOI: http://dx.doi.org/10.2147/DDDT.S83588",Non-OADS,/arxiv_data1/oa_pdf/a1/a4/dddt-9-4551.PMC4539081.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/a1/a4/dddt-9-4551.PMC4539081.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a1/a4/dddt-9-4551.PMC4539081.pdf
Available from: http://policycures.org/downloads/ COHRED-NEPAD_Strengthening_Pharmaceutical_Innovation_ AfricaREPORT.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a1/a4/dddt-9-4551.PMC4539081.pdf
Available from: http://www.who.int/ drugresistance/documents/surveillancereport/en /.,OADS,/arxiv_data1/oa_pdf/a1/a4/dddt-9-4551.PMC4539081.pdf
Available from: http://www.amcp.org/workarea/downloadasset.,Non-OADS,/arxiv_data1/oa_pdf/a1/a4/dddt-9-4551.PMC4539081.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/51/a6/dddt-9-4479.PMC4539082.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 4479–4499Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4479Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S8662 1Clinical development of galunisertib (LY2157299  monohydrate), a small molecule inhibitor of  transforming growth factor-beta signaling pathway Stephan Herbertz,1 J Scott  Sawyer,2 Anja J Stauber,2  ivelina Gueorguieva,3  Kyla e Driscoll,4 Shawn T  estrem,2 Ann L Cleverly3  Durisala Desaiah,2 Susan C  Guba,2 Karim A Benhadji,2  Christopher A Slapak,2  Michael M Lahn2 1Lilly Deutschland GmbH, Bad  Homburg, Germany; 2Lilly Research  Laboratories, eli Lilly and Company,   indianapolis, iN, USA; 3Lilly Research  Laboratories, eli Lilly and Company,   windlesham, Surrey, UK; 4Lilly  Research Laboratories, eli Lilly and  Company, New Y ork, NY, USAAbstract:  Transforming growth factor-beta (TGF- β) signaling regulates a wide range of  biological processes.",Non-OADS,/arxiv_data1/oa_pdf/51/a6/dddt-9-4479.PMC4539082.pdf
"Here, we will focus on the role of the TGF- β/ALK5-mediated  pathway and describe the experiences of developing galunisertib.Correspondence: Michael M Lahn 6820 wisconsin Avenue, Condo 8008,  Bethesda, MD 20815, USA Tel +1 240 899 9415 email michalahn@aol.co m Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2015 Volume: 9 Running head verso: Herbertz et al Running head recto: Clinical development of galunisertib DOI: http://dx.doi.org/10.2147/DDDT.S86621 Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/51/a6/dddt-9-4479.PMC4539082.pdf
Or use: http://youtu.be/cN-vG9YO22 Ivideo abstract,Non-OADS,/arxiv_data1/oa_pdf/51/a6/dddt-9-4479.PMC4539082.pdf
"Drug Design, Development and Therapy 2015:9submit your manuscript | www.dovepress.co m Dove press Dove press 4482Herbertz et alTable 2  TGF- β inhibitors in clinical development Target/mode of action Generic name Clinical development   phaseIndications in clinical trials Company References TGF-β receptor serine/threonine kinase inhibitors TGF- βRi ALK5Galunisertib LY2157299ii/iii Pancreatic carcinoma, glioblastoma,   hepatocellular carcinoma, myelodysplastic   syndromes (MDS)eli Lilly and   CompanyNCT01746004 NCT01965808 NCT01582269 NCT01722825 NCT02008318 NCT01220271 NCT01246986 NCT01373164 NCT01682187 TGF- βRi ALK5Tew-7197 i Melanoma, breast cancer, hepatocellular   carcinoma, prostate cancerMedPacto inc.   (South Korea)NCT02160106 Antibodies and protein therapeutics against TGF- β and TGF- β receptors ALK1, ALK5, ALK6 TGF- βRii LY3022859 iMC-TR1i Advanced solid tumors eli Lilly and   CompanyNCT01646203 TGF- β-1 LY2382770 ii Diabetic kidney disease, diabetic nephropathy,   diabetic glomerulosclerosiseli Lilly and   CompanyNCT01113801 Pan TGF- β Fresolimumab (GC-1008)ii Systemic sclerosis, metastatic breast cancer,   focal segmental glomerulosclerosis, glioma,   renal cell carcinoma, melanoma, malignant   pleural mesothelioma, myelofibrosisGenzyme, a Sanofi  CompanyNCT01284322 NCT01401062 NCT01665391 NCT01472731 NCT00356460 NCT00923169 NCT01112293 ALK-1 PF-03446962 ii Hepatocellular carcinoma, urothelial cancer,   malignant pleural mesotheliomaPfizer NCT01911273 NCT01620970 NCT01486368 BMP9/BMP10 ALK-1   interaction (soluble form  of ALK-1)Dalantercept ACe-041ii Squamous cell carcinoma of the head and neck,   renal cell carcinoma, ovarian epithelial, fallopian   tube, or primary peritoneal cavity cancerAcceleron Pharma inc. NCT01458392 NCT01727336 NCT01720173 http://www.acceleronpharma.com/ products/dalantercept / Soluble fusion protein   of receptor type iiA   (ActRiiA) linked to the   Fc protein of human igG1Sotatercept ACe-011ii Anemia in rare blood diseases, including   β-thalassemia, MDS, and diamond blackfan;  chronic kidney disease; multiple myelomaAcceleron Pharma inc.   and Celgene CorporationNCT01736683 NCT01571635 NCT01146574 NCT01999582 NCT01464164 NCT01712308 NCT01562405 http://www.acceleronpharma.com/ products/sotatercept /",Non-OADS,/arxiv_data1/oa_pdf/51/a6/dddt-9-4479.PMC4539082.pdf
"Drug Design, Development and Therapy 2015:9submit your manuscript | www.dovepress.co m Dove press Dove press 4483Clinical development of galunisertibModified type II activin  receptor fusion protein  that acts as a ligand trap  for members in the  TGF- β superfamilyLuspartecept ACe-536ii β-thalassemia; anemia in patients with   MDSAcceleron Pharma inc.   and Celgene CorporationNCT01749540 NCT01749514 http://www.acceleronpharma.com/ products/luspatercept / TGF- β-1 blocking peptide P144 Peptide 144 Disirtertideii Skin fibrosis in systemic sclerosis Digna Biotech S.L.",Non-OADS,/arxiv_data1/oa_pdf/51/a6/dddt-9-4479.PMC4539082.pdf
"NCT00781053 NCT00574613 NCT00656825 Direct and indirect inhibitors of TGF- β synthesis and secretion TGF- β mRNA antisense Trabedersen (AP-12009),   intravenous (convection   enhanced delivery   formulation terminated)ii Pancreatic neoplasms, melanoma, colorectal   neoplasmsisarna Therapeutics GmbH NCT00844064 NCT00431561 NCT00761280 http://www.isar na-the rapeutics.",Non-OADS,/arxiv_data1/oa_pdf/51/a6/dddt-9-4479.PMC4539082.pdf
Available  from: https://clinicaltrials.gov/ct2/show/NCT02160106?term =nct021 60106&rank =1.,Non-OADS,/arxiv_data1/oa_pdf/51/a6/dddt-9-4479.PMC4539082.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/51/a6/dddt-9-4479.PMC4539082.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/51/a6/dddt-9-4479.PMC4539082.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4d/22/dddt-9-4573.PMC4539083.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 4573–4586Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4573Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S9017 0Therapeutic designed poly (lactic-co-glycolic acid)  cylindrical oseltamivir phosphate-loaded implants  impede tumor neovascularization, growth and  metastasis in mouse model of human pancreatic  carcinoma Michael hrynyk1 Jordon P ellis1 Fiona haxho2 stephanie allison1 Joseph aM steele1 samar abdulkhalek2 ronald J neufeld1 Myron r szewczuk2 1Department of chemical engineering,   2Department of Biomedical and  Molecular sciences, Queen’s  University, Kingston, On , canadaAbstract:  Poly (lactic-co-glycolic acid) (PLGA) copolymers have been extensively used in can - cer research.",Non-OADS,/arxiv_data1/oa_pdf/4d/22/dddt-9-4573.PMC4539083.pdf
"The current research interest on targeting the tumor microenvironment has  focused on anti-angiogenesis therapy, which involves drugs that either prevent the  formation of new blood vessel supply to the tumor or impair existing blood vessels.1  The strategic approach of these anti-angiogenic drugs can involve either selective  targeting of the tumor-associated vasculature, increasing the bioavailability of tumor  endothelial cells to systemically-administered anti-angiogenic drugs, or using met - ronomic therapy to reduce systemic drug toxicity.2,3 To achieve these therapeutic correspondence: ronald J neufeld Department of chemical engineering,   19 Division st, Bioscience complex  room 1443a, Queen’s University,  Kingston, On, K7l 3n6, canada Tel +1 613 553 2827 Fax +1 613 533 6637 email neufeld@queensu.c a  Myron r szewczuk Department of Biomedical and Molecular  sciences, 18 stuart st, Botterell hall rm  827, Kingston, On K7l 3n6, canada Tel +1 613 533 2457 Fax +1 613 533 6796 email szewczuk@queensu.c a Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Hrynyk et al Running head recto: Therapeutic designed PLGA cylindrical oseltamivir phosphate-loaded implants DOI: http://dx.doi.org/10.2147/DDDT.S90170",Non-OADS,/arxiv_data1/oa_pdf/4d/22/dddt-9-4573.PMC4539083.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/4d/22/dddt-9-4573.PMC4539083.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/4d/22/dddt-9-4573.PMC4539083.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/96/04/dddt-9-4431.PMC4539084.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 4431–4440Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4431Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8662 9Transarterial chemoembolization versus hepatic  resection in hepatocellular carcinoma treatment:  a meta-analysis Xin Tian1 Ying Dai1 Da-qing Wang2 li Zhang1 cheng-guang sui1 Fan-dong Meng1 shen-yi Jiang1 Yun-peng liu1 Y ou-hong Jiang1 1Molecular Oncology laboratory  of cancer research institute,   The First affiliated hospital of china  Medical University, shenyang, 2health  and Family Planning commission  of liaoning Province, People’s  republic of chinaBackground:  A number of cohort studies have compared the outcomes of transarterial  chemoembolization (TACE) and hepatic resection (HR) in the treatment of hepatocellular car - cinoma (HCC).",Non-OADS,/arxiv_data1/oa_pdf/96/04/dddt-9-4431.PMC4539084.pdf
"Keywords:  transarterial chemoembolization, hepatic resection, hepatocellular carcinoma,  meta-analysis Introduction Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related deaths  worldwide, accounting for almost half a million deaths annually.1,2 The known  causes of HCC are hepatitis B virus, hepatitis C virus, and chronic alcohol use.3,4  With improved periodic surveillance of high-risk patients with chronic hepatitis and correspondence: You-hong Jiang Molecular Oncology laboratory of  cancer research institute, the First  Affiliated Hospital of China Medical  University, 155 nanjing north street,  heping district, shenyang 110001,  People’s republic of china Tel +86 24 8328 2354 Fax +86 24 8328 2473 email youhongj19@hotmail.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Tian et al Running head recto: Transarterial chemoembolization versus hepatic resection DOI: http://dx.doi.org/10.2147/DDDT.S86629",Non-OADS,/arxiv_data1/oa_pdf/96/04/dddt-9-4431.PMC4539084.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/96/04/dddt-9-4431.PMC4539084.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/96/04/dddt-9-4431.PMC4539084.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/af/39/dddt-9-4515.PMC4539085.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 4515–4549Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4515Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8652 9navigating the chemical space of dipeptidyl  peptidase-4 inhibitors Watshara shoombuatong1 Veda Prachayasittikul1,2 nuttapat anuwongcharoen1 napat songtawee1 T eerawat Monnor1 supaluk Prachayasittikul1 Virapong Prachayasittikul2 chanin nantasenamat1,2 1center of Data Mining and  Biomedical informatics, 2Department  of clinical Microbiology and applied  Technology, Faculty of Medical  T echnology, Mahidol University,   Bangkok, ThailandAbstract:  This study represents the first large-scale study on the chemical space of inhibitors of  dipeptidyl peptidase-4 (DPP4), which is a potential therapeutic protein target for the treatment  of diabetes mellitus.",Non-OADS,/arxiv_data1/oa_pdf/af/39/dddt-9-4515.PMC4539085.pdf
"Generally, these two hormones exert a great effect on reducing  blood glucose concentration; however, the rapid degradation of these hormones by  DPP4 in T2D results in persistent high glucose level.7 Therefore, the inhibition of correspondence: chanin nantasenamat center of Data Mining and Biomedical  informatics, Faculty of Medical  Technology, Mahidol University  999 Phutthamonthon 4 road,  salaya, Phutthamonthon,   nakhon Pathom 73170, Thailand Tel +66 2 441 4371 Fax +66 2 441 4380 email chanin.nan@mahidol.ac.t h Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Shoombuatong et al Running head recto: Navigating chemical space of DPP4 inhibitors DOI: http://dx.doi.org/10.2147/DDDT.S86529",Non-OADS,/arxiv_data1/oa_pdf/af/39/dddt-9-4515.PMC4539085.pdf
"Available from: http://www.cdc.gov/diabetes/data/ statistics/2014statisticsreport.htm l. Accessed Juyly 7, 2015.",Non-OADS,/arxiv_data1/oa_pdf/af/39/dddt-9-4515.PMC4539085.pdf
Avail - able from: http://www.chemaxon.co m 24.,Non-OADS,/arxiv_data1/oa_pdf/af/39/dddt-9-4515.PMC4539085.pdf
Available from: http://www.eyesopen.co m 25.,Non-OADS,/arxiv_data1/oa_pdf/af/39/dddt-9-4515.PMC4539085.pdf
Available  from: http://www.chemaxon.co m 36.,Non-OADS,/arxiv_data1/oa_pdf/af/39/dddt-9-4515.PMC4539085.pdf
Avail - able from: http://www.chemaxon.co m50.,Non-OADS,/arxiv_data1/oa_pdf/af/39/dddt-9-4515.PMC4539085.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/af/39/dddt-9-4515.PMC4539085.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/af/39/dddt-9-4515.PMC4539085.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/50/f8/dddt-9-4559.PMC4539086.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 4559–4563Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4559Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8946 4effects of amoxicillin/clavulanic acid on the  pharmacokinetics of valproic acid soo-Yun lee1 Wooseong huh2 Jin ah Jung3 hye Min Y oo2 Jae-Wook Ko1,2 Jung-ryul Kim2,4 1Department of health sciences and  Technology, saihs T, sungkyunkwan  University, 2Department of clinical  Pharmacology and Therapeutics,   samsung Medical center,  seoul,   3Department of clinical Pharmacology,   inje University, Busan Paik hospital,   Busan, 4Department of clinical  research and evaluation, saihsT,   sungkyunkwan University, seoul,   republic of KoreaAbstract:  Valproic acid (VPA) is mainly metabolized via glucuronide, which is hydrolyzed by  β-glucuronidase and undergoes enterohepatic circulation.",Non-OADS,/arxiv_data1/oa_pdf/50/f8/dddt-9-4559.PMC4539086.pdf
"For this reason, VPA concentration is correspondence: Jae-Wook Ko;  Jung-ryul Kim Department of clinical Pharmacology and  Therapeutics, Main Building, 9th Floor,  samsung Medical center, 81 irwon-ro,  gangnam-gu, seoul 135-710, republic   of Korea Tel +82 2 3410 3686 Fax +82 2 3410 0915 email jw0701.ko@samsung.co m;   jungryul.kim@samsung.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Lee et al Running head recto: Effects of amoxicillin/clavulanic acid on valproic acid DOI: http://dx.doi.org/10.2147/DDDT.S89464",Non-OADS,/arxiv_data1/oa_pdf/50/f8/dddt-9-4559.PMC4539086.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/50/f8/dddt-9-4559.PMC4539086.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/50/f8/dddt-9-4559.PMC4539086.pdf
Available from: http://www.epilepsy.org.uk/.,Non-OADS,/arxiv_data1/oa_pdf/50/f8/dddt-9-4559.PMC4539086.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7f/56/tcrm-11-1153.PMC4539087.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2015:11 1153–1162Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1153Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S8108 8exenatide once-weekly injection for the treatment  of type 2 diabetes in Chinese patients: current  perspectives wuquan Deng1,* Sheng Qiu1,* Gangyi Yang2 Bing Chen1 1Department of endocrinology,   Southwest Hospital, Third Military  Medical University, 2Department  of endocrinology, Second Affiliated  Hospital, Chongqing Medical  University, Chongqing, People’s  Republic of China *These authors contributed equally  to this workAbstract:  Glucagon-like peptide-1 (GLP-1) analogs, such as exenatide, have played an impor - tant role as antidiabetic medications in the treatment of type 2 diabetes (T2DM).",Non-OADS,/arxiv_data1/oa_pdf/7f/56/tcrm-11-1153.PMC4539087.pdf
"In one report, only 25.8% of patients with diabetes received antidiabetic treatment and  only 39.7% of those treated had adequate glycemic control (HbA1c  ,7.0%).2 The results  of other studies revealed that 64% of patients still fail to achieve adequate glycemic Correspondence: Bing Chen Department of endocrinology,  Southwest Hospital, Third Military  Medical University, Gaotanyan Street 29,  Shapingba District, Chongqing 400038,  People’s Republic of China Tel +86 23 6875 4138 email chenbing3@medmail.com.c n  Gangyi Yang Department of endocrinology, Second  Affiliated Hospital, Chongqing Medical  University, 76 Linjiang Road, Yuzhong  District, Chongqing 400010, People’s  Republic of China Tel +86 23 6848 6115 email gangyiyang@163.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Review Y ear: 2015 Volume: 11 Running head verso: Deng et al Running head recto: Exenatide once-weekly injection for type 2 diabetes in the PRC DOI: http://dx.doi.org/10.2147/TCRM.S81088",Non-OADS,/arxiv_data1/oa_pdf/7f/56/tcrm-11-1153.PMC4539087.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/7f/56/tcrm-11-1153.PMC4539087.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/7f/56/tcrm-11-1153.PMC4539087.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/65/bc/tcrm-11-1163.PMC4539088.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2015:11 1163–1175Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1163Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S7416 5A review of the clinical utility of duloxetine in the  treatment of diabetic peripheral neuropathic pain Jordan B King Marisa B Schauerhamer Brandon K Bellows Pharmacotherapy Outcomes Research  Center, University of Utah College of  Pharmacy, Salt Lake City, UT, USAAbstract:  Diabetes mellitus is a world-wide epidemic with many long-term complications, with  neuropathy being the most common.",Non-OADS,/arxiv_data1/oa_pdf/65/bc/tcrm-11-1163.PMC4539088.pdf
"In contrast to loss of sensation, diabetic peripheral neuropathic pain (DPNP) is associ - ated with burning, tingling, shock-like, or shooting pain in the extremities.5,6 While it  is unknown how many patients suffer from DPNP, it has been reported that 26.8% of  patients with diabetes experience pain or tingling.2 According to the American Diabetes Association guidelines, the best way to  prevent or slow the progression of neuropathy is to maintain proper glucose control.7 Correspondence: Brandon K Bellows University of Utah College of Pharmacy,  30 South 2000 east, Room 4963, Salt  Lake City, UT 84112, USA Tel +1 801 587 8011 Fax +1 801 587 7923 email brandon.bellows@pharm.utah.ed u Journal name: Therapeutics and Clinical Risk Management Article Designation: Review Y ear: 2015 Volume: 11 Running head verso: King et al Running head recto: Clinical utility of duloxetine DOI: http://dx.doi.org/10.2147/TCRM.S74165",Non-OADS,/arxiv_data1/oa_pdf/65/bc/tcrm-11-1163.PMC4539088.pdf
"Available from: http://www.cdc.gov/diabetes/ data/statistics/2014statisticsreport.htm l. Accessed April 2, 2015.",OADS,/arxiv_data1/oa_pdf/65/bc/tcrm-11-1163.PMC4539088.pdf
Available from: http://diabetes.niddk.nih.gov/dm/ pubs/neuropathies /.,Non-OADS,/arxiv_data1/oa_pdf/65/bc/tcrm-11-1163.PMC4539088.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/65/bc/tcrm-11-1163.PMC4539088.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/65/bc/tcrm-11-1163.PMC4539088.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c0/87/ott-8-1979.PMC4539089.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 1979–1988OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1979Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8544 3The histone demethylase P hF8 promotes prostate  cancer cell growth by activating the oncomi r   mir-125b Qiang Ma* Zhuo chen* guojin Jia Xueqiang lu Xuefeng Xie Wei Jin Department of Urology, Jinshan  hospital, Fudan University, shanghai,   People’s republic of china *These authors contributed equally  to this workAims:  Prostate cancer (PCa) is the most frequently diagnosed malignancy in men.",Non-OADS,/arxiv_data1/oa_pdf/c0/87/ott-8-1979.PMC4539089.pdf
"Both local and circulating microRNAs have been reported to participate in  human PCa.11–14 For instance, the oncomiR miR-125b has been demonstrated to promote correspondence: Wei Jin Department of Urology, Jinshan hospital,  Fudan University, no 1508 longhang  road, shanghai 201508, People’s republic  of china Tel +86 21 3418 9990 email jinwei_ch@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Ma et al Running head recto: PHF8 in prostate cancer DOI: http://dx.doi.org/10.2147/OTT.S85443",Non-OADS,/arxiv_data1/oa_pdf/c0/87/ott-8-1979.PMC4539089.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/c0/87/ott-8-1979.PMC4539089.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c0/87/ott-8-1979.PMC4539089.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/55/46/ott-8-2075.PMC4539090.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 2075–2079OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2075Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8585 6a polymorphism at the microrna binding site  in the 3 ′ untranslated region of RYR3 is associated  with outcome in hepatocellular carcinoma chenxing Peng1 Zhanjun guo2 Xiaoyan Wu3 Xiao-lan Zhang1 1Department of gastroenterology  and hepatology, The second  hospital of hebei Medical University,    2Department of gastroenterology  and hepatology, The Fourth hospital  of hebei Medical University,    3Department of Pharmacy, The  second hospital of hebei Medical  University, shijiazhuang, hebei,   People’s republic of chinaObjective:  MicroRNAs can bind to the 3 ′ untranslated regions (UTRs) of messenger RNAs,  where they interfere with the translation of targeting genes, thereby regulating cell differentia - tion, apoptosis, and tumorigenesis.",Non-OADS,/arxiv_data1/oa_pdf/55/46/ott-8-2075.PMC4539090.pdf
"While the  molecular mechanism of HCC carcinogenesis is still not fully understood, there are  many prognostic factors and predictors of recurrence associated with the disease,  including tumor size, tumor quantity, cell differentiation, venous invasion, and degree  of inflammation.3–7 MicroRNAs (miRNAs) are ~22 nucleotide RNA molecules that act as posttran - scriptional regulators of messenger RNA (mRNA) expression by base pairing to the  3′ untranslated region (UTR) of mRNAs to repress translation.7–9 Specifically, miRNAs correspondence: Xiao-lan Zhang Department of gastroenterology  and hepatology, The second  hospital of hebei Medical University,  shijiazhuang 050000, hebei,  People’s republic of china Tel +86 311 6600 2023 Fax +86 311 6600 2037 email x iao-lanzhangxiaolanzh@126.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Peng et al Running head recto: rs1044129 and HCC outcome DOI: http://dx.doi.org/10.2147/OTT.S85856",Non-OADS,/arxiv_data1/oa_pdf/55/46/ott-8-2075.PMC4539090.pdf
"snP genotyping of mirna binding site  snPs The miRNA binding site SNPs, including RYR3 (rs1044129),  C14orf101 (rs4901706), and KIAA0423  (rs1053667), were  genotyped using the ligation detection reaction method,  with forward and reverse primers to amplify the DNA frag - ments flanking the SNPs, based on the NCBI SNP database (http://www.ncbi.nlm.nih.gov/snp /).",OADS,/arxiv_data1/oa_pdf/55/46/ott-8-2075.PMC4539090.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/55/46/ott-8-2075.PMC4539090.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/55/46/ott-8-2075.PMC4539090.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d2/3a/dddt-9-3969.PMC4539091.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 3969–3987Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3969Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8452 720(s)-ginsenoside rg3 promotes senescence  and apoptosis in gallbladder cancer cells via  the p53 pathway Fei Zhang,* Maolan li,*  Xiangsong Wu,* Yunping  hu, Yang cao, Xu’an Wang,   shanshan Xiang, huaifeng  li, lin Jiang, Zhujun Tan,   Wei lu, hao Weng, Yijun  shu, Wei gong, Xuefeng  Wang, Yong Zhang, Weibin  shi, Ping Dong,# Jun gu,#  Yingbin liu# Department of general surgery  and laboratory of general surgery,   Xinhua hospital affiliated to  shanghai Jiao T ong University, school  of Medicine, institute of Biliary Tract  Disease, shanghai Jiao Tong University  school of Medicine, shanghai, People’s  republic of china *These authors contributed equally  to this work #These authors jointly directed  this workAbstract:  Gallbladder cancer (GBC), the most frequent malignancy of the biliary tract, is  associated with high mortality and extremely poor prognosis.",Non-OADS,/arxiv_data1/oa_pdf/d2/3a/dddt-9-3969.PMC4539091.pdf
"Ginseng, such as American ginseng ( Panax quinquefolius  L.) and Asian ginseng  (Panax ginseng  CA Meyer), is the root of different Panax  species (Araliaceae)  and is one of the most commonly used traditional medicines.9 Ginsenoside Rg3,  one of the active ingredients in ginseng, has been reported to exhibit various correspondence: Yingbin liu; Ping Dong Department of general surgery  and laboratory of general surgery,  Xinhua Hospital Affiliated to Shanghai  Jiao Tong University, school of Medicine,  institute of Biliary Tract Disease, shanghai  Jiao Tong University school of Medicine,  shanghai 200092, People’s republic  of china email liuybphd@126.co m;  dongping1050@163.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Zhang et al Running head recto: 20(S)-ginsenoside Rg3 promotes senescence and apoptosis DOI: http://dx.doi.org/10.2147/DDDT.S84527",Non-OADS,/arxiv_data1/oa_pdf/d2/3a/dddt-9-3969.PMC4539091.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/d2/3a/dddt-9-3969.PMC4539091.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d2/3a/dddt-9-3969.PMC4539091.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d7/dc/dddt-9-4501.PMC4539092.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 4501–4513Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4501Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8417 8stepwise design, synthesis, and in vitro antifungal  screening of ( Z)-substituted-propenoic acid  derivatives with potent broad-spectrum antifungal  activity Mohammed a Khedr Department of Pharmaceutical  chemistry, Faculty of Pharmacy,   helwan University, cairo, egyptAbstract:  Fungal infections are a main reason for the high mortality rate worldwide.",Non-OADS,/arxiv_data1/oa_pdf/d7/dc/dddt-9-4501.PMC4539092.pdf
"Azole antifungal  drugs exert their antifungal effect via the inhibition of L14 αDM, thus preventing the  biosynthesis of ergosterol.6correspondence: Mohammed a Khedr Department of Pharmaceutical chemistry,  Faculty of Pharmacy, helwan University,  cairo 11795, egypt Tel +20 10 6640 2786 email mohammed_abdou0@yahoo.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Khedr Running head recto: Design, synthesis, and anti fungal screening of propenoic acid derivatives DOI: http://dx.doi.org/10.2147/DDDT.S84178",Non-OADS,/arxiv_data1/oa_pdf/d7/dc/dddt-9-4501.PMC4539092.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/d7/dc/dddt-9-4501.PMC4539092.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d7/dc/dddt-9-4501.PMC4539092.pdf
Available from: http://www.rcsb.org/pdb/ explore/explore.do?structureId=3jus .,OADS,/arxiv_data1/oa_pdf/d7/dc/dddt-9-4501.PMC4539092.pdf
Availablefrom:http://www.ncbi.nlm.nih.gov/pubmed/23697514.,OADS,/arxiv_data1/oa_pdf/7d/bf/JSO-112-18.PMC4539147.pdf
[Internet].JAMA 2012;Available from:307:2418–2429.http://www.pubmedcentral.,OADS,/arxiv_data1/oa_pdf/7d/bf/JSO-112-18.PMC4539147.pdf
[Internet].JAmCollRadiol2013;Available from: 10:931–936.http://www.ncbi.nlm.nih.gov/pubmed/24357736.,OADS,/arxiv_data1/oa_pdf/7d/bf/JSO-112-18.PMC4539147.pdf
http://www.ncbi.nlm.nih.gov/pubmed/21536253.,Non-OADS,/arxiv_data1/oa_pdf/7d/bf/JSO-112-18.PMC4539147.pdf
[Internet].JThorac Imaging2010;Available from25:204–212.http://www.ncbi.nlm.,OADS,/arxiv_data1/oa_pdf/7d/bf/JSO-112-18.PMC4539147.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/81/5a/main.PMC4539162.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2015.07.019 2049-0801/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/81/5a/main.PMC4539162.pdf
A Candida parapsilosis was identi ﬁe di na l lb l o o dc u l t u r e so nd a y1 0b yM a t r i x - assisted laser desorpt ion ionization-time of ﬂight mass spectrometryContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/mmcrMedical Mycology Case Reports http://dx.doi.org/10.1016/j.mmcr.2015.07.004 2211-7539/ &2015 International Society for Human and Animal Mycology.,Non-OADS,/arxiv_data1/oa_pdf/27/cb/main.PMC4539163.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6e/61/main.PMC4539183.pdf
URL:http://www.alvarogarciamd.com Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2015.07.002 2049-0801/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/6e/61/main.PMC4539183.pdf
Supplementary video related to this article can be found at http://dx.doi.org/10.1016/j.amsu.2015.07.002 .,Non-OADS,/arxiv_data1/oa_pdf/6e/61/main.PMC4539183.pdf
"Demeester, Onlay ventral hernia repairs using porcine non- cross-linked dermal biologic mesh, Hernia (2013), http://dx.doi.org/10.1007/ s10029-013-1054-2 .",OADS,/arxiv_data1/oa_pdf/6e/61/main.PMC4539183.pdf
"93 (5) (2013) 1111 e1133, http://dx.doi.org/10.1016/ j.suc.2013.06.010 (epub 2013 Jul 25).",OADS,/arxiv_data1/oa_pdf/6e/61/main.PMC4539183.pdf
"(2012), http://dx.doi.org/10.1155/2012/918345 .",Non-OADS,/arxiv_data1/oa_pdf/6e/61/main.PMC4539183.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b6/32/main.PMC4539184.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2015.07.017 2049-0801/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b6/32/main.PMC4539184.pdf
"49 (2010) 1051 e1057, http://dx.doi.org/10.2169/internalmedicine.49.2964 .",Non-OADS,/arxiv_data1/oa_pdf/b6/32/main.PMC4539184.pdf
"9 (2014) 57, http://dx.doi.org/ 10.1186/1749-7922-9-57 .",Non-OADS,/arxiv_data1/oa_pdf/b6/32/main.PMC4539184.pdf
"39 (2010) 261e265, http://dx.doi.org/10.1016/j.jemermed.2008.06.024 .",OADS,/arxiv_data1/oa_pdf/b6/32/main.PMC4539184.pdf
"1 (2014) 36, http://dx.doi.org/10.3389/fsurg.2014.00036 .",Non-OADS,/arxiv_data1/oa_pdf/b6/32/main.PMC4539184.pdf
"5 (2004)1695e1700, http://dx.doi.org/10.1517/14656566.5.8.1695 .",Non-OADS,/arxiv_data1/oa_pdf/b6/32/main.PMC4539184.pdf
"59 (2014) 358 e365, http://dx.doi.org/10.1093/cid/ciu304 .",Non-OADS,/arxiv_data1/oa_pdf/b6/32/main.PMC4539184.pdf
"Care 30 (3) (2015Jun) 652.e9 e652.e16, http://dx.doi.org/10.1016/j.jcrc.2015.01.022 .",Non-OADS,/arxiv_data1/oa_pdf/b6/32/main.PMC4539184.pdf
"28 (1999) 800 e807, http://dx.doi.org/10.1086/515199 .",Non-OADS,/arxiv_data1/oa_pdf/b6/32/main.PMC4539184.pdf
"37 (2003) 333 e340, http://dx.doi.org/10.1086/376630 .",Non-OADS,/arxiv_data1/oa_pdf/b6/32/main.PMC4539184.pdf
"6 (2006) 155 e165, http://dx.doi.org/10.1517/ 14712598.6.2.155 .",Non-OADS,/arxiv_data1/oa_pdf/b6/32/main.PMC4539184.pdf
"208 (2009) 279 e288, http://dx.doi.org/10.1016/j.jamcollsurg.2008.10.032 .C.",OADS,/arxiv_data1/oa_pdf/b6/32/main.PMC4539184.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0f/bb/main.PMC4539185.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2015.07.018 2049-0801/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0f/bb/main.PMC4539185.pdf
"110 (6) (2014 Nov) 666 e669, http://dx.doi.org/10.1002/ jso.23707 .",OADS,/arxiv_data1/oa_pdf/0f/bb/main.PMC4539185.pdf
Available from: http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/0f/bb/main.PMC4539185.pdf
http://creativecommons.org/licenses/by-nc-nd/3.0.,Non-OADS,/arxiv_data1/oa_pdf/df/9d/tp-99-1321.PMC4539198.pdf
"; Nigel Cooper, PI); Grant sponsor: NigelCooper, PI.Software available at: http://software.cesb.uky.edu *Correspondence to: Hunter N. B. Moseley, Center for Environmental and Sys- tems Biochemistry, University of Kentucky, Lexington, KY 40356.",Non-OADS,/arxiv_data1/oa_pdf/7d/15/PROT-83-1470.PMC4539273.pdf
Available at: https://www.stat.berkeley.edu/~breiman/Using_random_forests_v4.0.pdf 30.,Non-OADS,/arxiv_data1/oa_pdf/7d/15/PROT-83-1470.PMC4539273.pdf
"Ray et al., 2015, Developmental Cell 34, 310–322 August 10, 2015 ª2015 The Authors http://dx.doi.org/10.1016/j.devcel.2015.06.019",OADS,/arxiv_data1/oa_pdf/33/6c/main.PMC4539345.pdf
"Box 56, FIN-00014 Helsinki, Finland 7Co-ﬁrst author 8Co-senior author *Correspondence: robert.ray@crick.ac.uk http://dx.doi.org/10.1016/j.devcel.2015.06.019This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/33/6c/main.PMC4539345.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, ﬁve ﬁgures, one table, and three movies and can be found with this article on-line at http://dx.doi.org/10.1016/j.devcel.2015.06.019 .",Non-OADS,/arxiv_data1/oa_pdf/33/6c/main.PMC4539345.pdf
Received 12 January 2015 Revised 27 May 2015 Accepted 15 June 2015 ▸http://dx.doi.org/10.1136/ bmjopen-2015-008086 For numbered affiliations see end of article.,Non-OADS,/arxiv_data1/oa_pdf/d2/6a/bmjopen-2015-007645.PMC4539389.pdf
A full list of study sites is available at: https://www.clinicaltrials.gov/ ct2/show/NCT00994617?term=pathway-1&rank=1 Adverse events and serious adverse events All observed or volunteered adverse events consideredrelated to treatment will be recorded on the adverse events page of the eCRF .,Non-OADS,/arxiv_data1/oa_pdf/d2/6a/bmjopen-2015-007645.PMC4539389.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commer cial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Microbial Ecology in Health & Disease 2015, 26: 27997 - http://dx.doi.org/10.3402/mehd.v26.27997 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/9b/ef/MEHD-26-27997.PMC4539392.pdf
"2 (page number not for citation purpose)Citation: Microbial Ecology in Health & Disease 2015, 26: 27997 - http://dx.doi.org/10.3402/mehd.v26.27997",Non-OADS,/arxiv_data1/oa_pdf/9b/ef/MEHD-26-27997.PMC4539392.pdf
"Reproduced with permission from (8).Indole /C1the scent of a healthy ‘inner soil’ Citation: Microbial Ecology in Health & Disease 2015, 26: 27997 - http://dx.doi.org/10.3402/mehd.v26.27997 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/9b/ef/MEHD-26-27997.PMC4539392.pdf
"4 (page number not for citation purpose)Citation: Microbial Ecology in Health & Disease 2015, 26: 27997 - http://dx.doi.org/10.3402/mehd.v26.27997",Non-OADS,/arxiv_data1/oa_pdf/9b/ef/MEHD-26-27997.PMC4539392.pdf
"N Engl J Med 2013; 368: 407 /C115.Indole /C1the scent of a healthy ‘inner soil’ Citation: Microbial Ecology in Health & Disease 2015, 26: 27997 - http://dx.doi.org/10.3402/mehd.v26.27997 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/9b/ef/MEHD-26-27997.PMC4539392.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commer cial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Microbial Ecology in Health & Disease 2015, 26: 27799 - http://dx.doi.org/10.3402/mehd.v26.27799 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/fc/9d/MEHD-26-27799.PMC4539393.pdf
"2 (page number not for citation purpose)Citation: Microbial Ecology in Health & Disease 2015, 26: 27799 - http://dx.doi.org/10.3402/mehd.v26.27799",Non-OADS,/arxiv_data1/oa_pdf/fc/9d/MEHD-26-27799.PMC4539393.pdf
"The dendrogram above the bar plot represents the hierarchical average-linkage clustering of the microbiota proﬁles based on the computed weighted UniFrac distances.Vaginal microbiota changes Citation: Microbial Ecology in Health & Disease 2015, 26: 27799 - http://dx.doi.org/10.3402/mehd.v26.27799 3 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/fc/9d/MEHD-26-27799.PMC4539393.pdf
"4 (page number not for citation purpose)Citation: Microbial Ecology in Health & Disease 2015, 26: 27799 - http://dx.doi.org/10.3402/mehd.v26.27799",Non-OADS,/arxiv_data1/oa_pdf/fc/9d/MEHD-26-27799.PMC4539393.pdf
"Signiﬁcantly different groups are marked with a bar and asterisk for a Bonferroni-corrected p-valueB0.01 from a Wilcoxon rank-sum test.Vaginal microbiota changes Citation: Microbial Ecology in Health & Disease 2015, 26: 27799 - http://dx.doi.org/10.3402/mehd.v26.27799 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/fc/9d/MEHD-26-27799.PMC4539393.pdf
"6 (page number not for citation purpose)Citation: Microbial Ecology in Health & Disease 2015, 26: 27799 - http://dx.doi.org/10.3402/mehd.v26.27799",Non-OADS,/arxiv_data1/oa_pdf/fc/9d/MEHD-26-27799.PMC4539393.pdf
"J Infect Dis 2006; 193: 1478 /C186.Vaginal microbiota changes Citation: Microbial Ecology in Health & Disease 2015, 26: 27799 - http://dx.doi.org/10.3402/mehd.v26.27799 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/fc/9d/MEHD-26-27799.PMC4539393.pdf
"8 (page number not for citation purpose)Citation: Microbial Ecology in Health & Disease 2015, 26: 27799 - http://dx.doi.org/10.3402/mehd.v26.27799",Non-OADS,/arxiv_data1/oa_pdf/fc/9d/MEHD-26-27799.PMC4539393.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/e3/76/ijpbs-09-228.PMC4539396.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/5e/71/ijpbs-09-230.PMC4539397.pdf
Available from: http://apps.who.int/classifications/ apps/icd/icd10online.,OADS,/arxiv_data1/oa_pdf/5e/71/ijpbs-09-230.PMC4539397.pdf
Available  from: http://apps.who.int/medicinedocs/en/d/Js7919e/11.html.,OADS,/arxiv_data1/oa_pdf/5e/71/ijpbs-09-230.PMC4539397.pdf
"Vienna, Aus-tria: R Foundation for Statistical Computing, October 17, 2014.Available at: http://jason.bryer.org/likert.",Non-OADS,/arxiv_data1/oa_pdf/4c/25/e2015.00046.PMC4539491.pdf
"Vienna, Austria: R Foundation for Statistical Computing; 2014.Available at: http://www.r-project.org/.",Non-OADS,/arxiv_data1/oa_pdf/4c/25/e2015.00046.PMC4539491.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2e/e6/rjv105.PMC4539510.pdf
"This isan Open Access article distributed under the terms of theCreative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution ofthework, in any medium, provided the original work is not alteredor transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/56/ca/ofv088.PMC4539511.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribu - tion-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncom - mercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/5e/61/jjm-08-06-18264.PMC4539568.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/e2/7e/ijpbs-09-1041.PMC4539582.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/28/d1/ijpbs-09-1047.PMC4539583.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/b8/2b/ijpbs-09-1116.PMC4539584.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.The exact origin of opium poppy is uncertain (1).",Non-OADS,/arxiv_data1/oa_pdf/ab/bd/ijpbs-09-2074.PMC4539585.pdf
Arlington: DEA  Museum & Visitors Center; Available from: http://www.deamuseum.,Non-OADS,/arxiv_data1/oa_pdf/ab/bd/ijpbs-09-2074.PMC4539585.pdf
Available from: http://en.wikipedia.,Non-OADS,/arxiv_data1/oa_pdf/ab/bd/ijpbs-09-2074.PMC4539585.pdf
Available from: http://ahmadbabai.blogfa.com/post/56.,Non-OADS,/arxiv_data1/oa_pdf/ab/bd/ijpbs-09-2074.PMC4539585.pdf
Available from: http://en.wikipedia.org/ wiki/Hadith.,Non-OADS,/arxiv_data1/oa_pdf/ab/bd/ijpbs-09-2074.PMC4539585.pdf
Available from: http://en.wikipedia.org/wiki/ Sunnah.,Non-OADS,/arxiv_data1/oa_pdf/ab/bd/ijpbs-09-2074.PMC4539585.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/0b/62/ijpbs-09-838.PMC4539586.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/bc/4b/ijpbs-09-839.PMC4539587.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/3f/5e/ijpbs-09-845.PMC4539588.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/18/c7/ijpbs-09-952.PMC4539589.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/6f/db/ijpbs-09-953.PMC4539590.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/7d/5d/ijpbs-09-956.PMC4539591.pdf
SUPPLEMENTARY MATERIAL Supplementary material is linked to the online version of the paper at  http://www.nature.com/pr ACKNOWLEDGMENT We thank Tore Wentzel-Larsen for statistical advice.,Non-OADS,/arxiv_data1/oa_pdf/cd/37/pr201595a.PMC4539602.pdf
"To view a copy of this license, visit http://creativecommons.org/   licenses/by-nc-sa/4.0/ Volume 78  |  N umber 3  |  September 2015       Pediatric ReSeaRCh  335",Non-OADS,/arxiv_data1/oa_pdf/cd/37/pr201595a.PMC4539602.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b1/66/main.PMC4539615.pdf
2352-345X http://dx.doi.org/10.1016/j.jcmgh.2015.06.005,OADS,/arxiv_data1/oa_pdf/b1/66/main.PMC4539615.pdf
Gastroenterol Hepatol 2015;1:489 –502; http://dx.doi.org/ 10.1016/j.jcmgh.2015.06.005 ) Keywords: Inﬂammatory Bowel Disease; NADPH Oxidase; NOX1 ; DUOX2 ; Reactive Oxygen Species; VEOIBD.,Non-OADS,/arxiv_data1/oa_pdf/b1/66/main.PMC4539615.pdf
"15Sanger sequencing was used to verify all genetic defects identi ﬁed using targeted sequencing of the NOX1 and DUOX2 genes at the Centre for Applied Genomics (TCAG; http://www.tcag.ca ; Hospital for Sick Children, Toronto, ON, Canada).",OADS,/arxiv_data1/oa_pdf/b1/66/main.PMC4539615.pdf
"15,16Function and minor allele frequency (MAF) were searched for using the National Heart, Lung, and Blood Institute Exome Sequencing Project (ESP) Exome Variant Server ( http://evs.gs.washington.edu/ EVS/ ), the National Center for Biotechnology Information dbSNP ( http://www.ncbi.nlm.nih.gov/projects/SNP/ ), the National Institute of Environmental Health Sciences FuncPred(http://snpinfo.niehs.nih.gov/snpinfo/snpfunc.htm ), Polyphen2 (http://genetics.bwh.harvard.edu/pph2/ ), 17SIFT ( http:// sift.jcvi.org/ ),18FastSNP ( http://fastsnp.ibms.sinica.edu.tw/ ),19 Human Splicing Finder ( http://www.umd.be/HSF/ ),20and pfSNP ( http://pfs.nus.edu.sg/ ).21 Setting Patients included in the study were recruited from the Inﬂammatory Bowel Disease Clinic at the Hospital from Sick Children, University of Toronto.",OADS,/arxiv_data1/oa_pdf/b1/66/main.PMC4539615.pdf
Modeling and Docking Procedure Three-dimensional (3D) models of C-terminal domains of NOX1 and DUOX2 were generated using the homologymodeling program Modeller 9v11 ( http://www.salilab.,OADS,/arxiv_data1/oa_pdf/b1/66/main.PMC4539615.pdf
"Similarly, in the publicly available International IBD Genetics Consortium ( http://www.ibdgenetics.org ) database none of the NOX1 and DUOX2 missense variants were identi ﬁed as this data set does not examine rare vari- ants, only common polymorphisms, and the p.Asp360Asnvariant is not analyzed by the immunochip.",Non-OADS,/arxiv_data1/oa_pdf/b1/66/main.PMC4539615.pdf
Pro330 and Asp360 are conserved in NOX1 –4 proteins identi ﬁed in vertebrates and lower organisms.36 CYBB missense variants (X-CGD) leading to loss or dimin- ished ROS generation in neutrophils are located in closevicinity to the identi ﬁed NOX1 variants ( http://bioinf.uta.,Non-OADS,/arxiv_data1/oa_pdf/b1/66/main.PMC4539615.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/content/ full/1/3/e1400223/DC1Materials and MethodsFig.,Non-OADS,/arxiv_data1/oa_pdf/af/97/1400223.PMC4539616.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International  License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original  work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/49/e7/hepatmon-15-07-28969.PMC4539731.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International  License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original  work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/11/c1/hepatmon-15-07-28806.PMC4539732.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International  License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original  work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/86/35/hepatmon-15-07-27740.PMC4539733.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International  License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/e9/61/hepatmon-15-07-28287.PMC4539734.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6d/0f/ofv049.PMC4539735.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International  License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original  work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/25/e1/hepatmon-15-07-30336.PMC4539736.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribu - tion-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncom - mercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/b3/da/jjm-08-06-17201.PMC4539791.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International  License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original  work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/03/ec/hepatmon-15-07-29697.PMC4539792.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International  License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original  work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/d9/fb/hepatmon-15-07-27120.PMC4539793.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International  License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original  work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/08/b2/hepatmon-15-07-30507.PMC4539794.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International  License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original  work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/86/2b/hepatmon-15-07-29052.PMC4539848.pdf
"Details of 19 rare germline variants found in 14 CMN patients on whole-exome sequencing Gene symbolPosition (Hg19)Reference allele/Sample allele Protein variantsTranslation impactPredicted functional impact: SIFT function prediction (score),PolyPhen-2 function predictionConservation phyloP p-value (http://compgen.bscb.cornell.edu/phast/ help-pages/phyloP.txt)dbSNP ID (http://www.ncbi.",OADS,/arxiv_data1/oa_pdf/27/06/jid2015114a.PMC4539947.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/JS Pawlikowski et al.",Non-OADS,/arxiv_data1/oa_pdf/27/06/jid2015114a.PMC4539947.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/75/e8/JCB_201502046.PMC4539978.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).Correspondence to Kerry Bloom: Kerry_Bloom@unc.edu Abbreviations used in this paper: kMT, kinetochore microtubule; MSD, mean  square displacement; R c, radius of confinement; SPB, spindle pole body.THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/75/e8/JCB_201502046.PMC4539978.pdf
Online supplemental material is available at http://www.jcb.org/cgi/content/full/jcb.201502046/DC1.,Non-OADS,/arxiv_data1/oa_pdf/75/e8/JCB_201502046.PMC4539978.pdf
"http://dx.doi.org/10.1016/0022-   2836(92)91023-I Bloom, K.S.",OADS,/arxiv_data1/oa_pdf/75/e8/JCB_201502046.PMC4539978.pdf
"http://dx.doi.org/10.1146/ annurev-genet-120213-092033 Blumberg, S., A.V .",OADS,/arxiv_data1/oa_pdf/75/e8/JCB_201502046.PMC4539978.pdf
"http://dx.doi.org/10.1038/nature02328 Gardner, M.K., C.G.",OADS,/arxiv_data1/oa_pdf/75/e8/JCB_201502046.PMC4539978.pdf
"http://dx.doi.org/10.1091/mbc   .E05-04-0275 Goshima, G., and M. Yanagida.",OADS,/arxiv_data1/oa_pdf/75/e8/JCB_201502046.PMC4539978.pdf
"http://dx.doi.org/10.1016/ S0092-8674(00)80699-6 Haase, J., A. Stephens, J. Verdaasdonk, E. Yeh, and K. Bloom.",OADS,/arxiv_data1/oa_pdf/75/e8/JCB_201502046.PMC4539978.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/75/e8/JCB_201502046.PMC4539978.pdf
"http://dx.doi.org/10.1016/S0092-   8674(00)80888-0 Hertwig, O. 1906.",OADS,/arxiv_data1/oa_pdf/75/e8/JCB_201502046.PMC4539978.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/75/e8/JCB_201502046.PMC4539978.pdf
"http://dx.doi.org/10.1126/science.1180189 Kendall, A., M.W.",OADS,/arxiv_data1/oa_pdf/75/e8/JCB_201502046.PMC4539978.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/75/e8/JCB_201502046.PMC4539978.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/75/e8/JCB_201502046.PMC4539978.pdf
"http://dx.doi.org/10.1126/science.1247514 Kopski, K.M., and T.C. Huffaker.",OADS,/arxiv_data1/oa_pdf/75/e8/JCB_201502046.PMC4539978.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/75/e8/JCB_201502046.PMC4539978.pdf
"http://dx.doi.org/10.1016/j.cub.2004.11.051 Lowary, P.T., and J.  Widom.",OADS,/arxiv_data1/oa_pdf/75/e8/JCB_201502046.PMC4539978.pdf
"http://dx.doi.org/10.1006/jmbi.1997  .1494 Maeshima, K., and U.K.  Laemmli.",OADS,/arxiv_data1/oa_pdf/75/e8/JCB_201502046.PMC4539978.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/75/e8/JCB_201502046.PMC4539978.pdf
"http://dx.doi.org/10.1016/S0092-8674(01)80007-6 Naumova, N., M.  Imakaev, G.  Fudenberg, Y .",OADS,/arxiv_data1/oa_pdf/75/e8/JCB_201502046.PMC4539978.pdf
"http://dx.doi.org/10.1126/science.1236083 Panyukov, S., E.B.",OADS,/arxiv_data1/oa_pdf/75/e8/JCB_201502046.PMC4539978.pdf
102:148301. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/75/e8/JCB_201502046.PMC4539978.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/75/e8/JCB_201502046.PMC4539978.pdf
"http://dx.doi.org/10.1083/jcb.152.6.1255 Pearson, C.G., P.S.",Non-OADS,/arxiv_data1/oa_pdf/75/e8/JCB_201502046.PMC4539978.pdf
http://dx.doi.org/10.1091/mbc.,Non-OADS,/arxiv_data1/oa_pdf/75/e8/JCB_201502046.PMC4539978.pdf
"http://dx.doi.org/10.1016/j.cell.2014.11.021 Roberts, B.T., K.A.",OADS,/arxiv_data1/oa_pdf/75/e8/JCB_201502046.PMC4539978.pdf
"http://dx.doi.org/10.1083/jcb.201405028 Stephens, A.D., J. Haase, L. Vicci, R.M.",OADS,/arxiv_data1/oa_pdf/75/e8/JCB_201502046.PMC4539978.pdf
"http://dx.doi.org/10.1016/S0960-9822(02)70783-5 Tanaka, T.U., N.  Rachidi, C.  Janke, G.  Pereira, M.  Galova, E.  Schiebel,  M.J. Stark, and K. Nasmyth.",OADS,/arxiv_data1/oa_pdf/75/e8/JCB_201502046.PMC4539978.pdf
http://dx.doi.org/10.1016/S0092-8674(02)00633-5,OADS,/arxiv_data1/oa_pdf/75/e8/JCB_201502046.PMC4539978.pdf
"http://dx.doi.org/10.1091/mbc.12.9.2800 Vasquez, P.A., and K.  Bloom.",OADS,/arxiv_data1/oa_pdf/75/e8/JCB_201502046.PMC4539978.pdf
"http://dx.doi.org/10.4161/nucl.36275 Verdaasdonk, J.S., P.A.",OADS,/arxiv_data1/oa_pdf/75/e8/JCB_201502046.PMC4539978.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/75/e8/JCB_201502046.PMC4539978.pdf
"http://dx.doi.org/10.1002/ (SICI)1097-0061(19970915)13:11<1065::AID-YEA159>3.0.CO;2-K Wan, X., R.P.",OADS,/arxiv_data1/oa_pdf/75/e8/JCB_201502046.PMC4539978.pdf
"http://dx.doi.org/10.1016/j.cell.2009.03.035 Wan, X., D. Cimini, L.A. Cameron, and E.D. Salmon.",OADS,/arxiv_data1/oa_pdf/75/e8/JCB_201502046.PMC4539978.pdf
"http://dx.doi.org/10.1091/mbc.E11-09-0767Weber, S.C., A.J.",Non-OADS,/arxiv_data1/oa_pdf/75/e8/JCB_201502046.PMC4539978.pdf
"http://dx.doi.org/10.1073/ pnas.1119505109 Xue, Y ., J.C. Canman, C.S.",OADS,/arxiv_data1/oa_pdf/75/e8/JCB_201502046.PMC4539978.pdf
http://dx.doi.org/10.1091/mbc.,Non-OADS,/arxiv_data1/oa_pdf/75/e8/JCB_201502046.PMC4539978.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/75/e8/JCB_201502046.PMC4539978.pdf
http://dx.doi.org/10.1146/ annurev.genet.33.1.603,Non-OADS,/arxiv_data1/oa_pdf/75/e8/JCB_201502046.PMC4539978.pdf
"Together, these data reveal a central biophysical role for NMIIB in nuclear translocation during 3D invasive migration,  a result with relevance not only to cancer metastasis but for 3D migration in other settings such as embryonic cell migra - tion and wound healing.Non-muscle myosin IIB is critical for nuclear  translocation during 3D invasion Dustin G. Thomas,1,2 Aishwarya Yenepalli,1 Celine Marie Denais,3 Andrew Rape,4 Jordan R. Beach,5 Yu-li Wang,6  William P. Schiemann,7 Harihara Baskaran,8 Jan Lammerding,3 and Thomas T. Egelhoff1,2 1Department of Cellular and Molecular Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 441195 2Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH 44195 3Department of Biomedical Engineering, Weill Institute for Cell and Molecular Biology, Cornell University, Ithaca, NY 14853 4Department of Bioengineering, University of California, Berkeley, Berkeley, CA 94720 5Cell Biology and Physiology Center, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892 6Department of Biomedical Engineering, Carnegie Melon University, Pittsburgh, PA 15219 7General Medical Sciences-Oncology, Case Comprehensive Cancer Center and 8Department of Biomedical Engineering, Case Western Reserve University,   Cleveland, OH 44106 This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No  Mirror Sites license for the first six months after the publication date (see http://www.rupress.",Non-OADS,/arxiv_data1/oa_pdf/33/c1/JCB_201502039.PMC4539979.pdf
Online supplemental material is available at http://www.jcb.org/cgi/content/full/jcb.201502039/DC1.,Non-OADS,/arxiv_data1/oa_pdf/33/c1/JCB_201502039.PMC4539979.pdf
"http://dx.doi.org/10.1074/jbc.M702731200 Beach, J.R., G.S.",OADS,/arxiv_data1/oa_pdf/33/c1/JCB_201502039.PMC4539979.pdf
"http://dx.doi.org/10.1016/j.cub.2014.03.071 Beadle, C., M.C.",OADS,/arxiv_data1/oa_pdf/33/c1/JCB_201502039.PMC4539979.pdf
"http://dx.doi.org/10.1091/mbc.E08-03-0319 Beningo, K.A., M.  Dembo, I.  Kaverina, J.V .",Non-OADS,/arxiv_data1/oa_pdf/33/c1/JCB_201502039.PMC4539979.pdf
"http://dx.doi.org/10.1007/ s10544-010-9411-8 Chancellor, T.J., J. Lee, C.K.",Non-OADS,/arxiv_data1/oa_pdf/33/c1/JCB_201502039.PMC4539979.pdf
"http://dx.doi.org/10.1016/j.bpj.2010.04.011 Chang, W., E.S.",OADS,/arxiv_data1/oa_pdf/33/c1/JCB_201502039.PMC4539979.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/33/c1/JCB_201502039.PMC4539979.pdf
"http://dx.doi.org/10.1038/ncb1763 Conti, M.A., and R.S. Adelstein.",Non-OADS,/arxiv_data1/oa_pdf/33/c1/JCB_201502039.PMC4539979.pdf
"http://dx.doi.org/10.1242/jcs.007112 Crisp, M., Q. Liu, K. Roux, J.B. Rattner, C. Shanahan, B. Burke, P.D.",OADS,/arxiv_data1/oa_pdf/33/c1/JCB_201502039.PMC4539979.pdf
"http://dx.doi.org/10.1083/ jcb.200509124 Davidson, P.M., C.  Denais, M.C.",Non-OADS,/arxiv_data1/oa_pdf/33/c1/JCB_201502039.PMC4539979.pdf
"http://dx.doi.org/10.1007/ s12195-014-0342-y Dembo, M., and Y .L.",Non-OADS,/arxiv_data1/oa_pdf/33/c1/JCB_201502039.PMC4539979.pdf
"http://dx.doi.org/10.1016/S0006-3495(99)77386-8 Doyle, A.D., F.W.",OADS,/arxiv_data1/oa_pdf/33/c1/JCB_201502039.PMC4539979.pdf
"http://dx.doi.org/10.1083/jcb.200810041 Doyle, A.D., M.L.",Non-OADS,/arxiv_data1/oa_pdf/33/c1/JCB_201502039.PMC4539979.pdf
"http://dx.doi.org/10.1242/jcs.098806 Duong, N.T., G.E.",OADS,/arxiv_data1/oa_pdf/33/c1/JCB_201502039.PMC4539979.pdf
http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/33/c1/JCB_201502039.PMC4539979.pdf
"http://dx.doi.org/10.1016/j.cub.2008.12.045 Friedl, P., and S.  Alexander.",OADS,/arxiv_data1/oa_pdf/33/c1/JCB_201502039.PMC4539979.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/33/c1/JCB_201502039.PMC4539979.pdf
"http://dx.doi.org/10.1083/jcb.200909003 Goswami, S., E.  Sahai, J.B.  Wyckoff, M.  Cammer, D.  Cox, F.J.  Pixley,  E.R.",Non-OADS,/arxiv_data1/oa_pdf/33/c1/JCB_201502039.PMC4539979.pdf
"http://dx.doi.org/10.1158/0008-5472.CAN-04-1853 Harada, T., J.",Non-OADS,/arxiv_data1/oa_pdf/33/c1/JCB_201502039.PMC4539979.pdf
"http://dx.doi.org/10.1083/ jcb.201308029 Isermann, P., and J. Lammerding.",OADS,/arxiv_data1/oa_pdf/33/c1/JCB_201502039.PMC4539979.pdf
"http://dx.doi.org/10.1016/j.cub.2013.11.009 Jacobelli, J., R.S.",OADS,/arxiv_data1/oa_pdf/33/c1/JCB_201502039.PMC4539979.pdf
"http://dx.doi.org/10.1242/bio.20133707 Kolega, J. 1998.",OADS,/arxiv_data1/oa_pdf/33/c1/JCB_201502039.PMC4539979.pdf
"http://dx.doi.org/10.1038/nature06887 Liu, Y .J., M. Le Berre, F. Lautenschlaeger, P. Maiuri, A. Callan-Jones, M. Heuzé,  T. Takaki, R. V oituriez, and M. Piel.",Non-OADS,/arxiv_data1/oa_pdf/33/c1/JCB_201502039.PMC4539979.pdf
"http://dx.doi.org/10.1016/j.cell.2015.01.007 Lombardi, M.L., D.E.",OADS,/arxiv_data1/oa_pdf/33/c1/JCB_201502039.PMC4539979.pdf
"http://dx.doi.org/10.1074/jbc.M111.233700 Luxton, G.W., E.R.",OADS,/arxiv_data1/oa_pdf/33/c1/JCB_201502039.PMC4539979.pdf
"http://dx.doi.org/10.1126/ science.1189072 Luxton, G.W., E.R.",OADS,/arxiv_data1/oa_pdf/33/c1/JCB_201502039.PMC4539979.pdf
"http://dx.doi.org/10.4161/ nucl.2.3.16243 Meshel, A.S., Q. Wei, R.S.",Non-OADS,/arxiv_data1/oa_pdf/33/c1/JCB_201502039.PMC4539979.pdf
"http://dx.doi.org/10.1038/ncb1216 Pasapera, A.M., I.C.",Non-OADS,/arxiv_data1/oa_pdf/33/c1/JCB_201502039.PMC4539979.pdf
"http://dx.doi.org/10.1083/jcb.200906012 Petrie, R.J., H. Koo, and K.M. Yamada.",OADS,/arxiv_data1/oa_pdf/33/c1/JCB_201502039.PMC4539979.pdf
"http://dx.doi.org/10.1126/science.1256965 Raab, M., J.",OADS,/arxiv_data1/oa_pdf/33/c1/JCB_201502039.PMC4539979.pdf
"http://dx.doi.org/10.1017/erm.2013.6 Randles, K.N., T. Lam, C.A.",OADS,/arxiv_data1/oa_pdf/33/c1/JCB_201502039.PMC4539979.pdf
"http://dx.doi.org/10.1002/dvdy.22229Rosenfeld, S.S., J.  Xing, L.Q.",OADS,/arxiv_data1/oa_pdf/33/c1/JCB_201502039.PMC4539979.pdf
"http://dx.doi.org/10.1074/jbc.M112.441535 Taylor, M.A., J.G.",Non-OADS,/arxiv_data1/oa_pdf/33/c1/JCB_201502039.PMC4539979.pdf
"http://dx.doi.org/10.1007/ s10911-010-9181-1 Tse, J.R., and A.J. Engler.",Non-OADS,/arxiv_data1/oa_pdf/33/c1/JCB_201502039.PMC4539979.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/33/c1/JCB_201502039.PMC4539979.pdf
"http://dx.doi.org/10.1083/jcb.201012159 Wang, A., X. Ma, M.A.",OADS,/arxiv_data1/oa_pdf/33/c1/JCB_201502039.PMC4539979.pdf
"http://dx.doi.org/10.1042/ BST0391131 Wolf, K., M.  Te Lindert, M.  Krause, S.  Alexander, J.  Te Riet, A.L.",Non-OADS,/arxiv_data1/oa_pdf/33/c1/JCB_201502039.PMC4539979.pdf
"http://dx.doi.org/10.1083/jcb.201210152 Zhang, J., W.H.",OADS,/arxiv_data1/oa_pdf/33/c1/JCB_201502039.PMC4539979.pdf
http://dx.doi.org/10.1007/978-1-62703-604-7_13,Non-OADS,/arxiv_data1/oa_pdf/33/c1/JCB_201502039.PMC4539979.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/df/51/JCB_201503088.PMC4539980.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).Correspondence to W. Mike Henne: Mike.Henne@utsouthwestern.edu; or Scott  D. Emr: sde26@cornell.edu Abbreviations used in this paper: CMAC, 7-amino-4-chloromethylcoumarin;  DIC, dynamic interference contrast; FL, full length; GPD, glyceraldehyde 3-phos - phate; KO, knockout; MCS, membrane contact site; nER, nuclear ER; NVJ, nER– vacuole junction; PM, plasma membrane; PMN, piecemeal autophagy of the  nucleus; PX, Phox; PXA, PX associated; RGS, regulator of G protein signaling;  SGA, synthetic genetic array; TEM, transmission EM.THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/df/51/JCB_201503088.PMC4539980.pdf
On-line supplemental material is available at http://www.jcb.org/cgi/content/full/jcb.201503088/DC1.,Non-OADS,/arxiv_data1/oa_pdf/df/51/JCB_201503088.PMC4539980.pdf
"http://dx.doi.org/10.1038/ng.3256 Alpy, F., A.  Rousseau, Y .",Non-OADS,/arxiv_data1/oa_pdf/df/51/JCB_201503088.PMC4539980.pdf
"http://dx.doi.org/10.1242/ jcs.139295 Beh, C.T., and J. Rine.",OADS,/arxiv_data1/oa_pdf/df/51/JCB_201503088.PMC4539980.pdf
"http://dx.doi.org/10.1242/jcs.01157 Brady, R.O., A.E.",Non-OADS,/arxiv_data1/oa_pdf/df/51/JCB_201503088.PMC4539980.pdf
"http://dx.doi.org/10.1056/ NEJM196705252762101 Buchkovich, N.J., W.M.",Non-OADS,/arxiv_data1/oa_pdf/df/51/JCB_201503088.PMC4539980.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/df/51/JCB_201503088.PMC4539980.pdf
http://dx.doi.org/10.1091/mbc.,Non-OADS,/arxiv_data1/oa_pdf/df/51/JCB_201503088.PMC4539980.pdf
"http://dx.doi.org/10.1007/978-1-59745-540-4_3 Eden, E.R., I.J.",Non-OADS,/arxiv_data1/oa_pdf/df/51/JCB_201503088.PMC4539980.pdf
"http://dx.doi.org/10.1016/j.tibs.2011.08.004Elbaz-Alon, Y ., E.  Rosenfeld-Gur, V .",OADS,/arxiv_data1/oa_pdf/df/51/JCB_201503088.PMC4539980.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/df/51/JCB_201503088.PMC4539980.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/df/51/JCB_201503088.PMC4539980.pdf
"http://dx.doi.org/10.1091/mbc.E08-11-1126 Henne, W.M., N.J.  Buchkovich, Y .",Non-OADS,/arxiv_data1/oa_pdf/df/51/JCB_201503088.PMC4539980.pdf
"http://dx.doi.org/10.1016/j.cell.2012.08.039 Hönscher, C., M. Mari, K. Auffarth, M. Bohnert, J. Griffith, W. Geerts, M. van  der Laan, M.  Cabrera, F.  Reggiori, and C.  Ungermann.",OADS,/arxiv_data1/oa_pdf/df/51/JCB_201503088.PMC4539980.pdf
"http://dx.doi.org/10.1091/mbc.E08-04-0363 Krogh, A., B. Larsson, G. von Heijne, and E.L. Sonnhammer.",OADS,/arxiv_data1/oa_pdf/df/51/JCB_201503088.PMC4539980.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/df/51/JCB_201503088.PMC4539980.pdf
"http://dx.doi.org/10.1242/ jcs.01372 Kvam, E., K. Gable, T.M.",OADS,/arxiv_data1/oa_pdf/df/51/JCB_201503088.PMC4539980.pdf
"http://dx.doi.org/10.1091/mbc.E05-04-0290 Lin, C.H., J.A.",OADS,/arxiv_data1/oa_pdf/df/51/JCB_201503088.PMC4539980.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/df/51/JCB_201503088.PMC4539980.pdf
"http://dx.doi.org/10.1074/jbc.M114.595959 McConnell, S.J., and M.P.",OADS,/arxiv_data1/oa_pdf/df/51/JCB_201503088.PMC4539980.pdf
"http://dx.doi.org/10.1083/ jcb.118.2.385 Munn, A.L., A.  Heese-Peck, B.J.",OADS,/arxiv_data1/oa_pdf/df/51/JCB_201503088.PMC4539980.pdf
"http://dx.doi.org/10.1091/ mbc.10.11.3943 Pan, X., P. Roberts, Y .",Non-OADS,/arxiv_data1/oa_pdf/df/51/JCB_201503088.PMC4539980.pdf
"http://dx.doi.org/10.1091/mbc.11.7.2445 Pichler, H., and H.  Riezman.",OADS,/arxiv_data1/oa_pdf/df/51/JCB_201503088.PMC4539980.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/df/51/JCB_201503088.PMC4539980.pdf
"http://dx.doi.org/10.1111/j.1600-0854.2010.01088.x Roberts, P., S.  Moshitch-Moshkovitz, E.  Kvam, E.  O’Toole, M.  Winey,  and D.S.",Non-OADS,/arxiv_data1/oa_pdf/df/51/JCB_201503088.PMC4539980.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/df/51/JCB_201503088.PMC4539980.pdf
"http://dx.doi.org/10.1016/j.cell.2014.10.023 Thomas, A.C., H.  Williams, N.  Setó-Salvia, C.  Bacchelli, D.  Jenkins,  M. O’Sullivan, K. Mengrelis, M. Ishida, L. Ocaka, E. Chanudet, et al.",OADS,/arxiv_data1/oa_pdf/df/51/JCB_201503088.PMC4539980.pdf
"http://dx.doi.org/10.1016/j.ajhg.2014.10.007 Toulmay, A., and W.A.",OADS,/arxiv_data1/oa_pdf/df/51/JCB_201503088.PMC4539980.pdf
"http://dx.doi.org/10.1242/jcs.085118 Yu, J.W., and M.A.",OADS,/arxiv_data1/oa_pdf/df/51/JCB_201503088.PMC4539980.pdf
"http://dx.doi.org/10.1074/ jbc.M108811200Zheng, B., Y .C.",OADS,/arxiv_data1/oa_pdf/df/51/JCB_201503088.PMC4539980.pdf
"http://dx.doi.org/10.1126/ science.1064757 Zheng, B., T.  Tang, N.  Tang, K.  Kudlicka, K.  Ohtsubo, P.  Ma, J.D.",OADS,/arxiv_data1/oa_pdf/df/51/JCB_201503088.PMC4539980.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/df/51/JCB_201503088.PMC4539980.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/f8/5f/JCB_201504117.PMC4539981.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).*S.",Non-OADS,/arxiv_data1/oa_pdf/f8/5f/JCB_201504117.PMC4539981.pdf
These gene sequences are published on the Human Gene and Protein Database website (HGPD; http://www.HGPD.jp).,OADS,/arxiv_data1/oa_pdf/f8/5f/JCB_201504117.PMC4539981.pdf
On- line supplemental material is available at http://www.jcb.org/cgi/content/full/jcb.201504117/DC1.,Non-OADS,/arxiv_data1/oa_pdf/f8/5f/JCB_201504117.PMC4539981.pdf
"http://dx.doi.org/10.1128/MCB.24.1.442-453.2004 Brangwynne, C.P., C.R.",Non-OADS,/arxiv_data1/oa_pdf/f8/5f/JCB_201504117.PMC4539981.pdf
"http://dx.doi.org/10.1126/science.1172046 Chen, L.L., and G.G. Carmichael.",OADS,/arxiv_data1/oa_pdf/f8/5f/JCB_201504117.PMC4539981.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f8/5f/JCB_201504117.PMC4539981.pdf
"http://dx.doi.org/10.1038/nn.3412 Clemson, C.M., J.N.",OADS,/arxiv_data1/oa_pdf/f8/5f/JCB_201504117.PMC4539981.pdf
"http://dx.doi.org/10.1016/j.molcel.2009.01.026 Couthouis, J., M.P.",OADS,/arxiv_data1/oa_pdf/f8/5f/JCB_201504117.PMC4539981.pdf
"http://dx.doi.org/10.1073/ pnas.1109434108 Couthouis, J., M.P.",Non-OADS,/arxiv_data1/oa_pdf/f8/5f/JCB_201504117.PMC4539981.pdf
"http://dx.doi.org/10.1093/hmg/ dds116 Donnelly, C.J., P.W.",Non-OADS,/arxiv_data1/oa_pdf/f8/5f/JCB_201504117.PMC4539981.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f8/5f/JCB_201504117.PMC4539981.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f8/5f/JCB_201504117.PMC4539981.pdf
"http://dx.doi.org/10.1042/BJ20081135 Golemis, E.A., I.  Serebriiskii, R.L.",OADS,/arxiv_data1/oa_pdf/f8/5f/JCB_201504117.PMC4539981.pdf
"http://dx.doi.org/10.1016/j.cell.2012.04.016 Hirose, T., G. Virnicchi, A. Tanigawa, T. Naganuma, R. Li, H. Kimura, T. Yokoi,  S.  Nakagawa, M.  Bénard, A.H.  Fox, and G.  Pierron.",OADS,/arxiv_data1/oa_pdf/f8/5f/JCB_201504117.PMC4539981.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f8/5f/JCB_201504117.PMC4539981.pdf
"http://dx.doi.org/10.1016/j.molcel.2014.01.009 Ingley, E., J.H.",OADS,/arxiv_data1/oa_pdf/f8/5f/JCB_201504117.PMC4539981.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f8/5f/JCB_201504117.PMC4539981.pdf
"http://dx.doi.org/10.1074/jbc.M101517200 Kato, M., T.W.",OADS,/arxiv_data1/oa_pdf/f8/5f/JCB_201504117.PMC4539981.pdf
"http://dx.doi.org/10.1016/j.cell.2012.04.017 Kawaguchi, T., A. Tanigawa, T. Naganuma, Y .",OADS,/arxiv_data1/oa_pdf/f8/5f/JCB_201504117.PMC4539981.pdf
"http://dx.doi.org/10.1038/ nature11922 King, O.D., A.D.  Gitler, and J.",OADS,/arxiv_data1/oa_pdf/f8/5f/JCB_201504117.PMC4539981.pdf
"http://dx.doi.org/10.1016/j.brainres.2012.01.016 Kwon, I., M. Kato, S. Xiang, L. Wu, P. Theodoropoulos, H. Mirzaei, T. Han,  S. Xie, J.L.",OADS,/arxiv_data1/oa_pdf/f8/5f/JCB_201504117.PMC4539981.pdf
"http://dx.doi.org/10.1016/j.cell.2013.10.033 Kwon, I., S.  Xiang, M.  Kato, L.  Wu, P.  Theodoropoulos, T.  Wang, J.  Kim,  J. Yun, Y .",OADS,/arxiv_data1/oa_pdf/f8/5f/JCB_201504117.PMC4539981.pdf
"http://dx.doi.org/10.1126/science.1254917 Lancaster, A.K., A. Nutter-Upham, S. Lindquist, and O.D. King.",OADS,/arxiv_data1/oa_pdf/f8/5f/JCB_201504117.PMC4539981.pdf
"http://dx.doi.org/10.1093/bioinformatics/btu310 Lee, M., A. Sadowska, I. Bekere, D. Ho, B.S.",OADS,/arxiv_data1/oa_pdf/f8/5f/JCB_201504117.PMC4539981.pdf
"http://dx.doi.org/10.1093/ nar/gkv156 Mao, Y .S., H. Sunwoo, B. Zhang, and D.L. Spector.",OADS,/arxiv_data1/oa_pdf/f8/5f/JCB_201504117.PMC4539981.pdf
"http://dx.doi.org/10.1038/ncb2140 Naganuma, T., S.  Nakagawa, A.  Tanigawa, Y .F.",OADS,/arxiv_data1/oa_pdf/f8/5f/JCB_201504117.PMC4539981.pdf
"http://dx.doi.org/10.1038/emboj.2012.251 Nishimoto, Y ., S.  Nakagawa, T.  Hirose, H.J.",OADS,/arxiv_data1/oa_pdf/f8/5f/JCB_201504117.PMC4539981.pdf
"6:31. http://dx.doi.org/10.1186/1756-6606-6-31 Passon, D.M., M. Lee, O. Rackham, W.A.",Non-OADS,/arxiv_data1/oa_pdf/f8/5f/JCB_201504117.PMC4539981.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f8/5f/JCB_201504117.PMC4539981.pdf
"http://dx.doi.org/10.1073/ pnas.0807899106 Schwartz, J.C., X. Wang, E.R.",OADS,/arxiv_data1/oa_pdf/f8/5f/JCB_201504117.PMC4539981.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f8/5f/JCB_201504117.PMC4539981.pdf
"http://dx.doi.org/10.1093/hmg/ddt622 Shevtsov, S.P., and M. Dundr.",OADS,/arxiv_data1/oa_pdf/f8/5f/JCB_201504117.PMC4539981.pdf
"http://dx.doi.org/10.1038/ncb2157 Shiratsuchi, G., K.  Takaoka, T.  Ashikawa, H.  Hamada, and D.  Kitagawa.",OADS,/arxiv_data1/oa_pdf/f8/5f/JCB_201504117.PMC4539981.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f8/5f/JCB_201504117.PMC4539981.pdf
"http://dx.doi.org/10.1101/ gr.087775.108 Tollervey, J.R., T. Curk, B. Rogelj, M. Briese, M. Cereda, M. Kayikci, J. König,  T. Hortobágyi, A.L.",Non-OADS,/arxiv_data1/oa_pdf/f8/5f/JCB_201504117.PMC4539981.pdf
"http://dx.doi.org/10.1038/nn.2778 Toretsky, J.A., and P.E.",OADS,/arxiv_data1/oa_pdf/f8/5f/JCB_201504117.PMC4539981.pdf
"http://dx.doi.org/10.1083/jcb.201404124 Vance, C., B. Rogelj, T. Hortobágyi, K.J.",Non-OADS,/arxiv_data1/oa_pdf/f8/5f/JCB_201504117.PMC4539981.pdf
"http://dx.doi.org/10.1126/science.1165942 V ojtek, A.B., S.M.",OADS,/arxiv_data1/oa_pdf/f8/5f/JCB_201504117.PMC4539981.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/5e/67/JCB_201504006.PMC4539982.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).Correspondence to Don C. Lamb: d.lamb@lmu.de J. Hendrix’s present address is Laboratory for Photochemistry and Spectroscopy,  Department of Chemistry, KU Leuven, B-3001 Leuven, Belgium.",Non-OADS,/arxiv_data1/oa_pdf/5e/67/JCB_201504006.PMC4539982.pdf
Online supplemental material is available at http://www.jcb.org/cgi/ content/full/jcb.201504006/DC1.,Non-OADS,/arxiv_data1/oa_pdf/5e/67/JCB_201504006.PMC4539982.pdf
"http://dx.doi.org/10.1038/ncb2215 Becker, W. 2014.",Non-OADS,/arxiv_data1/oa_pdf/5e/67/JCB_201504006.PMC4539982.pdf
70:1835. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5e/67/JCB_201504006.PMC4539982.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5e/67/JCB_201504006.PMC4539982.pdf
"http://dx.doi.org/10.1016/j.jmb.2011.04.021 Chen, J., D. Grunwald, L. Sardo, A. Galli, S. Plisov, O.A.",OADS,/arxiv_data1/oa_pdf/5e/67/JCB_201504006.PMC4539982.pdf
"http://dx.doi.org/10.1016/j.jmb.2011.04.015 Chukkapalli, V ., S.J.",OADS,/arxiv_data1/oa_pdf/5e/67/JCB_201504006.PMC4539982.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5e/67/JCB_201504006.PMC4539982.pdf
"http://dx.doi.org/10.1016/j.jmb.2010.11.051 Derdowski, A., L. Ding, and P. Spearman.",OADS,/arxiv_data1/oa_pdf/5e/67/JCB_201504006.PMC4539982.pdf
"http://dx.doi.org/10.1128/JVI.78.3.1230-1242.2004 Digman, M.A., C.M.",OADS,/arxiv_data1/oa_pdf/5e/67/JCB_201504006.PMC4539982.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5e/67/JCB_201504006.PMC4539982.pdf
"http://dx.doi.org/10.1016/j.bpj.2008.09.051 Di Rienzo, C., E. Gratton, F. Beltram, and F. Cardarelli.",OADS,/arxiv_data1/oa_pdf/5e/67/JCB_201504006.PMC4539982.pdf
"http://dx.doi.org/10.1016/j.jmb.2015.01.015 Fogarty, K.H., Y .",OADS,/arxiv_data1/oa_pdf/5e/67/JCB_201504006.PMC4539982.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5e/67/JCB_201504006.PMC4539982.pdf
"http://dx.doi.org/10.3390/v3060770 Fogarty, K.H., S. Berk, I.F.",OADS,/arxiv_data1/oa_pdf/5e/67/JCB_201504006.PMC4539982.pdf
"http://dx.doi.org/10.1126/science.278.5339.849 Ganser-Pornillos, B.K., M. Yeager, and O. Pornillos.",OADS,/arxiv_data1/oa_pdf/5e/67/JCB_201504006.PMC4539982.pdf
"http://dx.doi.org/10.1007/978-1-4614-0980-9_20 Grigorov, B., D. Décimo, F. Smagulova, C. Péchoux, M. Mougel, D. Muriaux,  and J.L. Darlix.",Non-OADS,/arxiv_data1/oa_pdf/5e/67/JCB_201504006.PMC4539982.pdf
"http://dx.doi.org/10.1063/1.1141542 Hendrix, J., R. Gijsbers, J.",OADS,/arxiv_data1/oa_pdf/5e/67/JCB_201504006.PMC4539982.pdf
"http://dx.doi.org/10.1093/ nar/gkq933 Hendrix, J., W. Schrimpf, M. Höller, and D.C. Lamb.",OADS,/arxiv_data1/oa_pdf/5e/67/JCB_201504006.PMC4539982.pdf
"http://dx.doi.org/10.1016/j.bpj.2013.05.059 Hillesheim, L.N., and J.D. Müller.",OADS,/arxiv_data1/oa_pdf/5e/67/JCB_201504006.PMC4539982.pdf
"http://dx.doi.org/10.1016/S0006-3495(03)   74622-0 Ivanchenko, S., and D.C. Lamb.",OADS,/arxiv_data1/oa_pdf/5e/67/JCB_201504006.PMC4539982.pdf
"http://dx.doi.org/10.1371/ journal.ppat.1000652 Jones, C.P., S.A. Datta, A.",OADS,/arxiv_data1/oa_pdf/5e/67/JCB_201504006.PMC4539982.pdf
"http://dx.doi.org/10.1128/ JVI.01809-10 Jouvenet, N., P.D.",Non-OADS,/arxiv_data1/oa_pdf/5e/67/JCB_201504006.PMC4539982.pdf
"http://dx.doi.org/10.1038/nature06998 Jouvenet, N., S.M.",Non-OADS,/arxiv_data1/oa_pdf/5e/67/JCB_201504006.PMC4539982.pdf
"http://dx.doi.org/10.1073/ pnas.0907364106 Kapusta, P. 2010.",OADS,/arxiv_data1/oa_pdf/5e/67/JCB_201504006.PMC4539982.pdf
"http://www.research- gate.net/publication/269278844_Absolute_Diffusion_Coefficients_ Compilation_of_Reference_Data_for_FCS_Calibration Kohl, T., E. Haustein, and P. Schwille.",OADS,/arxiv_data1/oa_pdf/5e/67/JCB_201504006.PMC4539982.pdf
"http://dx.doi.org/10.1371/journal.ppat.1001200 Kutluay, S.B., T. Zang, D. Blanco-Melo, C. Powell, D. Jannain, M. Errando, and  P.D. Bieniasz.",Non-OADS,/arxiv_data1/oa_pdf/5e/67/JCB_201504006.PMC4539982.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5e/67/JCB_201504006.PMC4539982.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/5e/67/JCB_201504006.PMC4539982.pdf
"http://dx.doi.org/10.1016/S0006-3495(00)76366-1 Lamb, D.C., B.K.",OADS,/arxiv_data1/oa_pdf/5e/67/JCB_201504006.PMC4539982.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5e/67/JCB_201504006.PMC4539982.pdf
"http://dx.doi.org/10.1073/ pnas.0504812102 Lee, Y .M., and X.F. Yu.",OADS,/arxiv_data1/oa_pdf/5e/67/JCB_201504006.PMC4539982.pdf
"http://dx.doi.org/10.1006/viro.1998.9064 Lee, Y .M., B. Liu, and X.F. Yu.",OADS,/arxiv_data1/oa_pdf/5e/67/JCB_201504006.PMC4539982.pdf
"http://dx.doi.org/10.1128/ JVI.01280-07 Lorizate, M., and H.G.",OADS,/arxiv_data1/oa_pdf/5e/67/JCB_201504006.PMC4539982.pdf
"http://dx.doi.org/10.1101/ cshperspect.a004820 Mark-Danieli, M., N.  Laham, M.  Kenan-Eichler, A.  Castiel, D.  Melamed,  M. Landau, N.M. Bouvier, M.J. Evans, and E. Bacharach.",Non-OADS,/arxiv_data1/oa_pdf/5e/67/JCB_201504006.PMC4539982.pdf
"10:5. http://dx.doi.org/10.1186/1742-4690-10-5 Mergener, K., M.  Fäcke, R.  Welker, V .",Non-OADS,/arxiv_data1/oa_pdf/5e/67/JCB_201504006.PMC4539982.pdf
"http://dx.doi.org/10.1016/0042-6822(92)90058-W Müller, B., J.  Daecke, O.T.",OADS,/arxiv_data1/oa_pdf/5e/67/JCB_201504006.PMC4539982.pdf
"http://dx.doi.org/10.1128/ JVI.78.19.10803-10813.2004 Müller, B.K., E. Zaychikov, C. Bräuchle, and D.C. Lamb.",Non-OADS,/arxiv_data1/oa_pdf/5e/67/JCB_201504006.PMC4539982.pdf
"http://dx.doi.org/10.1529/ biophysj.105.064766 Muriaux, D., and J.L.",OADS,/arxiv_data1/oa_pdf/5e/67/JCB_201504006.PMC4539982.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5e/67/JCB_201504006.PMC4539982.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5e/67/JCB_201504006.PMC4539982.pdf
"http://dx.doi.org/10.1128/JVI.06287-11 O’Carroll, I.P., F.  Soheilian, A.  Kamata, K.  Nagashima, and A.",Non-OADS,/arxiv_data1/oa_pdf/5e/67/JCB_201504006.PMC4539982.pdf
http://dx.doi.org/10.1016/j.virusres.2012.10.016,OADS,/arxiv_data1/oa_pdf/5e/67/JCB_201504006.PMC4539982.pdf
"http://dx.doi.org/10.1016/j.bpj.2010.02.058 Ott, D.E., L.V .",OADS,/arxiv_data1/oa_pdf/5e/67/JCB_201504006.PMC4539982.pdf
"http://dx.doi.org/10.1529/ biophysj.105.079467 Petersen, N.O., P.L.",OADS,/arxiv_data1/oa_pdf/5e/67/JCB_201504006.PMC4539982.pdf
"http://dx.doi.org/10.1016/S0006-3495(93)81173-1 Poon, D.T., J. Wu, and A. Aldovini.",OADS,/arxiv_data1/oa_pdf/5e/67/JCB_201504006.PMC4539982.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5e/67/JCB_201504006.PMC4539982.pdf
"http://dx.doi.org/10.1128/JVI.02833-06 Saad, J.S., J. Miller, J. Tai, A. Kim, R.H. Ghanam, and M.F. Summers.",OADS,/arxiv_data1/oa_pdf/5e/67/JCB_201504006.PMC4539982.pdf
"366:574– 585. http://dx.doi.org/10.1016/j.jmb.2006.11.068 Saad, J.S., S.D.",OADS,/arxiv_data1/oa_pdf/5e/67/JCB_201504006.PMC4539982.pdf
"http://dx.doi.org/10.1016/j.jmb.2008.07.027 Saito, K., I. Wada, M. Tamura, and M. Kinjo.",OADS,/arxiv_data1/oa_pdf/5e/67/JCB_201504006.PMC4539982.pdf
"http://dx.doi.org/10.1016/j.bbrc.2004.09.126 Schur, F.K., W.J.",OADS,/arxiv_data1/oa_pdf/5e/67/JCB_201504006.PMC4539982.pdf
"http://dx.doi.org/10.1038/nature13838 Srivastava, M., and N.O.",OADS,/arxiv_data1/oa_pdf/5e/67/JCB_201504006.PMC4539982.pdf
"http://dx.doi.org/10.1016/S0301-4622(98)00206-3 Sundquist, W.I., and H.G.",OADS,/arxiv_data1/oa_pdf/5e/67/JCB_201504006.PMC4539982.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5e/67/JCB_201504006.PMC4539982.pdf
"http://dx.doi.org/10.1093/emboj/17.6.1555 Waheed, A.A., and E.O.",Non-OADS,/arxiv_data1/oa_pdf/5e/67/JCB_201504006.PMC4539982.pdf
"http://dx.doi.org/10.1089/aid.2011.0230 Weidemann, T., M. Wachsmuth, M. Tewes, K. Rippe, and J. Langowski.",OADS,/arxiv_data1/oa_pdf/5e/67/JCB_201504006.PMC4539982.pdf
"http://dx.doi.org/10.1002/  1438-5171(200204)3:1<49::AID-SIMO49>3.0.CO;2-T Wiseman, P.W., J.A.",OADS,/arxiv_data1/oa_pdf/5e/67/JCB_201504006.PMC4539982.pdf
"http://dx.doi.org/10.1046/j.1365-  2818.2000.00736.x Wiseman, P.W., C.M.",OADS,/arxiv_data1/oa_pdf/5e/67/JCB_201504006.PMC4539982.pdf
"http://dx.doi.org/10.1242/ jcs.01416 Zacharias, D.A., J.D.",Non-OADS,/arxiv_data1/oa_pdf/5e/67/JCB_201504006.PMC4539982.pdf
http://dx.doi.org/10.1126/science   .1068539,Non-OADS,/arxiv_data1/oa_pdf/5e/67/JCB_201504006.PMC4539982.pdf
"http://dx.doi  .org/10.1083/jcb.201504117 ) show that formation of  the paraspeckle, a nuclear body that regulates gene ex - pression, requires low-complexity prion-like domains  (PLDs) within paraspeckle proteins.",OADS,/arxiv_data1/oa_pdf/bd/09/JCB_201507052.PMC4539984.pdf
"The same proteins  were shown to form hydrogels, shedding light on the role  of “functional aggregation” in nuclear substructure.Paraspeckles: Paragons of functional aggregation Edward Courchaine and Karla M. Neugebauer Yale University, New Haven, CT 06511 © 2015 Neugebauer and Courchaine This article is distributed under the terms of an  Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after  the publication date (see http://www.rupress.org/terms).",Non-OADS,/arxiv_data1/oa_pdf/bd/09/JCB_201507052.PMC4539984.pdf
"After six months it is available  under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported  license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/bd/09/JCB_201507052.PMC4539984.pdf
"http://dx.doi.org/10.1126/science.1172046 Brangwynne, C.P., T.J.  Mitchison, and A.A.  Hyman.",OADS,/arxiv_data1/oa_pdf/bd/09/JCB_201507052.PMC4539984.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bd/09/JCB_201507052.PMC4539984.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bd/09/JCB_201507052.PMC4539984.pdf
"http://dx.doi.org/10.1016/j.cell.2007.06.024 Frey, S., R.P.",OADS,/arxiv_data1/oa_pdf/bd/09/JCB_201507052.PMC4539984.pdf
"http://dx.doi.org/10.1126/science.1132516 Han, T.W., M. Kato, S. Xie, L.C.",OADS,/arxiv_data1/oa_pdf/bd/09/JCB_201507052.PMC4539984.pdf
"http://dx.doi.org/10.1016/j.cell.2012.04.016 Handwerger, K.E., J.A.",OADS,/arxiv_data1/oa_pdf/bd/09/JCB_201507052.PMC4539984.pdf
http://dx.doi.org/10.1091/mbc.,Non-OADS,/arxiv_data1/oa_pdf/bd/09/JCB_201507052.PMC4539984.pdf
"http://dx.doi.org/10.1083/jcb.201504117 Kato, M., T.W.",Non-OADS,/arxiv_data1/oa_pdf/bd/09/JCB_201507052.PMC4539984.pdf
"http://dx.doi.org/10.1016/j.cell.2012.04.017 King, O.D., A.D.  Gitler, and J.",OADS,/arxiv_data1/oa_pdf/bd/09/JCB_201507052.PMC4539984.pdf
"http://dx.doi.org/10.1016/j.brainres.2012.01.016 Kwon, I., M. Kato, S. Xiang, L. Wu, P. Theodoropoulos, H. Mirzaei, T. Han,  S. Xie, J.L.",OADS,/arxiv_data1/oa_pdf/bd/09/JCB_201507052.PMC4539984.pdf
"http://dx.doi.org/10.1016/j.cell.2013.10.033 Kwon, I., S.  Xiang, M.  Kato, L.  Wu, P.  Theodoropoulos, T.  Wang, J.  Kim,  J. Yun, Y .",OADS,/arxiv_data1/oa_pdf/bd/09/JCB_201507052.PMC4539984.pdf
"http://dx.doi.org/10.1126/science.1254917 Li, P., S.  Banjade, H.C.  Cheng, S.  Kim, B.  Chen, L.  Guo, M.  Llaguno,  J.V .",OADS,/arxiv_data1/oa_pdf/bd/09/JCB_201507052.PMC4539984.pdf
"http://dx.doi.org/10.1038/nature10879 Machyna, M., S.  Kehr, K.  Straube, D.  Kappei, F.  Buchholz, F.  Butter, J.  Ule,  J. Hertel, P.F.",OADS,/arxiv_data1/oa_pdf/bd/09/JCB_201507052.PMC4539984.pdf
"http://dx.doi.org/10.1016/j.molcel.2014.10.004 Machyna, M., K.M.",OADS,/arxiv_data1/oa_pdf/bd/09/JCB_201507052.PMC4539984.pdf
"http://dx.doi.org/10.1080/15476286.2015.1034923 Mao, Y .S., H. Sunwoo, B. Zhang, and D.L. Spector.",OADS,/arxiv_data1/oa_pdf/bd/09/JCB_201507052.PMC4539984.pdf
"http://dx.doi.org/10.1038/ncb2140 Nott, T.J., E.  Petsalaki, P.  Farber, D.  Jervis, E.  Fussner, A.  Plochowietz,  T.D.",Non-OADS,/arxiv_data1/oa_pdf/bd/09/JCB_201507052.PMC4539984.pdf
"http://dx.doi.org/10.1101/cshperspect.a000638 Platani, M., I. Goldberg, J.R. Swedlow, and A.I. Lamond.",Non-OADS,/arxiv_data1/oa_pdf/bd/09/JCB_201507052.PMC4539984.pdf
"http://dx.doi.org/10.1083/jcb.151.7.1561 Ranum, L.P.W., and T.A.",OADS,/arxiv_data1/oa_pdf/bd/09/JCB_201507052.PMC4539984.pdf
"http://dx.doi.org/10.1146/ annurev.neuro.29.051605.113014 Schmidt, H.B., and D. Görlich.",OADS,/arxiv_data1/oa_pdf/bd/09/JCB_201507052.PMC4539984.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bd/09/JCB_201507052.PMC4539984.pdf
This article is distributed under the terms of an Attribution–Noncommercial– Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/be/2e/JCB_201501073.PMC4539989.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).*X.-D.",Non-OADS,/arxiv_data1/oa_pdf/be/2e/JCB_201501073.PMC4539989.pdf
Online supplemental material is available at http://www.jcb.org/cgi/content/full/jcb.201501073/DC1.,Non-OADS,/arxiv_data1/oa_pdf/be/2e/JCB_201501073.PMC4539989.pdf
http://dx.doi.org/10.1016/S0092-8674(04)00045-5 Cancer Genome Atlas Research Network.,OADS,/arxiv_data1/oa_pdf/be/2e/JCB_201501073.PMC4539989.pdf
"http://dx.doi.org/10.1158/0008-5472.CAN-10-0638 Clément, J.F., S.  Meloche, and M.J.  Servant.",Non-OADS,/arxiv_data1/oa_pdf/be/2e/JCB_201501073.PMC4539989.pdf
"http://dx.doi.org/10.2217/fon.10.37Eferl, R., and E.F. Wagner.",OADS,/arxiv_data1/oa_pdf/be/2e/JCB_201501073.PMC4539989.pdf
"http://dx.doi.org/10.1038/nrc1209 Esquela-Kerscher, A., and F.J.",OADS,/arxiv_data1/oa_pdf/be/2e/JCB_201501073.PMC4539989.pdf
"http://dx.doi.org/10.1038/nrc1840 Fang, Y ., J.L.",OADS,/arxiv_data1/oa_pdf/be/2e/JCB_201501073.PMC4539989.pdf
"http://dx.doi.org/10.1002/hep.25576 Fearon, E.R., and B. V ogelstein.",OADS,/arxiv_data1/oa_pdf/be/2e/JCB_201501073.PMC4539989.pdf
"http://dx.doi.org/10.1016/0092-8674(90)90186-I Giles, K.M., R.A. Brown, M.R.",OADS,/arxiv_data1/oa_pdf/be/2e/JCB_201501073.PMC4539989.pdf
"http://dx.doi.org/10.1016/j.bbrc.2012.11.086 Gregory, P.A., A.G.  Bert, E.L.  Paterson, S.C.  Barry, A.  Tsykin, G.  Farshid,  M.A.",OADS,/arxiv_data1/oa_pdf/be/2e/JCB_201501073.PMC4539989.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/be/2e/JCB_201501073.PMC4539989.pdf
"http://dx.doi.org/10.1016/j.cell.2011.02.013 He, L., and G.J.",OADS,/arxiv_data1/oa_pdf/be/2e/JCB_201501073.PMC4539989.pdf
"http://dx.doi.org/10.1038/nrg1379 Herrera, V ., and J.  Parsonnet.",Non-OADS,/arxiv_data1/oa_pdf/be/2e/JCB_201501073.PMC4539989.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/be/2e/JCB_201501073.PMC4539989.pdf
"http://dx.doi.org/10.1126/science.1151651 Hu, W., C.S.",OADS,/arxiv_data1/oa_pdf/be/2e/JCB_201501073.PMC4539989.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/be/2e/JCB_201501073.PMC4539989.pdf
"http://dx.doi.org/10.1042/BJ20100859 Kalinowski, F.C., K.M.",Non-OADS,/arxiv_data1/oa_pdf/be/2e/JCB_201501073.PMC4539989.pdf
http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/be/2e/JCB_201501073.PMC4539989.pdf
"http://dx.doi.org/10.1038/nri1703 Kefas, B., J. Godlewski, L. Comeau, Y .",OADS,/arxiv_data1/oa_pdf/be/2e/JCB_201501073.PMC4539989.pdf
"http://dx.doi.org/10.1158/0008-5472.CAN-07-6639 Kong, D., Y .S.",Non-OADS,/arxiv_data1/oa_pdf/be/2e/JCB_201501073.PMC4539989.pdf
"http://dx.doi.org/10.1038/onc.2011.558 Li, Q., and I.M. Verma.",OADS,/arxiv_data1/oa_pdf/be/2e/JCB_201501073.PMC4539989.pdf
"http://dx.doi.org/10.1038/nri910 Li, C., Q. Xiong, J. Zhang, F. Ge, and L.J. Bi.",OADS,/arxiv_data1/oa_pdf/be/2e/JCB_201501073.PMC4539989.pdf
"http://dx.doi.org/10.1586/epr.12.49 Li, Y ., Y .",OADS,/arxiv_data1/oa_pdf/be/2e/JCB_201501073.PMC4539989.pdf
"http://dx.doi.org/10.1007/ s10620-013-2929-x Liu, S., P.  Zhang, Z.  Chen, M.  Liu, X.  Li, and H.  Tang.",Non-OADS,/arxiv_data1/oa_pdf/be/2e/JCB_201501073.PMC4539989.pdf
"http://dx.doi.org/10.1016/j.febslet.2013.05.054 Ma, J., B. Fang, F. Zeng, H. Pang, J. Zhang, Y .",OADS,/arxiv_data1/oa_pdf/be/2e/JCB_201501073.PMC4539989.pdf
http://dx.doi.org/10.1016/j.toxlet.2014.09.014,OADS,/arxiv_data1/oa_pdf/be/2e/JCB_201501073.PMC4539989.pdf
"http://dx.doi.org/10.1053/gast.2000.8540 Park, S.M., A.B.",OADS,/arxiv_data1/oa_pdf/be/2e/JCB_201501073.PMC4539989.pdf
"http://dx.doi.org/10.1038/nrc2857 Quante, M., J. Varga, T.C.",OADS,/arxiv_data1/oa_pdf/be/2e/JCB_201501073.PMC4539989.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/be/2e/JCB_201501073.PMC4539989.pdf
"http://dx.doi.org/10.1158/1535-7163.MCT-11-0220 Reddy, S.D., K.  Ohshiro, S.K.",Non-OADS,/arxiv_data1/oa_pdf/be/2e/JCB_201501073.PMC4539989.pdf
"http://dx.doi.org/10.1158/0008- 5472.CAN-08-2103 Ruland, J. 2011.",Non-OADS,/arxiv_data1/oa_pdf/be/2e/JCB_201501073.PMC4539989.pdf
"http://dx.doi.org/10.1038/ni.2055 Saydam, O., O. Senol, T. Würdinger, A. Mizrak, G.B.",Non-OADS,/arxiv_data1/oa_pdf/be/2e/JCB_201501073.PMC4539989.pdf
"71:852– 861. http://dx.doi.org/10.1158/0008-5472.CAN-10-1219 Sethupathy, P., M.  Megraw, and A.G.  Hatzigeorgiou.",Non-OADS,/arxiv_data1/oa_pdf/be/2e/JCB_201501073.PMC4539989.pdf
"http://dx.doi.org/10.1038/nmeth954 Siegel, R., J. Ma, Z. Zou, and A. Jemal.",Non-OADS,/arxiv_data1/oa_pdf/be/2e/JCB_201501073.PMC4539989.pdf
"http://dx.doi.org/10.3322/caac.21208 Siomi, H., and M.C. Siomi.",OADS,/arxiv_data1/oa_pdf/be/2e/JCB_201501073.PMC4539989.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/be/2e/JCB_201501073.PMC4539989.pdf
"http://dx.doi.org/10.1038/nrgastro.2012.210 Staudt, L.M. 2010.",OADS,/arxiv_data1/oa_pdf/be/2e/JCB_201501073.PMC4539989.pdf
"http://dx.doi.org/10.1101/cshperspect.a000109 Thomas, M., J. Lieberman, and A. Lal.",OADS,/arxiv_data1/oa_pdf/be/2e/JCB_201501073.PMC4539989.pdf
"http://dx.doi.org/10.1038/ nsmb.1921 Verhelst, K., L. Verstrepen, I. Carpentier, and R. Beyaert.",OADS,/arxiv_data1/oa_pdf/be/2e/JCB_201501073.PMC4539989.pdf
"http://dx.doi.org/10.1016/j.bcp.2013.01.007 Webster, R.J., K.M.",OADS,/arxiv_data1/oa_pdf/be/2e/JCB_201501073.PMC4539989.pdf
"http://dx.doi.org/10.7150/ ijbs.7.805 Xu, L., Z.  Wen, Y .",OADS,/arxiv_data1/oa_pdf/be/2e/JCB_201501073.PMC4539989.pdf
"http://dx.doi.org/10.1091/mbc.E12-07-0519 Yu, Z., L.  Ni, D.  Chen, Q.  Zhang, Z.  Su, Y .",Non-OADS,/arxiv_data1/oa_pdf/be/2e/JCB_201501073.PMC4539989.pdf
"http://dx.doi.org/10.1007/ s10735-013-9516-5 Zhang, N., X. Li, C.W.",Non-OADS,/arxiv_data1/oa_pdf/be/2e/JCB_201501073.PMC4539989.pdf
"http://dx.doi.org/10.1038/onc.2012.526 Zhang, X., S. Hu, X. Zhang, L. Wang, X. Zhang, B. Yan, J. Zhao, A. Yang, and  R. Zhang.",OADS,/arxiv_data1/oa_pdf/be/2e/JCB_201501073.PMC4539989.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/be/2e/JCB_201501073.PMC4539989.pdf
http://dx.doi.org/10.1038/onc.2012.156,Non-OADS,/arxiv_data1/oa_pdf/be/2e/JCB_201501073.PMC4539989.pdf
This article is distributed under the terms of an Attribution–Noncommercial– Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/ac/02/JCB_201505011.PMC4539990.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).Correspondence to Naoyuki Inagaki: ninagaki@bs.naist.jp Abbreviations used in this paper: CAM, cell adhesion molecule; CMV, cyto - megalovirus; DIC, differential interference contrast; FA, focal adhesion; NES,  nuclear export signal; WT, wild type.THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/ac/02/JCB_201505011.PMC4539990.pdf
S4 B. Online supplemental mate-rial is available at http://www.jcb.org/cgi/content/full/jcb.201505011/ DC1.,Non-OADS,/arxiv_data1/oa_pdf/ac/02/JCB_201505011.PMC4539990.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ac/02/JCB_201505011.PMC4539990.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ac/02/JCB_201505011.PMC4539990.pdf
"http://dx.doi.org/10.1126/science.1163595 Cheng, Y ., S. Leung, and D. Mangoura.",OADS,/arxiv_data1/oa_pdf/ac/02/JCB_201505011.PMC4539990.pdf
"http://dx.doi.org/10.1074/jbc.M114.608117 Decourt, B., V .",Non-OADS,/arxiv_data1/oa_pdf/ac/02/JCB_201505011.PMC4539990.pdf
"http://dx.doi.org/10.1002/jnr.21937 Delorme-Walker, V .D., J.R. Peterson, J. Chernoff, C.M.",OADS,/arxiv_data1/oa_pdf/ac/02/JCB_201505011.PMC4539990.pdf
"http://dx.doi.org/10.1083/ jcb.201010059 Du, Y ., S.A.  Weed, W.C.  Xiong, T.D.",OADS,/arxiv_data1/oa_pdf/ac/02/JCB_201505011.PMC4539990.pdf
"http://dx.doi.org/10.1083/jcb.107.4.1505 Fukuda, M., I. Gotoh, Y .",OADS,/arxiv_data1/oa_pdf/ac/02/JCB_201505011.PMC4539990.pdf
http://dx.doi.org/10.1074/ jbc.271.33.20024,Non-OADS,/arxiv_data1/oa_pdf/ac/02/JCB_201505011.PMC4539990.pdf
"http://dx.doi.org/10.1111/j.1600-0854.2010.01075.x Higashida, C., T.  Miyoshi, A.  Fujita, F.  Oceguera-Yanez, J.  Monypenny,  Y .",Non-OADS,/arxiv_data1/oa_pdf/ac/02/JCB_201505011.PMC4539990.pdf
"http://dx.doi.org/10.1126/science.1093923 Inagaki, N., M. Toriyama, and Y .",OADS,/arxiv_data1/oa_pdf/ac/02/JCB_201505011.PMC4539990.pdf
"http://dx.doi.org/10.1002/dneu.20837 Jacobs, T., F. Causeret, Y .V .",Non-OADS,/arxiv_data1/oa_pdf/ac/02/JCB_201505011.PMC4539990.pdf
"http://dx.doi.org/10.1146/annurev.neuro.21.1.97 Katoh, K., K. Hammar, P.J.",OADS,/arxiv_data1/oa_pdf/ac/02/JCB_201505011.PMC4539990.pdf
"http://dx.doi.org/10.1091/ mbc.10.1.197 Kinley, A.W., S.A.  Weed, A.M.  Weaver, A.V .",OADS,/arxiv_data1/oa_pdf/ac/02/JCB_201505011.PMC4539990.pdf
"13:384– 393. http://dx.doi.org/10.1016/S0960-9822(03)00107-6 Kirkbride, K.C., B.H.",OADS,/arxiv_data1/oa_pdf/ac/02/JCB_201505011.PMC4539990.pdf
"5:187– 198. http://dx.doi.org/10.4161/cam.5.2.14773 Kurklinsky, S., J. Chen, and M.A. McNiven.",OADS,/arxiv_data1/oa_pdf/ac/02/JCB_201505011.PMC4539990.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ac/02/JCB_201505011.PMC4539990.pdf
"http://dx.doi.org/10.1152/physrev.00021.2007 Li, X., X. Gao, G. Liu, W. Xiong, J. Wu, and Y .",OADS,/arxiv_data1/oa_pdf/ac/02/JCB_201505011.PMC4539990.pdf
"http://dx.doi.org/10.1038/ nn2022 Lowery, L.A., and D. Van Vactor.",OADS,/arxiv_data1/oa_pdf/ac/02/JCB_201505011.PMC4539990.pdf
"http://dx.doi.org/10.1021/bi300722t MacGrath, S.M., and A.J. Koleske.",Non-OADS,/arxiv_data1/oa_pdf/ac/02/JCB_201505011.PMC4539990.pdf
"http://dx.doi.org/10.1242/ jcs.093781 Mai, J., L. Fok, H. Gao, X. Zhang, and M.M. Poo.",OADS,/arxiv_data1/oa_pdf/ac/02/JCB_201505011.PMC4539990.pdf
"29:7450– 7458. http://dx.doi.org/10.1523/JNEUROSCI.1121-09.2009 Medeiros, N.A., D.T.",Non-OADS,/arxiv_data1/oa_pdf/ac/02/JCB_201505011.PMC4539990.pdf
"http://dx.doi.org/10.1038/ncb1367 Miki, H., H.  Yamaguchi, S.  Suetsugu, and T.  Takenawa.",OADS,/arxiv_data1/oa_pdf/ac/02/JCB_201505011.PMC4539990.pdf
"http://dx.doi.org/10.1038/35047107 Mingorance-Le Meur, A., and T.P. O’Connor.",Non-OADS,/arxiv_data1/oa_pdf/ac/02/JCB_201505011.PMC4539990.pdf
"http://dx.doi.org/10.1038/emboj.2008.265 Mitchison, T., and M. Kirschner.",OADS,/arxiv_data1/oa_pdf/ac/02/JCB_201505011.PMC4539990.pdf
"http://dx.doi.org/10.1016/0896-6273(88)90124-9 Niwa, H., K. Yamamura, and J. Miyazaki.",OADS,/arxiv_data1/oa_pdf/ac/02/JCB_201505011.PMC4539990.pdf
"108:193– 199. http://dx.doi.org/10.1016/0378-1119(91)90434-D Peng, J., B.J.",OADS,/arxiv_data1/oa_pdf/ac/02/JCB_201505011.PMC4539990.pdf
"http://dx.doi.org/10.1016/S0960-9822(03)00170-2 Pollard, T.D., and G.G.",OADS,/arxiv_data1/oa_pdf/ac/02/JCB_201505011.PMC4539990.pdf
"http://dx.doi.org/10.1016/S0092-8674(03)00120-XRohatgi, R., L.  Ma, H.  Miki, M.  Lopez, T.  Kirchhausen, T.  Takenawa, and  M.W. Kirschner.",OADS,/arxiv_data1/oa_pdf/ac/02/JCB_201505011.PMC4539990.pdf
"97:221– 231. http://dx.doi.org/10.1016/S0092-8674(00)80732-1 Sapir, T., T. Levy, A. Sakakibara, A. Rabinkov, T. Miyata, and O. Reiner.",OADS,/arxiv_data1/oa_pdf/ac/02/JCB_201505011.PMC4539990.pdf
"http://dx.doi.org/10.1523/ JNEUROSCI.5425-12.2013 Sauvonnet, N., A. Dujeancourt, and A. Dautry-Varsat.",Non-OADS,/arxiv_data1/oa_pdf/ac/02/JCB_201505011.PMC4539990.pdf
"http://dx.doi.org/10.1083/ jcb.200406174 Serafini, T., T.E.",Non-OADS,/arxiv_data1/oa_pdf/ac/02/JCB_201505011.PMC4539990.pdf
"http://dx.doi.org/10.1523/ JNEUROSCI.1920-04.2005 Shimada, T., M. Toriyama, K. Uemura, H. Kamiguchi, T. Sugiura, N. Watanabe,  and N. Inagaki.",OADS,/arxiv_data1/oa_pdf/ac/02/JCB_201505011.PMC4539990.pdf
"http://dx.doi.org/10.1083/jcb.200712138 Spillane, M., A. Ketschek, C.J.",OADS,/arxiv_data1/oa_pdf/ac/02/JCB_201505011.PMC4539990.pdf
"http://dx.doi.org/10.1016/j.cub.2011.06.065 Suter, D.M., and P.  Forscher.",OADS,/arxiv_data1/oa_pdf/ac/02/JCB_201505011.PMC4539990.pdf
"http://dx.doi.org/10.1002/1097-4695(200008)44:2<97::AID-NEU2>3.0.CO;2-U Suter, D.M., L.D.",OADS,/arxiv_data1/oa_pdf/ac/02/JCB_201505011.PMC4539990.pdf
"http://dx.doi.org/10.1083/jcb.201303129 Toriyama, M., T.  Shimada, K.B.",OADS,/arxiv_data1/oa_pdf/ac/02/JCB_201505011.PMC4539990.pdf
"http://dx.doi.org/10.1083/jcb.200604160 Toriyama, M., Y .",OADS,/arxiv_data1/oa_pdf/ac/02/JCB_201505011.PMC4539990.pdf
"6:394. http://dx.doi.org/10.1038/ msb.2010.51 Toriyama, M., S. Kozawa, Y .",OADS,/arxiv_data1/oa_pdf/ac/02/JCB_201505011.PMC4539990.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ac/02/JCB_201505011.PMC4539990.pdf
"http://dx.doi.org/10.1038/35060051 Van Haastert, P.J., and P.N.",OADS,/arxiv_data1/oa_pdf/ac/02/JCB_201505011.PMC4539990.pdf
"http://dx.doi.org/10.1038/ nrm1435 Vidal, C., B. Geny, J. Melle, M. Jandrot-Perrus, and M. Fontenay-Roupie.",Non-OADS,/arxiv_data1/oa_pdf/ac/02/JCB_201505011.PMC4539990.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ac/02/JCB_201505011.PMC4539990.pdf
"http://dx.doi.org/10.1126/science.1067470 Weaver, A.M., A.V .",OADS,/arxiv_data1/oa_pdf/ac/02/JCB_201505011.PMC4539990.pdf
http://dx.doi.org/10.1016/S0960-9822(01)00098-7,OADS,/arxiv_data1/oa_pdf/ac/02/JCB_201505011.PMC4539990.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ac/02/JCB_201505011.PMC4539990.pdf
"http://dx.doi.org/10.1083/ jcb.151.1.29 Wu, H., and J.T. Parsons.",OADS,/arxiv_data1/oa_pdf/ac/02/JCB_201505011.PMC4539990.pdf
"http://dx.doi.org/10.1083/jcb.120.6.1417 Xu, J., F.  Wang, A.",OADS,/arxiv_data1/oa_pdf/ac/02/JCB_201505011.PMC4539990.pdf
"http://dx.doi.org/10.1016/ S0092-8674(03)00555-5Yamada, H., T. Abe, A. Satoh, N. Okazaki, S. Tago, K. Kobayashi, Y .",OADS,/arxiv_data1/oa_pdf/ac/02/JCB_201505011.PMC4539990.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.2762-12.2013 Yang, Q., X.F.",OADS,/arxiv_data1/oa_pdf/ac/02/JCB_201505011.PMC4539990.pdf
"http://dx.doi.org/10.1083/ jcb.201111052 Zhang, X., Z. Yuan, Y .",OADS,/arxiv_data1/oa_pdf/ac/02/JCB_201505011.PMC4539990.pdf
"27:197– 213. http://dx.doi.org/10.1016/j.molcel.2007.05.033 Zhang, X., G. Jiang, Y .",OADS,/arxiv_data1/oa_pdf/ac/02/JCB_201505011.PMC4539990.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ac/02/JCB_201505011.PMC4539990.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/46/37/JCB_201502107.PMC4539992.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).Correspondence to Vibe H.  Oestergaard: vibe@bio.ku.dk; or Michael Lisby:  mlisby@bio.ku.dk Abbreviations used in this paper: APH, aphidicolin; araC, arabinofuranosyl cyt - idine; ATRi, ATR inhibitor; CFS, common fragile site; CPT, camptothecin; IAA,  indole-3-acetic acid; UFB, ultrafine anaphase bridge; UFB-l, UFB-like.THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/46/37/JCB_201502107.PMC4539992.pdf
"1:7. http://dx.doi.org/10.1186/1472-6750-1-7 Bai, L., W.M.",Non-OADS,/arxiv_data1/oa_pdf/46/37/JCB_201502107.PMC4539992.pdf
"http://dx.doi.org/10.1016/j.cellsig.2014.01.006 Bartkova, J., Z. Horejsí, K. Koed, A. Krämer, F. Tort, K. Zieger, P. Guldberg,  M. Sehested, J.M.",OADS,/arxiv_data1/oa_pdf/46/37/JCB_201502107.PMC4539992.pdf
"http://dx.doi.org/10.1038/nature03482 Baumann, C., R.  Körner, K.  Hofmann, and E.A.",OADS,/arxiv_data1/oa_pdf/46/37/JCB_201502107.PMC4539992.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/46/37/JCB_201502107.PMC4539992.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/46/37/JCB_201502107.PMC4539992.pdf
"http://dx.doi.org/10.1038/nature08822 Bhat, A., P.L.",Non-OADS,/arxiv_data1/oa_pdf/46/37/JCB_201502107.PMC4539992.pdf
"http://dx.doi.org/10.1093/nar/gks1442 Bignell, G.R., C.D.",OADS,/arxiv_data1/oa_pdf/46/37/JCB_201502107.PMC4539992.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/46/37/JCB_201502107.PMC4539992.pdf
http://dx.doi.org/10.1038/emboj.2010.238,Non-OADS,/arxiv_data1/oa_pdf/46/37/JCB_201502107.PMC4539992.pdf
"http://dx.doi.org/10.1038/ sj.emboj.7601777 Chan, K.L., T. Palmai-Pallag, S. Ying, and I.D. Hickson.",Non-OADS,/arxiv_data1/oa_pdf/46/37/JCB_201502107.PMC4539992.pdf
"http://dx.doi.org/10.1038/ncb1882 Cormack, B.P., R.H. Valdivia, and S. Falkow.",Non-OADS,/arxiv_data1/oa_pdf/46/37/JCB_201502107.PMC4539992.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/46/37/JCB_201502107.PMC4539992.pdf
"http://dx.doi.org/10.1146/annurev.genet.41.042007.165900 Eykelenboom, J.K., E.C.",OADS,/arxiv_data1/oa_pdf/46/37/JCB_201502107.PMC4539992.pdf
"http://dx.doi.org/10.1016/j.celrep.2013.10.027 Fekairi, S., S.  Scaglione, C.  Chahwan, E.R.",OADS,/arxiv_data1/oa_pdf/46/37/JCB_201502107.PMC4539992.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/46/37/JCB_201502107.PMC4539992.pdf
"http://dx.doi.org/10.1093/nar/gks599 Germann, S.M., V .H.",Non-OADS,/arxiv_data1/oa_pdf/46/37/JCB_201502107.PMC4539992.pdf
"http://dx.doi.org/10.1016/j.dnarep.2010.11.001 Germann, S.M., V .",OADS,/arxiv_data1/oa_pdf/46/37/JCB_201502107.PMC4539992.pdf
"http://dx.doi.org/10.1083/jcb.201305157 Germe, T., and O. Hyrien.",OADS,/arxiv_data1/oa_pdf/46/37/JCB_201502107.PMC4539992.pdf
"http://dx.doi.org/10.1038/sj.embor.7400465 Goedhart, J., L.  van Weeren, M.A.",OADS,/arxiv_data1/oa_pdf/46/37/JCB_201502107.PMC4539992.pdf
"http://dx.doi.org/10.1038/nmeth.1415 Gritenaite, D., L.N.",OADS,/arxiv_data1/oa_pdf/46/37/JCB_201502107.PMC4539992.pdf
"http://dx.doi.org/10.1101/gad.240515.114 Guervilly, J.H., A. Takedachi, V .",Non-OADS,/arxiv_data1/oa_pdf/46/37/JCB_201502107.PMC4539992.pdf
"http://dx.doi.org/10.1101/gad.842500 Halazonetis, T.D., V .G.",Non-OADS,/arxiv_data1/oa_pdf/46/37/JCB_201502107.PMC4539992.pdf
"http://dx.doi.org/10.1126/science.1140735 Harrigan, J.A., R.  Belotserkovskaya, J.  Coates, D.S.",OADS,/arxiv_data1/oa_pdf/46/37/JCB_201502107.PMC4539992.pdf
"193:97– 108. http://dx.doi.org/10.1083/jcb.201011083 Johnson, M., H.H.",Non-OADS,/arxiv_data1/oa_pdf/46/37/JCB_201502107.PMC4539992.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/46/37/JCB_201502107.PMC4539992.pdf
"25:10907– 10915. http://dx.doi.org/10.1128/MCB.25.24.10907-10915.2005 Kruse, T., G. Zhang, M.S.",OADS,/arxiv_data1/oa_pdf/46/37/JCB_201502107.PMC4539992.pdf
"http://dx.doi.org/10.1242/jcs.122481 Kumagai, A., J. Lee, H.Y .",OADS,/arxiv_data1/oa_pdf/46/37/JCB_201502107.PMC4539992.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/46/37/JCB_201502107.PMC4539992.pdf
"http://dx.doi.org/10.1093/hmg/7.4.755 Lee, D.H., S.S.  Acharya, M.  Kwon, P.  Drane, Y .",Non-OADS,/arxiv_data1/oa_pdf/46/37/JCB_201502107.PMC4539992.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/46/37/JCB_201502107.PMC4539992.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/46/37/JCB_201502107.PMC4539992.pdf
"http://dx.doi.org/10.1128/MCB.00373-13 Lukas, C., V .",Non-OADS,/arxiv_data1/oa_pdf/46/37/JCB_201502107.PMC4539992.pdf
"http://dx.doi.org/10.1038/ncb2201 Mäkiniemi, M., T.  Hillukkala, J.  Tuusa, K.  Reini, M.  Vaara, D.  Huang,  H.  Pospiech, I.  Majuri, T.  Westerling, T.P.",OADS,/arxiv_data1/oa_pdf/46/37/JCB_201502107.PMC4539992.pdf
"http://dx.doi.org/10.1016/j.cell.2011.08.032 Matos, J., M.G.",OADS,/arxiv_data1/oa_pdf/46/37/JCB_201502107.PMC4539992.pdf
"http://dx.doi.org/10.1016/j.celrep.2013.05.039 Muñoz, I.M., K.  Hain, A.C.  Déclais, M.  Gardiner, G.W.",OADS,/arxiv_data1/oa_pdf/46/37/JCB_201502107.PMC4539992.pdf
"http://dx.doi.org/10.1016/j.molcel.2009.06.020 Nagai, T., K. Ibata, E.S.",OADS,/arxiv_data1/oa_pdf/46/37/JCB_201502107.PMC4539992.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/46/37/JCB_201502107.PMC4539992.pdf
"http://dx.doi.org/10.1038/ncb1883 Naim, V ., T. Wilhelm, M. Debatisse, and F. Rosselli.",Non-OADS,/arxiv_data1/oa_pdf/46/37/JCB_201502107.PMC4539992.pdf
"http://dx.doi.org/10.1038/ncb2793 Nishimura, K., T.  Fukagawa, H.  Takisawa, T.  Kakimoto, and M.  Kanemaki.",OADS,/arxiv_data1/oa_pdf/46/37/JCB_201502107.PMC4539992.pdf
"http://dx.doi.org/10.1038/ nmeth.1401 Oestergaard, V .H., B.R.",OADS,/arxiv_data1/oa_pdf/46/37/JCB_201502107.PMC4539992.pdf
http://dx.doi.org/10.1074/jbc.,Non-OADS,/arxiv_data1/oa_pdf/46/37/JCB_201502107.PMC4539992.pdf
"http://dx.doi.org/10.1016/j.dnarep.2012.08.005 Ohouo, P.Y ., F.M.",OADS,/arxiv_data1/oa_pdf/46/37/JCB_201502107.PMC4539992.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/46/37/JCB_201502107.PMC4539992.pdf
"http://dx.doi.org/10.1038/ncb2018 Orthwein, A., A. Fradet-Turcotte, S.M.",Non-OADS,/arxiv_data1/oa_pdf/46/37/JCB_201502107.PMC4539992.pdf
"http://dx.doi.org/10.1126/science.1248024 Ouyang, J., E.  Garner, A.  Hallet, H.D.",OADS,/arxiv_data1/oa_pdf/46/37/JCB_201502107.PMC4539992.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/46/37/JCB_201502107.PMC4539992.pdf
"http://dx.doi.org/10.1038/ nrm2974 Reini, K., L. Uitto, D. Perera, P.B.",Non-OADS,/arxiv_data1/oa_pdf/46/37/JCB_201502107.PMC4539992.pdf
"http://dx.doi.org/10.1007/ s00412-004-0277-5 Roca, J., R.  Ishida, J.M.",Non-OADS,/arxiv_data1/oa_pdf/46/37/JCB_201502107.PMC4539992.pdf
"http://dx.doi.org/10.1038/sj.emboj.7600129 Samejima, K., I. Samejima, P. Vagnarelli, H. Ogawa, G. Vargiu, D.A.",OADS,/arxiv_data1/oa_pdf/46/37/JCB_201502107.PMC4539992.pdf
"http://dx.doi.org/10.1083/ jcb.201202155 Shaner, N.C., R.E.",Non-OADS,/arxiv_data1/oa_pdf/46/37/JCB_201502107.PMC4539992.pdf
"http://dx.doi.org/10.1038/nbt1037 Svendsen, J.M., A.  Smogorzewska, M.E.",OADS,/arxiv_data1/oa_pdf/46/37/JCB_201502107.PMC4539992.pdf
"http://dx.doi.org/10.1016/j.cell.2009.06.030 Szakal, B., and D.  Branzei.",OADS,/arxiv_data1/oa_pdf/46/37/JCB_201502107.PMC4539992.pdf
"http://dx.doi.org/10.1038/emboj.2013.67Toledo, L.I., M. Murga, R. Zur, R. Soria, A. Rodriguez, S. Martinez, J. Oyarzabal,  J. Pastor, J.R. Bischoff, and O. Fernandez-Capetillo.",Non-OADS,/arxiv_data1/oa_pdf/46/37/JCB_201502107.PMC4539992.pdf
"http://dx.doi.org/10.1038/nsmb.2076 Uhlmann, F., D.  Wernic, M.A.",OADS,/arxiv_data1/oa_pdf/46/37/JCB_201502107.PMC4539992.pdf
"http://dx.doi.org/10.1016/ S0092-8674(00)00130-6 Van Hatten, R.A., A.V .",OADS,/arxiv_data1/oa_pdf/46/37/JCB_201502107.PMC4539992.pdf
"http://dx.doi.org/10.1083/jcb.200207090 Wang, J., J.  Chen, and Z.  Gong.",OADS,/arxiv_data1/oa_pdf/46/37/JCB_201502107.PMC4539992.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/46/37/JCB_201502107.PMC4539992.pdf
"http://dx.doi.org/10.1016/j.molcel.2013.08.035 Yamamoto, K.N., S. Kobayashi, M. Tsuda, H. Kurumizaka, M. Takata, K. Kono,  J. Jiricny, S. Takeda, and K. Hirota.",OADS,/arxiv_data1/oa_pdf/46/37/JCB_201502107.PMC4539992.pdf
"http://dx.doi.org/10.1073/ pnas.1018487108 Yamane, K., M.  Kawabata, and T.  Tsuruo.",OADS,/arxiv_data1/oa_pdf/46/37/JCB_201502107.PMC4539992.pdf
"http://dx.doi.org/10.1111/j.1432-1033.1997.00794.x Yamane, K., J.  Chen, and T.J.  Kinsella.",OADS,/arxiv_data1/oa_pdf/46/37/JCB_201502107.PMC4539992.pdf
This article is distributed under the terms of an Attribution–Noncommercial– Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/07/aa/JCB_201410112.PMC4539993.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).*M.",Non-OADS,/arxiv_data1/oa_pdf/07/aa/JCB_201410112.PMC4539993.pdf
Online supplemental material is available at http://www.jcb.org/cgi/ content/full/jcb.201410112/DC1.,Non-OADS,/arxiv_data1/oa_pdf/07/aa/JCB_201410112.PMC4539993.pdf
"http://dx.doi.org/10.1091/mbc.12.9.2742 Anderson, D.H., M.J.  Radeke, N.B.",Non-OADS,/arxiv_data1/oa_pdf/07/aa/JCB_201410112.PMC4539993.pdf
http://dx.doi.org/10.1016/j.preteyeres.2009.11.003,OADS,/arxiv_data1/oa_pdf/07/aa/JCB_201410112.PMC4539993.pdf
"http://dx.doi.org/10.1038/nature11889 Bacallao, R., C.  Antony, C.  Dotti, E.  Karsenti, E.H.  Stelzer, and K.  Simons.",Non-OADS,/arxiv_data1/oa_pdf/07/aa/JCB_201410112.PMC4539993.pdf
"http://dx.doi.org/10.1083/jcb.109.6.2817 Blocker, A., F.F.",OADS,/arxiv_data1/oa_pdf/07/aa/JCB_201410112.PMC4539993.pdf
"http://dx.doi.org/10.1083/jcb.137.1.113 Blocker, A., G.  Griffiths, J.C.  Olivo, A.A.  Hyman, and F.F.",Non-OADS,/arxiv_data1/oa_pdf/07/aa/JCB_201410112.PMC4539993.pdf
"http://dx.doi.org/10.1177/41.2.8419462 Bowes Rickman, C., S. Farsiu, C.A.",Non-OADS,/arxiv_data1/oa_pdf/07/aa/JCB_201410112.PMC4539993.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/07/aa/JCB_201410112.PMC4539993.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/07/aa/JCB_201410112.PMC4539993.pdf
"http://dx.doi.org/10.1097/IAE.0b013e31827e25e0 Desjardins, M., L.A.  Huber, R.G.",Non-OADS,/arxiv_data1/oa_pdf/07/aa/JCB_201410112.PMC4539993.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/07/aa/JCB_201410112.PMC4539993.pdf
"http://dx.doi.org/10.1007/978-0-387-74904-4_37 Encalada, S.E., L. Szpankowski, C.H.",Non-OADS,/arxiv_data1/oa_pdf/07/aa/JCB_201410112.PMC4539993.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/07/aa/JCB_201410112.PMC4539993.pdf
"http://dx.doi.org/10.1007/978-1-4614-3209-8_11 Euteneuer, U., and J.R.  McIntosh.",Non-OADS,/arxiv_data1/oa_pdf/07/aa/JCB_201410112.PMC4539993.pdf
"http://dx.doi.org/10.1083/jcb.87.2.509 Fan, S., T.W.",Non-OADS,/arxiv_data1/oa_pdf/07/aa/JCB_201410112.PMC4539993.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/07/aa/JCB_201410112.PMC4539993.pdf
"http://dx.doi.org/10.1073/ pnas.052025899 Friedman, D.S., and R.D. Vale.",Non-OADS,/arxiv_data1/oa_pdf/07/aa/JCB_201410112.PMC4539993.pdf
"http://dx.doi.org/10.1038/13008 Frost, L.S., V .S.",Non-OADS,/arxiv_data1/oa_pdf/07/aa/JCB_201410112.PMC4539993.pdf
"http://dx.doi.org/10.1007/s12035-014-8920-5 Fu, M.M., and E.L.  Holzbaur.",Non-OADS,/arxiv_data1/oa_pdf/07/aa/JCB_201410112.PMC4539993.pdf
"http://dx.doi.org/10.1083/jcb.201302078 Fu, M.M., and E.L. Holzbaur.",OADS,/arxiv_data1/oa_pdf/07/aa/JCB_201410112.PMC4539993.pdf
"http://dx.doi.org/10.1016/j.tcb.2014.05.002 Fu, M.M., J.J.  Nirschl, and E.L.  Holzbaur.",OADS,/arxiv_data1/oa_pdf/07/aa/JCB_201410112.PMC4539993.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/07/aa/JCB_201410112.PMC4539993.pdf
"http://dx.doi.org/10.1007/978-1-4615-0067-4_44 Gibbs, D., J.  Kitamoto, and D.S.",Non-OADS,/arxiv_data1/oa_pdf/07/aa/JCB_201410112.PMC4539993.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/07/aa/JCB_201410112.PMC4539993.pdf
"117:6473– 6483. http://dx.doi.org/10.1242/jcs.01580 Gilbert, T., A.",Non-OADS,/arxiv_data1/oa_pdf/07/aa/JCB_201410112.PMC4539993.pdf
"http://dx.doi.org/10.1083/jcb.113.2.275 Gordiyenko, N.V ., R.N.",OADS,/arxiv_data1/oa_pdf/07/aa/JCB_201410112.PMC4539993.pdf
"http://dx.doi.org/10.1177/36.10.2458408 Hendricks, A.G., E.  Perlson, J.L.",OADS,/arxiv_data1/oa_pdf/07/aa/JCB_201410112.PMC4539993.pdf
"http://dx.doi.org/10.1016/j.cub.2010.02.058 Herman, K.G., and R.H. Steinberg.",OADS,/arxiv_data1/oa_pdf/07/aa/JCB_201410112.PMC4539993.pdf
"http://dx.doi.org/10.1038/nm1709 Hosein, R.E., S.A. Williams, and R.H. Gavin.",Non-OADS,/arxiv_data1/oa_pdf/07/aa/JCB_201410112.PMC4539993.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/07/aa/JCB_201410112.PMC4539993.pdf
"http://dx.doi.org/10.1073/ pnas.0602131103 Justilien, V ., J.J.  Pang, K.  Renganathan, X.  Zhan, J.W.",Non-OADS,/arxiv_data1/oa_pdf/07/aa/JCB_201410112.PMC4539993.pdf
"http://dx.doi.org/10.1167/iovs.07-0432 Kim, J.Y ., H.  Zhao, J.  Martinez, T.A.",OADS,/arxiv_data1/oa_pdf/07/aa/JCB_201410112.PMC4539993.pdf
"http://dx.doi.org/10.1016/j.cell.2013.06.012 Krock, B.L., J. Bilotta, and B.D. Perkins.",OADS,/arxiv_data1/oa_pdf/07/aa/JCB_201410112.PMC4539993.pdf
http://dx.doi.org/10.1126/ science.982063,Non-OADS,/arxiv_data1/oa_pdf/07/aa/JCB_201410112.PMC4539993.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/07/aa/JCB_201410112.PMC4539993.pdf
"http://dx.doi.org/10.1002/ (SICI)1097-0169(1997)37:3<240::AID-CM6>3.0.CO;2-A Liu, X., I.P.",OADS,/arxiv_data1/oa_pdf/07/aa/JCB_201410112.PMC4539993.pdf
"http://dx.doi.org/10.1111/j.1600-0854.2007.00548.x Lopes, V .S., D. Jimeno, K. Khanobdee, X.",Non-OADS,/arxiv_data1/oa_pdf/07/aa/JCB_201410112.PMC4539993.pdf
http://dx.doi.org/10.1091/mbc.,Non-OADS,/arxiv_data1/oa_pdf/07/aa/JCB_201410112.PMC4539993.pdf
"http://dx.doi.org/10.1093/hmg/ddr155 Luhmann, U.F., L.S.",OADS,/arxiv_data1/oa_pdf/07/aa/JCB_201410112.PMC4539993.pdf
"http://dx.doi.org/10.1083/jcb.201106120 Marshall, G.E., A.G. Konstas, G.G.",Non-OADS,/arxiv_data1/oa_pdf/07/aa/JCB_201410112.PMC4539993.pdf
"http://dx.doi.org/10.1136/bjo.76.10.607 Mattapallil, M.J., E.F.  Wawrousek, C.C.",Non-OADS,/arxiv_data1/oa_pdf/07/aa/JCB_201410112.PMC4539993.pdf
"http://dx.doi.org/10.1167/iovs.12-9662 Mazzoni, F., H. Safa, and S.C. Finnemann.",Non-OADS,/arxiv_data1/oa_pdf/07/aa/JCB_201410112.PMC4539993.pdf
"http://dx.doi.org/10.1016/j.exer.2014.01.010 Müller, M.J., S.  Klumpp, and R.  Lipowsky.",OADS,/arxiv_data1/oa_pdf/07/aa/JCB_201410112.PMC4539993.pdf
"http://dx.doi.org/10.1073/ pnas.0706825105 Nishiyama, K., H.  Sakaguchi, J.G.",OADS,/arxiv_data1/oa_pdf/07/aa/JCB_201410112.PMC4539993.pdf
"http://dx.doi.org/10.1002/ar.10102 Osterberg, G.A. 1935.",Non-OADS,/arxiv_data1/oa_pdf/07/aa/JCB_201410112.PMC4539993.pdf
"http://dx.doi.org/10.1126/science.1234264 Pikuleva, I.A., and C.A. Curcio.",OADS,/arxiv_data1/oa_pdf/07/aa/JCB_201410112.PMC4539993.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/07/aa/JCB_201410112.PMC4539993.pdf
"http://dx.doi.org/10.1083/jcb.116.1.95 Rahman, A., D.S.",Non-OADS,/arxiv_data1/oa_pdf/07/aa/JCB_201410112.PMC4539993.pdf
"http://dx.doi.org/10.1074/ jbc.273.25.15395 Rahman, A., A. Kamal, E.A.",Non-OADS,/arxiv_data1/oa_pdf/07/aa/JCB_201410112.PMC4539993.pdf
"http://dx.doi.org/10.1083/jcb.146.6.1277 Rakoczy, P.E., D.  Zhang, T.  Robertson, N.L.",Non-OADS,/arxiv_data1/oa_pdf/07/aa/JCB_201410112.PMC4539993.pdf
"http://dx.doi.org/10.1016/ S0002-9440(10)64427-6 Regan, C.M., W.J.",OADS,/arxiv_data1/oa_pdf/07/aa/JCB_201410112.PMC4539993.pdf
"30:183– 191. http://dx.doi.org/10.1016/0014-4835(80)90112-8 Reis, G.F., G.  Yang, L.  Szpankowski, C.  Weaver, S.B.",OADS,/arxiv_data1/oa_pdf/07/aa/JCB_201410112.PMC4539993.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/07/aa/JCB_201410112.PMC4539993.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/07/aa/JCB_201410112.PMC4539993.pdf
"http://dx.doi.org/10.1242/jcs.053850 Seabra, M.C., M.S.",OADS,/arxiv_data1/oa_pdf/07/aa/JCB_201410112.PMC4539993.pdf
"http://dx.doi.org/10.1126/science.8380507 Seabra, M.C., Y .K.",OADS,/arxiv_data1/oa_pdf/07/aa/JCB_201410112.PMC4539993.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/07/aa/JCB_201410112.PMC4539993.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/07/aa/JCB_201410112.PMC4539993.pdf
"http://dx.doi.org/10.1126/ science.1105681 Strunnikova, N.V ., A.  Maminishkis, J.J.  Barb, F.  Wang, C.  Zhi, Y .",OADS,/arxiv_data1/oa_pdf/07/aa/JCB_201410112.PMC4539993.pdf
"http://dx.doi.org/10.1093/ hmg/ddq129 Troutt, L.L., and B. Burnside.",OADS,/arxiv_data1/oa_pdf/07/aa/JCB_201410112.PMC4539993.pdf
"http://dx.doi.org/10.1083/jcb.107.4.1461 Tsang, S.H., M.E.",OADS,/arxiv_data1/oa_pdf/07/aa/JCB_201410112.PMC4539993.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/07/aa/JCB_201410112.PMC4539993.pdf
"http://dx.doi.org/10.1083/jcb.143.6.1547 Udovichenko, I.P., D. Gibbs, and D.S. Williams.",OADS,/arxiv_data1/oa_pdf/07/aa/JCB_201410112.PMC4539993.pdf
"http://dx.doi.org/10.1167/ iovs.09-4457 Verhey, K.J., D.L.",OADS,/arxiv_data1/oa_pdf/07/aa/JCB_201410112.PMC4539993.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/07/aa/JCB_201410112.PMC4539993.pdf
"http://dx.doi.org/10.1371/ journal.pone.0125631 Wavre-Shapton, S.T., T.  Tolmachova, M.  Lopes da Silva, C.E.",Non-OADS,/arxiv_data1/oa_pdf/07/aa/JCB_201410112.PMC4539993.pdf
"http://dx.doi.org/10.1371/journal.pone.0057769 Wavre-Shapton, S.T., I.P.",OADS,/arxiv_data1/oa_pdf/07/aa/JCB_201410112.PMC4539993.pdf
"http://dx.doi.org/10.1242/jcs.154757 Weil, D., S. Blanchard, J. Kaplan, P. Guilford, F. Gibson, J. Walsh, P. Mburu,  A. Varela, J. Levilliers, M.D.",Non-OADS,/arxiv_data1/oa_pdf/07/aa/JCB_201410112.PMC4539993.pdf
"http://dx.doi.org/10.1038/nature10449Welte, M.A.",OADS,/arxiv_data1/oa_pdf/07/aa/JCB_201410112.PMC4539993.pdf
"http://dx.doi.org/10.1016/j.cub.2004.06.045 Williams, D.S. 2008.",OADS,/arxiv_data1/oa_pdf/07/aa/JCB_201410112.PMC4539993.pdf
"http://dx.doi.org/10.1083/jcb.143.7.1899 Young, R.W. 1967.",Non-OADS,/arxiv_data1/oa_pdf/07/aa/JCB_201410112.PMC4539993.pdf
"http://dx.doi.org/10.1083/jcb.33.1.61 Young, R.W., and D. Bok.",OADS,/arxiv_data1/oa_pdf/07/aa/JCB_201410112.PMC4539993.pdf
"http://dx.doi.org/10.1083/jcb.42.2.392 Zhang, L., J.W.",OADS,/arxiv_data1/oa_pdf/07/aa/JCB_201410112.PMC4539993.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/07/aa/JCB_201410112.PMC4539993.pdf
This article is distributed under the terms of an Attribution–Noncommercial– Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/36/7f/JCB_201412064.PMC4539995.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).*C.-S.",Non-OADS,/arxiv_data1/oa_pdf/36/7f/JCB_201412064.PMC4539995.pdf
Online supplemental material is available at http://www.jcb.org/cgi/content/full/jcb.201412064/DC1.,Non-OADS,/arxiv_data1/oa_pdf/36/7f/JCB_201412064.PMC4539995.pdf
"http://dx.doi.org/10.1016/S0955-0674(98)80031-8 Adams, C.L., Y .T.",OADS,/arxiv_data1/oa_pdf/36/7f/JCB_201412064.PMC4539995.pdf
"142:1105– 1119. http://dx.doi.org/10.1083/jcb.142.4.1105 Brasch, J., O.J.",Non-OADS,/arxiv_data1/oa_pdf/36/7f/JCB_201412064.PMC4539995.pdf
"http://dx.doi.org/10.1016/j.tcb.2012.03.004 Buckley, C.D., J.  Tan, K.L.",OADS,/arxiv_data1/oa_pdf/36/7f/JCB_201412064.PMC4539995.pdf
"346:1254211. http://dx.doi.org/10.1126/science.1254211 Canel, M., A. Serrels, K.I.",OADS,/arxiv_data1/oa_pdf/36/7f/JCB_201412064.PMC4539995.pdf
"http://dx.doi.org/10.4161/cam.4.4.12661 Cavey, M., M. Rauzi, P.F.",Non-OADS,/arxiv_data1/oa_pdf/36/7f/JCB_201412064.PMC4539995.pdf
"http://dx.doi.org/10.1038/nature06953 Choi, H.J., S.  Pokutta, G.W.",Non-OADS,/arxiv_data1/oa_pdf/36/7f/JCB_201412064.PMC4539995.pdf
"http://dx.doi.org/10.1046/j.1365-2818.2003.01222.x de Beco, S., C.  Gueudry, F.  Amblard, and S.  Coscoy.",Non-OADS,/arxiv_data1/oa_pdf/36/7f/JCB_201412064.PMC4539995.pdf
"http://dx.doi.org/10.1073/ pnas.0811253106 Desai, R., R. Sarpal, N. Ishiyama, M. Pellikka, M. Ikura, and U. Tepass.",Non-OADS,/arxiv_data1/oa_pdf/36/7f/JCB_201412064.PMC4539995.pdf
"http://dx.doi.org/10.1038/ncb2685 Drees, F., S. Pokutta, S. Yamada, W.J.",Non-OADS,/arxiv_data1/oa_pdf/36/7f/JCB_201412064.PMC4539995.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/36/7f/JCB_201412064.PMC4539995.pdf
"http://dx.doi.org/10.1091/mbc.E12-06-0485 Gomez, G.A., R.W.",Non-OADS,/arxiv_data1/oa_pdf/36/7f/JCB_201412064.PMC4539995.pdf
"http://dx.doi.org/10.1016/j.tcb.2011.05.006 Green, K.J., S. Getsios, S. Troyanovsky, and L.M. Godsel.",OADS,/arxiv_data1/oa_pdf/36/7f/JCB_201412064.PMC4539995.pdf
"http://dx.doi.org/10.1101/cshperspect.a000125 Gumbiner, B.M.",Non-OADS,/arxiv_data1/oa_pdf/36/7f/JCB_201412064.PMC4539995.pdf
"http://dx.doi.org/10.1038/ nrm1699 Hansen, S.D., A.V .",OADS,/arxiv_data1/oa_pdf/36/7f/JCB_201412064.PMC4539995.pdf
"http://dx.doi.org/10.1091/mbc.E13-07-0388 Harrison, O.J., F. Bahna, P.S.",Non-OADS,/arxiv_data1/oa_pdf/36/7f/JCB_201412064.PMC4539995.pdf
"http://dx.doi.org/10.1038/nsmb.1784 Harrison, O.J., X.  Jin, S.  Hong, F.  Bahna, G.  Ahlsen, J.  Brasch, Y .",Non-OADS,/arxiv_data1/oa_pdf/36/7f/JCB_201412064.PMC4539995.pdf
"http://dx.doi.org/10.1016/j.str.2010.11.016 Hazan, R.B., L.  Kang, S.  Roe, P.I.",OADS,/arxiv_data1/oa_pdf/36/7f/JCB_201412064.PMC4539995.pdf
"http://dx.doi.org/10.1074/jbc.272.51.32448 Heuser, J.E., and M.W. Kirschner.",OADS,/arxiv_data1/oa_pdf/36/7f/JCB_201412064.PMC4539995.pdf
http://dx.doi.org/10.1083/jcb.86.1.212,Non-OADS,/arxiv_data1/oa_pdf/36/7f/JCB_201412064.PMC4539995.pdf
"http://dx.doi.org/10.1073/ pnas.0911027107 Hong, S., R.B.",Non-OADS,/arxiv_data1/oa_pdf/36/7f/JCB_201412064.PMC4539995.pdf
"http://dx.doi.org/10.1083/jcb.201006113 Hong, S., R.B.",Non-OADS,/arxiv_data1/oa_pdf/36/7f/JCB_201412064.PMC4539995.pdf
"http://dx.doi.org/10.1083/jcb.201211054 Huveneers, S., J.  Oldenburg, E.  Spanjaard, G.  van der Krogt, I.  Grigoriev,  A.  Akhmanova, H.  Rehmann, and J.  de Rooij.",Non-OADS,/arxiv_data1/oa_pdf/36/7f/JCB_201412064.PMC4539995.pdf
"http://dx.doi.org/10.1083/ jcb.201108120 Imamura, Y ., M. Itoh, Y .",OADS,/arxiv_data1/oa_pdf/36/7f/JCB_201412064.PMC4539995.pdf
"http://dx.doi.org/10.1083/ jcb.144.6.1311 Indra, I., S. Hong, R. Troyanovsky, B. Kormos, and S. Troyanovsky.",OADS,/arxiv_data1/oa_pdf/36/7f/JCB_201412064.PMC4539995.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/36/7f/JCB_201412064.PMC4539995.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/36/7f/JCB_201412064.PMC4539995.pdf
"http://dx.doi.org/10.1016/B978-0-12-407697-6.00002-7 Kametani, Y ., and M. Takeichi.",OADS,/arxiv_data1/oa_pdf/36/7f/JCB_201412064.PMC4539995.pdf
"http://dx.doi.org/10.1038/ncb1520 Klingelhöfer, J., O.Y .",Non-OADS,/arxiv_data1/oa_pdf/36/7f/JCB_201412064.PMC4539995.pdf
"http://dx.doi.org/10.1128/ MCB.22.21.7449-7458.2002 Kobielak, A., and E. Fuchs.",OADS,/arxiv_data1/oa_pdf/36/7f/JCB_201412064.PMC4539995.pdf
"http://dx.doi.org/10.1016/S0955-0674(99)00020-4 Lambert, M., O. Thoumine, J. Brevier, D. Choquet, D. Riveline, and R.M. Mège.",OADS,/arxiv_data1/oa_pdf/36/7f/JCB_201412064.PMC4539995.pdf
"http://dx.doi.org/10.1016/j.yexcr.2007.07.035 Maiers, J.L., X. Peng, A.S. Fanning, and K.A. DeMali.",OADS,/arxiv_data1/oa_pdf/36/7f/JCB_201412064.PMC4539995.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/36/7f/JCB_201412064.PMC4539995.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/36/7f/JCB_201412064.PMC4539995.pdf
"http://dx.doi.org/10.1083/jcb.200606007 Nagafuchi, A., S. Ishihara, and S. Tsukita.",OADS,/arxiv_data1/oa_pdf/36/7f/JCB_201412064.PMC4539995.pdf
"http://dx.doi.org/10.1083/ jcb.127.1.235 Nieman, M.T., J.B. Kim, K.R.",OADS,/arxiv_data1/oa_pdf/36/7f/JCB_201412064.PMC4539995.pdf
"http://dx.doi.org/10.1152/physrev.00004.2010 Ozawa, M. 1998.",OADS,/arxiv_data1/oa_pdf/36/7f/JCB_201412064.PMC4539995.pdf
"http://dx.doi.org/10.1074/jbc.273.45.29524 Pappas, D.J., and D.L.",OADS,/arxiv_data1/oa_pdf/36/7f/JCB_201412064.PMC4539995.pdf
"http://dx.doi.org/10.1080/15419060600726142Peng, X., L.E.",Non-OADS,/arxiv_data1/oa_pdf/36/7f/JCB_201412064.PMC4539995.pdf
"http://dx.doi.org/10.1242/jcs.056432 Peng, G.E., S.R.",OADS,/arxiv_data1/oa_pdf/36/7f/JCB_201412064.PMC4539995.pdf
"22:3986– 3994. http://dx.doi.org/10.1091/mbc.E11-04-0379 Pokutta, S., F. Drees, Y .",Non-OADS,/arxiv_data1/oa_pdf/36/7f/JCB_201412064.PMC4539995.pdf
http://dx.doi.org/10.1074/jbc.,Non-OADS,/arxiv_data1/oa_pdf/36/7f/JCB_201412064.PMC4539995.pdf
"http://dx.doi.org/10.1074/jbc.M112.351023 Rangarajan, E.S., and T.  Izard.",OADS,/arxiv_data1/oa_pdf/36/7f/JCB_201412064.PMC4539995.pdf
"http://dx.doi.org/10.1038/ nsmb.2479 Ray, S., H.P.",OADS,/arxiv_data1/oa_pdf/36/7f/JCB_201412064.PMC4539995.pdf
"http://dx.doi.org/10.1083/jcb.201410111 Svitkina, T.M., E.A.",OADS,/arxiv_data1/oa_pdf/36/7f/JCB_201412064.PMC4539995.pdf
"http://dx.doi.org/10.1083/jcb.200210174 Taguchi, K., T.  Ishiuchi, and M.  Takeichi.",OADS,/arxiv_data1/oa_pdf/36/7f/JCB_201412064.PMC4539995.pdf
"http://dx.doi.org/10.1083/jcb.201104124 Takeichi, M. 2014.",OADS,/arxiv_data1/oa_pdf/36/7f/JCB_201412064.PMC4539995.pdf
"http://dx.doi.org/10.1083/jcb.201303129 Thomas, W.A., C. Boscher, Y .S.",OADS,/arxiv_data1/oa_pdf/36/7f/JCB_201412064.PMC4539995.pdf
http://dx.doi.org/10.1074/jbc.,Non-OADS,/arxiv_data1/oa_pdf/36/7f/JCB_201412064.PMC4539995.pdf
"60:89– 108. http://dx.doi.org/10.1007/978-94-007-4186-7_5 Troyanovsky, R.B., E.P.",Non-OADS,/arxiv_data1/oa_pdf/36/7f/JCB_201412064.PMC4539995.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/36/7f/JCB_201412064.PMC4539995.pdf
http://dx.doi.org/10.1091/mbc.,Non-OADS,/arxiv_data1/oa_pdf/36/7f/JCB_201412064.PMC4539995.pdf
"http://dx.doi.org/10.1091/mbc.E11-03-0250 Twiss, F., Q.",OADS,/arxiv_data1/oa_pdf/36/7f/JCB_201412064.PMC4539995.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/36/7f/JCB_201412064.PMC4539995.pdf
"100:209– 219. http://dx.doi.org/10.1016/S0092-8674(00)81559-7 Watabe-Uchida, M., N.  Uchida, Y .",OADS,/arxiv_data1/oa_pdf/36/7f/JCB_201412064.PMC4539995.pdf
"http://dx.doi.org/10.1016/j.cell.2005.09.020 Yap, A.S., W.M.",OADS,/arxiv_data1/oa_pdf/36/7f/JCB_201412064.PMC4539995.pdf
"http://dx.doi.org/10.1016/ S0960-9822(06)00154-0 Yonemura, S.  2011.",OADS,/arxiv_data1/oa_pdf/36/7f/JCB_201412064.PMC4539995.pdf
"http://dx.doi.org/10.1016/j.ceb.2011.07.001 Yonemura, S., Y .",OADS,/arxiv_data1/oa_pdf/36/7f/JCB_201412064.PMC4539995.pdf
"http://dx.doi.org/10.1038/ncb2055 Zhang, J., M.  Betson, J.  Erasmus, K.  Zeikos, M.  Bailly, L.P.  Cramer, and  V .M. Braga.",Non-OADS,/arxiv_data1/oa_pdf/36/7f/JCB_201412064.PMC4539995.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribu - tion-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncom - mercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/f7/0f/jjm-08-06-16822.PMC4539999.pdf
"194Original Article http://dx.doi.org/10.9758/cpn.2015.13.2.194 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2015;13(2):194-200 Copyrightⓒ 2015, Korean College of Neuropsychopharmacology                       Received:  January 12, 2015/ Revised:  February 11, 2015 Accepted:  March 6, 2015 Address for correspondence: Özge Saraçlı, MD Department of Psychiatry, Bulent Ecevit University Faculty of  Medicine, Esenk öy-Kozlu, 67600 Zonguldak, Turkey Tel: +90-372-2612379, Fax: +90-372-2610155E-mail: osimsekyilmaz@yahoo.com  This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.The Relationship between Quality of Life  and Cognitive Functions, Anxiety and  Depression among Hospitalized Elderly Patients Özge Sara çlı1, Ayşe Semra Demir Akca2, Nuray Atasoy1, Özde Önder3, Ömer Şenormanc ı1, İsmet Kaygis ız1, Levent  Atik1 Departments of 1Psychiatry and 2Family Medicine, Bulent Ecevit University Faculty of Medicine, 3Public Health Center, Zonguldak,Turkey Objective: Older people seek not only a longer life, but also a better qua lity of life (QOL).",Non-OADS,/arxiv_data1/oa_pdf/ec/ae/cpn-13-194.PMC4540029.pdf
"188Original Article http://dx.doi.org/10.9758/cpn.2015.13.2.188 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2015;13(2):188-193 Copyrightⓒ 2015, Korean College of Neuropsychopharmacology                       Received:  December 8, 2014/ Revised:  January 30, 2015 Accepted:  March 4, 2015 Address for correspondence: Khaled Saad, MD Department of Pediatrics, Faculty of Medicine, Assiut Universit y,  Assiut 71516, Egypt Tel: +20-100-608-0182, Fax: +20-88-236-8371E-mail: khaled.ali@med.au.edu.eg  This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.A Randomized, Placebo-controlled Trial of Digestive Enzymes in Children with  Autism Spectrum Disorders Khaled Saad1, Azza A. Eltayeb1, Ismail L. Mohamad1, Abdulrahman A. Al-Atram2, Yasser Elserogy3,  Geir Bj ørklund4, Amira A. El-Houfey5,6, Bubba Nicholson7 1Department of Pediatrics, Faculty of Medicine, Assiut Universit y, Assiut, Egypt, 2Department of Psychiatry, College of Medicine, Almajmaah  University, Kingdom of Saudi Arabia, 3Department of Neuropsychiatry, Assiut University, Assiut, Egypt , 4Council for Nutritional and  Environmental Medicine, Mo i Rana, Norway, 5Department of Community Health Nursing, Faculty of Nursing and Health Allied, Jazan  University, Kingdom of Saudi Arabia, 6Faculty of Nursing, Assiut University, Assiut, Egypt, 7Nicholson Science, Tampa, FL, USA Objective: There is growing evidence for a gut-brain connection associated  with autism spectrum disorders (ASDs).",Non-OADS,/arxiv_data1/oa_pdf/6a/17/cpn-13-188.PMC4540030.pdf
Available from: http://autism.asu.edu.,Non-OADS,/arxiv_data1/oa_pdf/6a/17/cpn-13-188.PMC4540030.pdf
"144Original Article http://dx.doi.org/10.9758/cpn.2015.13.2.144 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2015;13(2):144-149 Copyrightⓒ 2015, Korean College of Neuropsychopharmacology                       Received:  October 30, 2014/ Revised:  December 17, 2014 Accepted:  December 22, 2014 Address for correspondence: Won-Myong Bahk, MD, PhD Department of Psychiatry, Yeouido St. Mary ’s Hospital, College of  Medicine, The Catholic University of Korea, 10, 63-ro, Yeongdeu ngpo- gu, Seoul 07345, KoreaTel: +82-2-3779-1051, Fax: +82-2-780-6577E-mail: wmbahk@catholic.ac.kr  This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.Efficacy and Tolerability of Generic Mirtazapine (Mirtax) for Major Depressive  Disorder: Multicenter, Open-label, Uncontrolled, Prospective Study Hoo Rim Song1,2, Won-Myong Bahk2, Young Sup Woo2, Jong-Hyun Jeong2, Young-Joon Kwon1, Jeong Seok Seo3,  Won Kim4, Moon-Doo Kim5, Young-Chul Shin6, Sang-Yeol Lee7, Kyung Joon Min8 Department of Psychiatry, 1Soonchunhyang University Cheonan Hospital, Cheonan, 2College of Medicine, The Catholic University of Korea,  Seoul, 3Konkuk University Chungju Hospital, Chungju, 4Inje University Seoul Paik Hospital, Seoul, 5Jeju National University Hospital, Jeju,  6Kangbuk Samsung Hospital, Seoul, 7Wonkwang University Hospital, Iksan, 8Chung-Ang University Hospital, Seoul, Korea Objective:  Mirtax is a generic mirtazapine widely used since 2003.",Non-OADS,/arxiv_data1/oa_pdf/0f/56/cpn-13-144.PMC4540031.pdf
"212Case Report http://dx.doi.org/10.9758/cpn.2015.13.2.212 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2015;13(2):212-214 Copyrightⓒ 2015, Korean College of Neuropsychopharmacology                       Received:  December 5, 2014/ Revised:  January 12, 2015 Accepted:  January 23, 2015 Address for correspondence: Kyoung-Uk Lee, MD, PhD Department of Psychiatry, Uijeongbu St. Mary ’s Hosptial, The  Catholic University of Korea College of Medicine, 271 Cheonbo-r o,  Uijeongbu 11765, KoreaTel: +82-31-820-3609, Fax: +82-31-847-3630E-mail: smwang11@daum.net  This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.Overactive Bladder Successfully Treated with Duloxetine in a Female Adolescent Sheng-Min Wang1,2, Hae-Kook Lee3, Yong-Sil Kweon3, Chung Tai Lee3, Kyoung-Uk Lee3 1Department of Psychiatry and 2International Health Care Center, Seoul St. Mary ’s Hospital, The Catholic University of Korea College of  Medicine, Seoul, 3Department of Psychiatry, Uijeongbu St. Mary ’s Hospital, The Catholic University of Korea College of Medicin e, Uijeongbu,  Korea Overactive bladder (OAB) is defined as urgency, usually with fr equency and nocturia, and with or without urge incontinence.",Non-OADS,/arxiv_data1/oa_pdf/ab/36/cpn-13-212.PMC4540032.pdf
"150Original Article http://dx.doi.org/10.9758/cpn.2015.13.2.150 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2015;13(2):150-156 Copyrightⓒ 2015, Korean College of Neuropsychopharmacology                       Received:  September 1, 2014/ Revised:  January 4, 2015 Accepted:  January 7, 2015 Address for correspondence: Ajeet B. Singh, MD Baycrest Biotechnology Pty Ltd, MDPO Box 9148, St Albans Park,  Victoria, AustraliaTel: +613-5248-7211, Fax: +613-5248-4767E-mail: ajeetsingh@dodo.com.au    This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.Improved Antidepressant Remission in Major Depression via a Pharmacokinetic  Pathway Polygene Pharmacogenetic Report  Ajeet B. Singh Baycrest Biotechnology Pty Ltd, Victoria, Australia Objective:  Major depressive disorder (MDD) is projected to be a leading c ause of disability globally by 2030.",Non-OADS,/arxiv_data1/oa_pdf/58/f1/cpn-13-150.PMC4540033.pdf
"129Review http://dx.doi.org/10.9758/cpn.2015.13.2.129 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2015;13(2):129-137 Copyrightⓒ 2015, Korean College of Neuropsychopharmacology                       Received:  January 20, 2015/ Revised:  February 21, 2015 Accepted:  February 22, 2015 Address for correspondence: Kuan-Pin Su, MD, PhD  Department of Psychiatry, China Medical University Hospital, No .",Non-OADS,/arxiv_data1/oa_pdf/34/83/cpn-13-129.PMC4540034.pdf
"157Original Article http://dx.doi.org/10.9758/cpn.2015.13.2.157 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2015;13(2):157-162 Copyrightⓒ 2015, Korean College of Neuropsychopharmacology                       Received:  November 22, 2014/ Revised:  January 13, 2015 Accepted:  January 14, 2015 Address for correspondence: Ippei Takeuchi, M.Sharm Department of Psychiatry, Okehazama Hospital, Minamiyakata  3-879, Sakae-cho, Toyoake, Aichi 470-1168, Japan Tel: +81-562-97-1361, Fax: +81-562-97-8004E-mail: 134331503@ccalumni.meijo-u.ac.jp  This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.Effect of Adenine on Clozapine-induced Neutropenia in Patients with  Schizophrenia: A Preliminary Study Ippei Takeuchi1,2, Taro Kishi1, Manako Hanya2, Junji Uno1, Kiyoshi Fujita1, Hiroyuki Kamei2 1Department of Psychiatry, Okehazama Hospital, Toyoake, Aichi, 2Office of Clinical Pharmacy Practice and Health Care Management ,  Faculty of Pharmacy, Meijo University, Nagoya, Japan Objective: This study examined the utility of adenine for preventing cloza pine-induced neutropenia.",Non-OADS,/arxiv_data1/oa_pdf/90/e5/cpn-13-157.PMC4540035.pdf
"222Letter to the Editor http://dx.doi.org/10.9758/cpn.2015.13.2.222 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2015;13(2):222-223 Copyrightⓒ 2015, Korean College of Neuropsychopharmacology                       Received:  April 10, 2015/ Accepted:  April 13, 2015 Address for correspondence: Sayantanava Mitra, MD Department of Psychiatry, Sarojini Naidu Medical College, Mahat ma  Gandhi Rd, Raja Mandi Crossing, Bagh Muzaffar Khan, Shahganj, Agra, Uttar Pradesh 282002, IndiaE-mail: sayantanava@gmail.com  This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.Mirtazapine in Paroxetine Induced Hyper-prolactinemic Galactorrhoea Manjeet Singh, Zeeshan Anwar, Vishal Sinha, Vipin Narwal, Sayan tanava Mitra, Abhishek Bharti, Ashwani Kumar  Mishra Department of Psychiatry, Sarojini Naidu Medical College, Agra,  India TO THE EDITOR Selective serotonin reuptake inhibitors (SSRIs) are  commonly used to treat a gamut of depression-anxi- ety-spectrum disorders.",Non-OADS,/arxiv_data1/oa_pdf/59/eb/cpn-13-222.PMC4540036.pdf
"224Correction http://dx.doi.org/10.9758/cpn.2015.13.2.224 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2015;13(2):224-225 Copyrightⓒ 2015, Korean College of Neuropsychopharmacology                       Address for correspondence: John P. John, MD Department of Psychiatry, National Institute of Mental Health a nd Neurosciences (NIMHANS), PB No 2900 Dharmaram P.O., Hosur Ro ad,  Bangalore Karnataka 560 029, IndiaTel: +091-80-26995329/26995250, Fax: +091-80-26564492/ 26564822E-mail: jpjnimhans@gmail.com*Current affiliation of Harsha N. Halahalli is Department of Ph ysiology, K.S.",Non-OADS,/arxiv_data1/oa_pdf/44/39/cpn-13-224.PMC4540037.pdf
"Clin Psychopharmacol Neurosci  2015;13(1):68-82.  http://dx.doi.org/10.9758/cpn.2015.13.1.68”, the data in Fig.",Non-OADS,/arxiv_data1/oa_pdf/44/39/cpn-13-224.PMC4540037.pdf
"180Original Article http://dx.doi.org/10.9758/cpn.2015.13.2.180 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2015;13(2):180-187 Copyrightⓒ 2015, Korean College of Neuropsychopharmacology                       Received:  October 27, 2014/ Revised:  January 28, 2015 Accepted:  March 2, 2015 Address for correspondence: Seung-Hwan Lee, MD, PhD Department of Psychiatry, Inje University Ilsan Paik Hospital, 170  Juhwa-ro, Ilsanseo-gu, Goyang 10380, KoreaTel: +82-31-910-7260, Fax: +82-31-910-7268E-mail: Ishpss@paik.ac.kr  This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.Quantitative Electroencephalography Reflects Inattention, Visual Error  Responses, and Reaction Times in Male  Patients with Attention Deficit  Hyperactivity Disorder Sang-Choong Roh1, Eun-Jin Park2, Young-Chun Park1,3, Sun-Kyung Yoon1,4, Joong-Gu Kang1, Do-won Kim1,5,  Seung-Hwan Lee1,2 1Clinical Emotion and Cognition Research Laboratory, Inje Univer sity, Seoul, 2Department of Psychiatry, Inje University Ilsan Paik Hospital,  Goyang, 3Department of Psychiatry, Korea University, 4Department of Psychiatry, Sogang University, 5Department of Biomedical  Engineering, Hanyang University, Seoul, Korea Objective: Quantitative electroencephalography (qEEG) has been increasingl y used to evaluate patients with attention deficit  hyperactivity disorder (ADHD).",Non-OADS,/arxiv_data1/oa_pdf/fc/ab/cpn-13-180.PMC4540038.pdf
"209Case Report http://dx.doi.org/10.9758/cpn.2015.13.2.209 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2015;13(2):209-211 Copyrightⓒ 2015, Korean College of Neuropsychopharmacology                       Received:  December 9, 2014/ Revised:  December 30, 2014 Accepted:  December 31, 2014 Address for correspondence: Changsu Han, MD, PhD Department of Psychiatry, Korea University Ansan Hospital, 123  Jeokgeum-ro, Danwon-gu, Ansan 15355, KoreaTel: +82-31-412-4931, Fax: +82-31-412-5144E-mail: hancs@korea.ac.kr  This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.Psychiatric Symptoms in a Patient with Influenza A (H1N1) Treated with  Oseltamivir (Tamiflu): A Case Report Sang Won Jeon, Changsu Han Department of Psychiatry, Korea University Ansan Hospital, Kore a University College of Medicine, Ansan, Korea Oseltamivir is the most common antiviral drug used to treat and  prevent influenza.",Non-OADS,/arxiv_data1/oa_pdf/58/ef/cpn-13-209.PMC4540039.pdf
"138Review http://dx.doi.org/10.9758/cpn.2015.13.2.138 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2015;13(2):138-143 Copyrightⓒ 2015, Korean College of Neuropsychopharmacology                       Received:  January 14, 2015/ Revised:  March 9, 2015 Accepted:  March 10, 2015 Address for correspondence: Yen Kuang Yang, MD Department of Psychiatry, National Cheng Kung University Hospit al,  138 Sheng Li Road, North Dist., Tainan 70403, TaiwanTel: +886-6-2353535 ext, 5213, Fax: +886-6-2084767E-mail: ykyang@mail.ncku.edu.tw  This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.Holistic Consideration of Patients with  Schizophrenia to Improve Medication  Adherence and Outcomes Lan-Ting Lee1, Kao Chin Chen1,2, Wei Hung Chang1,3, Po See Chen1,2, I Hui Lee1,2,3, Yen Kuang Yang1,2 1Department of Psychiatry, National Cheng Kung University Hospit al, College of Medicine, National Cheng Kung University, 2Addiction  Research Center, National Cheng Kung University, Tainan, 3Department of Psychiatry, National Cheng Kung University, Dou-L iou Branch,  Yunlin, Taiwan Although several algorithms have been applied to treat patients  with schizophrenia, their clinical use remains still limited, because  most emphasize the prescription of antipsychotics.",Non-OADS,/arxiv_data1/oa_pdf/b0/38/cpn-13-138.PMC4540040.pdf
"201Original Article http://dx.doi.org/10.9758/cpn.2015.13.2.201 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2015;13(2):201-208 Copyrightⓒ 2015, Korean College of Neuropsychopharmacology                       Received:  November 22, 2014/ Revised:  February 16, 2015 Accepted:  March 6, 2015 Address for correspondence: Kyeong-Sook Choi, MD, PhD Department of Neuropsychiatry, Eulji University Hospital, 95  Dunsanseo-ro, Seo-gu, Daejeon 35233, KoreaTel: +82-42-611-3443, Fax: +82-42-611-3445E-mail: cksinj@eulji.ac.kr  This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.The Relationship between Chronotype and Sleep Quality in Korean Firefighters Ji-Ae Yun1, Yeon-Soon Ahn2, Kyoung-Sook Jeong2, Eun-Jeong Joo3, Kyeong-Sook Choi1 1Department of Neuropsychiatry, Eulji University Hospital, Eulji  University School of Medicine, Daejeon, 2Department of Occupational and  Environmental Medicine, Dongguk University Ilsan Hospital, Goya ng, 3Department of Neuropsychiatry, Eulji General Hospital, Eulji  University School of Medicine, Seoul, Korea Objective: We examined the relationship between chronotype and sleep distu rbance, and assessed various factors that might  be associated with sleep disturbance in Korean firefighters.",Non-OADS,/arxiv_data1/oa_pdf/37/20/cpn-13-201.PMC4540041.pdf
"168Original Article http://dx.doi.org/10.9758/cpn.2015.13.2.168 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2015;13(2):168-173 Copyrightⓒ 2015, Korean College of Neuropsychopharmacology                       Received:  January 7, 2015/ Revised:  February 23, 2015 Accepted:  February 24, 2015 Address for correspondence: Jin Hyeong Jhoo, MD, PhD Department of Psychiatry, Kangwon National University Hospital,   156 Baengnyeong-ro, Ch uncheon 24289, Korea Tel: +82-33-254-9300, Fax: +82-33-244-2271E-mail: jhoojh@kangwon.ac.kr  This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.The Effect of Choline Acetyltransferase Genotype on Donepezil Treatment  Response in Patients with Alzheimer’s Disease Kang Uk Lee1, Jung Hie Lee1, Dong Young Lee2,3, Jong Chul Youn4, Jeong Lan Kim5, Seok Woo Moon6,  Bong-Jo Kim7, Seung-Ho Ryu8, Moon Doo Kim9, Chang-Uk Lee10, Nam-Jin Lee11, Sung Man Chang12,  Young Hoon Kim13, Do Hoon Kim14, Hae-Kook Lee15, Jong Inn Woo3, Ki Woong Kim3,16,17, Jin Hyeong Jhoo1 1Department of Psychiatry, Kangwon National University School of  Medicine, Chuncheon, 2Department of Neuropsychiatry, Seoul National  University Hospital, Seoul, 3Department of Psychiatry, Seoul National University College of Medicine, Seoul, 4Department of  Neuropsychiatry, Kyunggi Provincial Hospital for the Elderly, Y ongin, 5Department of Psychiatry, Chungnam National University Hospital ,  Daejeon, 6Department of Psychiatry, Konkuk University Chungju Hospital, C hungju, 7Department of Psychiatry, Gyeongsang National  University Hospital, Jinju, 8Department of Neuropsychiatry, Konkuk University Hospital, Seou l, 9Department of Neuropsychiatry, Jeju National  University Hospital, Jeju, 10Department of Psychiatry, Seoul St. Mary ’s Hospital, The Catholic University of Korea, Seoul, 11Department of  Psychiatry, Jeonju City Welfare Hospital for the Elderly, Jeonj u, 12Department of Psychiatry, Kyungbook National University Hospita l, Daegu,  13Department of Psychiatry, Haeundae Paik Hospital, Busan, 14Department of Psychiatry, Chunch eon Sacred Hospital, Chuncheon,   15Department of Psychiatry, Uijeongbu St. Mary ’s Hospital, Uijeongbu, 16Department of Brain and Cognitive Science, Seoul National Unive rsity  College of Natural Sciences, Seoul, 17Department of Neuropsychiatry, Seoul National University Bundan g Hospital, Seongnam, Korea Objective: We examined the difference in responses to donepezil between ca rriers and non-carriers of the A allele at the +4  position of the choline acetyltransferase (ChAT) gene in Korean s. Methods: Patients who met the criteria for probable Alzheimer ’s disease (AD) (n=199) were recruited.",Non-OADS,/arxiv_data1/oa_pdf/e7/9f/cpn-13-168.PMC4540042.pdf
"218Case Report http://dx.doi.org/10.9758/cpn.2015.13.2.218 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2015;13(2):218-221 Copyrightⓒ 2015, Korean College of Neuropsychopharmacology                       Received:  December 29, 2014/ Revised:  February 2, 2015 Accepted:  February 25, 2015 Address for correspondence: Stanley N. Caroff, MD Philadelphia Veterans Affairs Medical Center, 3900 Woodland  Avenue, Philadelphia, PA 19104, USATel: +1-215-823-4066, Fax: +1-215-823-4610E-mail: stanley.caroff@va.gov  This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.Recurrent Idiopathic Catatonia: Imp lications beyond the Diagnostic and  Statistical Manual of Ment al Disorders 5th Edition Stanley N. Caroff, Irene Hurford, Henry R. Bleier, Gregg E. Gor ton, E. Cabrina Campbell Philadelphia Veterans Affairs Medical Center and Perelman Schoo l of Medicine, University of Pennsylvania, Philadelphia, PA, US A We describe a case of recurrent, life-threatening, catatonic st upor, without evidence of any associated medical, toxic or ment al  disorder.",Non-OADS,/arxiv_data1/oa_pdf/97/43/cpn-13-218.PMC4540043.pdf
"121Review http://dx.doi.org/10.9758/cpn.2015.13.2.121 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2015;13(2):121-128 Copyrightⓒ 2015, Korean College of Neuropsychopharmacology                       Received:  October 10, 2014/ Revised:  December 30, 2014 Accepted:  January 19, 2015 Address for correspondence: Yuan Hwa Chou, MD, PhD Department of Psychiatry, Taipei Veterans General Hospital, No  201, Sec 2, Shih Pai Rd, Beitou, Taipei 112, TaiwanTel: +886-2-2871-1290, Fax: +886-2-2871-1290E-mail: c520608@ms64.hinet.net  This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.A Systemic Review and Experts’ Consensus for Long-acting Injectable  Antipsychotics in Bipolar Disorder Yuan Hwa Chou1, Po-Chung Chu2,3, Szu-Wei Wu4, Jen-Chin Lee5, Yi-Hsuan Lee6, I-Wen Sun7, Chen-Lin Chang8,  Chien-Liang Huang9, I-Chao Liu10, Chia-Fen Tsai11, Yung-Chieh Yen12 1Department of Psychiatry, Taipei Veterans General Hospital & Na tional Yang Ming University, Taipei, 2Department of Psychiatry, Chung  Shan Medical University Hospital, Taichung, 3School of Medicine, Chung Shan Medical University, Taichung, 4Department of Psychiatry,  Wei-Gong Memorial Hospital, Miaoli, 5Department of General Psychiatry, Taoyuan Psychiatric Center, M inistry of Health and Welfare,  Taoyuan, 6Department of Psychiatry, Tainan Municipal Hospital, Tainan, 7Department of Psychiatry, Mackay Memorial Hospital, Taipei,  8Department of Psychiatry, Kaohsiung Armed Forces General Hospit al, Kaohsiung, 9Department of Psychiatry, China Medical University  Hospital, Taichung, 10Department of Psychiatry, Cardinal Tien Hospital, Taipei, 11Department of Psychiatry, Taipei Veterans General Hospital,  12Department of Psychiatry, E-Da Hospital, Kaohsiung, Taiwan Bipolar disorder (BD) is a major psychiatric disorder that is e asily misdiagnosed.",Non-OADS,/arxiv_data1/oa_pdf/72/78/cpn-13-121.PMC4540044.pdf
"163Original Article http://dx.doi.org/10.9758/cpn.2015.13.2.163 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2015;13(2):163-167 Copyrightⓒ 2015, Korean College of Neuropsychopharmacology                       Received:  December 5, 2014/ Revised:  January 21, 2015 Accepted:  January 28, 2015 Address for correspondence: Soyoung Irene Lee, MD, PhD Department of Psychiatry, Soonchunhyang University Bucheon  Hospital, 170 Jomaru-ro, Wonmi-gu, Bucheon 14584, KoreaTel: +82-32-621-5017, Fax: +82-32-621-5018E-mail: irenelee@schmc.ac.kr  This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.Association between Abacus Training a nd Improvement in Response Inhibition:  A Case-control Study Kyoung-Sae Na1, Soyoung Irene Lee2, Jun-Ho Park3, Han-Yong Jung2, Jung-Hee Ryu4 1Department of Psychiatry, Gachon University Gil Medical Center,  Incheon, 2Department of Psychiatry, Soonchunhyang University Bucheon  Hospital, Bucheon, 3Department of Industrial and Adv ertising Psychology, Daejeon Un iversity, Daejeon, 4Hankuk Academy of Foreign  Studies, Yongin, Korea Objective: The abacus, first used in Asian countries more than 800 years a go, enables efficient arithmetic calculation via visuo- spatial configuration.",Non-OADS,/arxiv_data1/oa_pdf/76/54/cpn-13-163.PMC4540045.pdf
"215Case Report http://dx.doi.org/10.9758/cpn.2015.13.2.215 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2015;13(2):215-217 Copyrightⓒ 2015, Korean College of Neuropsychopharmacology                       Received:  December 22, 2014/ Revised:  February 12, 2015 Accepted:  February 13, 2015 Address for correspondence: Dushad Ram, MD Department of Psychiatry, JSS Hospital, MG Road, Mysore,  Karnataka 570004, IndiaTel: +91-0821-2335501, Fax: +91-0821-2335187E-mail: akashji1972@gmail.com  This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.Multimodal  Hallucination (Audio-visual, Kinaesthetic and Scenic) Associated  with the Use of Zolpidem Dushad Ram1, Najla Eiman1, Basavana Gowdappa2 Departments of 1Psychiatry and 2Medicine, JSS Medical College, Mysore, India We are reporting a case of zolpidem induced multimodal hallucin ations in a 22 year old female without any history of psychiatr ic  disorders.",Non-OADS,/arxiv_data1/oa_pdf/51/c2/cpn-13-215.PMC4540046.pdf
"174Original Article http://dx.doi.org/10.9758/cpn.2015.13.2.174 pISSN 1738-1088 / eISSN 2093-4327 Clinical Psychopharmacology and Neuroscience 2015;13(2):174-179 Copyrightⓒ 2015, Korean College of Neuropsychopharmacology                       Received:  January 21, 2015/ Revised:  February 23, 2015 Accepted:  February 24, 2015 Address for correspondence: Mikio Sakakibara, BS NPO Japanese Drug Organization of Appropriate Use and Research,   Headquarters, Department of Regional Pharmaceutical Care and Sciences, Faculty of Pharmacy, Meijo University, 3-1509, Omotey ama, Tenpaku-ku, Nagoya, Aichi Prefecture 468-0073, JapanTel: +81-52-834-5963, Fax: +81-52-834-5963E-mail: sakakibara606@gmail.com  This is an Open-Access article distributed under the terms of t he Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, an d reproduction in any medium, provided the original work is pro perly cited.Comparison of the Effects of a Brand-name Drug and Its Generic Drug on  the Quality of Life of Alzheimer ’s Disease Patients Mikio Sakakibara1,2,3, Mitsuhiko Kido1,2,4, Jun Kuribayashi2,4, Hiroshi Okada1,2, Ataru Igarashi5, Hiroyuki Kamei3,  Toshitaka Nabeshima1,4 1NPO Japanese Drug Organization o f Appropriate Us e and Research,  2Sugi Pharmacy Co., Ltd., 3Pharmaceutical Hospital Laboratory,  Faculty of Pharmacy, Meijo University, 4Department of Regional Pharmaceutical Care and Sciences, Facult y of Pharmacy, Meijo University,  Nagoya, 5Department of Drug Policy and Management, Graduate School of Ph armaceutical Sciences, The University of Tokyo, Tokyo,  Japan Objective: The pharmacological effects of generic (GE) donepezil are the s ame as Aricept, its brand-name counterpart.",Non-OADS,/arxiv_data1/oa_pdf/72/7c/cpn-13-174.PMC4540047.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/45/ef/evu242.PMC4540083.pdf
"In addition, genome-wide genetic variation maps have been compiled for population-sp eciﬁc genetics research, such as Dutch ( Genome of the Netherlands Consortium 2014 )a n d British ( http://www.uk10k.org ).",Non-OADS,/arxiv_data1/oa_pdf/45/ef/evu242.PMC4540083.pdf
We also used the RepeatMasker (version 3.3.0) ( http://repeatmasker.org ) with the repeat library (RepBase 16.01) to predict known translo- cation elements and applied the Tandem Repeat Finder to identify tandem repeats.,OADS,/arxiv_data1/oa_pdf/45/ef/evu242.PMC4540083.pdf
"The assembled genome, annotation results, SNPs, short indels,and SVs produced in the study have been deposited in our Mongolian genome database, http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/45/ef/evu242.PMC4540083.pdf
They also can be obtained from another ftp site:ftp://public.genomics.org.cn/BGI/MongolianGenome .,OADS,/arxiv_data1/oa_pdf/45/ef/evu242.PMC4540083.pdf
"Correspondence to: Patrick J. Cummings at cupat@jhu.edu URL: http://www.jove.com/video/52008 DOI: doi:10.3791/52008 Keywords: Bioengineering, Issue 92, single-use bioreactor, cell culture, mammalian cell culture, pneumatic wheel, upstream bioprocessing, Air- Wheel bioreactor Date Published: 10/10/2014 Citation: Obom, K.M., Cummings, P.J., Ciafardoni, J.A., Hashimura, Y., Giroux, D. Cultivation of Mammalian Cells Using a Single-use Pneumatic Bioreactor System.",Non-OADS,/arxiv_data1/oa_pdf/3c/85/jove-92-52008.PMC4540086.pdf
"Video Link The video component of this article can be found at http://www.jove.com/video/52008/ Introduction Mammalian cells lines can be classified into one of three categories based on their growth characteristics: cells that grow in suspension, cells that grow as aggregates, and cells that grow anchored to a substrate.",Non-OADS,/arxiv_data1/oa_pdf/3c/85/jove-92-52008.PMC4540086.pdf
"Seminole, FL, USA, http://www.infors-ht.com/index.php/en/products/bioreactors/bench-top- bioreactors/minifors .",OADS,/arxiv_data1/oa_pdf/3c/85/jove-92-52008.PMC4540086.pdf
"Published by Oxford University Press on behalf of CINP.International Journal of Neuropsychopharmacology, 2015, 1–11 doi:10.1093/ijnp/pyu114 Research Article 1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License   (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8c/d3/pyu114.PMC4540095.pdf
"Published by Oxford University Press on behalf of CINP.International Journal of Neuropsychopharmacology, 2015, 1–7 doi:10.1093/ijnp/pyu118 Research Article 1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License   (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/51/b4/pyu118.PMC4540097.pdf
"Published by Oxford University Press on behalf of CINP.International Journal of Neuropsychopharmacology, 2015, 1–10 doi:10.1093/ijnp/pyu119 Research Article 1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License   (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2e/df/pyu119.PMC4540098.pdf
"Published by Oxford University Press on behalf of CINP.International Journal of Neuropsychopharmacology, 2015, 1–12 doi:10.1093/ijnp/pyu120 Research Article 1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/54/97/pyu120.PMC4540099.pdf
"Published by Oxford University Press on behalf of CINP.International Journal of Neuropsychopharmacology, 2015, 1–7 doi:10.1093/ijnp/pyv001 Research Article 1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License   (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/42/b0/pyv001.PMC4540103.pdf
"Published by Oxford University Press on behalf of CINP.International Journal of Neuropsychopharmacology, 2015, 1–10 doi:10.1093/ijnp/pyv016 Research Article 1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License   (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ad/9c/pyv016.PMC4540109.pdf
MRI data was analyzed with FSL version 5.0.2 (http://fsl.fmrib.,OADS,/arxiv_data1/oa_pdf/ad/9c/pyv016.PMC4540109.pdf
"Published by Oxford University Press on behalf of CINP.International Journal of Neuropsychopharmacology, 2015, 1–7 doi:10.1093/ijnp/pyv021 Research Article 1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License   (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/80/bf/pyv021.PMC4540110.pdf
"For allelic association analyses, all of the allele frequencies were close to the allele frequency data of the reference HapMap population (http://www.ncbi.nlm.nih.gov/snp/).",OADS,/arxiv_data1/oa_pdf/80/bf/pyv021.PMC4540110.pdf
2011A080300001).The trial registry name is “Exploration of Genotype Based Personalized Prescription of Valproate Sodium in Anti-epileptic Treatment (EGBPPVPA)” and theClinicalTrials.gov Identifier is NCT01172626 (http://clinicaltrials.gov/show/NCT01172626).,Non-OADS,/arxiv_data1/oa_pdf/80/bf/pyv021.PMC4540110.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8a/ef/ott-8-2097.PMC4540113.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOncoTargets and Therapy 2015:8 2097–2100OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2097Case repO rTopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8014 3a recurrent ovarian cancer patient with a history  of nine prior chemotherapy regimens who  was safely treated with weekly paclitaxel plus  bevacizumab and achieved a complete response:  a case report eriko Takatori1 Tadahiro shoji1 Takayuki Nagasawa1 satoshi Takeuchi1 akira Hosoyachi2 T oru sugiyama1 1Department of Obstetrics and  Gynecology, school of Medicine,   Iwate Medical University, Morioka,   Japan; 2Department of Obstetrics and  Gynecology, Iwate prefectural Miyako  Hospital, Miyako, JapanAbstract:  Herein, we describe our experience with a recurrent ovarian cancer patient who was  treated safely with bevacizumab and who achieved a complete response despite receiving nine  prior chemotherapy regimens.",Non-OADS,/arxiv_data1/oa_pdf/8a/ef/ott-8-2097.PMC4540113.pdf
"Relative to progression-free survival  (PFS), the absolute median PFS advantage of bevacizumab added to chemotherapy  followed by maintenance compared with chemotherapy alone (and placebo, in GOG- 0218) as first-line treatment was 3.8 months (14.1 vs 10.3 months, respectively) in  the GOG-0218 trial1 and 1.5 months (21.8 vs 20.3 months, respectively) in ICON7.2  The median PFS benefit as measured in months associated with adding bevacizumab  to chemotherapy seems to be similar in recurrent ovarian cancer, being 4 months in  platinum-sensitive relapse (lengthening PFS from 8.4 to 12.4 months in the OCEANS  Trial)3 and 3.3 months in platinum-resistant disease (from 3.4 to 6.7 months in the Correspondence: eriko Takatori school of Medicine, Iwate Medical  University, 19-1 Uchimaru, Morioka,  Iwate 020-8505, Japan Tel +81 19 651 5111 Fax +81 19 622 1900 email sppe8459@yahoo.co.j p Journal name: OncoTargets and Therapy Article Designation: Case report Y ear: 2015 Volume: 8 Running head verso: Takatori et al Running head recto: Bevacizumab for the patients of nine prior chemotherapy regimens DOI: http://dx.doi.org/10.2147/OTT.S80143",Non-OADS,/arxiv_data1/oa_pdf/8a/ef/ott-8-2097.PMC4540113.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/8a/ef/ott-8-2097.PMC4540113.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/8a/ef/ott-8-2097.PMC4540113.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f9/ac/ijnrd-8-083.PMC4540114.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of Nephrology and Renovascular Disease 2015:8 83–90International Journal of Nephrology and Renovascular Disease Dove press submit your manuscript | www.dovepress.co m Dove press  83ORIg INal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJNRD.S8491 0c-reactive protein levels in combination with  abdominal cT scans is a useful tool to predict   the macroscopic appearance in late-stage ePs  patients prior to surgery Daniel Kitterer1 stephan segerer2 Wolfgang steurer3 Juergen Dippon4 angela geissler5 christoph Ulmer3 Niko Braun1 Mark Dominik alscher1 Joerg latus1 1Department of Internal Medicine,   Division of Nephrology, Robert- Bosch-hospital, stuttgart, germany;   2Division of Nephrology, University  hospital, Zurich, switzerland;   3Department of general, Visceral  and Trauma surgery, Robert- Bosch-hospital,  4Department of  Mathematics, University of stuttgart,   5Department of Radiology and  Nuclear Medicine, Robert-Bosch- hospital, stuttgart, germany correspondence: Joerg latus   Department of Internal Medicine,  Division of Nephrology, Robert-Bosch- hospital, auerbachstraße  110, 70376  stuttgart, germany   Tel +49 7118 1010  Fax +49 711 8101 3792  email joerg.latus@rbk.d eBackground:  Diagnosis of encapsulating peritoneal sclerosis (EPS) is based on clinical  symptoms, radiologic findings, and macroscopic or histological criteria.",Non-OADS,/arxiv_data1/oa_pdf/f9/ac/ijnrd-8-083.PMC4540114.pdf
"International Journal of Nephrology and Renovascular Disease Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nephrology-and-renovascular-disease-journa lThe International Journal of Nephrology and Renovascular Disease is  an international, peer-reviewed open-access journal focusing on the  pathophysiology of the kidney and vascular supply.",Non-OADS,/arxiv_data1/oa_pdf/f9/ac/ijnrd-8-083.PMC4540114.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f9/ac/ijnrd-8-083.PMC4540114.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/bc/a9/bctt-7-231.PMC4540115.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pBreast Cancer: Targets and Therapy 2015:7 231–237Breast Cancer: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  231Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/BCTT .S8704 1Molecular heterogeneity in adjacent cells   in triple-negative breast cancer Michael l huebschman1 nancy l lane1 huaying liu1 Venetia r sarode2 Judith l Devlin1 eugene P Frenkel1,3 1harold C simmons Comprehensive  Cancer Center, 2Department of  Pathology, 3Division of hematology- Medical Oncology, Department of  internal Medicine, UT southwestern  Medical Center, Dallas, TX, Usa Correspondence: eugene P Frenkel   UT southwestern Medical Center, harold  C simmons Comprehensive Cancer  Center, 5323 harry hines Boulevard,  Dallas, TX 75390-8852, Usa   T el +1 214 648 4194   Fax +1 214 648 1955   email eugene.frenkel@utsouthwestern.ed uPurpose:  This study interrogates the molecular status of individual cells in patients with  triple-negative breast cancers and explores the molecular identification and characterization of  these tumors to consider the exploitation of a potential-targeted therapeutic approach.",Non-OADS,/arxiv_data1/oa_pdf/bc/a9/bctt-7-231.PMC4540115.pdf
"Breast Cancer: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/breast-cancer---targets-and-therapy-journa lBreast Cancer: Targets and Therapy is an international, peer-   reviewed open access journal focusing on breast cancer research,  identification of therapeutic targets and the optimal use of preven - tative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/bc/a9/bctt-7-231.PMC4540115.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/aa/8a/ijn-10-5139.PMC4540116.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 5139–5157International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  5139RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJN.S8503 7Nanotechnology for treating osteoporotic  vertebral fractures Chunxia Gao1,* Donglei wei1,* Huilin Yang1 Tao Chen2 Lei Yang1,3 1Department of Orthopaedic  Surgery and Orthopaedic  Institute, First Affiliated Hospital,   2Robotics  and Microsystems  Center,   Collaborative Innovation Center of  Suzhou Nano Science and T echnology,   Soochow University,  Suzhou,  3Laboratory of Nonlinear Mechanics,   Institute of Mechanics, Chinese  Academy of Sciences, Beijing,   People’s  Republic of China *These authors contributed equally  to this workAbstract:  Osteoporosis is a serious public health problem affecting hundreds of millions of aged  people worldwide, with severe consequences including vertebral fractures that are associated  with significant morbidity and mortality.",Non-OADS,/arxiv_data1/oa_pdf/aa/8a/ijn-10-5139.PMC4540116.pdf
"According to the International Osteoporosis Foundation,  osteoporosis is estimated to affect one in three women and one in eight men over the  age of 50 years.6,7 In the USA, it is estimated that at least 10 million people suffer  from osteoporosis and over 1.5 million cases of osteoporotic vertebral fracture (OVF)  occur every year, generating direct health care costs of US$12–18 billion each year.8  In fact, the direct annual costs of treating osteoporotic fractures in the workplace in  the USA, Canada, and Europe alone are estimated to be approximately $48 billion.9  As of 2006, in the Chinese population aged 50 years or older, 65 million people were  estimated to have osteoporosis, while an additional 200 million were estimated to Correspondence: Lei Yang; Tao Chen Department of Orthopaedic Surgery,  Robotics Microsystems Center, 708  Renmin Road, Suzhou, Jiangsu 215006,  People’s Republic of China Tel +86 512 6778 1540 Fax +86 512 6778 1165 email ylei@suda.edu.c n;   chent@suda.edu.c n Journal name: International Journal of Nanomedicine Article Designation: Review Y ear: 2015 Volume: 10 Running head verso: Gao et al Running head recto: Nanotechnology for treating osteoporotic vertebral fractures DOI: http://dx.doi.org/10.2147/IJN.S85037",Non-OADS,/arxiv_data1/oa_pdf/aa/8a/ijn-10-5139.PMC4540116.pdf
"Available from: http://www.bbcbonehealth.org/ documents/workplacereportEN.pd f. Accessed June 6, 2015.",Non-OADS,/arxiv_data1/oa_pdf/aa/8a/ijn-10-5139.PMC4540116.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/aa/8a/ijn-10-5139.PMC4540116.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/aa/8a/ijn-10-5139.PMC4540116.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6a/58/ott-8-2101.PMC4540117.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 2101–2109OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2101Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8566 0hepatoma-derived growth factor predicts  unfavorable prognosis of epithelial ovarian cancer Xue-jun liu1 Wen-lian liu1 Fang-mei Yang1 Xiao-qing Yang2 Xiao-fei lu3 1Department of Obstetrics, linyi  hospital affiliated to shandong  University, linyi city, 2Department  of Pathology, Qianfoshan hospital  affiliated to shandong University,   Jinan city, 3Department of general  surgery, Jinan central hospital  affiliated to shandong University,   Jinan city, People’s republic of chinaAim:  To evaluate the expression and clinical significance of hepatoma-derived growth factor  (HDGF) in epithelial ovarian cancer (EOC).",Non-OADS,/arxiv_data1/oa_pdf/6a/58/ott-8-2101.PMC4540117.pdf
"The most vulnerable organs to ovarian  cancer invasion include lung, liver, or lymph nodes, usually via direct planting, local  invasion, and lymphatic metastasis.1 The histologies of ovary cancer include epithelial  ovarian cancer (EOC), malignant germ cell carcinoma, etc.5 As with the majority of  ovarian cancers, EOCs consist of several histologic subtypes including serous, endo - metrioid, clear cell, and mucinous adenocarcinomas.6 Approximately, 70% of patients with ovarian cancer show clinical response, thanks  to the development of surgery and adjacent therapies, including chemotherapy and  radiotherapy.7 However, the majority of patients will experience relapse.1 Targeted  therapy is one effective method to reduce the relapse of ovarian cancer, which may correspondence: Xiaofei lu Department of Pathology, Jinan  Central Hospital Affiliated to  shandong University, 105 Jiefang road,  Jinan 250013, People’s republic of china Tel +86 138 5419 8278 email sduly2015@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Liu et al Running head recto: HDGF as prognostic factor in epithelial ovarian cancer DOI: http://dx.doi.org/10.2147/OTT.S85660",Non-OADS,/arxiv_data1/oa_pdf/6a/58/ott-8-2101.PMC4540117.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/6a/58/ott-8-2101.PMC4540117.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/6a/58/ott-8-2101.PMC4540117.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/dd/97/ijn-10-5121.PMC4540118.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/dd/97/ijn-10-5121.PMC4540118.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/97/ijn-10-5121.PMC4540118.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6c/08/ndt-11-2079.PMC4540121.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 2079–2090Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  2079OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S8223 6The structural equation analysis of childhood  abuse, adult stressful life events, and temperaments  in major depressive disorders and their influence  on refractoriness hiroyuki T oda,1 Takeshi  inoue,2,3 T omoya Tsunoda,1  Yukiei Nakai,2 Masaaki  Tanichi,1 T eppei Tanaka,1  Naoki hashimoto,2 Yasuya  Nakato,2 shin Nakagawa,2  Yuji Kitaichi,2 Nobuyuki  Mitsui,2 shuken Boku,4  hajime Tanabe,5 Masashi  Nibuya,1 aihide Y oshino,1  ichiro Kusumi2 1Department of Psychiatry, National  Defense Medical college, T okorozawa,   saitama, Japan; 2Department of  Psychiatry, hokkaido University  graduate school of Medicine,   sapporo, Japan; 3Department of  Psychiatry, T okyo Medical University,   T okyo, Japan; 4Department of  Psychiatry, Kobe University graduate  school of Medicine, Kobe, Japan;   5Department of clinical human  sciences, graduate school of  humanities and social sciences,   shizuoka University, shizuoka, JapanBackground:  Previous studies have shown the interaction between heredity and childhood  stress or life events on the pathogenesis of a major depressive disorder (MDD).",Non-OADS,/arxiv_data1/oa_pdf/6c/08/ndt-11-2079.PMC4540121.pdf
"Adult stressful life events and childhood abuse are well- known major environmental factors for MDD,3–5,11,12 and interestingly, these two correspondence: hiroyuki Toda Department of Psychiatry, National  Defense Medical college, Namiki 3-2,  Tokorozawa, saitama 359-8513, Japan Tel +81 4 2995 1619 Fax +81 4 2996 5203 email toda1973@ndmc.ac.j p  Takeshi inoue Department of Psychiatry, Tokyo Medical   University, 6-7-1, Nishishinjuku,  shinjuku-ku, Tokyo, 160-0023, Japan Tel +81 3 3342 6111 Fax +81 3 3340 4499 email tinoue@tokyo-med.ac.j p Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Toda et al Running head recto: Childhood abuse, adult stressful life events, and temperaments in MDD DOI: http://dx.doi.org/10.2147/NDT.S82236",Non-OADS,/arxiv_data1/oa_pdf/6c/08/ndt-11-2079.PMC4540121.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/6c/08/ndt-11-2079.PMC4540121.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/6c/08/ndt-11-2079.PMC4540121.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b8/b4/opth-9-1443.PMC4540122.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 1443–1448Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1443Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S8785 2Visual recovery following open globe injury  with initial no light perception Y ong s han shaheen C Kavoussi ron a adelman Department of Ophthalmology and  Visual science, Yale University school  of Medicine, new haven, CT, UsaBackground:  The purpose of this study was to analyze eyes presenting with no light perception  (NLP) after open globe injury (OGI) to determine visual outcomes and prognostic indicators  for visual recovery.",Non-OADS,/arxiv_data1/oa_pdf/b8/b4/opth-9-1443.PMC4540122.pdf
"Given the controversy  concerning the management of eyes presenting with NLP after OGI, we present a  study of 25 consecutive patients with initial NLP, four of whom regained vision Correspondence: Yong s han Department of Ophthalmology and  Visual science, Yale University school  of Medicine, 40 Temple st, new haven,  CT, 06519, Usa Tel +1 203 785 2020 Fax +1 203 785 6123 email han8025@gmail.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Han et al Running head recto: Open globe injury with initial no light perception DOI: http://dx.doi.org/10.2147/OPTH.S87852",Non-OADS,/arxiv_data1/oa_pdf/b8/b4/opth-9-1443.PMC4540122.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/b8/b4/opth-9-1443.PMC4540122.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b8/b4/opth-9-1443.PMC4540122.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b2/ce/ijn-10-5123.PMC4540123.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 5123–5137International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  5123OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S8701 1Lactoferrin-modified PEGylated liposomes  loaded with doxorubicin for targeting delivery  to hepatocellular carcinoma Minyan Wei1,2 Xiucai guo1,3 liuxiao T u1 Qi Zou1 Qi li1 Chenyi Tang1 Bao chen1 Yuehong Xu1 Chuanbin Wu1 1Department of Pharmaceutics,   School of Pharmaceutical Sciences,   Sun Yat-sen University, 2Department  of Pharmaceutics, School of  Pharmaceutical Sciences, Guangzhou  Medical University, 3Department of  Pharmacy, 12th People’s Hospital of  Guangzhou City, Guangzhou, People’s  republic of chinaAbstract:  Lactoferrin (Lf) is a potential-targeting ligand for hepatocellular carcinoma (HCC)  cells because of its specific binding with asialoglycoprotein receptor (ASGPR).",Non-OADS,/arxiv_data1/oa_pdf/b2/ce/ijn-10-5123.PMC4540123.pdf
"Keywords:  asialoglycoprotein receptor, immunoliposome, PEGylated modification, post- insertion, hepatic cancer, active targeting Introduction Hepatocellular carcinoma (HCC) is the sixth most prevalent cancer and the third most  frequent cause of cancer-related death worldwide.1 Treatments of HCC can be divided  into curative and palliative.2 Curative treatments conventionally include surgical  resection, liver transplantation, and percutaneous ablation.2,3 Patients with early HCC  should be considered for curative treatments that may achieve long-term complete  response and improved survival.3–5 Unfortunately, more than 80% of patients present  with advanced or unresectable disease, and these patients are just suitable for palliative  approaches.2–5 Systemic chemotherapy is commonly used as a palliative treatment for  improved survival.2–4 Currently, doxorubicin (DOX), an anthracycline antibiotic, is one of the most impor - tant chemotherapeutic agents for HCC.6–8 DOX exerts its cytotoxicity by inhibiting the  synthesis of nucleic acids within cancer cells.8 However, the systemic administration  of DOX is severely obstructed by its limited therapeutic responses and undesirable  systemic toxicities.6–8 Therefore, improving the selective accumulation of DOX in  HCC tumor cells might be an effective method to enhance its antitumor efficacies and  minimize its systemic toxicities.7,8correspondence: Yuehong Xu;   Chuanbin Wu School of Pharmaceutical Sciences,  Sun Yat-sen University, 132 Outer Ring  East Road, University Town, Guangzhou  510006, People’s Republic of China Tel +86 020 3994 3119;   +86 20 3994 3117 Fax +86 020 3994 3119;   +86 20 3994 3120 email lssxyh@mail.sysu.edu.c n;   chuanbin_wu@126.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Wei et al Running head recto: Lactoferrin-modified liposomes for hepatoma targeting DOI: http://dx.doi.org/10.2147/IJN.S87011",Non-OADS,/arxiv_data1/oa_pdf/b2/ce/ijn-10-5123.PMC4540123.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/b2/ce/ijn-10-5123.PMC4540123.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b2/ce/ijn-10-5123.PMC4540123.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/fd/aa/lra-8-033.PMC4540124.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pLocal and Regional Anesthesia 2015:8 33–43Local and Regional Anesthesia Dove press submit your manuscript | www.dovepress.co m Dove press  33Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/LRA.S6822 3Simulation in teaching regional anesthesia:   current perspectives Ankeet D Udani1 T edward Kim2,3 Steven K Howard2,3 edward R Mariano2,3 On behalf of the ADAPT  (Anesthesiology-Directed  Advanced Procedural  Training) Research Group 1Department of Anesthesiology,   Duke University School of Medicine,   Durham, NC, USA;  2Department of  Anesthesiology, Perioperative and Pain  Medicine, Stanford University School  of Medicine, Stanford, CA, USA;   3Anesthesiology and Perioperative  Care Service, veterans Affairs Palo  Alto Health Care System, Palo Alto,   CA, USA Correspondence: edward R Mariano   Anesthesiology and Perioperative Care  Service, veterans Affairs Palo Alto Health  Care System,  3801 Miranda Avenue  (112A), Palo Alto, CA  94304, USA   Tel +1 650 849 0254  Fax +1 650 852 3423  email emariano@stanford.ed uAbstract:  The emerging subspecialty of regional anesthesiology and acute pain medicine  represents an opportunity to evaluate critically the current methods of teaching regional anes - thesia techniques and the practice of acute pain medicine.",Non-OADS,/arxiv_data1/oa_pdf/fd/aa/lra-8-033.PMC4540124.pdf
"Local and Regional Anesthesia Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/local-and-regional-anesthesia-journa lLocal and Regional Anesthesia is an international, peer-reviewed,  open access journal publishing on the development, pharmacology,  delivery and targeting and clinical use of local and regional anesthet - ics and analgesics.",Non-OADS,/arxiv_data1/oa_pdf/fd/aa/lra-8-033.PMC4540124.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/fd/aa/lra-8-033.PMC4540124.pdf
"Copyright © 2015 The Korean Society of Environmental Health and Toxicology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Page 1 of 5 http://e-eht.org/ Introduction Although chemical substances are a very important factor in  the realization of current industrialization, because they were  used indiscriminately without a full understanding of the dam - age they could cause, issues have arisen on a continual basis,  such as global environment changes like ozone depletion and global warming, and chemical damage cases like Minamata dis - ease and Itai-Itai disease, so that the importance of safe chemical  use has emerged.",Non-OADS,/arxiv_data1/oa_pdf/20/ba/eht-30-s2015001.PMC4540125.pdf
"Consequently, the major developed countries  and international society agreed in 1972, at the United Nations  (UN) Conference on the Human Environment held for safe use  and control of chemicals, to the need for a specialized agency af - filiated to the UN to deal with global environmental problems; Green Chemistry at the present in Korea Seung-Kyu Lee, Hyeon-Soo Park TO21, Co.,Ltd., Seoul, Korea• Special TopicOpen Access Environmental Health and Toxicology Volume: 30 Suppl, Article ID: s2015001, 5 pages http://dx.doi.org/10.5620/eht.s2015001 eISSN: 2233-6567  Objectives  Despite the great contribution made by chemical substances to the develop - ment of modern civilization, their indiscriminate use has caused various kinds of dam - age to the global environment and human beings.",Non-OADS,/arxiv_data1/oa_pdf/20/ba/eht-30-s2015001.PMC4540125.pdf
"of Chemical  Substances and the Chemical Control act, making it possible to establish an infrastruc - ture for Green Chemistry in Korea and to increase national competitiveness.. Keywords  Alternative chemicals, Chemical regulation, Eco-innovation, Green Chemistry,  Green solution, Substitute chemicalsCorrespondence:  Hyeon-Soo Park 24 Boramae-ro 5ga-gil, Dongjak-gu,   Seoul 156-710, Korea Tel: +82-2-6005-1200 Fax: +82-2-6005-1299 E-mail: hspark@to21.co.kr Received:  January 7, 2015 Accepted:  April 20, 2015 Published online:  June 12, 2015 This article is available from: http://e-eht.org/",Non-OADS,/arxiv_data1/oa_pdf/20/ba/eht-30-s2015001.PMC4540125.pdf
http://e-eht.org/ Page 2 of 5Environmental Health and Toxicology     ;30 Suppl:s2015001 the the UN Environment Programme was thus established  through the 27th UN General Assembly.,Non-OADS,/arxiv_data1/oa_pdf/20/ba/eht-30-s2015001.PMC4540125.pdf
"http://e-eht.org/ Page 3 of 5Seung-Kyu Lee, et al.",Non-OADS,/arxiv_data1/oa_pdf/20/ba/eht-30-s2015001.PMC4540125.pdf
"http://e-eht.org/ Page 4 of 5Environmental Health and Toxicology     ;30 Suppl:s2015001 Current Support Situations for Green Chemistry in  Korea In 2009, the Ministry of Environment of Korea formed a fo - rum composed of representatives from industry, academia, and  research institutes in recognition of the strengthening interna - tional regulation of hazard and risk controls of chemicals; the  ministry proposed a measure for the advance of chemical man - agement to move toward a Green Chemistry system in order to  improve the chemical management system in Korea and to sup - port the chemical industry.",Non-OADS,/arxiv_data1/oa_pdf/20/ba/eht-30-s2015001.PMC4540125.pdf
"http://e-eht.org/ Page 5 of 5Seung-Kyu Lee, et al.",Non-OADS,/arxiv_data1/oa_pdf/20/ba/eht-30-s2015001.PMC4540125.pdf
Low carbon envi - ronmental goods and services (LECGS); 2013 [cited 2015 Apr  22].Available from: https://www.gov.uk/government/uploads/ system/uploads/attachment_data/file/224068/bis-13-p143-low- carbon-and-environmental-goods-and-services-report-2011-12.,OADS,/arxiv_data1/oa_pdf/20/ba/eht-30-s2015001.PMC4540125.pdf
Available from:  http://nepis.epa.gov/Exe/ZyNET .exe/P1001KD8.TXT?ZyAction D=ZyDocument&Client=EPA&Index=2000+Thru+2005&Docs =&Query=&Time=&EndTime=&SearchMethod=1&T ocRestrict =n&T oc=&T ocEntry=&QField=&QFieldY ear=&QFieldMonth= &QFieldDay=&IntQFieldOp=0&ExtQFieldOp=0&XmlQuery= &File=D%3A%5Czyfiles%5CIndex%20Data%5C00thru05%5CTx t%5C00000016%5CP1001KD8.txt&User=ANONYMOUS&Pass word=anonymous&SortMethod=h%7C-&MaximumDocuments =1&FuzzyDegree=0&ImageQuality=r75g8/r75g8/x150y150g16/ i425&Display=p%7Cf&DefSeekPage=x&SearchBack=ZyActionL &Back=ZyActionS&BackDesc=Results%20page&MaximumPages =1&ZyEntry=1&SeekPage=x&ZyPURL.,OADS,/arxiv_data1/oa_pdf/20/ba/eht-30-s2015001.PMC4540125.pdf
Available from: http://fusion.stolaf.edu/gca/.,OADS,/arxiv_data1/oa_pdf/20/ba/eht-30-s2015001.PMC4540125.pdf
Available from: http://www.turi.org/ Our_Work/Research/Alternatives_Assessment/Chemical_Haz - ard_Comparison_T ools/P2OASys_T ool_to_Compare_Materi - als.,OADS,/arxiv_data1/oa_pdf/20/ba/eht-30-s2015001.PMC4540125.pdf
Available from: http://ehs.mit.edu/ site/content/green-chemical-alternatives-purchasing-wizard.,Non-OADS,/arxiv_data1/oa_pdf/20/ba/eht-30-s2015001.PMC4540125.pdf
Available from: http://www.greenscreenchemi - cals.org/method.,Non-OADS,/arxiv_data1/oa_pdf/20/ba/eht-30-s2015001.PMC4540125.pdf
Available  from: http://www.catsub.dk.,Non-OADS,/arxiv_data1/oa_pdf/20/ba/eht-30-s2015001.PMC4540125.pdf
"Copyright © 2015 The Korean Society of Environmental Health and Toxicology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Page 1 of 11 http://e-eht.org/ Introduction There is widespread interest in synergistic relationship be - tween ecological conservation and economic development for  the achievement of sustainable development.",Non-OADS,/arxiv_data1/oa_pdf/d0/02/eht-30-s2015003.PMC4540126.pdf
"Safer solvents and auxiliaries: use of solvents and Priority survey between indicators and analytic  hierarchy process analysis for green chemistry  technology assessment Sungjune Kim, Seokpyo Hong, Kilsoo Ahn, Sungyong Gong Department of Environmental Economy and Policy Research, Korea Environment Institute, Sejong, Korea• Original ArticleOpen Access Environmental Health and Toxicology Volume: 30 Suppl, Article ID: s2015003, 11 pages http://dx.doi.org/10.5620/eht.s2015003 eISSN: 2233-6567  Objectives  This study presents the indicators and proxy variables for the quantitative as - sessment of green chemistry technologies and evaluates the relative importance of each  assessment element by consulting experts from the fields of ecology, chemistry, safety,  and public health.",OADS,/arxiv_data1/oa_pdf/d0/02/eht-30-s2015003.PMC4540126.pdf
"Keywords  Green chemistry technology assessment, Priority survey, Analytic hierarchy  process analysis, Toxic potential indicator, Impact metrics for environmental, safety, and  socioeconomicCorrespondence:  Sungyong Gong 370 Sicheong-daero, Sejong 339-007, Korea Tel: +82-44-415-7618 Fax: +82-44-415-7764 E-mail: sgong@kei.re.kr Received:  January 8, 2015 Accepted:  April 13, 2015 Published online:  June 12, 2015 This article is available from: http://e-eht.org/",Non-OADS,/arxiv_data1/oa_pdf/d0/02/eht-30-s2015003.PMC4540126.pdf
"http://e-eht.org/ Page 2 of 11Environmental Health and Toxicology    2015;30 Suppl:s2015003 chemicals other than starting materials should be minimized,  and they should be innocuous if used.",Non-OADS,/arxiv_data1/oa_pdf/d0/02/eht-30-s2015003.PMC4540126.pdf
"http://e-eht.org/ Page 3 of 11Sungjune Kim, et al.",Non-OADS,/arxiv_data1/oa_pdf/d0/02/eht-30-s2015003.PMC4540126.pdf
"http://e-eht.org/ Page 4 of 11Environmental Health and Toxicology    2015;30 Suppl:s2015003 viding them into GHGs (global dimension) and those hazard - ous to humans ecosystems (local dimension); 2) “safety,” indi - cating the potential for industrial chemical accidents such as ex - plosions and fires; 3) “resource,” indicating resource consump - tion from a social viewpoint; and 4) “economy,” indicating the  economic feasibility of green chemistry technologies.",Non-OADS,/arxiv_data1/oa_pdf/d0/02/eht-30-s2015003.PMC4540126.pdf
"http://e-eht.org/ Page 5 of 11Sungjune Kim, et al.",Non-OADS,/arxiv_data1/oa_pdf/d0/02/eht-30-s2015003.PMC4540126.pdf
"http://e-eht.org/ Page 6 of 11Environmental Health and Toxicology    2015;30 Suppl:s2015003 From the pairwise comparisons, the following conclusions  were drawn.",OADS,/arxiv_data1/oa_pdf/d0/02/eht-30-s2015003.PMC4540126.pdf
"http://e-eht.org/ Page 7 of 11Sungjune Kim, et al.",Non-OADS,/arxiv_data1/oa_pdf/d0/02/eht-30-s2015003.PMC4540126.pdf
"http://e-eht.org/ Page 8 of 11Environmental Health and Toxicology    2015;30 Suppl:s2015003 Discussion This study presented indicators and proxy variables for quanti - tative assessment of green chemistry technologies and evaluated  their relative importance (weights) by conducting a survey with  experts from the fields of environment, chemistry, safety, and  public health.",OADS,/arxiv_data1/oa_pdf/d0/02/eht-30-s2015003.PMC4540126.pdf
Available from: http://www.chemicalspolicy.com/down - loads/uml-aafreport10.06.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d0/02/eht-30-s2015003.PMC4540126.pdf
"http://e-eht.org/ Page 9 of 11Sungjune Kim, et al.",Non-OADS,/arxiv_data1/oa_pdf/d0/02/eht-30-s2015003.PMC4540126.pdf
Available from: https://osha.euro -pa.eu/en/legislation/directives/exposure-to-chemical-agents-and- chemical-safety/osh-related-aspects/58.,Non-OADS,/arxiv_data1/oa_pdf/d0/02/eht-30-s2015003.PMC4540126.pdf
http://e-eht.org/ Page 10 of 11Environmental Health and Toxicology    2015;30 Suppl:s2015003 Table S1.,Non-OADS,/arxiv_data1/oa_pdf/d0/02/eht-30-s2015003.PMC4540126.pdf
"http://e-eht.org/ Page 11 of 11Sungjune Kim, et al.",Non-OADS,/arxiv_data1/oa_pdf/d0/02/eht-30-s2015003.PMC4540126.pdf
"Copyright © 2015 The Korean Society of Environmental Health and Toxicology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Page 1 of 7 http://e-eht.org/ Introduction The Act on the Registration and Evaluation, etc.",Non-OADS,/arxiv_data1/oa_pdf/78/5d/eht-30-s2015004.PMC4540127.pdf
"of Chemical  Substances Bong-In Choi1, Y eong-Don Kwak1, Yu-Mi Jung1, Byung-T aek Ryu1, Chang Gyun Kim2 1Environmental Safety Center, Korea Environmental Corporation, Incheon;2Department of Environmental Engineering, Inha  Univercity, Incheon, Korea• Original ArticleOpen Access Environmental Health and Toxicology Volume: 30 Suppl, Article ID: s2015004, 7 pages http://dx.doi.org/10.5620/eht.s2015004 eISSN: 2233-6567  Objectives  Approximately 2000 phase-in substances are subject to registration accord - ing to the Act on the Registration and Evaluation, etc.",Non-OADS,/arxiv_data1/oa_pdf/78/5d/eht-30-s2015004.PMC4540127.pdf
"Keywords : Chemical safety, Hazardous chemicals, Hazard management, RegistrationCorrespondence:  Chang Gyun Kim 100 Inha-ro, Nam-gu, Incheon 402-751,  Korea Tel: +82-32-860-7561  Fax: +82-32-865-1425  E-mail: cgk@inha.ac.kr Received:  January 9, 2015 Accepted:  March 19, 2015 Published online:  June 12, 2015 This article is available from: http://e-eht.org/",Non-OADS,/arxiv_data1/oa_pdf/78/5d/eht-30-s2015004.PMC4540127.pdf
"http://e-eht.org/ Page 2 of 7Environmental Health and Toxicology    2015;30 Suppl:s2015004 test data have previously been generated, permission from the  owner of the corresponding test data should be obtained, either  for a fee or at no cost.",Non-OADS,/arxiv_data1/oa_pdf/78/5d/eht-30-s2015004.PMC4540127.pdf
"http://e-eht.org/ Page 3 of 7Bong-In Choi, et al.",Non-OADS,/arxiv_data1/oa_pdf/78/5d/eht-30-s2015004.PMC4540127.pdf
http://e-eht.org/ Page 4 of 7Environmental Health and Toxicology    2015;30 Suppl:s2015004 73.8% did not have test data.,OADS,/arxiv_data1/oa_pdf/78/5d/eht-30-s2015004.PMC4540127.pdf
Avail - able from: http://www.law.go.kr/lsInfoP .do?lsiSeq=140402#0000  (Korean).,Non-OADS,/arxiv_data1/oa_pdf/78/5d/eht-30-s2015004.PMC4540127.pdf
"http://e-eht.org/ Page 5 of 7Bong-In Choi, et al.",Non-OADS,/arxiv_data1/oa_pdf/78/5d/eht-30-s2015004.PMC4540127.pdf
http://e-eht.org/ Page 6 of 7Environmental Health and Toxicology    2015;30 Suppl:s2015004 Table S2.,Non-OADS,/arxiv_data1/oa_pdf/78/5d/eht-30-s2015004.PMC4540127.pdf
Reference databases (DBs)      Reference DB DB website Test data available Physical and  chemical propertiesHuman hazardsEnvironmental  hazards NCIS (Korea) ncis.nier.go.kr ○ ○ ○ Safety test (Korea) ncis.nier.go.kr ○ ○ ○ OECD SIDS (EU) www.chem.unep.ch/irptc/sids/OECDSIDS/indexcasnumb.htm ○ ○ ○ GHS classification result (EU) esis.jrc.ec.europa.eu/index.html ○ ○ ○ GHS classification result (Korea) ncis.nier.go.kr/ghs/search/toxic_contain_chem_label.jsp ○ ○ ○ ECB IUCLID (EU) esis.jrc.ec.europa.eu/ ○ ○ ○ HSDB (USA) toxnet.nlm.nih.gov/newtoxnet/hsdb.htm ○ ○ ○ IPCS EHCs (EU) http://www.inchem.org/pages/ehc.html - ○ ○ ATSDR (USA) www.atsdr.cdc.gov/toxprofiles/index.asp - ○ - Japan safety  Evaluation report (Japan)www.safe.nite.go.jp/english/sougou/view/ TotalSrchInput_en.faces- ○ ○ CCRIS (USA) toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?CCRIS - ○ - GENETOX (USA) toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?GENETOX - ○ - EPA IRIS (USA) cfpub.epa.gov/ncea/iris/index.cfm?fuseaction=iris.showsubstanceList - ○ - ECOTOX (USA) cfpub.epa.gov/ecotox/quick_query.htm - - ○ Chemical DB (USA) ull.chemistry.uakron.edu/erd/ ○ - - ChemID plus (USA) chem.sis.nlm.nih.gov/chemidplus/chemidlite.jsp ○ - - Total 16 9 13 10,OADS,/arxiv_data1/oa_pdf/78/5d/eht-30-s2015004.PMC4540127.pdf
"http://e-eht.org/ Page 7 of 7Bong-In Choi, et al.",Non-OADS,/arxiv_data1/oa_pdf/78/5d/eht-30-s2015004.PMC4540127.pdf
"Copyright © 2015 The Korean Society of Environmental Health and Toxicology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Page 1 of 5 http://e-eht.org/ Introduction Industrial chemicals are essential to life in modern society and  bring benefits in the form of improved health, food supply,  goods, general lifestyle and well-being.",Non-OADS,/arxiv_data1/oa_pdf/43/d9/eht-30-s2015005.PMC4540128.pdf
"The evalua - tion of the SEA needs the technique of benefit estimation,  which can be derived from evaluating the value of risk reduction Value of a statistical life estimation of carcinogenic  chemicals for socioeconomic analysis in Korea Geonwoo Lee1, Y ongjin Lee1, Hanseul Lee1, Jiyeon Hong2,3, Jiyeon Yang1 1Institute for Environmental Research, Yonsei University Health System, Seoul; 2Enterprise Risk Service Deloitte Anjin LLC,  Seoul; 3Department of Environmental Engineering, Yonsei University, Wonju, Korea• Brief ReportOpen Access Environmental Health and Toxicology Volume: 30 Suppl, Article ID: s2015005, 5 pages http://dx.doi.org/10.5620/eht.s2015005  eISSN: 2233-6567  Objectives  To protect public health from risk, the Minister of Environment in Korea leg - islated an act concerning the registration and evaluation of chemical substances.",Non-OADS,/arxiv_data1/oa_pdf/43/d9/eht-30-s2015005.PMC4540128.pdf
"Keywords  Chemical substance, Contingent valuation method, Socioeconomic analysis,  Value of a statistical life, Willingness to payCorrespondence:  Jiyeon Yang 50 -1 Yonsei-ro, Seodaemun-gu,  Seoul 120-752, Korea Tel: +82-2-2228-1896 Fax: +82-2-392-0239 E-mail: jyyang67@yuhs.ac Received:  January 8, 2015 Accepted:  March 3, 2015 Published online:  June 12, 2015 This article is available from: http://e-eht.org/",Non-OADS,/arxiv_data1/oa_pdf/43/d9/eht-30-s2015005.PMC4540128.pdf
http://e-eht.org/ Page 2 of 5Environmental Health and Toxicology    2015;30 Suppl:s2015005 and the technique of estimating the potential cost of replacing a  chemical with other chemical substances.,Non-OADS,/arxiv_data1/oa_pdf/43/d9/eht-30-s2015005.PMC4540128.pdf
"http://e-eht.org/ Page 3 of 5Geonwoo Lee, et al.",Non-OADS,/arxiv_data1/oa_pdf/43/d9/eht-30-s2015005.PMC4540128.pdf
http://e-eht.org/ Page 4 of 5Environmental Health and Toxicology    2015;30 Suppl:s2015005 7.,Non-OADS,/arxiv_data1/oa_pdf/43/d9/eht-30-s2015005.PMC4540128.pdf
"http://e-eht.org/ Page 5 of 5Geonwoo Lee, et al.",Non-OADS,/arxiv_data1/oa_pdf/43/d9/eht-30-s2015005.PMC4540128.pdf
"Copyright © 2015 The Korean Society of Environmental Health and Toxicology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Page 1 of 4 http://e-eht.org/ Introduction Accidents and disease have increased at a constant and steady  rate alongside the growth of industrial development and the use  of chemicals.",Non-OADS,/arxiv_data1/oa_pdf/df/9e/eht-30-s2015006.PMC4540129.pdf
"The benefit element refers to the  positive effect towards improving social members’ welfare and The evaluation of cost-of-illness due to use of cost- of-illness-based chemicals Jiyeon Hong1,2, Y ongjin Lee3, Geonwoo Lee3, Hanseul Lee3, Jiyeon Yang3 1Enterprise Risk Service Deloitte Anjin LLC, Seoul; 2Department of Environmental Engineering, Yonsei University, Wonju;  3Institute for Environmental Research, Yonsei University Health System, Seoul, Korea• Brief ReportOpen Access Environmental Health and Toxicology Volume: 30 Suppl, Article ID: s2015006, 4 pages http://dx.doi.org/10.5620/eht.s2015006 eISSN: 2233-6567  Objectives  This study is conducted to estimate the cost paid by the public suffering  from disease possibly caused by chemical and to examine the effect on public health.",Non-OADS,/arxiv_data1/oa_pdf/df/9e/eht-30-s2015006.PMC4540129.pdf
"Published online:  June 12, 2015 This article is available from: http://e-eht.org/",Non-OADS,/arxiv_data1/oa_pdf/df/9e/eht-30-s2015006.PMC4540129.pdf
http://e-eht.org/ Page 2 of 4Environmental Health and Toxicology    2015;30 Suppl:s2015006 is regulated and reformed by policy.,Non-OADS,/arxiv_data1/oa_pdf/df/9e/eht-30-s2015006.PMC4540129.pdf
"http://e-eht.org/ Page 3 of 4Jiyeon Hong, et al.",Non-OADS,/arxiv_data1/oa_pdf/df/9e/eht-30-s2015006.PMC4540129.pdf
"http://e-eht.org/ Page 4 of 4Environmental Health and Toxicology    2015;30 Suppl:s2015006 Therefore, in order to establish a level of usage and restriction  of chemicals, there should be a cost-benefit analysis and the re - sults of this analysis are needed to be supported with examples.",Non-OADS,/arxiv_data1/oa_pdf/df/9e/eht-30-s2015006.PMC4540129.pdf
Available from: http://ec.europa.eu/environment/ chemicals/reach/pdf/background/finrep_occ_health.pdf.,Non-OADS,/arxiv_data1/oa_pdf/df/9e/eht-30-s2015006.PMC4540129.pdf
Available from: http://ec.europa.,Non-OADS,/arxiv_data1/oa_pdf/df/9e/eht-30-s2015006.PMC4540129.pdf
"Copyright © 2015 The Korean Society of Environmental Health and Toxicology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Page 1 of 10 http://e-eht.org/ Introduction The number of chemical substances currently in global circu - lation is about 100000, and according to statistics from the Min -istry of Environment, approximately 40000 chemical substances  are used in the Republic of Korea (hereafter Korea).",Non-OADS,/arxiv_data1/oa_pdf/52/b6/eht-30-s2015007.PMC4540130.pdf
"Moreover,  over 90% of the nearly 400 new chemical substances that are in - troduced each year, are distributed without the necessary infor -Assessment of quantitative structure-activity  relationship of toxicity prediction models for  Korean chemical substance control legislation Kwang-Y on Kim1, Seong Eun Shin1, Kyoung T ai No1,2  1Materials Design T eam, Bioinformatics and Molecular Design Research Center, Seoul; 2Computational Systems Biology  Laboratory, Department of Bioengineering, Yonsei University, Seoul, Korea• Original ArticleOpen Access Environmental Health and Toxicology Volume: 30 Suppl, Article ID: s2015007, 10 pages http://dx.doi.org/10.5620/eht.s2015007 eISSN: 2233-6567  Objectives  For successful adoption of legislation controlling registration and assess - ment of chemical substances, it is important to obtain sufficient toxicological experi - mental evidence and other related information.",Non-OADS,/arxiv_data1/oa_pdf/52/b6/eht-30-s2015007.PMC4540130.pdf
"Published online:  June 12, 2015 This article is available from: http://e-eht.org/",Non-OADS,/arxiv_data1/oa_pdf/52/b6/eht-30-s2015007.PMC4540130.pdf
http://e-eht.org/ Page 2 of 10Environmental Health and Toxicology    2015;30 Suppl:s2015007 mation about their harmfulness [1].,Non-OADS,/arxiv_data1/oa_pdf/52/b6/eht-30-s2015007.PMC4540130.pdf
"http://e-eht.org/ Page 3 of 10Kwang-Yon Kim, et al.",Non-OADS,/arxiv_data1/oa_pdf/52/b6/eht-30-s2015007.PMC4540130.pdf
http://e-eht.org/ Page 4 of 10Environmental Health and Toxicology    2015;30 Suppl:s2015007Table 1.,Non-OADS,/arxiv_data1/oa_pdf/52/b6/eht-30-s2015007.PMC4540130.pdf
"http://e-eht.org/ Page 5 of 10Kwang-Yon Kim, et al.",Non-OADS,/arxiv_data1/oa_pdf/52/b6/eht-30-s2015007.PMC4540130.pdf
"http://e-eht.org/ Page 6 of 10Environmental Health and Toxicology    2015;30 Suppl:s2015007 non-testing methods assessed for REACH substances (AN - TARES) project of the EU, efforts were made to develop criteria  for the quantitative evaluation of the QSAR models, and a self- contained scoring system was presented [20].",Non-OADS,/arxiv_data1/oa_pdf/52/b6/eht-30-s2015007.PMC4540130.pdf
"http://e-eht.org/ Page 7 of 10Kwang-Yon Kim, et al.",Non-OADS,/arxiv_data1/oa_pdf/52/b6/eht-30-s2015007.PMC4540130.pdf
http://e-eht.org/ Page 8 of 10Environmental Health and Toxicology    2015;30 Suppl:s2015007 Table 5.,Non-OADS,/arxiv_data1/oa_pdf/52/b6/eht-30-s2015007.PMC4540130.pdf
"http://e-eht.org/ Page 9 of 10Kwang-Yon Kim, et al.",Non-OADS,/arxiv_data1/oa_pdf/52/b6/eht-30-s2015007.PMC4540130.pdf
Avaliable from: http://www.reach.me.go.kr/board/ boardDownload.asp?id=2907&fn=1 (Korean).,Non-OADS,/arxiv_data1/oa_pdf/52/b6/eht-30-s2015007.PMC4540130.pdf
Available from: http://echa.europa.eu/documents/  10162/13632/registration_en.pdf.,Non-OADS,/arxiv_data1/oa_pdf/52/b6/eht-30-s2015007.PMC4540130.pdf
Avail - able from: http://www.law.go.kr/lsInfoP .do?lsiSeq=140402#0000  (Korean).,Non-OADS,/arxiv_data1/oa_pdf/52/b6/eht-30-s2015007.PMC4540130.pdf
Available from: http://www.prism.go.kr/homepage/re - searchCommon/retrieveResearchDetailPopup.do;jsessionid=53B4 7AF8E1BB6B007845C668E9DAF279.node02?research_ id=1480000-200700151 (Korean).,OADS,/arxiv_data1/oa_pdf/52/b6/eht-30-s2015007.PMC4540130.pdf
http://e-eht.org/ Page 10 of 10Environmental Health and Toxicology    2015;30 Suppl:s2015007 5.,Non-OADS,/arxiv_data1/oa_pdf/52/b6/eht-30-s2015007.PMC4540130.pdf
Avail - able from: http://www.epa.gov/oppt/exposure/pubs/episuite.,OADS,/arxiv_data1/oa_pdf/52/b6/eht-30-s2015007.PMC4540130.pdf
Available from: http://www.vega-qsar.eu.,Non-OADS,/arxiv_data1/oa_pdf/52/b6/eht-30-s2015007.PMC4540130.pdf
Available from:  http://www.epa.gov/nrmrl/std/qsar/qsar.html.,OADS,/arxiv_data1/oa_pdf/52/b6/eht-30-s2015007.PMC4540130.pdf
Available from: https://eurl-ecvam.jrc.ec.europa.eu/ laboratories-research/predictive_toxicology/qsar_tools/toxtree.,Non-OADS,/arxiv_data1/oa_pdf/52/b6/eht-30-s2015007.PMC4540130.pdf
Avail - able from: http://www.antares-life.eu/files/ANTARES_D2.pdf.,Non-OADS,/arxiv_data1/oa_pdf/52/b6/eht-30-s2015007.PMC4540130.pdf
"Copyright © 2015 The Korean Society of Environmental Health and Toxicology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Page 1 of 11 http://e-eht.org/ Introduction Rapid advancements in the chemical industry have helped in  maintaining the high quality of life of the modern society.",Non-OADS,/arxiv_data1/oa_pdf/37/c0/eht-30-s2015002.PMC4540131.pdf
"They presented 12 principles of green  chemistry [1]: minimizing waste generation, maximizing syn - thetic production efficacy, using less hazardous chemical syn - thesis methods, using low-toxicity chemical product design,  minimizing the use of auxiliary substances such as solvents,  minimizing energy consumption, maximizing the use of renew - able raw material, minimizing the use of derivatives, using cata - lysts with high selectivity, designing products degradable into  innocuous materials at the end of their function, preventing the Research on the development of green chemistry  technology assessment techniques: a material  reutilization case Seokpyo Hong, Kilsoo Ahn, Sungjune Kim, Sungyong Gong Department of Environmental Economy and Policy Research, Korea Environment Institute, Sejong, Korea• Original ArticleOpen Access Environmental Health and Toxicology Volume: 30 Suppl, Article ID: s2015002, 11 pages http://dx.doi.org/10.5620/eht.e2015002 eISSN: 2233-6567  Objectives  This study presents a methodology that enables a quantitative assessment  of green chemistry technologies.",Non-OADS,/arxiv_data1/oa_pdf/37/c0/eht-30-s2015002.PMC4540131.pdf
"Keywords  Degree of green assessment, Economics assessment, Environmental assess - ment, Exhaustion of resources assessment, Green chemistry technology assessment  techniquesCorrespondence:  Sungyong Gong  370 Sicheong-daero, Sejong 339-007, Korea Tel: +82-44-415-7618 Fax: +82-44-415-7764 E-mail: sgong@kei.re.kr Received:   January 8, 2015 Accepted:  April 13, 2015 Published online:  June 12, 2015 This article is available from: http://e-eht.org/",Non-OADS,/arxiv_data1/oa_pdf/37/c0/eht-30-s2015002.PMC4540131.pdf
"http://e-eht.org/ Page 2 of 11Environmental Health and Toxicology    2015;30 Suppl:s2015002 formation of hazardous substances through real-time monitor - ing, and selecting materials with low risk for accidents.",Non-OADS,/arxiv_data1/oa_pdf/37/c0/eht-30-s2015002.PMC4540131.pdf
"http://e-eht.org/ Page 3 of 11Seokpyo Hong, et al.",Non-OADS,/arxiv_data1/oa_pdf/37/c0/eht-30-s2015002.PMC4540131.pdf
http://e-eht.org/ Page 4 of 11Environmental Health and Toxicology    2015;30 Suppl:s2015002 waste acid from the pickling process of electronic parts.,Non-OADS,/arxiv_data1/oa_pdf/37/c0/eht-30-s2015002.PMC4540131.pdf
"http://e-eht.org/ Page 5 of 11Seokpyo Hong, et al.",Non-OADS,/arxiv_data1/oa_pdf/37/c0/eht-30-s2015002.PMC4540131.pdf
http://e-eht.org/ Page 6 of 11Environmental Health and Toxicology    2015;30 Suppl:s2015002 spective material safety data sheets (R-Phase: EU Directive  67/548/EEC; PEL: OSHA; EC 50: EPA).,Non-OADS,/arxiv_data1/oa_pdf/37/c0/eht-30-s2015002.PMC4540131.pdf
Available from: https://www.osha.gov.,Non-OADS,/arxiv_data1/oa_pdf/37/c0/eht-30-s2015002.PMC4540131.pdf
Available from: https://osha.euro - pa.eu/en/legislation/directives/exposure-to-chemical-agents-and- chemical-safety/osh-related-aspects/58.,Non-OADS,/arxiv_data1/oa_pdf/37/c0/eht-30-s2015002.PMC4540131.pdf
"http://e-eht.org/ Page 7 of 11Seokpyo Hong, et al.",Non-OADS,/arxiv_data1/oa_pdf/37/c0/eht-30-s2015002.PMC4540131.pdf
"http://e-eht.org/ Page 8 of 11Environmental Health and Toxicology    2015;30 Suppl:s2015002 IRIS category Description Reference scale Group A Human carcinogen 7 Group B Probable human carcinogen 7 Group B1 Indicative of a limited causal relationship in epidemiological research 7 Group B2 Indicative of a sufficient causal relationship in animals, with little or no human data 7 Group C Possible human carcinogen 7 Group D Not classifiable as to human carcinogen 6 Group E Evidence of non-carcinogen for human 4Table S2.",Non-OADS,/arxiv_data1/oa_pdf/37/c0/eht-30-s2015002.PMC4540131.pdf
"http://e-eht.org/ Page 9 of 11Seokpyo Hong, et al.",Non-OADS,/arxiv_data1/oa_pdf/37/c0/eht-30-s2015002.PMC4540131.pdf
"http://e-eht.org/ Page 10 of 11Environmental Health and Toxicology    2015;30 Suppl:s2015002 Index Proxy variable Related data Environment GHG Hazardous substancesGHG emissions IRIS category PEL R-Phrase EC50- kg-CO 2 conversion - IRIS (US EPA) - PEL (OSHA) - EU Directive 67/548/EEC - EC 50 (US EPA_ECOTOX) Safety Risk for explosion/fire R-Phrase - EU Directive 67/548/EEC Resource Depleting resource Resource consumption - Material balance (GHG, metal) Economy Production cost/retail price Market share Production cost Retail price- Production cost: actual or estimated - Retail price: actual or estimated GHG, greenhouse gas; IRIS, Integrated Risk Information System; EPA, Environmental Protection Agency; PEL, permissible exposure limit; OSHA, Occupational Safety  and Health Administration; EU, European Union; EC50, median effective concentration; R-Phrase, risk phrase.Table S4.",Non-OADS,/arxiv_data1/oa_pdf/37/c0/eht-30-s2015002.PMC4540131.pdf
"http://e-eht.org/ Page 11 of 11Seokpyo Hong, et al.",Non-OADS,/arxiv_data1/oa_pdf/37/c0/eht-30-s2015002.PMC4540131.pdf
"Copyright © 2015 The Korean Society of Environmental Health and Toxicology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Page 1 of 5 http://e-eht.org/ Introduction  Perfluorooctane sulfonic acid (PFOS, C 8F17SO 3H), a perfluo - rinated compound, is a synthetic material.",Non-OADS,/arxiv_data1/oa_pdf/0f/de/eht-30-s2015008.PMC4540132.pdf
"The 3M company voluntarily stopped PFOS production in Study on the biodegradation of alternatives   (four species including C 8H8F9KO 3S) for  perfluorooctane sulfonate  Bong-In Choi1, Suk-Hyun Na2, Y eong-Don Kwak1, Byung-T aek Ryu1, Seon-Y ong Chung2 1Environmental Safety Center, Korea Environmental Corporation, Incheon; 2Department of Environment and Energy  Engineering, Chonnam National University College of Engineering, Gwangju, Korea• Original ArticleOpen Access Environmental Health and Toxicology Volume: 30 Suppl, Article ID: s2015008, 5 pages http://dx.doi.org/10.5620/eht.s2015008 eISSN: 2233-6567  Objectives  The objective of this study was to evaluate the biodegradation potential of  four perfluorooctane sulfonic acid (PFOS) alternatives that were developed at Chang - won National University.",Non-OADS,/arxiv_data1/oa_pdf/0f/de/eht-30-s2015008.PMC4540132.pdf
"Keywords  Biodegradation, Green chemistry technology, Perfluorooctane sulfonic acid Correspondence:  Seon-Yong Chung  77 Yongbong-ro, Buk-gu, Gwangju 500-757,  Korea Tel: +82-62-530-1858 Fax: +82-62-530-0742 E-mail: sychung@jnu.ac.kr Received:  January 8, 2015 Accepted:  March 19, 2015 Published online:  June 12, 2015 This article is available from: http://e-eht.org/",Non-OADS,/arxiv_data1/oa_pdf/0f/de/eht-30-s2015008.PMC4540132.pdf
"http://e-eht.org/ Page 2 of 5Environmental Health and Toxicology    2015;30 Suppl:s2015008 2002 and began developing alternatives such as perfluorobutane  sulfonate with a reduced number of carbon chains; but they have  not yet succeeded in developing a substance that can completely  replace PFOS to date (UNEP/POPS/POPRC.6/Add.3/Rev.1,  2011.10.14).",Non-OADS,/arxiv_data1/oa_pdf/0f/de/eht-30-s2015008.PMC4540132.pdf
"http://e-eht.org/ Page 3 of 5Bong-In Choi, et al.",Non-OADS,/arxiv_data1/oa_pdf/0f/de/eht-30-s2015008.PMC4540132.pdf
"http://e-eht.org/ Page 4 of 5Environmental Health and Toxicology    2015;30 Suppl:s2015008 For three PFOS alternatives (bottle 7 with C 10H8F13KO 3S, bot - tle 8 with C 8H8F9KO 3S, and bottle 9 with C 6H8F5KO 3S) that  were confirmed to undergo biodegration, the degrading microor - ganisms were separated and subjected to sequencing analyses.",Non-OADS,/arxiv_data1/oa_pdf/0f/de/eht-30-s2015008.PMC4540132.pdf
"http://e-eht.org/ Page 5 of 5Bong-In Choi, et al.",Non-OADS,/arxiv_data1/oa_pdf/0f/de/eht-30-s2015008.PMC4540132.pdf
"Copyright © 2015 The Korean Society of Environmental Health and Toxicology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Page 1 of 1 http://e-eht.org/ We are pleased to publish this supplementary issue of Environ - mental Health and T oxicology , where we have eight articles relat - ed to the research achievement of the “Research group of green  chemistry management technology.",Non-OADS,/arxiv_data1/oa_pdf/a2/5e/eht-30-s2015009.PMC4540133.pdf
"Mina Ha  Editor-in-Chief  Environmental Health and T oxicology  Department of Preventive Medicine, Dankook University  College of Medicine, Cheonan, Korea Green chemistry management technology in  Korea• EditorialOpen Access Environmental Health and Toxicology Volume: 30 Suppl, Article ID: s2015009, 1 page http://dx.doi.org/10.5620/eht.s2015009 eISSN: 2233-6567",Non-OADS,/arxiv_data1/oa_pdf/a2/5e/eht-30-s2015009.PMC4540133.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/60/d8/ijgm-8-255.PMC4540134.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of General Medicine 2015:8 255–260International Journal of General Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  255OrIGInal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJGM.S8742 9acute metabolic response to fasted and  postprandial exercise Filipe Dinato de lima1,2 ana luiza Matias correia1 Denilson da silva T eixeira2 Domingos Vasco da silva  neto2 Ítalo sávio Gonçalves  Fernandes2 Mário Boratto Xavier Viana2 Mateus Petitto2 rodney antônio da silva  sampaio2 sandro nobre chaves2 simone T eixeira alves2 renata aparecida elias  Dantas2 Márcio rabelo Mota2 1University of Brasília, Brasília, DF ,   Brazil; 2Universitary center of Brasília  (UniceUB), Brasília, DF , Brazil correspondence: Filipe Dinato de lima   Universitary center of Brasília  (UniceUB), sePn 707/907, asa norte,  70790-075, Brasília, Brazil   Tel +55 61 8435 5610   email fdinatolima@gmail.co mAbstract:  The aim of this study was to analyze the acute metabolic response to exercise in fast - ing and postprandial.",Non-OADS,/arxiv_data1/oa_pdf/60/d8/ijgm-8-255.PMC4540134.pdf
"International Journal of General Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-general-medicine-journa lThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal  medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat - ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/60/d8/ijgm-8-255.PMC4540134.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/60/d8/ijgm-8-255.PMC4540134.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/be/57/ott-8-2111.PMC4540135.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 2111–2120OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2111Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S8513 0CAG repeat polymorphisms in the androgen  receptor and breast cancer risk in women:  a meta-analysis of 17 studies Qixing Mao1–3,* Mantang Qiu1–3,* Gaochao Dong3 wenjie Xia1–3 Shuai Zhang1,3 Y outao Xu1,3 Jie wang3 Yin Rong1,3 Lin Xu1,3 Feng Jiang1,3  1Department of Thoracic Surgery,   Nanjing Medical University Affiliated  Cancer institute of Jiangsu Province,   2Fourth Clinical College of Nanjing  Medical University, 3Jiangsu Key  Laboratory of Molecular and  Translational Cancer Research,   Nanjing, People’s Republic of China  *These authors contributed equally  to this workAbstract:  The association between polymorphic CAG repeats in the androgen receptor gene in  women and breast cancer susceptibility has been studied extensively.",Non-OADS,/arxiv_data1/oa_pdf/be/57/ott-8-2111.PMC4540135.pdf
"Alleles with long repeat lengths have been associated with  decreased efficacy of androgenic activity, and this decreased activity will inhibit androgen  signaling, which inhibits breast carcinogenesis by limiting the proliferation of breast cancer  cells.4 This finding is consistent with in vitro studies, which have shown that androgen  inhibits breast epithelial cell proliferation.5,6 Furthermore, recent investigations have Correspondence: Lin Xu; Feng Jiang  Department of Thoracic Surgery, Nanjing  Medical University Affiliated Cancer  institute of Jiangsu Province, Baiziting  42, Nanjing 210009, People’s Republic  of China Tel +86 25 8328 4700 Fax +86 25 8364 1062 email xulin83cn@gmail.co m;   zengnljf@hotmail.co m Journal name: OncoTargets and Therapy Article Designation: Review Y ear: 2015 Volume: 8 Running head verso: Mao et al Running head recto: CAG repeat polymorphisms in the AR and breast cancer risk DOI: http://dx.doi.org/10.2147/OTT.S85130",Non-OADS,/arxiv_data1/oa_pdf/be/57/ott-8-2111.PMC4540135.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/be/57/ott-8-2111.PMC4540135.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/be/57/ott-8-2111.PMC4540135.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a4/84/ijgm-8-247.PMC4540136.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of General Medicine 2015:8 247–254International Journal of General Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  247OrIGInal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJGM.S8547 3health behaviors and quality of life predictors   for risk of hospitalization in an electronic   health record-linked biobank Paul Y Takahashi1,2 euijung ryu3 Janet e Olson3 erin M Winkler4 Matthew a hathcock3 ruchi Gupta3 Jeff a sloan3 Jyotishman Pathak3 suzette J Bielinski3 James r cerhan3 1Division of Primary care Internal  Medicine,  2Department of Internal  Medicine,  3Department of health  sciences research,  4center for  Individualized Medicine, Mayo   clinic, rochester, M n, Usa correspondence: Paul Y Takahashi   Division of Primary care Internal  Medicine, Mayo clinic,  200 First street  sW, rochester, Mn  55905, Usa   Tel +1 507 284 2511  Fax +1 507 266 0036  email takahashi.paul@mayo.ed uBackground:  Hospital risk stratification models using electronic health records (EHRs) often  use age and comorbid health burden.",Non-OADS,/arxiv_data1/oa_pdf/a4/84/ijgm-8-247.PMC4540136.pdf
The biobank ques - tionnaires are available online ( http://www.mayo.edu/research/ documents/biobank-questionnaire/doc-2008643 0).,OADS,/arxiv_data1/oa_pdf/a4/84/ijgm-8-247.PMC4540136.pdf
"All analysis  was conducted using R software ( http://cran.us.r-project.org /)  including R library gbm for GBM modeling.22 Results On December  31, 2010, there were  16,631 people enrolled  in the MCB, of which  8,927 (54%) were also enrolled within",OADS,/arxiv_data1/oa_pdf/a4/84/ijgm-8-247.PMC4540136.pdf
"Available from: http://cran.us.r- project.or g. Accessed August  20, 2014.",Non-OADS,/arxiv_data1/oa_pdf/a4/84/ijgm-8-247.PMC4540136.pdf
